0001640334-23-000658.txt : 20230417 0001640334-23-000658.hdr.sgml : 20230417 20230417064748 ACCESSION NUMBER: 0001640334-23-000658 CONFORMED SUBMISSION TYPE: 10-K PUBLIC DOCUMENT COUNT: 80 CONFORMED PERIOD OF REPORT: 20221231 FILED AS OF DATE: 20230417 DATE AS OF CHANGE: 20230417 FILER: COMPANY DATA: COMPANY CONFORMED NAME: IGEN NETWORKS CORP CENTRAL INDEX KEY: 0001393540 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-HELP SUPPLY SERVICES [7363] IRS NUMBER: 205879021 STATE OF INCORPORATION: NV FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-K SEC ACT: 1934 Act SEC FILE NUMBER: 000-55289 FILM NUMBER: 23822777 BUSINESS ADDRESS: STREET 1: 28375 ROSTRATA AVE CITY: LAKE ELSINORE STATE: CA ZIP: 92532 BUSINESS PHONE: 855-912-5378 MAIL ADDRESS: STREET 1: 28375 ROSTRATA AVE CITY: LAKE ELSINORE STATE: CA ZIP: 92532 FORMER COMPANY: FORMER CONFORMED NAME: SYNC2 ENTERTAINMENT CORP. DATE OF NAME CHANGE: 20081009 FORMER COMPANY: FORMER CONFORMED NAME: NURSE SOLUTIONS, INC. DATE OF NAME CHANGE: 20070316 10-K 1 igen_10k.htm FORM 10-K igen_10k.htm

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D. C. 20549

 

FORM 10-K

 

ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

FOR THE FISCAL YEAR ENDED DECEMBER 31, 2022.

 

 TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

FOR THE TRANSITION PERIOD FROM ______ TO ______.

 

Commission File No. 333-141875

 

IGEN Networks Corp.

(Exact name of registrant as specified in its charter)

 

Nevada

 

20-5879021

(State or Other Jurisdiction of incorporation or organization)

 

(I.R.S. Employer Identification No.)

 

31772 Casino Drive, Suite C. Lake Elsinore, CA 92530 

(Address of principal executive offices) (Zip Code) 

 

1-855-912-5378

(Registrant’s telephone number including area code) 

 

Securities registered pursuant to Section 12(b) of the Act: None

 

Securities registered pursuant to Section 12(g) of the Act:

 

Common Stock

Title of Class

 

Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Yes ☐ No

 

Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act. Yes ☐ No

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days: Yes ☒ No ☐

 

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes ☒ No ☐

 

Indicate by check mark if disclosure of delinquent filers pursuant to Item 405 of Regulation S-K (§ 229.405 of this chapter) is not contained herein, and will not be contained, to the best of registrant’s knowledge, in definitive proxy or information statements incorporated by reference in Part III of this Form 10-K or any amendment to this Form 10-K. ☒

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

 

Large accelerated filer

Accelerated filer

Non-accelerated Filer

Smaller reporting company

 

 

Emerging growth company

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act). Yes No ☒

 

The aggregate market value of the Common Stock of IGEN Networks Corp. held by non-affiliates as of June 30, 2022, the last business day of the registrant’s most recently completed second fiscal quarter, was approximately $4,452,725 based on the closing price of the common stock of $0.003.

 

The number of shares of the registrant’s common stock outstanding as of March 15, 2023 was 2,007,815,097.

 

 

 

 

TABLE OF CONTENTS

 

 

 

 

Page

 

PART I

 

 

 

 

 

 

 

 

 

ITEM 1.

BUSINESS

 

3

 

ITEM 1A.

RISK FACTORS

 

4

 

ITEM 1B.

UNRESOLVED STAFF COMMENTS

 

4

 

ITEM 2.

PROPERTIES

 

4

 

ITEM 3.

LEGAL PROCEEDINGS

 

4

 

ITEM 4.

MINE SAFETY DISCLOSURES

 

4

 

 

 

 

 

 

PART II

 

 

 

 

 

 

 

 

 

ITEM 5.

MARKET FOR REGISTRANT’S COMMON EQUITY, RELATED STOCKHOLDER MATTERS AND ISSUER PURCHASES OF EQUITY SECURITIES

 

5

 

ITEM 6.

SELECTED FINANCIAL DATA

 

5

 

ITEM 7.

MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

 

5

 

ITEM 7A.

QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

 

10

 

ITEM 8.

FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA

 

11

 

ITEM 9.

CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING AND FINANCIAL DISCLOSURE

 

34

 

ITEM 9A.

CONTROLS AND PROCEDURES

 

34

 

ITEM 9B.

OTHER INFORMATION

 

34

 

 

 

 

 

 

PART III

 

 

 

 

 

 

 

 

 

ITEM 10.

DIRECTORS, EXECUTIVE OFFICERS AND CORPORATE GOVERNANCE

 

35

 

ITEM 11.

EXECUTIVE COMPENSATION

 

36

 

ITEM 12.

SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND RELATED STOCKHOLDER MATTERS

 

37

 

ITEM 13.

CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS, AND DIRECTOR INDEPENDENCE

 

39

 

ITEM 14.

PRINCIPAL ACCOUNTING FEES AND SERVICES

 

39

 

 

 

 

 

 

PART IV

 

 

 

 

 

 

 

 

 

ITEM 15.

EXHIBITS, FINANCIAL STATEMENT SCHEDULES

 

40

 

 

 

 

 

 

 

SIGNATURES

 

41

 

 

 
2

Table of Contents

  

Part I

 

Item 1. Business

 

Description of Business

 

IGEN Networks Corp. (“IGEN”, the “Company”, “we”, “our”) was incorporated in the State of Nevada on November 14, 2006, under the name of Nurse Solutions Inc. On September 19, 2008, the Company changed its name to Sync2 Entertainment Corporation and traded under the symbol SYTO. On September 15, 2008, the Company became a reporting issuer in British Columbia, Canada. On May 26, 2009, the Company changed its name to IGEN Networks Corp. On March 25, 2015, the Company was listed on the Canadian Securities Exchange (CSE) under the trading symbol IGN and the Company became a reporting Venture Issuer in British Columbia and Ontario, Canada.

 

The Company’s principal business is the development and marketing of software services for the automotive and fleet management industry. The Company works with wireless carriers and distribution partners to provide direct and secure access to information on vehicle assets and driver behavior. The software services are based on AWS Cloud infrastructure created to provide valuable information to its customers over the wireless network and accessible from internet connected devices. The software services are marketed through automotive dealers, financial institutions, and government channels as distinct commercial and consumer brands that include Nimbo Tracking, CU Trak, Medallion GPS and most recently “FamilyShield” sold direct to consumers.

 

The Company’s head office is located at 31772 Casino Drive, Suite C. Lake Elsinore, CA 92530. Direct line is 855-912-5378.

 

The Company owns the DTC Patent No. 11,037,378 issued from the U.S. Patent Office as of June 15, 2021 for normalization of driver behavior data for consistent and accurate measurement of driver performance regardless of asset-type or data source. The Company also owns Patent-Pending No.17/850,258 filed on June 27, 2022. The Company has secured trademarks and distribution licenses through increased ownership of privately held technology companies.

 

The Company is not aware of any government approval or regulations, other than those governing the normal course of business, which will affect its own business. However, the Company is invested in and foresees future investment in, or possible joint ventures with, companies for which local, regional or national regulatory approvals, particularly those pertaining to wireless networks or GPS-based applications, may apply.

 

The Company is not aware of any significant costs or effects of compliance with environmental laws.

 

 
3

Table of Contents

  

The Company’s executive management activities are undertaken by Directors of the Company on a contract basis. The Company also relies on subcontractors for product development, finance, legal, and other related professional services. On a consolidated basis, including the Company’s wholly-owned subsidiaries, the Company has 10 or less full time employees.

 

Item 1A. Risk Factors

 

For a discussion of risk factors affecting the Company please refer to the Cautionary Note Regarding Forward-looking Statements included in Item 7 Management’s Discussion and Analysis of Financial Condition and Results of Operations.

 

Item 1B. Unresolved Staff Comments

 

As a smaller reporting company, the Company is not required to provide the information required by this item.

 

Item 2. Properties

 

The Company owns no plants, mines and other materially important physical properties. The Company’s office locations are specified in Item 1 of this document.

 

Item 3. Legal Proceedings

 

The Company currently does not have any open legal proceedings.

 

Item 4. Mine Safety Disclosures

 

The Company is not an operator, nor has a subsidiary that is an operator, of a coal or other mine.

 

 
4

Table of Contents

  

Part II

 

Item 5. Market for Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities.

 

Market Information

 

The Company’s common shares currently trade on the both the OTC Link OTCQB in the United States under the symbol IGEN, and the Canadian Securities Exchange (CSE) in Canada under the trading symbol IGN.

 

Holders

 

As of December 31, 2022, there were 150 registered shareholders of common shares, not including objecting beneficial owners.

 

Dividend Policy

 

The Company has paid no cash dividends in the past and as of yet has had no retained earnings from which to do so.

 

Item 6. Selected Financial Data

 

As a smaller reporting company, the Company is not required to provide the information required by this item.

 

Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations.

 

The following Management’s Discussion and Analysis of Financial Condition and Results of Operations (“MD&A”) provides information for the year ended December 31, 2022. This MD&A should be read together with our audited consolidated financial statements and the accompanying notes for the year ended December 31, 2022 (the “consolidated financial statements”). The consolidated financial statements have been prepared in accordance with generally accepted accounting principles in the United States (“U.S. GAAP”). Except where otherwise specifically indicated, all amounts in this MD&A are expressed in United States dollars.

 

Certain statements in this MD&A constitute forward-looking statements or forward-looking information within the meaning of applicable securities laws. You should carefully read the cautionary note in this MD&A regarding forward-looking statements and should not place undue reliance on any such forward-looking statements. See “Cautionary Note Regarding Forward-Looking Statements”.

 

Additional information about the Company, including our most recent consolidated financial statements and our Annual Information Form, is available on our website at www.igen-networks.com, or on SEDAR at www.sedar.com and on EDGAR at www.sec.gov .

 

Cautionary Note Regarding Forward-looking Statements

 

Certain statements and information in this MD&A are not based on historical facts and constitute forward- looking statements or forward-looking information within the meaning of the U.S. Private Securities Litigation Reform Act of 1995 and Canadian securities laws (“forward-looking statements”), including our business outlook for the short and longer term and our strategy, plans and future operating performance. Forward-looking statements are provided to help you understand our views of our short and longer term prospects. We caution you that forward-looking statements may not be appropriate for other purposes. We will not update or revise our forward-looking statements unless we are required to do so by securities laws. Forward-looking statements:

 

 

·

Typically include words and phrases about the future such as “outlook”, “may”, “estimates”, “intends”, “believes”, “plans”, “anticipates” and “expects”;

 

 

 

 

·

Are not promises or guarantees of future performance. They represent our current views and may change significantly;

 

 

 

 

·

Are based on a number of assumptions, including those listed below, which could prove to be significantly incorrect:

 

 
5

Table of Contents

 

 

 

 

·

Our ability to find viable companies in which to invest;

 

 

 

 

·

Our ability to successfully manage companies in which we invest;

 

 

 

 

·

Our ability to successfully raise capital;

 

 

 

 

·

Our ability to successfully expand and leverage the distribution channels of our portfolio companies;

 

 

 

 

·

Our ability to develop new distribution partnerships and channels;

 

 

 

 

·

Expected tax rates and foreign exchange rates.

 

 

·

Are subject to substantial known and unknown material risks and uncertainties. Many factors could cause our actual results, achievements and developments in our business to differ significantly from those expressed or implied by our forward-looking statements. Actual revenues and growth projections of the Company or companies in which we are invested may be lower than we expect for any reason, including, without limitation:

 

 

·

the continuing uncertain economic conditions;

 

 

 

 

·

price and product competition;

 

 

 

 

·

changing product mixes;

 

 

 

 

·

the loss of any significant customers;

 

 

 

 

·

competition from new or established companies;

 

 

 

 

·

higher than expected product, service, or operating costs;

 

 

 

 

·

inability to leverage intellectual property rights;

 

 

 

 

·

delayed product or service introductions;

 

Investors are cautioned not to place undue reliance on these forward-looking statements. No forward-looking statement is a guarantee of future results.

 

Overview

 

During fiscal-year 2022, the Company’s automotive dealership channels faced significant supply-chain issues that reduced available inventory and diminished profit margins. Despite these challenges IGEN continued to make progress with creating new opportunities and products in 2022. The Company moved into new offices located in Lake Elsinore in anticipation of significant growth post 2022 challenges. Creating new channels and partnerships in 2022 were key initiatives to secure longer term market share with both our consumer and commercial customers. Product and software innovation was our priority with the recent launch of our Next-Generation Platform and Medallion GPS created for Light-to-Heavy Commercial Fleets, both developed with IGEN’s patented Driver Signature and Behavior algorithms.

 

For the year ended December 31, 2022, the Company recognized revenues of $318,016 with a gross loss of (1)% and $(4,550) gross loss. Expenses for the year ended December 31, 2022, totaled $864,970, a decrease of $2,708,313, or 76%, from total expenses reported for 2021. Excluding stock-based compensation expense to our directors, operational expenses decreased by 16% year on year.

 

For the year ended December 31, 2022, the Company saw a net decrease in cash of $64,429. Cash used in operating activities was $978,056, an increase in cash used of 2% from the $962,960 net cash used in 2021. This was offset by net financings of $543,746 raised via private placements. Cash at the end of the year was $0.

 

Notable highlights of the year ended December 31, 2022 include the following Company achievements:

 

I)

IGEN established a partnership with Prolog with the integration of technology platforms to better serve the US Government markets

IGEN launches Medallion GPS PRO for Medium-to-Heavy Duty Commercial Fleets

 

 

ii)

IGEN announces an exclusive marketing agreement with the Association of Credit Unions Executives of Puerto Rico

 

 

iii)

IGEN files Patent-Pending Application for creating real-time driver Telematic Signatures for autonomous vehicles

 

 

iv)

IGEN receives patent acceptance for its Digital Telematics Signature (DTC) patent for greater accuracy in measuring driver performance

 

 

v)

IGEN is awarded a contract to provide Fleet Management Services to all New-York State Counties

 

 

vi)

IGEN reports a net income and profit for the June 30, 2022 reporting period

 

 

 

 
6

Table of Contents

 

CRITICAL ACCOUNTING POLICIES AND SIGNIFICANT JUDGMENTS AND ESTIMATES

 

Our management’s discussion and analysis of our financial condition and results of operations are based on our consolidated financial statements, which have been prepared in accordance with accounting principles generally accepted in the United States (“GAAP”). The preparation of these consolidated financial statements requires us to make estimates and judgments that affect the reported amount of assets, liabilities, and expenses and the disclosure of contingent assets and liabilities as of the date of the consolidated financial statements. On an ongoing basis, we evaluate our estimates and judgments. We base our estimates on historical experience, known trends and events, and various other factors that are believed to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying value of assets and liabilities that are not readily apparent from other sources. Actual results may differ materially from these estimates under different assumptions or conditions.

 

Accounts Receivable

 

Accounts receivable are recognized and carried at the original invoice amount less an allowance for expected uncollectible amounts. Inherent in the assessment of the allowance for doubtful accounts are certain judgments and estimates including, among others, the customer’s willingness or ability to pay, the Company’s compliance with customer invoicing requirements, the effect of general economic conditions and the ongoing relationship with the customer. Accounts with outstanding balances longer than the payment terms are considered past due. We do not charge interest on past due balances. The Company writes off trade receivables when all reasonable collection efforts have been exhausted. Bad debt expense is reflected as a component of general and administrative expenses in the consolidated statements of operations.

 

Goodwill

 

Goodwill represents the excess of the acquisition price over the fair value of identifiable net assets acquired. Goodwill is allocated at the date of the business combination. Goodwill is not amortized, but is tested for impairment annually on December 31 of each year or more frequently if events or changes in circumstances indicate the asset may be impaired. These events and circumstances may include a significant change in legal factors or in the business climate, a significant decline in the Company’s share price, an adverse action of assessment by a regulator, unanticipated competition, a loss of key personnel, significant disposal activity and the testing of recoverability for a significant asset group.

 

Goodwill impairment is measured as the amount by which a reporting unit’s carrying value exceeds its fair value.

 

The Company has only one reporting unit. Therefore, all of the Company’s goodwill relates to that reporting unit, and at December 31, 2022 and 2021, the carrying value for that reporting unit is negative.

 

Fair Value Measurements

 

In accordance with Financial Accounting Standard Board (“FASB”) Accounting Standards Codification (“ASC”) 820, “Fair Value Measurements and Disclosures,” the Company is to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. ASC 820 establishes a fair value hierarchy based on the level of independent, objective evidence surrounding the inputs used to measure fair value. A financial instrument’s categorization within the fair value hierarchy is based upon the lowest level of input that is significant to the fair value measurement. ASC 820 prioritizes the inputs into three levels that may be used to measure fair value:

 

Level 1

 

Level 1 applies to assets or liabilities for which there are quoted prices in active markets for identical assets or liabilities.

 

Level 2

 

Level 2 applies to assets or liabilities for which there are inputs other than quoted prices that are observable for the asset or liability such as quoted prices for similar assets or liabilities in active markets; quoted prices for identical assets or liabilities in markets with insufficient volume or infrequent transactions (less active markets); or model-derived valuations in which significant inputs are observable or can be derived principally from, or corroborated by, observable market data.

 

Level 3

 

Level 3 applies to assets or liabilities for which there are unobservable inputs to the valuation methodology that are significant to the measurement of the fair value of the assets or liabilities.

 

 
7

Table of Contents

 

The fair values of cash and cash equivalents, accounts and other receivables, restricted cash, and accounts payable and accrued liabilities, approximate their carrying values due to the immediate or short-term maturity of these financial instruments. Foreign currency transactions are primarily undertaken in Canadian dollars. The fair value of cash is determined based on “Level 1” inputs and the fair value of derivative liabilities is determined based on “Level 3” inputs. The recorded values of notes payable, approximate their current fair values because of their nature and respective maturity dates or durations. The financial risk is the risk to the Company’s operations that arise from fluctuations in foreign exchange rates and the degree of volatility to these rates. Currently, the Company does not use derivative instruments to reduce its exposure to foreign currency risk. Financial instruments that potentially subject the Company to concentrations of credit risk consists of cash. The Company places its cash and cash equivalents in what it believes to be credit-worthy financial institutions.

 

Revenue Recognition and Deferred Revenue

 

We recognize revenue in accordance with ASC 606, “Revenue from Contracts with Customers”, using the five-step model, including (1) identify the contract with the customer, (2) identify the performance obligations in the contract, (3) determine the transaction price, (4) allocate the transaction price to the performance obligations in the contract, and (5) recognize revenue in accordance with U.S. GAAP. Title and risk of loss generally pass to our customers upon delivery, as we have insurance for lost shipments. In limited circumstances where either title or risk of loss pass upon destination or acceptance or when collection is not reasonably assured, we defer revenue recognition until such events occur. We derive substantially all our revenues from the sale of products and services combined into one performance obligation. Product revenue includes the shipment of product according to the agreement with our customers. Service revenue include vehicle tracking services and customer support (technical support), installations and consulting. A contract usually includes both product and services. For these contracts, the Company accounts for individual performance obligations separately if they are distinct. Performance obligations include, but are not limited to, pass-thru harnesses and vehicle tracking services. Almost all of our revenues are derived from customers located in United States of America in the auto industry. The transaction price is allocated to the separate performance obligations on a relative standalone selling price basis. Standalone selling prices are typically estimated based on observable transactions when these services are not sold on a standalone basis. At contract inception, an assessment of the goods and services promised in the contracts with customers is performed and a performance obligation is identified for each distinct promise to transfer to the customer a good or service (or bundle of goods or services). To identify the performance obligations, the Company considers all of the goods or services promised in the contract regardless of whether they are explicitly stated or are implied by customary business practices. Revenue is recognized when our performance obligation has been met. The Company considers control to have transferred upon delivery because the Company has a present right to payment at that time, the Company has transferred use of the asset, and the customer is able to direct the use of, and obtain substantially all of the remaining benefits from, the asset. For arrangements under which the Company provides vehicle tracking services, the Company satisfies its performance obligations as those services are performed whereby the customer simultaneously receives and consumes the benefits of such services under the agreement. Revenues are recognized net of any taxes collected from customers, which are subsequently remitted to governmental authorities.

 

The Company provides product warranties with varying lengths of time and terms. The product warranties are considered to be assurance-type in nature and do not cover anything beyond ensuring that the product is functioning as intended. Based on the guidance in ASC 606, assurance-type warranties do not represent separate performance obligations. The Company has historically experienced a low rate of product returns under the warranty program.

 

Management assesses the business environment, customers’ financial condition, historical collection experience, accounts receivable aging, and customer disputes to determine whether collectability is reasonably assured. If collectability is not reasonably assured at the time of sale, the Company does not recognize revenue until collection occurs.

 

Revenue relating to the sale of service fees on its vehicle tracking and recovery services is recognized over the life of the contact. The service renewal fees are offered in terms ranging from 12 to 36 months and are generally payable upon delivery of the vehicle tracking devices or in full upon renewal.

 

Deferred revenues are recorded net of contract assets when cash payments are received from customers in advance of the Company’s performance. Contract assets represent the costs of the underlying hardware to enable the Company to perform on its contracts with customers and are amortized using the same method and term as deferred revenues. Any revenue that has been deferred and is expected to be recognized beyond one year is classified as deferred revenue, net of current portion.

 

Financing Costs and Debt Discount

 

Financing costs and debt discounts are recorded net of notes payable and convertible debentures in the consolidated balance sheets. Amortization of financing costs and the debt discounts is calculated using the effective interest method over the term of the debt and is recorded as interest expense in the consolidated statement of operations.

 

Recent Accounting Pronouncements

 

See the notes to the consolidated financial statements of this Form 10-K for further discussion.

 

 
8

Table of Contents

 

Capital Resources and Liquidity

 

Current Assets and Liabilities, Working Capital

 

As of December 31, 2022, the Company had total current assets of $52,043, a 70% decrease from the end of 2021. This decrease was mostly due to a $122,323 decrease in cash, accounts receivable, and inventory, because of the timing of payments to Nimbo from its customers and a decrease in new sales contracts in Q4 2022.

 

The Company’s current liabilities as of December 31, 2022, were $1,186,049, a 9% increase over those reported at the end of the 2021. However, $81,066 (or 7%) of the Company’s current liabilities were deferred revenues, net to be recognized in future periods. The increase in current liabilities was mostly due to a $482,408 increase in notes payable as of December 31, 2022.

 

IGEN ended 2022 with negative working capital of $1,134,006. Adequate working capital remains a core requirement for growth and profitability and to facilitate further acquisitions, and the Company continues to work at improving its working capital position through ongoing equity and debt financing and actively managing the Company’s growth to achieve sustainable positive cash flow.

 

In 2022, the Company raised an additional $1,070,746 in financings and borrowing on notes payable and converted $437,139 of preferred stock into shares of common stock. These transactions are further disclosed in notes to the consolidated financial statements.

 

Total Assets and Liabilities, Net Assets

 

As of December 31, 2022, the Company’s total assets were $616,290, a 19% decrease over the prior year, due primarily to the decrease in current assets previously discussed. The majority of the Company’s assets remain $505,508 in goodwill associated with the acquisition of Nimbo in 2014.

 

As of December 31, 2022, the Company’s total liabilities were $1,455,515, which reflects $81,632 in long-term deferred revenue, net in addition to the $1,186,049 in current liabilities previously discussed. This long-term deferred revenue is the portion of service contracts signed in previous years for which service, and the associated revenue recognition, occurs beyond 2023. Total liabilities increased by 6% over the previous year, however 11%, or $162,698 of the Company’s year-end total liabilities was deferred revenue, net, compared with $145,485 of deferred revenue, net reported at the end of 2021.

 

The above resulted in net assets as of December 31, 2022 being ($839,225) and an accumulated deficit of $20,170,140.

 

The Company is continuing its efforts to increase its asset base, raise funds and improve cashflow to improve its working capital position. As of the date these financial statements were issued, the Company believes it has adequate working capital and projected net revenues and cash flows to maintain existing operations for approximately six months without requiring additional funding. The Company’s business plan is predicated on raising further capital for the purpose of further investment and acquisition of targeted technologies and companies, to fund growth in these technologies and companies, and to expand sales and distribution channels for companies it currently owns or is invested. It is anticipated the Company will continue to raise additional capital through private placements or other means in the both the near and medium term.

 

The reader is cautioned that the Company’s belief in the adequacy of its working capital, the continuation and growth of future revenue, the ability of the Company to operate any stated period without additional funding, and the ability to successfully raise capital are forward looking statements for which actual results may vary, to the extent that the company may need capital earlier than anticipated and/or may not be able to raise additional capital.

 

Results of Operations

 

Revenues and Net Loss

 

Revenues

 

For the year ended December 31, 2022, the Company had revenues of $318,016, an 18% increase over the revenues reported for same period in 2021. Increase in revenue was primarily due to the impact of COVID-19 in 2021 on demand for new vehicles at our customers’ franchise dealerships.

 

Costs of goods sold for 2022 were $322,566, representing an increase of 161% year on year. These costs are primarily mobile hardware and cellular carrier costs.

 

The resulting gross loss was $4,550, representing a decrease of 103% year on year, and gross margins of (1%).

 

Though the Company increased revenues, decreased gross profit, and decreased gross margins year on year, we continue to review hardware vendor, inventory, and order fulfillment strategies as well as product and service pricing models to continually improve overall margins.

 

 
9

Table of Contents

 

Expenses

 

Expenses for the year ended December 31, 2022, totaled $903,048, a decrease of $2,670,235, or 75%, from total expenses reported for 2021. Excluding stock-based compensation expense to our directors, operational expenses increased by 4% year on year.

 

Net Loss

 

For the year ended December 31, 2022, the Company had a net loss of $907,598 (or ($0.00) per basic and diluted share) compared with a net loss of $3,428,937 (or ($0.00) per basic and diluted share) in 2021. Included in the net loss of $907,598, is $301,360 of other income related to the Company’s gain on settlement of debt recognized in 2022.

 

The Company continues to invest in personnel, channels, and product development in order to drive revenue growth and increase gross profits sufficient to enable the Company to achieve profitability.

 

Cash Flows

 

For the year ended December 31, 2022, the Company saw a net decrease in cash of $64,429. Cash used in operating activities was $978,056, an increase in cash used of 2% from the $962,960 net cash used in 2021. This was offset by net financings of $543,746 raised via private placements. Cash at the end of the year was $0.

 

Item 7A. Quantitative and Qualitative Disclosures About Market Risk.

 

As a smaller reporting company, the Company is not required to provide the information required by this item.

 

 
10

Table of Contents

 

Item 8. Financial Statements and Supplementary Data.

 

The Company’s consolidated financial statements for the years ended December 31, 2022 and 2021 are included herewith.

 

 

igen_10kimg7.jpg

 

 

IGEN NETWORKS CORP.

Consolidated Financial Statements

For the Years Ended December 31, 2022 and 2021

 

 
11

Table of Contents

 

 

igen_10kimg17.jpg

 

Report of Independent Registered Public Accounting Firm

 

To the Board of Directors and Shareholders of

IGEN Networks Corp.

 

Opinion on the Financial Statements

 

We have audited the accompanying consolidated balance sheets of IGEN Networks Corp. and subsidiary (the “Company”) as of December 31, 2022 and 2021, the related consolidated statements of operations, redeemable convertible preferred stock and stockholders’ deficit, and cash flows for the two years ended December 31, 2022, and the related notes (collectively referred to as the “financial statements”).

 

In our opinion, the financial statements present fairly, in all material respects, the financial position of the Company as of December 31, 2021, and the results of its operations and its cash flows for the two years ended December 31, 2022 in conformity with accounting principles generally accepted in the United States of America.

 

Going Concern

 

The accompanying financial statements have been prepared assuming that the Company will continue as a going concern. As discussed in Note 1 to the financial statements, the Company has suffered recurring losses and negative cash flows from operations and has a net capital deficiency that raise substantial doubt about its ability to continue as a going concern. Management’s plans in regard to these matters are also described in Note 1. The financial statements do not include any adjustments that might result from the outcome of this uncertainty.

 

Basis for Opinion

 

These financial statements are the responsibility of the Company’s management. Our responsibility is to express an opinion on the Company’s financial statements based on our audits. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (PCAOB) and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.

 

We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement, whether due to error or fraud. The Company is not required to have, nor were we engaged to perform, an audit of its internal control over financial reporting. As part of our audits, we are required to obtain an understanding of internal control over financial reporting, but not for the purpose of expressing an opinion on the effectiveness of the Company’s internal control over financial reporting. Accordingly, we express no such opinion.

 

Our audits included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the financial statements. We believe that our audits provide a reasonable basis for our opinion.

 

Critical Audit Matters

 

The critical audit matter communicated below is a matter arising from the current period audit of the financial statements that were communicated or required to be communicated to the audit committee and that: (1) relate to accounts or disclosures that are material to the financial statements and (2) involved especially challenging, subjective, or complex judgments. The communication of critical audit matters does not alter in any way our opinion on the financial statements, taken as a whole, and we are not, by communicating the critical audit matters below, providing separate opinions on the critical audit matters or on the accounts or disclosures to which they relate.

 

Revenue Recognition

 

Description of the Matter

 

As described in Note 2 to the financial statements, the Company recognizes revenue in accordance with Accounting Standards Codification 606, Revenues from Contracts with Customers (“ASC 606”). In applying ASC 606 to the Company’s customer contracts, there is significant judgement regarding the identification of the performance obligations, and in particular as it relates to whether hardware is a separate performance obligation or part of the performance obligation that relates to tracking services. In addition, there is also judgement as to the period of the time that revenue should be recognized for certain performance obligations, and for certain transactions there is judgement as to whether a single contract is a single contract with two performance obligations or in substance two separate contracts for accounting purposes. These matters require significant judgement and ultimately affect the timing of revenue recognition, and as a result, we identified revenue recognition as a critical audit matter.

 

 
12

Table of Contents

 

How We Addressed the Matter in Our Audit

 

To address the above matters relating to revenue recognition, our audit procedures included reviewing management’s detailed evaluation of the application of ASC 606 as it applies to its various types of customer contracts and verifying that the evaluation properly considered the guidance in ASC 606. Further, our procedures also included reviewing customer contracts, testing the details of a number of transactions, and performing other procedures to verify the appropriateness of the Company’s application of ASC 606.

 

/s/ GreenGrowthCPAs

 

We have served as the Company’s auditor since 2021,

 

April 14, 2023

 

Los Angeles, California

 

PCAOB ID: 6580 

 

 
13

Table of Contents

 

IGEN NETWORKS CORP.

Consolidated Balance Sheets

(Expressed in U.S. dollars)

 

 

 

December 31,

2022

 

 

December 31,

2021

 

 

 

 

 

 

 

 

Assets

 

 

 

 

 

 

 

 

 

 

 

 

 

Current Assets

 

 

 

 

 

 

Cash

 

$-

 

 

$64,429

 

Accounts and other receivables, net

 

 

21,902

 

 

 

38,754

 

Inventory

 

 

30,141

 

 

 

71,183

 

Total Current Assets

 

 

52,043

 

 

 

174,366

 

 

 

 

 

 

 

 

 

 

Deposits

 

 

5,722

 

 

 

5,722

 

Operating lease asset, net

 

 

53,017

 

 

 

76,230

 

Goodwill

 

 

505,508

 

 

 

505,508

 

Total Assets

 

$616,290

 

 

$761,826

 

 

 

 

 

 

 

 

 

 

Liabilities and Stockholders’ Deficit

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Current Liabilities

 

 

 

 

 

 

 

 

Accounts payable and accrued liabilities

 

$360,227

 

 

$678,347

 

Current portion of deferred revenue, net of contract assets

 

 

81,066

 

 

 

65,715

 

Notes payable, current portion

 

 

596,746

 

 

 

114,338

 

Convertible debentures, current portion, net of discount of $0 and $30,586, respectively

 

 

37,000

 

 

 

89,064

 

Derivative liabilities

 

 

111,010

 

 

 

136,902

 

Total Current Liabilities

 

 

1,186,049

 

 

 

1,084,366

 

 

 

 

 

 

 

 

 

 

Notes payable, net of current portion

 

 

160,736

 

 

 

152,147

 

Operating lease liability, net of current portion

 

 

27,098

 

 

 

55,211

 

Deferred revenue, net of contract assets and current portion

 

 

81,632

 

 

 

79,770

 

Total Liabilities

 

 

1,455,515

 

 

 

1,371,494

 

 

 

 

 

 

 

 

 

 

Commitments and Contingencies

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Redeemable convertible preferred stock – Series A:

 

 

 

 

 

 

 

 

Authorized – 1,250,000 shares with $0.001 par value, 214,500 shares and 199,375 shares issued and outstanding as of December 31, 2022 and 2021, respectively, aggregate liquidation preference of $218,222 and $203,463 as of December 31, 2022 and 2021, respectively, and net of discount of $59,954 and $101,317 as of December 31, 2022 and 2021, respectively

 

 

138,429

 

 

 

84,022

 

 

 

 

 

 

 

 

 

 

Stockholders’ Deficit

 

 

 

 

 

 

 

 

Series B preferred stock – Authorized – 5,000,000 shares with $0.001 par value, issued and outstanding – 3,750,000 and 5,000,000 shares, as of December 31, 2022 and 2021, respectively

 

 

3,750

 

 

 

5,000

 

Common stock: Authorized – 2,190,000,000 shares with $0.001 par value issued and outstanding – 1,890,261,047 and 1,476,869,532 shares as of December 31, 2022 and 2021, respectively

 

 

1,890,262

 

 

 

1,476,870

 

Additional paid-in capital

 

 

17,298,474

 

 

 

16,900,962

 

Accumulated deficit

 

 

(20,170,140 )

 

 

(19,076,522 )

Total Stockholders’ Deficit

 

 

(977,654 )

 

 

(693,690 )

Total Liabilities and Stockholders’ Deficit

 

$616,290

 

 

$761,826

 

 

(The accompanying notes are an integral part of these consolidated financial statements)

 

 
14

Table of Contents

 

IGEN NETWORKS CORP.

Consolidated Statements of Operations

(Expressed in U.S. dollars)

 

 

 

Years ended December 31,

 

 

 

2022

 

 

2021

 

 

 

 

 

 

 

 

Revenues:

 

 

 

 

 

 

Sales, services

 

$318,016

 

 

$268,947

 

Total Revenues

 

 

318,016

 

 

 

268,947

 

Cost of goods sold

 

 

322,566

 

 

 

123,793

 

Gross (Loss) Profit

 

 

(4,550 )

 

 

145,154

 

 

 

 

 

 

 

 

 

 

Expenses:

 

 

 

 

 

 

 

 

Selling, general and administrative expenses

 

 

400,860

 

 

 

423,288

 

Payroll and related

 

 

338,594

 

 

 

284,110

 

Management and consulting fees

 

 

192,350

 

 

 

193,647

 

Stock-based director expense

 

 

36,000

 

 

 

2,590,040

 

Total Expenses

 

 

967,804

 

 

 

3,491,085

 

Loss Before Other Income (Expense)

 

 

(972,354 )

 

 

(3,345,931 )

Other Income (Expense):

 

 

 

 

 

 

 

 

Accretion of discounts on convertible debentures

 

 

(35,201 )

 

 

(134,014 )

Change in fair value of derivative liabilities

 

 

(48,691 )

 

 

79,337

 

Gain on extinguishment of debt, net

 

 

301,360

 

 

 

-

 

Interest expense

 

 

(151,912 )

 

 

(27,521 )

Total Other Income (Expense), net

 

 

65,556

 

 

 

(82,198 )

Net Loss before Provision for Income Taxes

 

 

(906,798 )

 

 

(3,428,129 )

Provision for Income Taxes

 

 

(800 )

 

 

(808 )

Net Loss

 

 

(907,598 )

 

 

(3,428,937 )

Accrued and deemed dividend on redeemable convertible preferred stock

 

 

(251,592 )

 

 

(371,926 )

Net loss attributable to common stockholders

 

 

(1,159,190 )

 

 

(3,800,863 )

Basic and Diluted Loss per Common Share

 

$(0.00 )

 

$(0.00 )

Weighted Average Number of Common Shares Outstanding

 

 

1,613,852,078

 

 

 

1,263,939,724

 

 

(The accompanying notes are an integral part of these consolidated financial statements)

 

 
15

Table of Contents

 

IGEN NETWORKS CORP.

Consolidated Statements of Redeemable Convertible Preferred stock and Stockholders’ Deficit

(Expressed in U.S. dollars)

 

 

 

Redeemable

Series A

Convertible

Preferred Stock

 

 

Series B

Preferred

Stock

 

 

Common Stock

 

 

Additional

Paid in

 

 

Accumulated

 

 

Total

Stockholders’

Equity

 

 

 

Shares

 

 

Amount

 

 

Shares

 

 

Amount

 

 

Shares

 

 

Amount

 

 

Capital

 

 

Deficit

 

 

(Deficit)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Balance, January 1, 2021

 

 

186,450

 

 

$51,907

 

 

 

1,000,000

 

 

$1,000

 

 

 

1,192,192,158

 

 

$1,192,192

 

 

$13,068,978

 

 

$(15,185,187 )

 

$(923,017 )

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Shares of Series A preferred stock for cash, net of costs and discounts

 

 

517,550

 

 

 

150,644

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

(76,304 )

 

 

(76,304 )

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Accrued dividends on Series A preferred stock

 

 

-

 

 

 

147,652

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

(147,652 )

 

 

(147,652 )

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Conversion of Series A preferred shares to common stock

 

 

(504,625 )

 

 

(266,181 )

 

 

-

 

 

 

-

 

 

 

113,571,223

 

 

 

113,573

 

 

 

747,999

 

 

 

(238,442 )

 

 

623,130

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Issuance of Series B preferred stock

 

 

-

 

 

 

-

 

 

 

4,000,000

 

 

 

4,000

 

 

 

-

 

 

 

-

 

 

 

2,550,447

 

 

 

-

 

 

 

2,554,447

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Shares of common stock issued for cash

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

151,368,383

 

 

 

151,368

 

 

 

470,377

 

 

 

-

 

 

 

621,745

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Shares of common stock issued for exercise of convertible note, including fees

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

1,780,825

 

 

 

1,781

 

 

 

16,829

 

 

 

-

 

 

 

18,610

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Stock-based compensation

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

7,235,356

 

 

 

7,235

 

 

 

34,810

 

 

 

-

 

 

 

42,045

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Cashless exercise of warrants

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

498,260

 

 

 

498

 

 

 

(498 )

 

 

-

 

 

 

-

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Issuance of common stock for conversion of payables

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

3,243,875

 

 

 

3,244

 

 

 

13,299

 

 

 

-

 

 

 

16,543

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Issuance of common stock for commitment fee on equity line

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

5,479,452

 

 

 

5,479

 

 

 

(5,479 )

 

 

-

 

 

 

-

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Issuance of common stock for loan extension

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

1,500,000

 

 

 

1,500

 

 

 

4,200

 

 

 

-

 

 

 

5,700

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net loss

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

(3,428,937 )

 

 

(3,428,937 )

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Balance, December 31, 2021

 

 

199,375

 

 

 

84,022

 

 

 

5,000,000

 

 

 

5,000

 

 

 

1,476,869,532

 

 

 

1,476,870

 

 

 

16,900,962

 

 

 

(19,076,522 )

 

 

(693,690 )

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Issuance of shares to directors

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

20,000,000

 

 

 

20,000

 

 

 

16,000

 

 

 

-

 

 

 

36,000

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Issuance of shares for services

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

3,113,005

 

 

 

3,113

 

 

 

10,500

 

 

 

-

 

 

 

13,613

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Issuance of shares for cash, net of commitment fees

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

105,990,998

 

 

 

105,991

 

 

 

47,755

 

 

 

-

 

 

 

153,746

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Cashless exercise of warrants

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

19,560,705

 

 

 

19,561

 

 

 

(19,561 )

 

 

-

 

 

 

-

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Shares of Series A preferred stock for cash, net of costs and discounts

 

 

445,500

 

 

 

229,362

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Accrued dividends on Series A preferred stock

 

 

-

 

 

 

126,186

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

(126,186 )

 

 

(126,186 )

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Conversion of Series A preferred shares to common stock

 

 

(430,375 )

 

 

(301,141 )

 

 

-

 

 

 

-

 

 

 

264,726,807

 

 

 

264,727

 

 

 

407,140

 

 

 

(125,406 )

 

 

546,461

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Repurchase of Series B Preferred Stock

 

 

-

 

 

 

-

 

 

 

(1,250,000 )

 

 

(1,250 )

 

 

-

 

 

 

-

 

 

 

(64,322 )

 

 

65,572

 

 

 

-

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net loss

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

(907,598 )

 

 

(907,598 )

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Balance, December 31, 2022

 

 

214,500

 

 

$138,429

 

 

 

3,750,000

 

 

$3,750

 

 

 

1,890,261,047

 

 

$1,890,262

 

 

$17,298,474

 

 

$(20,170,140 )

 

$(977,654 )

 

(The accompanying notes are an integral part of these consolidated financial statements)

 

 
16

Table of Contents

  

IGEN NETWORKS CORP.

Consolidated Statements of Cash Flows

(Expressed in U.S. dollars)

 

 

 

Years ended December 31,

 

 

 

2022

 

 

2021

 

Cash Flows from Operating Activities

 

 

 

 

 

 

Net loss

 

$(907,598 )

 

$(3,428,937 )

Adjustments to reconcile net loss to net cash used in operating activities:

 

 

 

 

 

 

 

 

Accretion of discounts on convertible debentures and preferred stock

 

 

35,201

 

 

 

134,014

 

Change in fair value of derivative liabilities

 

 

48,691

 

 

 

(79,337 )

Interest charge for derivative liabilities in excess of face amount of debt

 

 

 

 

 

 

-

 

Gain on settlement of debt

 

 

(301,360 )

 

 

-

 

Amortization of right of use asset

 

 

23,213

 

 

 

5,438

 

Stock-based compensation

 

 

49,613

 

 

 

2,602,191

 

 

 

 

 

 

 

 

 

 

Changes in operating assets and liabilities:

 

 

 

 

 

 

 

 

Accounts and other receivables

 

 

16,852

 

 

 

(3,924 )

Inventory

 

 

41,042

 

 

 

(50,727 )

Prepaid expenses and deposits

 

 

-

 

 

 

(5,722 )

Accounts payable and accrued liabilities

 

 

(923 )

 

 

(142,629 )

Deferred revenue, net

 

 

17,213

 

 

 

6,673

 

Net Cash Used in Operating Activities

 

 

(978,056 )

 

 

(962,960 )

 

 

 

 

 

 

 

 

 

Cash Flows from Financing Activities

 

 

 

 

 

 

 

 

Proceeds from issuance of preferred stock, net of offering costs

 

 

390,000

 

 

 

470,500

 

Proceeds from notes payable

 

 

527,000

 

 

 

49,965

 

Repayment of lease liability

 

 

(28,113 )

 

 

(5,438 )

Repayment of notes payable

 

 

(127,756 )

 

 

(136,115 )

Repurchase of Series B preferred stock

 

 

(1,250 )

 

 

-

 

Proceeds from issuance of common stock

 

 

153,746

 

 

 

621,746

 

Net Cash Provided by Financing Activities

 

 

913,627

 

 

 

1,000,658

 

 

 

 

 

 

 

 

 

 

Change in Cash

 

 

(64,429 )

 

 

37,698

 

Cash, Beginning of Year

 

 

64,429

 

 

 

26,731

 

Cash, End of Year

 

$-

 

 

$64,429

 

 

 

 

 

 

 

 

 

 

Supplemental Disclosures:

 

 

 

 

 

 

 

 

Interest paid

 

$104,164

 

 

$18,593

 

Income taxes paid

 

$-

 

 

$808

 

 

 

 

 

 

 

 

 

 

Non-cash Investing and Financing Activities:

 

 

 

 

 

 

 

 

Conversion of notes payable and accrued interest:

 

 

 

 

 

 

 

 

Fair value of common shares issued

 

$-

 

 

$18,610

 

Derecognition of notes payable and accrued interest

 

$-

 

 

$(9,616 )

Derecognition of unamortized discount

 

$-

 

 

$-

 

Derecognition of derivative liabilities

 

$-

 

 

$(9,013 )

Conversion of preferred stock:

 

 

 

 

 

 

 

 

Fair value of common stock issued

 

$671,866

 

 

$861,574

 

Derecognition of preferred stock

 

$(437,139 )

 

$(472,810 )

Derecognition of unamortized discount

 

$146,448

 

 

$206,629

 

Derecognition of derivative liabilities

 

$(241,490 )

 

$(356,951 )

Deemed divided

 

$(125,406 )

 

$(251,187 )

Discount related to issuance of preferred stock

 

$175,638

 

 

$319,856

 

Deemed dividends on preferred stock (excluding conversions)

 

$126,186

 

 

$(147,653 )

Cashless exercise of warrants

 

$19,561

 

 

$498

 

Issuance of common shares for commitment fee on equity line

 

$12,500

 

 

$5,481

 

Right of use asset

 

$-

 

 

$81,668

 

Reclassification of security deposit to accounts payable

 

$-

 

 

$4,013

 

 

(The accompanying notes are an integral part of these consolidated financial statements)

 

 
17

Table of Contents

 

IGEN NETWORKS CORP.

Notes to the Consolidated Financial Statements

Years Ended December 31, 2022 and 2021

(Expressed in U.S. dollars)

 

1. Organization and Description of Business

 

IGEN Networks Corp. (“IGEN”, the “Company”, “we”, “our”) was incorporated in the State of Nevada on November 14, 2006, under the name of Nurse Solutions Inc. On September 19, 2008, the Company changed its name to Sync2 Entertainment Corporation and traded under the symbol SYTO. On September 15, 2008, the Company became a reporting issuer in British Columbia, Canada. On May 26, 2009, the Company changed its name to IGEN Networks Corp. On March 25, 2015, the Company was listed on the Canadian Securities Exchange (CSE) under the trading symbol IGN and the Company became a reporting Venture Issuer in British Columbia and Ontario, Canada.

 

The Company’s principal business is the development and marketing of software services for the automotive industry. The Company works with wireless carriers, hardware suppliers and software developers to provide direct and secure access to information on the vehicle and the driver’s behavior. The software services are delivered from the AWS Cloud to the consumer and their families over the wireless networks and accessed from any mobile or desktop device. The software services are marketed to automotive dealers, financial institutions, and direct-to-consumer through various commercial and consumer brands.

 

Going Concern

 

The consolidated financial statements as of and for the year ended December 31, 2022 have been prepared assuming that the Company will continue as a going concern. The Company has experienced recurring losses from operations and has negative operating cash flows since inception, has a working capital deficit of $1,134,006 and an accumulated deficit of $20,170,140 as of December 31, 2022, and is dependent on its ability to raise capital from stockholders or other sources to sustain operations. These factors raise substantial doubt about the Company’s ability to continue as a going concern. Ultimately, the Company plans to achieve profitable operations through the increase in revenue base and successfully growing its operations organically or through acquisitions. The consolidated financial statements do not include any adjustments that might result from the outcome of these uncertainties.

 

2. Summary of Significant Accounting Policies

 

Basic of Presentation and Consolidation

 

These consolidated financial statements and related notes include the records of the Company and the Company’s wholly-owned subsidiary, Nimbo Tracking LLC, which is based in the USA.

 

All intercompany transactions and balances have been eliminated. These consolidated financial statements are presented in accordance with accounting principles generally accepted in the United States (“U.S. GAAP”), are expressed in U.S. dollars, and, in management’s opinion, have been properly prepared within reasonable limits of materiality and within the framework of the significant accounting policies summarized below.

 

Use of Estimates

 

The preparation of these consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements, and the reported amounts of revenues and expenses during the reporting period. The Company regularly evaluates estimates and assumptions related to allowance for doubtful accounts, valuation of inventory, the useful life and recoverability of equipment, impairment of goodwill, valuation of notes payable and convertible debentures, fair value of stock-based compensation and derivative liabilities, and deferred income tax asset valuation allowances. The Company bases its estimates and assumptions on current facts, historical experience and various other factors that it believes to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities and the accrual of costs and expenses that are not readily apparent from other sources. The actual results experienced by the Company may differ materially and adversely from the Company’s estimates. To the extent there are material differences between the estimates and the actual results, future results of operations will be affected.

 

Cash and Cash Equivalents

 

The Company considers all highly liquid instruments purchased with an original maturity of three months or less at the time of acquisition to be cash equivalents.

 

 
18

Table of Contents

 

 Accounts Receivable

 

Accounts receivable are recognized and carried at the original invoice amount less an allowance for expected uncollectible amounts. Inherent in the assessment of the allowance for doubtful accounts are certain judgments and estimates including, among others, the customer’s willingness or ability to pay, the Company’s compliance with customer invoicing requirements, the effect of general economic conditions and the ongoing relationship with the customer. Accounts with outstanding balances longer than the payment terms are considered past due. We do not charge interest on past due balances. The Company writes off trade receivables when all reasonable collection efforts have been exhausted. Bad debt expense is reflected as a component of general and administrative expenses in the consolidated statements of operations. As of December 31, 2022 and 2021, the allowance for doubtful accounts was approximately $16,000 and $11,000, respectively.

 

Inventory

 

Inventory consists of vehicle tracking and recovery devices and is comprised entirely of finished goods that can be resold. Inventory is stated at the lower of cost or net realizable value. Cost is determined on a first-in, first-out (FIFO) basis. Net realizable value is the estimated selling price in the ordinary course of business, less estimated costs of completion and selling costs. There was no provision for inventory recorded during the years ended December 31, 2022 and 2021.

 

Equipment

 

Office equipment, computer equipment, and software are recorded at cost. Depreciation is provided annually at rates and methods over their estimated useful lives. Management reviews the estimates of useful lives of the assets every year and adjusts them on prospective basis, if needed. All equipment was fully depreciated as of December 31, 2022 and 2021. For purposes of computing depreciation, the method of depreciating equipment is as follows:

 

Computer equipment

3 years straight-line

Office equipment

5 years straight-line

Software

3 years straight-line

 

Goodwill

 

Goodwill represents the excess of the acquisition price over the fair value of identifiable net assets acquired. Goodwill is allocated at the date of the business combination. Goodwill is not amortized, but is tested for impairment annually on December 31 of each year or more frequently if events or changes in circumstances indicate the asset may be impaired. These events and circumstances may include a significant change in legal factors or in the business climate, a significant decline in the Company’s share price, an adverse action of assessment by a regulator, unanticipated competition, a loss of key personnel, significant disposal activity and the testing of recoverability for a significant asset group.

 

Goodwill impairment is measured as the amount by which a reporting unit’s carrying value exceeds its fair value.

 

The Company has only one reporting unit. Therefore, all of the Company’s goodwill relates to that reporting unit, and at December 31, 2022 and 2021, the carrying value for that reporting unit is negative.

 

Impairment of Long-lived Assets

 

The Company reviews long-lived assets, such as equipment, for impairment whenever events or changes in the circumstances indicate that the carrying value may not be recoverable. If the total of the estimated undiscounted future cash flows is less than the carrying value of the asset, an impairment loss is recognized for the excess of the carrying value over the fair value of the asset during the year the impairment occurs.

 

Fair Value Measurements and Financial Instruments

 

In accordance with Financial Accounting Standard Board (“FASB”) Accounting Standards Codification (“ASC”) 820, “Fair Value Measurements and Disclosures,” the Company is to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. ASC 820 establishes a fair value hierarchy based on the level of independent, objective evidence surrounding the inputs used to measure fair value. A financial instrument’s categorization within the fair value hierarchy is based upon the lowest level of input that is significant to the fair value measurement. ASC 820 prioritizes the inputs into three levels that may be used to measure fair value:

 

Level 1

 

Level 1 applies to assets or liabilities for which there are quoted prices in active markets for identical assets or liabilities.

 

Level 2

 

Level 2 applies to assets or liabilities for which there are inputs other than quoted prices that are observable for the asset or liability such as quoted prices for similar assets or liabilities in active markets; quoted prices for identical assets or liabilities in markets with insufficient volume or infrequent transactions (less active markets); or model-derived valuations in which significant inputs are observable or can be derived principally from, or corroborated by, observable market data.

 

Level 3

 

Level 3 applies to assets or liabilities for which there are unobservable inputs to the valuation methodology that are significant to the measurement of the fair value of the assets or liabilities.

 

 
19

Table of Contents

 

See Note 7 for fair value measurement information related to the Company’s derivative liabilities.

 

The fair values of cash and cash equivalents, accounts and other receivables, restricted cash, and accounts payable and accrued liabilities, approximate their carrying values due to the immediate or short-term maturity of these financial instruments. Foreign currency transactions are primarily undertaken in Canadian dollars. The fair value of cash is determined based on “Level 1” inputs and the fair value of derivative liabilities is determined based on “Level 3” inputs. The recorded values of notes payable, approximate their current fair values because of their nature and respective maturity dates or durations. The financial risk is the risk to the Company’s operations that arise from fluctuations in foreign exchange rates and the degree of volatility to these rates. Currently, the Company does not use derivative instruments to reduce its exposure to foreign currency risk. Financial instruments that potentially subject the Company to concentrations of credit risk consists of cash and accounts receivable. The Company places its cash and cash equivalents in what it believes to be credit-worthy financial institutions.

 

Revenue Recognition and Deferred Revenue

 

We recognize revenue in accordance with ASC 606, “Revenue from Contracts with Customers”, using the five-step model, including (1) identify the contract with the customer, (2) identify the performance obligations in the contract, (3) determine the transaction price, (4) allocate the transaction price to the performance obligations in the contract, and (5) recognize revenue in accordance with U.S. GAAP. Title and risk of loss generally pass to our customers upon delivery, as we have insurance for lost shipments. In limited circumstances where either title or risk of loss pass upon destination or acceptance or when collection is not reasonably assured, we defer revenue recognition until such events occur. We derive substantially all our revenues from the sale of products and services combined into one performance obligation. Product revenue includes the shipment of product according to the agreement with our customers. Service revenue include vehicle tracking services and customer support (technical support), installations and consulting. A contract usually includes both product and services. For these contracts, the Company accounts for individual performance obligations separately if they are distinct. Performance obligations include, but are not limited to, pass-thru harnesses and vehicle tracking services. Almost all of our revenues are derived from customers located in United States of America in the auto industry. The transaction price is allocated to the separate performance obligations on a relative standalone selling price basis. Standalone selling prices are typically estimated based on observable transactions when these services are not sold on a standalone basis. At contract inception, an assessment of the goods and services promised in the contracts with customers is performed and a performance obligation is identified for each distinct promise to transfer to the customer a good or service (or bundle of goods or services). To identify the performance obligations, the Company considers all of the goods or services promised in the contract regardless of whether they are explicitly stated or are implied by customary business practices. Revenue is recognized when our performance obligation has been met. The Company has insignificant revenues related to product sales. For these revenues, the Company considers control to have transferred upon delivery because the Company has a present right to payment at that time, the Company has transferred use of the asset, and the customer is able to direct the use of, and obtain substantially all of the remaining benefits from, the asset. For arrangements under which the Company provides vehicle tracking services, which account for the substantial portion of the Company’s revenues, the Company satisfies its performance obligations as those services are performed whereby the customer simultaneously receives and consumes the benefits of such services under the agreement. Revenues are recognized net of any taxes collected from customers, which are subsequently remitted to governmental authorities.

 

The Company provides product warranties with varying lengths of time and terms. The product warranties are considered to be assurance-type in nature and do not cover anything beyond ensuring that the product is functioning as intended. Based on the guidance in ASC 606, assurance-type warranties do not represent separate performance obligations. The Company has historically experienced a low rate of product returns under the warranty program.

 

Management assesses the business environment, customers’ financial condition, historical collection experience, accounts receivable aging, and customer disputes to determine whether collectability is reasonably assured.

 

Revenue relating to the sale of service fees on its vehicle tracking and recovery services is recognized over the life of the contact. The service renewal fees are offered in terms ranging from 12 to 36 months and are generally payable upon delivery of the vehicle tracking devices or in full upon renewal.

 

Deferred revenues are recorded net of contract assets when cash payments are received from customers in advance of the Company’s performance. Contract assets represent the costs of (1) commission costs, (2) installation costs, and (3) the underlying hardware to enable the Company to perform on its contracts with customers and are amortized using the same method and term as deferred revenues. As of December 31, 2022 and 2021, deferred revenues, net of contract assets totaled $162,698 and $145,485, respectively, and contract assets totaled $73,450 and $71,441, respectively. Any revenue that has been deferred and is expected to be recognized beyond one year is classified as deferred revenue, net of current portion.

 

During the year ended December 31, 2022, the Company recorded additions to deferred revenues of $238,284 and recognized total revenues of $210,222 through the amortization of deferred revenues. During the year ended December 31, 2022, the Company recognized revenues of $112,323 related to deferred revenues outstanding as of December 31, 2021 as the services were performed.

 

 
20

Table of Contents

 

Financing Costs and Debt Discount

 

Financing costs and debt discounts are recorded net of notes payable and convertible debentures in the consolidated balance sheets. Amortization of financing costs and the debt discounts is calculated using the effective interest method over the term of the debt and is recorded as interest expense in the consolidated statements of operations.

 

Income Taxes

 

Deferred income taxes are provided on the asset and liability method whereby deferred income tax assets are recognized for deductible temporary differences and operating loss and tax credit carryforwards and deferred tax liabilities are recognized for taxable temporary differences. Temporary differences are the differences between the reported amounts of assets and liabilities and their tax bases. Deferred income tax assets are reduced by a valuation allowance when, in the opinion of management, it is more likely than not that some portion or all of the deferred income tax assets will not be realized. Deferred income tax assets and liabilities are adjusted for the effects of changes in tax laws and rates on the date of enactment.

 

Stock-based Compensation

 

The Company accounts for stock-based payments in accordance with stock-based payment accounting guidance which requires all stock-based payments to be recognized based upon their fair values. The fair value of stock-based awards is estimated at the grant date using the Black-Scholes Option Pricing Model and the portion that is ultimately expected to vest is recognized as compensation cost over the requisite service period. The determination of fair value using the Black-Scholes Option Pricing Model is affected by the Company’s stock price as well as assumptions regarding a number of complex and subjective variables, including expected stock price volatility, risk-free interest rate, expected dividends and projected employee stock option exercise behaviors. The Company accounts for forfeitures of unvested awards as they occur.

 

Derivative Financial Instruments

 

The Company classifies as equity any contracts that require physical settlement or net-share settlement or provide us a choice of net cash settlement or settlement in our own shares (physical settlement or net-share settlement) provided that such contracts are indexed to our own stock as defined in ASC Topic 815-40 “Contracts in Entity’s Own Equity.” The Company classifies as assets or liabilities any contracts (including embedded conversion features) that require net-cash settlement including a requirement to net cash settle the contract if an event occurs and if that event is outside our control or give the counterparty a choice of net-cash settlement or settlement in shares. The Company assesses classification of its derivatives at each reporting date to determine whether a change in classification between assets and liabilities is required.

 

Loss Per Share

 

Basic earnings (loss) per share are computed by dividing net income (loss) available to common shareholders (numerator) by the weighted average number of shares outstanding (denominator) during the period. Diluted earnings per share give effect to all dilutive potential common shares outstanding during the period including stock options, using the treasury stock method, and convertible debentures, using the if-converted method. In computing diluted earnings (loss) per share, the average stock price for the period is used in determining the number of shares assumed to be purchased from the exercise of stock options or warrants. Diluted earnings (loss) per share exclude all potentially issuable shares if their effect is anti-dilutive. Because the effect of conversion of the Company’s dilutive securities is anti-dilutive, diluted loss per share is the same as basic loss per share for the periods presented. As of December 31, 2022 and 2021, the Company has 442,441,431 and 239,950,260 potentially dilutive shares outstanding, respectively.

 

Recent Accounting Pronouncement

 

In August 2020, the FASB issued ASU 2020-06, “Debt - Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging - Contracts in Entity’s Own Equity (Subtopic 815 - 40)” (“ASU 2020-06”). ASU 2020-06 simplifies the accounting for certain financial instruments with characteristics of liabilities and equity, including convertible instruments and contracts on an entity’s own equity. The ASU is part of the FASB’s simplification initiative, which aims to reduce unnecessary complexity in U.S. GAAP. The ASU’s amendments are effective for fiscal years beginning after December 15, 2023, and interim periods within those fiscal years. The Company is currently evaluating the impact ASU 2020-06 will have on its financial statements.

 

 
21

Table of Contents

 

The Company does not believe that there are any other new accounting pronouncements that have been issued that might have a material impact on its consolidated financial position or results of operations.

 

3. Accounts and Other Receivables

 

 

 

December 31,

2022

 

 

December 31,

2021

 

Trade accounts receivable

 

$38,190

 

 

$49,462

 

Allowance for doubtful accounts

 

 

(16,288 )

 

 

(10,708 )

 

 

$21,902

 

 

$38,754

 

 

4. Goodwill

 

As of December 31, 2022 and 2021, the Company had goodwill of $505,508 related to the acquisition of Nimbo Tracking, LLC.

 

5. Accounts Payable and Accrued Liabilities

 

 

 

December 31,

2022

 

 

December 31,

2021

 

Trade accounts payable

 

$174,319

 

 

$540,288

 

Accrued liabilities

 

 

49,723

 

 

 

5,740

 

Lease liability, current portion

 

 

28,110

 

 

 

21,019

 

Accrued interest payable

 

 

2,386

 

 

 

6,097

 

Payroll and commissions payable

 

 

15,689

 

 

 

15,203

 

Unrecognized tax position

 

 

90,000

 

 

 

90,000

 

 

 

$360,227

 

 

$678,347

 

 

 
22

Table of Contents

 

6. Convertible Debentures and Notes Payable

 

On May 17, 2019, the Company entered into a Convertible Promissory Note (“Promissory Note”) with Crown Bridge Partners, LLC (the “Holder”). The Promissory Note bears interest at 7% per annum (with the understanding that the first 12 months of interest of each tranche will be guaranteed). The maturity date is 18 months from the effective date of each payment.

 

The Conversion Price, as defined in the agreement, is the lesser of (i) the lowest Trading Price (as defined below) during the previous 25 trading day period ending on the latest complete trading day prior to the date of this Promissory Note or (ii) the Variable Conversion Price (as defined below). The Variable Conversion Price means the lowest one Trading Price (as defined below) for the common stock during the 25 Trading Day period ending on the last complete Trading Day prior to the Conversion Date. Trading Price means, for any security as of any date, the lesser of the (i) lowest traded price and (ii) lowest closing bid price. Based on the Company’s examination of the conversion feature and the relative accounting guidance, the Company has determined that the conversion feature should be treated as a derivative liability for accounting purposes.

 

Additionally, if at any time while the Promissory Note is outstanding, the Conversion Price is equal to or lower than $0.025, then an additional $10,000 will be automatically added to the principal balance of each tranche funded under the Note.

 

In connection with the Promissory Note, the Company also entered into a Securities Purchase Agreement with the Holder which states that the Company will also issue to the Holder a warrant to purchase an amount of shares of its common stock equal to 50% of the face value of each respective tranche divided by $0.10.

 

Per the terms of the Common Stock Purchase Warrant agreement, on May 17, 2019, the Company issued a warrant to purchase 250,000 shares of common stock with an Exercise Price of $0.10 subject to adjustment (standard anti-dilution features). The agreement contains a down-round provision that automatically resets the exercise price of the warrant to a new exercise price that is equal to the per share price of common stock subsequently issued (including conversions of debt and preferred stock). Upon the lowing of the exercise price, the number of warrants will be increased such that the total proceeds upon exercise is the same amount (see Note 7). If the Market Price of one shares of common stock is greater than the Exercise Price, the Holder may elect to receive Warrant Shares pursuant to cashless exercise, in lieu of cash exercise, per a defined formula in the agreement.

 

On June 19, 2020, the Company received $19,250 in net cash proceeds from a note holder under the same terms as the Promissory Note. The related principal amount due for the convertible debt instrument was $25,000 and the note matures on December 19, 2021. Using the Binomial Lattice Model, the Company computed the estimated fair value of the embedded conversion feature to be approximately $142,000 and recorded a related derivative liability for that amount and a charge to interest expense of approximately $122,000. Related to the derivative liability, the shares issued, the bonus interest, and the direct financing costs, the Company recorded a debt discount totaling $25,000 for the note, which is being amortized to interest expense over the term of the note using the effective interest method. As of December 31, 2022, the principal and interest owed under this note totaled $12,000.

 

On July 10, 2020, the Company received $19,250 in net cash proceeds from a note holder under the same terms as the Promissory Note. The related principal amount due for the convertible debt instrument was $25,000 and the note matures on January 10, 2022. Using the Binomial Lattice Model, the Company computed the estimated fair value of the embedded conversion feature to be approximately $61,000 and recorded a related derivative liability for that amount and a charge to interest expense of approximately $42,000. Related to the derivative liability, the shares issued, the bonus interest, and the direct financing costs, the Company recorded a debt discount totaling $25,000 for the note, which is being amortized to interest expense over the term of the note using the effective interest method. As of December 31, 2022, the principal and interest owed under this note totaled $25,000.

 

On May 4, 2020, the Company entered into a Paycheck Protection Program (“PPP”) Loan with a principal amount of $59,949 through a financial institution under the PPP administered by the SBA and established as part of the CARES Act. The PPP Loan bears interest at 1.0% per annum and matures on May 4, 2022 with the first six months of interest and principal payments deferred. The amount borrowed under the PPP Loan is guaranteed by the U.S. Small Business Administration (“SBA”) and is eligible for forgiveness in an amount equal to the sum of the eligible costs, including payroll, benefits, rent and utilities, incurred by the Company during the 24-week period beginning on the date the Company received the proceeds. The PPP Loan contains customary events of default, and the occurrence of an event of default may result in a claim for the immediate repayment of all amounts outstanding under the PPP Loan. As of December 31, 2022, the balance of the PPP Loan, including accrued interest was $60,948.

 

On July 7, 2020, the Company entered into a secured disaster loan with the SBA with a principal amount of $150,000. The SBA loan bears interest at 3.75% per annum and matures in July 2050. The Company is required to make monthly principal and interest payments of $731 beginning in July 2021. As of December 31, 2022, the balance on the SBA loan, including interest was $164,063.

 

On November 2, 2020, the Company received $146,500 in net cash proceeds from a note holder under an Inventory Financing Promissory Note. The related principal amount due for the convertible debt instrument was $168,000. The note bears interest at 12% per annum and matures on May 2, 2022. Principal and accrued interest are convertible into common stock at a variable conversion price, which is 80% of the average two lowest traded prices for common stock during a 10-day trading period prior to conversion. Using the Binomial Lattice Model, the Company computed the estimated fair value of the embedded conversion feature to be approximately $99,000 and recorded a related derivative liability for that amount. The Company also issued 2,000,000 shares of common stock to the note holder as additional compensation. The value of the shares, $14,800. Related to the derivative liability, the shares issued, the bonus interest, and the direct financing costs, the Company recorded a debt discount totaling approximately $135,000 for the note, which is being amortized to interest expense over the term of the note using the effective interest method. During the year ended December 31, 2022, the Company received forgiveness of the note totaling $45,148 and paid down the remaining balance and accrued interest. As of December 31, 2022 the balance on the note is $0.

 

On December 13, 2021, the Company received $50,000 in net cash proceeds from a note holder under a short-term bridge note. During the year ended December 31, 2022, the Company borrowed an additional $127,000 under the note. The note matures on February 13, 2023. The Company is required to make 34 weekly payments of $4,633. As of December 31, 2022, the balance on the note was $130,355.

 

During the year ended December 31, 2021, the holders of the convertible notes converted a total of $9,616 of principal, interest and fees for a total of 1,780,825 shares of common stock. Related to these conversions during the year ended December 31, 2021, the Company recorded a reduction of the associated derivative liability for the conversion features of $9,013 and a reduction of the debt discount of $0 as components of the loss on settlement of debt. During the year ended December 31, 2021, the Company recorded $134,014 of interest expense related to the amortization of the debt discounts.

 

 
23

Table of Contents

 

During the year ended December 31, 2022, the Company entered into four separate notes with an investor, for total principal of $400,000. The notes mature through March 2023 and bear interest between 6% and 12% per annum. As of December 31, 2022, the principal and interest owed on these notes totaled $401,516.

 

As of December 31, 2022 long-term debt matures as follows: 

 

Year Ending

 

Notes Payable

 

 

Convertible Notes

 

 

Total

 

2023

 

$596,745

 

 

$37,000

 

 

$633,745

 

2024

 

 

3,454

 

 

 

-

 

 

 

3,454

 

2025

 

 

3,586

 

 

 

-

 

 

 

3,586

 

2026

 

 

3,718

 

 

 

-

 

 

 

3,718

 

2027

 

 

3,900

 

 

 

-

 

 

 

3,900

 

Thereafter

 

 

146,078

 

 

 

-

 

 

 

146,078

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

$757,482

 

 

$37,000

 

 

$794,482

 

 

7. Derivative Liabilities

 

During the years ended December 31, 2022 and 2021, the Company had outstanding convertible debentures with variable exercise prices based on market rates (see Note 6) and convertible series A preferred stock with variable exercise prices based on market rates (see Note 9). The Company records the fair value of the conversion features with variable exercise prices based on future market rates in accordance with ASC 815. The fair value of the derivative liabilities is revalued on each balance sheet date with corresponding gains and losses recorded in the consolidated statements of operations. The Company uses a multi-nominal lattice model to fair value the derivative liabilities. The following inputs and assumptions were used to value the conversion features outstanding during the years ended December 31, 2022 and 2021, assuming no expected dividends:

 

 

 

2022

 

 

2021

 

Expected volatility

 

 

145-166

%

 

 

135-275

%

Risk free interest rate

 

 

1.34-4.68

%

 

 

0.05-0.15

%

Expected life (in years)

 

 

0-1.5

 

 

 

0-1.5

 

 

The following table presents the Company’s embedded conversion features of its convertible debt and preferred stock measured at fair value on a recurring basis as of December 31, 2022 and 2021.

 

 

 

Level 3

Carrying

Value as of

December 31,

2022

 

 

Level 3

Carrying

Value as of

December 31,

2021

 

Derivative liabilities:

 

 

 

 

 

 

Embedded conversion feature – convertible debt

 

$-

 

 

$51,131

 

Embedded conversion feature – preferred stock

 

 

111,010

 

 

 

85,771

 

 

 

$111,010

 

 

$136,902

 

 

The following table provides a reconciliation of the beginning and ending balances for the Company’s derivative liabilities measured at fair value using Level 3 inputs:

 

 

 

For The

Year

Ended

December 31,

2022

 

 

For The

Year

Ended

December 31,

2021

 

Embedded Conversion Features – Debt Instruments

 

 

 

 

 

 

Balances, as of the beginning of the year

 

$51,131

 

 

$97,024

 

Derivative liabilities recorded upon issuance of debt instruments

 

 

-

 

 

 

-

 

Extinguishment due to conversion of debt instruments

 

 

-

 

 

 

(8,994 )

Net changes in fair value included in net loss

 

 

(51,131 )

 

 

(36,989 )

Ending balance

 

$-

 

 

$51,131

 

 

 

 

 

 

 

 

 

 

Embedded Conversion Features – Preferred Stock

 

 

 

 

 

 

 

 

Balances, as of the beginning of the year

 

$85,771

 

 

$92,751

 

Derivative liabilities recorded upon issuance of preferred stock

 

 

175,639

 

 

 

392,410

 

Extinguishment due to conversion of preferred stock

 

 

(241,490 )

 

 

(356,951 )

Net changes in fair value included in net loss

 

 

91,090

 

 

 

(42,439 )

Ending balance

 

$111,010

 

 

$85,771

 

 

 

 

 

 

 

 

 

 

Total ending balance

 

$111,010

 

 

$136,902

 

 

 
24

Table of Contents

 

8. Related Party Transactions

 

(a)

During the years ended December 31, 2022 and 2021, the Company incurred approximately $145,000 and $147,000, respectively, in management and consulting fees with an officer and an entity controlled by him. As of December 31, 2022 and 2021, the Company owed approximately $5,000 and $9,000, respectively, to directors and officers and a company controlled by a director, which is included in accounts payable and accrued liabilities. The amounts owed are unsecured, non-interest bearing, and due on demand.

 

 

(b)

During the years ended December 31, 2022 and 2021, the Company issued 0 and 4,608,173 shares of common stock for the conversion of $0 and $24,729, respectively of accrued expenses owed to the CEO and VP of Operations.

 

 

(c)

During the year ended December 31, 2022 and 2021, the Company recorded approximately $0 and $8,000, respectively to the VP and General Manager for rent and other office expenses.

 

9. Redeemable Preferred Stock and Stockholders’ Deficit

 

Preferred Stock

 

The Company is authorized to issue 10,000,000 shares of preferred stock with a par value of $0.001 per share. The Company has designated 1,250,000 of these shares as Series A Convertible Preferred Stock (“Series A Preferred Stock”).

 

On February 1, 2021, the Company entered into a Series A Preferred Stock Purchase Agreement with an investor. The Company issued 58,850 shares for proceeds of $53,500.

 

On March 1, 2021, the Company entered into a Series A Preferred Stock Purchase Agreements with an investor. The Company issued 80,850 shares for proceeds of $73,500.

 

On April 5, 2021, the Company entered into a Series A Preferred Stock Purchase Agreements with an investor. The Company issued 58,850 shares for proceeds of $53,500.

 

On April 30, 2021, the Company entered into a Series A Preferred Stock Purchase Agreements with an investor. The Company issued 59,125 shares for proceeds of $53,750.

 

On June 17, 2021, the Company entered into a Series A Preferred Stock Purchase Agreements with an investor. The Company issued 60,500 shares for proceeds of $55,000.

 

On August 11, 2021, the Company entered into a Series A Preferred Stock Purchase Agreements with an investor. The Company issued 59,125 shares for proceeds of $53,750.

 

On September 13, 2021, the Company entered into a Series A Preferred Stock Purchase Agreements with an investor. The Company issued 59,125 shares for proceeds of $53,750.

 

On December 27, 2021, the Company entered into a Series A Preferred Stock Purchase Agreement with an investor. The Company issued 81,125 shares for proceeds of $73,750.

 

On February 2, 2022, the Company entered into a Series A Preferred Stock Purchase Agreement with an investor. The Company issued 59,125 shares for proceeds of $53,500.

 

On March 24, 2022, the Company entered into a Series A Preferred Stock Purchase Agreement with an investor. The Company issued 59,125 shares for proceeds of $53,500.

 

On April 26, 2022, the Company entered into a Series A Preferred Stock Purchase Agreement with an investor. The Company issued 59,125 shares for proceeds of $53,500.

 

On May 20, 2022, the Company entered into a Series A Preferred Stock Purchase Agreement with an investor. The Company issued 53,625 shares for proceeds of $48,750.

 

On August 23, 2022, the Company entered into a Series A Preferred Stock Purchase Agreement with an investor. The Company issued 59,125 shares for proceeds of $53,500.

 

On September 26, 2022, the Company entered into a Series A Preferred Stock Purchase Agreement with an investor. The Company issued 59,125 shares for proceeds of $53,500.

 

On November 2, 2022, the Company entered into a Series A Preferred Stock Purchase Agreement with an investor. The Company issued 48,125 shares for proceeds of $43,750.

 

On December 14, 2022, the Company entered into a Series A Preferred Stock Purchase Agreement with an investor. The Company issued 48,125 shares for proceeds of $43,750.

 

Rights and Privileges of the Series A Preferred Stock

 

 

·

Voting – Series A Preferred Stockholders have no voting rights

 

·

Dividends8% cumulative dividend, compounded daily, payable solely upon redemption, liquidation, or conversion. (increases to 22% for an event of default)

 

·

Liquidation Preferenceequal to the then Stated Value (initially $1.00 per share) as adjusted pursuant to the terms in the agreement (including but not limited to the additional of any accrued unpaid dividends and the Default Adjustment (as defined), if applicable.

 

·

Redemption – Company has the right to redeem the shares from the issuance date through 270 days following the issuance date using the table noted in the Certificate of Designations, Preferences, Rights and Limitations of Series A Convertible Preferred Stock agreement. After 270 days, except for the Mandatory Redemption, the Company does not have the right to redeem the shares.

 

·

Mandatory Redemption18 months after the Issuance Date or upon the occurrence of an Event of Default, the Company is required to redeem all of the shares of Series A Preferred Stock of the Holder. The Company shall make a cash payment in an amount equal to the total number of shares of Series A Preferred Stock held by the Holder multiplied by the then current Stated Value as adjusted (including but not limited to the addition of any accrued unpaid dividends and the Default Adjustment

 

·

ConversionAt any time after 6 months following the Issuance Date, the Holder may convert all or any part of the outstanding Series A Preferred Stock into shares of Common Stock. The Variable Conversion Price is defined as 75% of the Market Price. The Market Price is defined as the average of the 3 lowest Trading Prices for the Common Stock during the 15 day Trading Period ending on the last complete Trading Day prior to the Conversion Date.

 

·

Default Adjustments – Upon the occurrence of any Event of Default, the Stated Value will be increased between 150% and 200%, depending on the Event of Default.

 

 
25

Table of Contents

 

Based on the terms of the conversion feature, the Company could be required to issue an infinite number of shares of common stock. As such, the Company has determined the conversion feature to be a derivative liability under relevant accounting guidance. The Company estimated the fair value of the conversion feature using the Binomial Lattice Model on the date of issuance, on the date of each conversion notice, and remeasures the fair value at each reporting period. During the year ended December 31, 2022, the Company issued 445,500 shares of series A preferred stock for proceeds of $405,000. Related to these issuances, the Company recorded derivative liabilities of $175,638 and discounts to the preferred stock of $175,638, which is being amortized to deemed dividends over the redemption period. Also related to these issuances the Company recorded deemed dividends of $126,186.

 

During the year ended December 31, 2022, the holder of the Series A preferred stock converted 430,375 shares of Series A preferred stock and accrued dividends into 264,726,807 shares of common stock. Related to these conversions during the year ended December 31, 2022, the Company recorded a reduction of the associated derivative liability for the conversion features of $241,490 and a reduction of the preferred stock discount of $142,620 and $125,406 of deemed dividend.

 

Rights and Privileges of the Series B Preferred Stock

 

In February 2021, the Company issued 500,000 shares of its Series B Super Voting Preferred Stock. Each share of Series B preferred stock has voting rights equal to 500 shares of common stock, is not entitled to receive dividends, is not convertible into shares of common stock. If the holder of the Series B preferred stock ceases to be a Board Member, the Company will repurchase any Series B preferred stock from the holder for a price of $0.001 per share. If the holder of the Series B preferred stock proposes to transfer any shares of Series B preferred stock, the Company will have 90 days to repurchase the shares for a price of $0.001 per share. The grant date fair value of the Series B preferred stock issued during the nine months ended September 30, 2021 was $278,447 and was recorded to stock-based compensation expense in the accompanying condensed consolidated statements of operations.

 

During the year ended December 31, 2022, the Company repurchased 1,250,000 shares of its Series B Super Voting Preferred Stock, valued at $65,572 and $1,250 cash, per the terms of the Series B shareholder agreement.

 

Common Stock

 

2022 

 

During the year ended December 31, 2022, the Company issued 3,113,005 shares of common stock for services provided by a vendor.

 

During the year ended December 31, 2022, the Company issued 19,560,705 shares of common stock for the exercise of a warrant on a cashless basis.

 

During the year ended December 31, 2022, the Company issued 264,726,807 shares of common stock for the conversion of Series A preferred stock and accrued dividends.

 

During the year ended December 31, 2022, the Company issued 12,500,000 shares of common stock as a commitment fee for a new equity line of credit.

 

During the year ended December 31, 2022, the Company issued 93,490,998 shares of common stock for cash proceeds of $153,746.

 

During the year ended December 31, 2022, the Company issued 20,000,000 shares of common stock for services provided by management and the board of directors.

 

2021

 

During the year ended December 31, 2021, the Company sold a total of 151,368,383 shares of common stock for proceeds of $621,745.

 

During the year ended December 31, 2021, the Company issued a total of 10,479,231 shares of common stock for the conversion of $58,588 of accrued expenses owed to the VP and General Manager and another employee.

 

During the year ended December 31, 2021, the Company issued 498,260 shares for the cashless exercise of warrants.

 

During the year ended December 31, 2021, the Company issued 113,571,223 shares of common stock for the conversion of Series A preferred stock and accrued dividends.

 

During the year ended December 31, 2021, the Company issued 1,780,825 shares of common stock for the conversion of debt and accrued interest.

 

During the year ended December 31, 2021, the Company issued a total of 6,979,452 shares of common stock for a loan commitment fee and a loan extension fee.

 

 
26

Table of Contents

 

10. Share Purchase Warrants

 

The following table summarizes the activity of the Company’s share purchase warrants:

 

 

 

Number of

warrants

 

 

Weighted

average

exercise

price

 

 

 

 

 

 

 

 

Balance, January 1, 2021

 

 

166,517,918

 

 

$0.00

 

Issued

 

 

-

 

 

 

-

 

Adjusted for triggered down-round provisions

 

 

 

 

 

 

0.00

 

Exercised

 

 

 

 

 

 

0.00

 

Expired

 

 

(980,392 )

 

 

0.00

 

Balance, December 31, 2021

 

 

165,537,526

 

 

 

0.00

 

Issued

 

 

-

 

 

 

-

 

Adjusted for triggered down-round provisions

 

 

-

 

 

 

0.00

 

Exercised

 

 

(20,408,163 )

 

 

0.00

 

Expired

 

 

(50,000 )

 

 

0.00

 

Balance, December 31, 2022

 

 

145,079,363

 

 

$0.00

 

 

As of December 31, 2022, the following share purchase warrants were outstanding:

 

Number of warrants outstanding

 

 

Exercise price

 

 

Expiration date

 

2,222,222

 

 

$

0.03

 

 

December 2, 2024

 

142,857,141

 

 

$

0.00

 

 

September 23, 2024

 

145,079,363

 

 

 

 

 

 

 

 

 

During the year ended December 31, 2022, a warrant holder exercised 20,408,163 warrants on a cashless basis resulting in the issuance of 19,560,705 shares of common stock.

 

 
27

Table of Contents

 

11. Stock Options

 

The Company established a stock option plan for directors, officers, employees and consultants of the Company (the “Plan”). The purpose of the Plan is to give to directors, officers, employees and consultants of the Company, as additional compensation, the opportunity to participate in the profitability of the Company by granting to such individuals options, exercisable over periods of up to ten (10) years as determined by the board of directors of the Company, to buy shares of the Company at a price equal to the Market Price (as defined) prevailing on the date the option is granted. As of December 31, 2022, there were 6,440,000 shares available under the Plan.

 

The following table summarizes the activity of the Company’s stock options:

 

 

 

Number of

options

 

 

Weighted

average

exercise

price

 

 

Aggregate

intrinsic value

 

 

 

 

 

 

 

 

 

 

 

Balance, January 1, 2021

 

 

3,250,000

 

 

$0.09

 

 

 

 

Granted

 

 

-

 

 

 

-

 

 

 

 

Exercised

 

 

-

 

 

 

-

 

 

 

 

Cancelled / forfeited

 

 

(75,000 )

 

 

0.16

 

 

 

 

Balance, December 31, 2021

 

 

3,175,000

 

 

$0.08

 

 

$-

 

Granted

 

 

-

 

 

 

-

 

 

 

 

 

Cancelled / forfeited

 

 

(1,675,000 )

 

 

0.12

 

 

 

 

 

Balance, December 31, 2022

 

 

1,500,000

 

 

$0.04

 

 

$-

 

Vested as of December 31, 2022

 

 

1,500,000

 

 

$0.04

 

 

$-

 

Unvested as of December 31, 2022

 

 

-

 

 

$-

 

 

$-

 

 

 

 

 

Outstanding

 

 

Exercisable

 

Range of

exercise prices

 

 

Number of

shares

 

 

Weighted average

remaining

contractual

life (years)

 

 

Weighted

average

exercise

price

 

 

Number of

shares

 

 

Weighted

average

exercise

price

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

$0.04

 

 

 

1,500,000

 

 

 

1.4

 

 

 

0.04

 

 

 

1,500,000

 

 

 

0.04

 

 

 

 

 

 

1,500,000

 

 

 

1.4

 

 

$0.04

 

 

 

1,500,000

 

 

$0.04

 

 

During the years ended December 31, 2022 and 2021, the Company did not issue any options to employees. As of December 31, 2022, the Company had no unrecognized compensation expense.

 

 
28

Table of Contents

 

12. Segments

 

The Company has one reportable segment: vehicle tracking and recovery solutions. The Company allocates resources to and assesses the performance of each reportable segment using information about its revenue and operating income (loss). The Company does not evaluate operating segments using discrete asset information.

 

Segmentation by geographical location is not presented as all revenues are earned in the U.S. Total assets by segment are not presented as that information is not used to allocate resources or assess performance at the segment level and is not reviewed by the Chief Operating Decision Maker of the Company.

 

13. Risks and Uncertainties

 

The Company extends credit to customers on an unsecured basis in the normal course of business. The Company’s policy is to perform an analysis of the recoverability of its receivables at the end of each reporting period and to establish allowances where appropriate. The Company analyzes historical bad debts and contract losses, customer concentrations, and customer credit-worthiness when evaluating the adequacy of the allowances.

 

During the year ended December 31, 2022 and 2021, the Company had four and two customers which accounted for 77% and 56%, respectively, of total invoiced amounts, which are recorded as deferred revenues and amortized over the related service period to revenues.

 

As of December 31, 2022 and 2021, the Company had three and one customers, respectively, which accounted for 99% and 99%, respectively, of the gross accounts receivable balance.

 

 
29

Table of Contents

 

14. Income Taxes

 

The Company’s income tax provision consists of the following:

 

 

 

2022

 

 

2021

 

Current:

 

 

 

 

 

 

Federal

 

$-

 

 

$-

 

State

 

 

800

 

 

 

808

 

Foreign

 

 

-

 

 

 

-

 

Total Current

 

 

800

 

 

 

808

 

Deferred:

 

 

 

 

 

 

 

 

Federal

 

 

-

 

 

 

-

 

State

 

 

-

 

 

 

-

 

Foreign

 

 

-

 

 

 

-

 

Total Deferred

 

 

-

 

 

 

-

 

Provision for income taxes

 

$800

 

 

$808

 

 

A reconciliation of income taxes computed by applying the statutory U.S. income tax rate to the Company’s loss before income taxes to the income tax provision is as follows:

 

 

 

2022

 

 

2021

 

Computed tax benefit at federal statutory rate

 

$(190,596 )

 

$764,147

 

State taxes

 

 

632

 

 

 

638

 

Permanent items

 

 

75

 

 

 

75

 

Stock-based compensation

 

 

175,196

 

 

 

8,829

 

Incentive stock options

 

 

-

 

 

 

-

 

Conversion feature derivative liability

 

 

-

 

 

 

-

 

Interest expense, derivative liability

 

 

-

 

 

 

-

 

Uncertain tax positions

 

 

-

 

 

 

-

 

Impact of difference related to foreign earnings

 

 

-

 

 

 

-

 

Gain on extinguishment of debt

 

 

-

 

 

 

-

 

Change in fair value of derivative liability

 

 

10,225

 

 

 

16,661

 

Valuation allowance

 

 

5,268

 

 

 

(789,542 )

Provision for income taxes

 

$800

 

 

$808

 

 

Deferred tax assets and liabilities reflect the net tax effects of temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes. Significant components of the Company’s deferred tax assets are as follows:

 

 

 

2022

 

 

2021

 

Deferred Tax Assets:

 

 

 

 

 

 

Net operating loss carryforwards

 

$2,967,000

 

 

$604,000

 

Stock-based compensation

 

 

529,000

 

 

 

767,000

 

Accounts receivable and other timing differences

 

 

140,000

 

 

 

138,000

 

Basis difference in assets and debt

 

 

(80,000 )

 

 

(71,000 )

Total Deferred Tax Asset

 

 

3,556,000

 

 

 

1,438,000

 

Valuation allowance

 

 

(3,556,000 )

 

 

(1,438,000 )

Net Deferred Tax Asset

 

$-

 

 

$-

 

 

Realization of deferred tax assets is dependent upon future earnings, if any, the timing and amount of which are uncertain. Accordingly, the net deferred tax assets for the U.S. federal and state have been fully offset by a valuation allowance.

 

As of December 31, 2022, the Company had net operating loss carryforwards for federal and state income tax purposes of $9,970,000 and $9,739,000, respectively, which expire beginning in the year 2029.

 

 
30

Table of Contents

 

The Company is required to file US federal and California tax returns, however the Company has not filed its federal or state returns since 2009 Due to the Company’s loss position the statute remains open for any losses carried over into the current year which means all years from 2007 remain open to examination.

 

The Company has adopted FASB ASC 740, “Income Taxes” to account for income taxes. ASC 740 clarifies the accounting for uncertainty in income taxes recognized in an enterprise’s financial statement. This standard prescribes a recognition threshold and measurement attribute for the financial statement recognition and measurement of a tax position taken or expected to be taken in the tax return. ASC 740 also provides guidance on derecognition of tax benefits, classification on the balance sheet, interest and penalties, accounting in interim periods, disclosure and transaction. In accordance with ASC 740-10-50, the Company is classifying interest and penalties as a component of tax expense.

 

The Company has a reserve related to unrecognized tax positions of $90,000 as of December 31, 2022, which is presented as part of accounts payable and accrued liabilities. These unrecognized tax positions, if recognized, would affect the effective tax rate. A reconciliation of the change in the unrecognized tax positions for the year ended December 31, 2022 is as follows:

 

 

 

Federal

and

State

 

Balance at January 1, 2022

 

$90,000

 

Additions for tax positions related to current year

 

 

-

 

Additions for tax positions related to prior years

 

 

-

 

Balance at December 31, 2022

 

$90,000

 

 

15. Commitments and Contingencies

 

Withheld Payroll Taxes

 

Since its inception, the Company has made several payments to employees for wages, net of state and federal income taxes. Due to cash constraints, the Company has not yet remitted all of these withheld amounts to the appropriate government agency. Accordingly, as of December 31, 2022 and 2021 the Company has recorded $37,984 and $37,984, respectively, related to this obligation in accounts payable and accrued liabilities, including estimated penalties and interest.

 

Operating Lease

 

On September 1, 2021 the Company entered into a lease for office space under an operating lease for approximately 2,500 square feet in Lake Elsinore, California, which is set to expire on October 31, 2024.

 

Operating lease assets and liabilities are recognized at the lease commencement date. Operating lease liabilities represent the present value of lease payments not yet paid. Operating lease assets represent our right to use an underlying asset and are based upon the operating lease liabilities as adjusted for prepayments or accrued lease payments, initial direct costs, lease incentives, and impairment of operating lease assets. To determine the present value of lease payments not yet paid, the Company estimates incremental secured borrowing rates corresponding to the maturities of the leases.

 

The Company’s lease contains rent escalations over the lease term. The Company recognizes expense for these leases on a straight-line basis over the lease term. Additionally, tenant incentives used to fund leasehold improvements are recognized when earned and reduce our right-of-use asset related to the lease. These are amortized through the right-of-use asset as reductions of expense over the lease term. The Company’s lease agreements do not contain any material residual value guarantees or material restrictive covenants.

 

The Company has elected the short-term lease recognition exemption for all applicable classes of underlying assets. Short-term disclosures include only those leases with a term greater than one month and 12 months or less, and expense is recognized on a straight-line basis over the lease term. Leases with an initial term of 12 months or less, that do not include an option to purchase the underlying asset that the Company is reasonably certain to exercise, are not recorded on the consolidated balance sheet.

 

The components of lease expense were as follows:

 

 

 

Year Ended

December 31,

 

 

 

2022

 

 

2021

 

Operating lease cost

 

$31,129

 

 

$5,438

 

 

 

 
31

Table of Contents

 

Other information related to leases was as follows:

 

 

 

Year Ended

December 31,

 

 

 

2021

 

 

2020

 

Supplemental Cash Flows Information

 

 

 

 

 

 

Cash paid for amounts included in the measurement of lease liability:

 

 

 

 

 

 

Operating cash flows from operating lease

 

$26,210

 

 

$7,785

 

Operating lease asset obtained in exchange for lease liability:

 

 

 

 

 

 

 

 

Operating lease

 

$-

 

 

$81,668

 

Remaining lease term

 

 

 

 

 

 

 

 

Operating lease

 

1.83 years

 

 

2.83 years

 

Discount rate

 

 

 

 

 

 

 

 

Operating lease

 

 

12.00%

 

 

12.00%

 

Future payments under noncancelable operating leases having initial or remaining terms of one year or more are as follows for the succeeding fiscal year and thereafter:

 

 

 

For the Years Ended

December 31,

 

 

 

 

 

2023

 

$33,244

 

2024

 

 

28,610

 

Total minimum lease payments

 

 

61,854

 

Less imputed interest

 

 

(6,646 )

Present value of lease liabilities

 

 

55,208

 

Less current portion of operating lease liability (included in accounts payable and accrued expenses)

 

 

(28,110 )

Non-current operating lease liability

 

$27,098

 

 

Indemnities and Guarantees

 

We have made certain indemnities and guarantees, under which we may be required to make payments to a guaranteed or indemnified party, in relation to certain transactions. We indemnify our officers and directors to the maximum extent permitted under the laws of the State of Nevada. The duration of these indemnities and guarantees varies and, in certain cases, is indefinite. These indemnities and guarantees do not provide for any limitation of the maximum potential future payments we could be obligated to make. Historically, we have not been obligated to make any payments for these obligations and no liabilities have been recorded for these indemnities and guarantees in the accompanying consolidated balance sheets.

 

Legal Matters

 

In the ordinary course of business, we may face various claims brought by third parties and may, from time to time, make claims or take legal actions to assert our rights, including intellectual property disputes, contractual disputes and other commercial disputes. Any of these claims could subject us to litigation. Management believes there are currently no claims that are likely to have a material effect on our consolidated financial position and results of operations.

 

 
32

Table of Contents

 

16. Subsequent Events

 

On February 15, 2023, the Company issued 20,000,000 shares of common stock to its CEO, valued at $21,000.

 

On February 22, 2023, the Company issued 34,064,050 shares of common stock for cash proceeds of $32,974.

 

On March 1, 2023, the Company issued 26,000,000 shares of common stock for the conversion of 25,000 shares of its Series A preferred stock.

 

On March 3, 2023, the Company issued 35,490,000 shares of common stock for the conversion of 34,125 shares of its Series A preferred stock.

 

The Company evaluates subsequent events and transactions that occur after the balance sheet date up to the date that the consolidated financial statements are available to be issued. Any material events that occur between the balance sheet date and the date that the consolidated financial statements were available for issuance are disclosed as subsequent events, while the consolidated financial statements are adjusted to reflect any conditions that existed at the balance sheet date. Based upon this review, except as disclosed within the footnotes or as discussed below, the Company did not identify any subsequent events that require adjustment or disclosure in the consolidated financial statements.

 

 
33

Table of Contents

 

Item 9. Changes in and Disagreements With Accountants on Accounting and Financial Disclosure.

 

No items noted.

 

Item 9A. Controls and Procedures.

 

Disclosure Controls and Procedures

 

The Company carried out an evaluation of the effectiveness of the Company’s disclosure controls and procedures with the participation of all the Company’s executives, the effectiveness of the Company’s disclosure controls and procedures as of December 31, 2022. The conclusions of the Company’s principal executives was that the controls and procedures in place were effective such that the information required to be disclosed in our SEC reports was a) recorded, processed, summarized and reported within the time periods specified in SEC rules and forms, and b) accumulated and communicated to our management, including our chief executive offer and chief operation officer, as appropriate to allow timely decisions regarding required disclosure.

 

Internal Control over Financial Reporting

 

As of December 31, 2022, management assessed the effectiveness of our internal control over financial reporting. The Company’s management is responsible for establishing and maintain adequate internal control over financial reporting for the Company. Internal control over financial reporting is a set of processes designed by or under the supervision of the Company’s CEO, COO and CFO (or executives performing equivalent functions) to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with GAAP and includes those policies and procedures that:

 

·

pertain to the maintenance of records that in reasonable detail accurately and fairly reflect our transactions and dispositions of our assets;

 

 

·

provide reasonable assurance our transactions are recorded as necessary to permit preparation of our financial statements in accordance with GAAP, and that receipts and expenditures are being made only in accordance with authorizations of our management and directors;

 

 

·

provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use or disposition of our assets that could have a material effect on the financial statements.

 

Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Therefore, even those systems determined to be effective can provide only reasonable assurance of achieving their control objectives. In evaluating the effectiveness of our internal control over financial reporting, our management used the criteria set forth by the Committee of Sponsoring Organizations of the Treadway Commission (COSO) in Internal Control – Integrated Framework (2013). Based on that evaluation, they concluded that during the period covered by this report, though there are weaknesses in the Company’s internal controls, given the current size of the organization, such internal controls and procedures as were in place were adequately effective to detect the inappropriate application of US GAAP. We did not identify any material weaknesses.

 

Changes in Internal Control over Financial Reporting

 

There has been no change in our internal control over financial reporting identified in connection with our evaluation we conducted of the effectiveness of our internal control over financial reporting as of December 31, 2022, that occurred during our fourth fiscal quarter that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.

 

This annual report does not include an attestation report of the Company’s independent registered public accounting firm regarding internal control over financial reporting. Management’s report was not subject to attestation by the Company’s independent registered public accounting firm pursuant to temporary rules of the Securities and Exchange Commission that permit our company to provide only management’s report in this annual report.

 

Item 9B. Other Information.

 

During the fourth quarter of the fiscal year ended December 31, 2022, there was no information required to be reported on Form 8-K which was not previously reported.

 

 
34

Table of Contents

 

PART III

 

Item 10. Directors, Executive Officers and Corporate Governance.

 

Directors and Executive Officers

 

The following lists the directors and executive officers of the Company as of March 30, 2023:

 

Name

 

Age

 

 

Position

 

Term of Office

 

Robert Nealon

 

 

67

 

 

Director, Chairman of the Board

 

July 8, 2010 to present

 

Neil G. Chan

 

 

61

 

 

Director, Chief Executive Officer

 

September 1, 2011 to present

 

Mark Wells

 

 

61

 

 

Director

 

January 17, 2018 to present

 

Abel I. Sierra

 

 

50

 

 

Director, Chief Operating Officer

 

September 15, 2017 to present

 

 

Business Experience

 

The following are brief backgrounds on the Directors and Officers of the Company

 

Robert Nealon, Chairman of the Board & Director

Mr. Nealon is the Principal Attorney in Nealon & Associates, P.C., and a Washington, D.C. based law and government relations firm. He has been practicing law for twenty-seven years and has achieved an AV rating from Martindale-Hubbell, the leading rating bureau for the legal profession. Mr. Nealon has a B.A. from University of Rochester (1977) and M.B.A. from Rochester Institute of Technology (1978). He received his Juris Doctorate, magna cum laude, from the University of Bridgeport in 1982 and his Masters of Law in Taxation (L.L.M.) degree from Georgetown University in 1984. He is a member of the bar associations of New York State and Virginia, the American Bar Association and the Federal Bar Association. Mr. Nealon served as Adjunct Instructor of Corporate Law, George Washington University from 1985 until 2005. Mr. Nealon has been lead counsel on hundreds of commercial trials, including multi-million dollar derivative action lawsuits, security fraud and government contract fraud. He has been counsel to hundreds of corporations, including insurance affinity marketing, manufacturing and multiple financial institutions. Mr. Nealon has been active over the years in national politics and government relations.

 

Mr. Nealon was appointed to the Virginia Small Business Advisory Board by former Virginia Governor Warner and was reappointed to this state board by Governor Kaine through 2010 as its Chairman. Mr. Nealon is also a current appointee to the George Mason University Advisory Board for the Institute for Conflict Analysis and Resolution in Arlington. He is also a member of the National Press Club and the Democratic National Club.

 

Neil G. Chan, Chief Executive Officer & Director

Mr. Chan is a career technologist who has pioneered disruptive technologies in more than 45 countries over the last 30 years. From start-up to $400M in annual revenues, Mr. Chan has led and created the best-in-class sales, marketing, and service organizations during the development of wireless data infrastructure, mobile solutions, Software-as-a-Service for commercial fleets, and Hybrid-Fiber-Cable(HFC) broadband infrastructure and solutions. Mr. Chan led the first technology transfer initiative between Canada and Mainland China on behalf of Spar Aerospace and Gandalf Technologies Inc., along with training, product marketing and sales responsibilities for growing Gandalf’s export markets. During early development of mobile data solutions, Mr. Chan was recruited to Motorola Inc., to lead the product marketing and development of the industry’s first mobile data solutions for public safety, taxi, utility, and field service markets. As Motorola’s Managing Director, Mr Chan lead the expansion of HFC broadband voice and data networks throughout the Asia Pacific region growing to $400M in annual revenues during the first three years of business formation. Along with founding members of the cable modem industry, Mr. Chan joined Airvana Inc., to lead business development for the early adoption of broadband wireless networks, leading to the industry’s first deployment of CDMA-based wireless broadband networks in North America. Most recently, Mr. Chan led worldwide sales and marketing of fleet management services for WebTech Wireless Inc., contributing five years of record growth and industry leadership across government and transportation markets. Mr. Chan has served on the Executive Review Board of Royal Roads University and continues to mentor and support early stage technology companies.

 

Mark Wells, Director

Mr. Wells is presently the President and CEO of Positioning Universal. During his 25 years of experience in the wireless industry, he has pioneered the development and marketing of wireless products, semiconductor technology, and leading edge wireless services. Mr. Wells co-founded DriveOK, which merged with Procon and eventually became Spireon where he led the company during its growth period in becoming the industry leader of GPS vehicle tracking technologies. Prior to Procon, Mr. Wells was the co-founder and CEO of Zucotto Wireless, where he raised $60M in venture capital to develop wireless semiconductor technologies and secured customers that included Panasonic, Nokia, and Alcatel. Mr. Wells has also held marketing roles with Nokia Mobile Phones where he managed a $10B revenue value of mobile phone products, and later served as Vice President & General Manager at DSP Communications which was eventually sold to Intel for $1.6B. Most recently, Mr. Wells has co-founded and mentored several dozen early-stage technology companies and served as a consultant to Fortune 500 companies.

 

Abel Sierra, Chief Operating Officer & Director

Mr. Sierra has served as President of the Antelope Valley Hispanic Chamber of Commerce (AVHCC) - the first President elected to a second term in the organization’s 20 year history. AVHCC’s mission is to provide Hispanic entrepreneurship, community growth, and development, by supporting economic programs designed to strengthen and expand the potential of all business. Prior and concurrent to Mr. Sierra’s role with AVHCC was his position as Agency Vice President of HBW Insurance and Financial Services. Mr. Sierra served as an Independent Associate with Legal Shield, Regional Vice President for Primerica Financial Services, marketing Representative for 21 st Century/AIG direct, community Representative for Palmdale School District and Palmdale Head Start. Mr. Sierra also served 14 years as a Counter Intelligence Specialist with the United States Marine Corps.

 

 
35

Table of Contents

 

Code of Ethics

 

The Company has not yet adopted a complete code of ethics policy as defined in Item 406 of Regulation S-K, however the company has adopted a disclosure policy that applies to all directors, officers and employees of the Company, as part of a program to establish a comprehensive code of ethics. The Company’s disclosure policy is available on its website www.igennetworks.net

 

Audit Committee and Financial Expert

 

The Company does not have an audit committee. The functions of an audit committee are done by the board of directors as a whole, as specified in section 3(a)(58)(B) of the Exchange Act. As such, the Company has no audit committee financial expert serving on an audit committee.

 

Item 11. Executive Compensation.

 

Summary Compensation Table

 

Name and principal position

 

Year

 

Salary

($)(1)

 

 

Stock

awards

($)

 

 

Option

awards

($)(2)

 

 

Total

($)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Neil G. Chan – CEO & Director

 

2022

 

 

142,000

 

 

 

9,000

 

 

 

0

 

 

 

149,000

 

Neil G. Chan – CEO & Director

 

2021

 

 

142,000

 

 

 

0

 

 

 

0

 

 

 

142,000

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Abel I. Sierra – COO

 

2022

 

 

121,000

 

 

 

9,000

 

 

 

0

 

 

 

130,000

 

Abel I. Sierra – COO

 

2021

 

 

121,000

 

 

 

0

 

 

 

25,000

 

 

 

146,000

 

_____________

(1)

Salary for services as an executive officer. No compensation for services as a director

(2)

Valuation of Stock and Option awards are based on the issuance details listed in Note 11 to the Company’s consolidated financial statements for the year ended December 31, 2021.

 

Outstanding Equity Awards at Fiscal Year-end –

 

Name

 

Number of

securities

underlying

unexercised

options

 

 

Number of

securities

underlying

unexercised

options

 

 

Option

exercise

price

 

 

Option

expiration

date

 

 

 

(#)

 

 

(#)

 

 

($)

 

 

 

 

 

exercisable

 

 

un-exercisable

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Neil Chan, CEO

 

 

1,000,000

 

 

 

0

 

 

$0.04

 

 

15-May-24

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Abel Sierra, COO

 

 

500,000

 

 

 

0

 

 

$0.04

 

 

15-May-24

 

 

The Company currently has no unearned or unvested stock awards, or equity incentive plan awards of either options or stock.

 

Director Compensation 1

 

Name and principal position

 

Year

 

Salary

($)

 

 

Stock

awards

($)

 

 

Option

awards

($)

 

 

Total

($)

 

Robert Nealon

 

2022

 

 

0

 

 

 

9,000

 

 

 

0

 

 

 

9,000

 

Neil G. Chan

 

2022

 

 

0

 

 

 

9,000

 

 

 

0

 

 

 

9,000

 

Abel Sierra

 

2022

 

 

0

 

 

 

9,000

 

 

 

0

 

 

 

9,000

 

Mark Wells

 

2022

 

 

0

 

 

 

9,000

 

 

 

0

 

 

 

9,000

 

 

1 Provides information on Directors not serving as executive officers only. Compensation for directors also servicing as executive officers is listed in the summary compensation table at the beginning of this Item.

 

 
36

Table of Contents

 

Discussion of Executive and Director Compensation

 

Compensation of Directors

 

Directors received no cash compensation in 2022 but each received 5,000,000 shares of common stock..

 

Compensation of Executives

 

The CEO, Neil Chan who is also a director of the Company earned a salary of $142,000 in 2022, same as 2021. In 2019, Mr. Chan was granted another 1,000,000 stock options, resulting in a total of 1,000,000 options as of December 31, 2022.

 

Mr. Abel Sierra, COO, is paid $121,000 per annum. Mr. Sierra was granted 500,000 stock options during 2019. Mr. Sierra has a total of 500,000 stock options unexercised as of December 31, 2022.

 

There are currently no long term incentive plans or pension plans for directors or officers of the Company.

 

The Company does provide indemnity insurance coverage for directors and officers of the Company. Presently assessing alternative coverage.

 

Compensation Committee Interlocks and Insider Participation

 

The Company has no compensation committee. The board of directors as a whole acts in the capacity of a compensation committee. All executive officers of the Company are also directors of the Company and as such were and are able to vote on matters of compensation. Though the Company is not legally obligated to establish a compensation committee, we may do so when deemed advisable by the board.

 

Compensation Committee Report

 

As a smaller reporting company, the Company is not required to report the Compensation Discussion and Analysis required by Item 402(b) of Regulation S-K, and as such there was no review or recommendation as to its inclusion in this report.

 

Item 12. Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters.

 

The following tables list information that is accurate as of December 31, 2022.

 

Securities authorized for issuance under equity compensation plans

 

The following details securities authorized for issuance as of December 31, 2022.

 

Equity Compensation Plan Information

 

Plan category

 

Number of

securities to

be issued

upon exercise

of outstanding

options,

warrants

and rights

 

 

Weighted-average exercise

price of

outstanding

options,

warrants

and rights

 

 

Number of

securities

remaining

available for

future issuance

under equity

compensation

plans (excluding securities

reflected in

column (a))

 

 

 

(a)

 

 

(a)

 

 

(a)

 

Equity compensation plans approved by security holders

 

 

1,500,000

 

 

 

0.04

 

 

 

6,515,000

 

Equity compensation plans not approved by security holders

 

 

0

 

 

 

N/A

 

 

 

0

 

Total

 

 

1,500,000

 

 

 

0.04

 

 

 

6,515,000

 

 

 
37

Table of Contents

 

 

Security Ownership of Certain Beneficial Owners and Management

 

The table below sets forth information regarding the ownership of our common stock, as of December 31, 2022 unless otherwise indicated in the footnotes to the table, by (i) all persons known by us to beneficially own more than 5% of our common stock, (ii) each of our current directors and director nominees, (iii) our principal executive officer and our other executive officers who were serving as such at the end of Fiscal 2022 (each, a “named executive officer”), and (iv) all of our directors, director nominees and executive officers as a group. We know of no agreements among our stockholders that relate to voting or investment power over our common stock or any arrangement the operation of which may at a subsequent date result in a change of control of us.

 

Beneficial ownership is determined in accordance with applicable SEC rules and generally reflects sole or shared voting or investment power over securities. Under these rules, a person is deemed to be the beneficial owner of securities that the person has the right to acquire as of or within 60 days after December 31, 2022, upon the exercise of outstanding stock options or warrants, the conversion of outstanding convertible notes, or the exercise or conversion of any other derivative securities affording the person the right to acquire shares of our common stock. As a result, each person’s percentage ownership set forth in the table below is determined by assuming that all outstanding stock options, warrants or other derivative securities held by such person that are exercisable or convertible as of or within 60 days after December 31, 2022 have been exercised or converted. Except in cases where community property laws apply or as indicated in the footnotes to the table, we believe that each person identified in the table below possesses sole voting and investment power over all shares of common stock shown as beneficially owned by such person. All ownership percentages in the table are based on 2,007,815,097 shares of our common stock outstanding as of March 15, 2023.

 

 

 

Shares Beneficially

 

 

 

Owned

 

Name and Address of Beneficial Owner:

 

Number

 

 

Percent

 

5% Stockholders:

 

 

 

 

 

 

 

 

 

 

 

 

 

Directors and Executive Officers:

 

 

 

 

 

 

Neil Chan(2)

 

 

55,120,008

 

 

 

2.7%

Abel Sierra(3)

 

 

20,408,170

 

 

 

1.0%

Robert Nealon(4)

 

 

8,316,667

 

 

*

 

Mark Wells

 

 

5,960,785

 

 

*

 

All executive officers and directors as a group (4 persons)

 

 

89,805,630

 

 

 

4.5%

_________

*

Represents beneficial ownership of less than 1%.

(1)

not used

(2)

Represents 1,000,000 shares of Common Stock issuable upon the exercise of stock options that are or will be vested and exercisable within 60 days after December 31, 2022, and 54,120,008 outstanding shares of Common Stock.

(3)

Represents 500,000 shares of Common Stock issuable upon the exercise of stock options that are or will be vested and exercisable within 60 days after December 31, 2022, and 19,758,170 outstanding shares of Common Stock.

(4)

Not used

(5)

Not used

 

 
38

Table of Contents

 

Item 13. Certain Relationships and Related Transactions, and Director Independence.

 

Transactions with related persons, promoters and certain control persons

 

(a) During the years ended December 31, 2022 and 2021, the Company incurred approximately $145,000 and $147,000, respectively, in management and consulting fees with an officer and an entity controlled by him. As of December 31, 2022 and 2021, the Company owed approximately $5,000 and $9,000, respectively, to directors and officers and a company controlled by a director, which is included in accounts payable and accrued liabilities. The amounts owed are unsecured, non-interest bearing, and due on demand.

 

(b) During the years ended December 31, 2022 and 2021, the Company issued 0 and 4,608,173 shares of common stock for the conversion of $0 and $24,729, respectively of accrued expenses owed to the CEO and COO.

 

(c) During the year ended December 31, 2022 and 2021, the Company recorded approximately $0 and $8,000, respectively to the CEO and COO for rent and other office expenses.

 

Director Independence

 

In the USA, the Company’s common stock is listed on the OTC Link OTC Pink inter-dealer quotation system, and in Canada on the CSE, neither of which have director independence requirements.

 

Item 14. Principal Accounting Fees and Services.

 

Audit Fees

 

Aggregate fees billed for professional services rendered by the Company’s principal accountant for the audit of the Company’s annual financial statements, review of financial statements in quarterly filings, or services associated with statutory and regulatory filings for the last two fiscal years are as follows:

 

2021: $68,000

2022: $56,000

 

Audit Related Fees

 

Aggregate fees billed in the last two fiscal years for assurance and related services by the Company’s principal accountant that are reasonably related to the performance of the audit or review of the registrant’s financial statements and are not reported above are as follows:

 

2021: $0

2022: $0

 

Tax Fees

 

Aggregate fees billed in each of the last two fiscal years for professional services rendered by the Company’s principal accountant for tax compliance, tax advice, and tax planning are as follows:

 

2021: $0

2022: $0

 

All Other Fees

 

Aggregate fees billed in each of the last two fiscal years for products and services provided by the principal accountant, other than the services reported above, are as follows:

 

2021: $0

2022: $0

 

Audit Committee’s Pre-Approval Policies and Procedures

 

The Company does not at this time have an audit committee and no formal pre-approval policies or procedures have yet been implemented. The board of directors acting in lieu of an audit committee is required to pre-approve the engagement of the Company’s principle accountant for non-auditing services.

 

 
39

Table of Contents

 

PART IV

 

Item 15. Exhibits, Financial Statement Schedules.

 

(1) Financial statements:

- Audited Financial Statements for the year ended December 31, 2022

 

(2) Financial statement schedules

- none

 

(3) Exhibits

 

Exhibit Index

 

3(i)

 

Articles of Incorporation and amendments

3(ii)

 

Bylaws

21

 

Subsidiary Information

31.1

 

Certification – Rule 13(a)-14(a)/15d-14(a) - CEO

31.2

 

Certification – Rule 13(a)-14(a)/15d-14(a) - COO

32.1

 

Certification – Section 1350 - CEO

32.2

 

Certification – Section 1350 – COO

101.INS

 

XBRL Instance Document

101.SCH

 

XBRL Taxonomy Extension Schema Document

101.CAL

 

XBRL Taxonomy Extension Calculation Linkbase Document

101.DEF

 

XBRL Taxonomy Extension Definition Linkbase Document

101.LAB

 

XBRL Taxonomy Extension Label Linkbase Document

101.PRE

 

XBRL Taxonomy Extension Presentation Linkbase Document

 

 
40

Table of Contents

 

SIGNATURES

 

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

 

IGEN Networks Corp

 

 

 

 

 

April 17, 2023

By:

/s/ Neil Chan

 

 

 

Neil Chan,

 

 

 

Chief Executive Officer and Director

(Principal Executive Officer,

Principal Financial Officer and

Principal Accounting Officer)

 

 

 
41
EX-21 2 igen_ex21.htm SUBSIDIARY INFORMATION igen_ex21.htm

EXHIBIT 21

 

IGEN Networks Corp

Subsidiary Information

 

IGEN Networks Corporation has a one wholly-owned California subsidiary:

 

Name:  Nimbo Tracking LLC

Address:  31772 Casino Drive, Suite C. Lake Elsinore, CA 92530

Formation Number: 201732410071

Date of Formation:  November 13, 2017

EX-31.1 3 igen_ex311.htm CERTIFICATION igen_ex311.htm

EXHIBIT 31.1

 

Certification of CEO

 

I, Neil Chan, certify that:

 

1.

I have reviewed this Form 10-K of IGEN Networks;

 

 

2.

Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

 

3.

Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 

 

4.

The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a–15(e) and 15d–15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a–15(f) and 15d–15(f)) for the registrant and have:

 

 

(a)

Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

 

 

 

(b)

Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

 

 

 

(c)

Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

 

 

 

(d)

Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

 

5.

The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

 

 

(a)

All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

 

 

 

 

(b)

Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

April 17, 2023

 

 

 

/s/ Neil Chan

 

Neil Chan

 

Chief Executive Officer and Director

(Principal Executive Officer,

Principal Financial Officer and

Principal Accounting Officer)

 

EX-32.1 4 igen_ex321.htm CERTIFICATION igen_ex321.htm

EXHIBIT 32.1

 

CEO Certification

Pursuant to Section 1350 of Chapter 63 of Title 18 of the United States Code (18 U.S.C. 1350)

 

I, Neil Chan, certify that pursuant to Section 1350 of Chapter 63 of Title 18 of the United States Code (18 U.S.C. 1350), the 10-K report for IGEN Networks for the fiscal year ended December 31, 2022 as filed with the Securities Exchange Commission fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act and that the information contained therein fairly presents, in all material respects, the financial condition and results of operations of the IGEN Networks.

 

April 17, 2023

 

 

 

/s/ Neil Chan

 

Neil Chan,

Chief Executive Officer and Director

(Principal Executive Officer,

Principal Financial Officer and

Principal Accounting Officer)

 

EX-101.SCH 5 igen-20221231.xsd XBRL TAXONOMY EXTENSION SCHEMA 000001 - Document - Cover link:presentationLink link:calculationLink link:definitionLink 000002 - Statement - Consolidated Balance Sheets link:presentationLink link:calculationLink link:definitionLink 000003 - Statement - Consolidated Balance Sheets (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 000004 - Statement - Consolidated Statements of Operations link:presentationLink link:calculationLink link:definitionLink 000005 - Statement - Consolidated Statements of Redeemable Convertible Preferred stock and Stockholders Deficit link:presentationLink link:calculationLink link:definitionLink 000006 - Statement - Consolidated Statements of Cash Flows link:presentationLink link:calculationLink link:definitionLink 000007 - Disclosure - Organization and Description of Business link:presentationLink link:calculationLink link:definitionLink 000008 - Disclosure - Summary of Significant Accounting Policies link:presentationLink link:calculationLink link:definitionLink 000009 - Disclosure - Accounts and Other Receivables link:presentationLink link:calculationLink link:definitionLink 000010 - Disclosure - Goodwill link:presentationLink link:calculationLink link:definitionLink 000011 - Disclosure - Accounts Payable and Accrued Liabilities link:presentationLink link:calculationLink link:definitionLink 000012 - Disclosure - Convertible Debentures and Notes Payable link:presentationLink link:calculationLink link:definitionLink 000013 - Disclosure - Derivative Liabilities link:presentationLink link:calculationLink link:definitionLink 000014 - Disclosure - Related Party Transactions link:presentationLink link:calculationLink link:definitionLink 000015 - Disclosure - Redeemable Preferred Stock and Stockholders Deficit link:presentationLink link:calculationLink link:definitionLink 000016 - Disclosure - Share Purchase Warrants link:presentationLink link:calculationLink link:definitionLink 000017 - Disclosure - Stock Options link:presentationLink link:calculationLink link:definitionLink 000018 - Disclosure - Segments link:presentationLink link:calculationLink link:definitionLink 000019 - Disclosure - Risk and Uncertainities link:presentationLink link:calculationLink link:definitionLink 000020 - Disclosure - Income Taxes link:presentationLink link:calculationLink link:definitionLink 000021 - Disclosure - Commitments and Contingencies link:presentationLink link:calculationLink link:definitionLink 000022 - Disclosure - Subsequent Events link:presentationLink link:calculationLink link:definitionLink 000023 - Disclosure - Summary of Significant Accounting Policies (Policies) link:presentationLink link:calculationLink link:definitionLink 000024 - Disclosure - Summary of Significant Accounting Policies (Tables) link:presentationLink link:calculationLink link:definitionLink 000025 - Disclosure - Accounts and Other Receivables (Tables) link:presentationLink link:calculationLink link:definitionLink 000026 - Disclosure - Accounts Payable and Accrued Liabilities (Tables) link:presentationLink link:calculationLink link:definitionLink 000027 - Disclosure - Convertible Debentures and Notes Payable (Tables) link:presentationLink link:calculationLink link:definitionLink 000028 - Disclosure - Derivative Liabilities (Tables) link:presentationLink link:calculationLink link:definitionLink 000029 - Disclosure - Share Purchase Warrants (Tables) link:presentationLink link:calculationLink link:definitionLink 000030 - Disclosure - Stock Options (Tables) link:presentationLink link:calculationLink link:definitionLink 000031 - Disclosure - Income Taxes (Tables) link:presentationLink link:calculationLink link:definitionLink 000032 - Disclosure - Commitments and Contingencies (Tables) link:presentationLink link:calculationLink link:definitionLink 000033 - Disclosure - Organization and Description of Business (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 000034 - Disclosure - Summary of Significant Accounting Policies (Details) link:presentationLink link:calculationLink link:definitionLink 000035 - Disclosure - Summary of Significant Accounting Policies (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 000036 - Disclosure - Accounts and Other Receivables (Details) link:presentationLink link:calculationLink link:definitionLink 000037 - Disclosure - Goodwill (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 000038 - Disclosure - Accounts Payable and Accrued Liabilities (Details) link:presentationLink link:calculationLink link:definitionLink 000039 - Disclosure - Convertible Debentures and Notes Payable (Details) link:presentationLink link:calculationLink link:definitionLink 000040 - Disclosure - Convertible Debentures and Notes Payable (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 000041 - Disclosure - Derivative Liabilities (Details) link:presentationLink link:calculationLink link:definitionLink 000042 - Disclosure - Derivative Liabilities (Details 1) link:presentationLink link:calculationLink link:definitionLink 000043 - Disclosure - Derivative Liabilities (Details 2) link:presentationLink link:calculationLink link:definitionLink 000044 - Disclosure - Related Party Transactions (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 000045 - Disclosure - Redeemable Preferred Stock and Stockholders Deficit (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 000046 - Disclosure - Share Purchase Warrants (Details) link:presentationLink link:calculationLink link:definitionLink 000047 - Disclosure - Share Purchase Warrants (Details 1) link:presentationLink link:calculationLink link:definitionLink 000048 - Disclosure - Share Purchase Warrants (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 000049 - Disclosure - Stock Options (Details) link:presentationLink link:calculationLink link:definitionLink 000050 - Disclosure - Stock Options (Details 1) link:presentationLink link:calculationLink link:definitionLink 000051 - Disclosure - Stock Options (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 000052 - Disclosure - Risks Uncertainties (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 000053 - Disclosure - Income Taxes (Details) link:presentationLink link:calculationLink link:definitionLink 000054 - Disclosure - Income Taxes (Details 1) link:presentationLink link:calculationLink link:definitionLink 000055 - Disclosure - Income Taxes (Details 2) link:presentationLink link:calculationLink link:definitionLink 000056 - Disclosure - Income Taxes (Details 3) link:presentationLink link:calculationLink link:definitionLink 000057 - Disclosure - Income Taxes (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 000058 - Disclosure - Commitments and Contingencies (Details) link:presentationLink link:calculationLink link:definitionLink 000059 - Disclosure - Commitments and Contingencies (Details 1) link:presentationLink link:calculationLink link:definitionLink 000060 - Disclosure - Commitments and Contingencies (Details 2) link:presentationLink link:calculationLink link:definitionLink 000061 - Disclosure - Commitments and Contingencies (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 000062 - Disclosure - Subsequent Events (Details Narrative) link:presentationLink link:calculationLink link:definitionLink EX-101.LAB 6 igen-20221231_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE Cover [Abstract] Entity Registrant Name Entity Central Index Key Document Type Amendment Flag Entity Voluntary Filers Current Fiscal Year End Date Entity Well Known Seasoned Issuer Entity Small Business Entity Shell Company Entity Emerging Growth Company Entity Current Reporting Status Document Period End Date Entity Filer Category Document Fiscal Period Focus Document Fiscal Year Focus Entity Common Stock Shares Outstanding Entity Public Float Document Annual Report Document Transition Report Entity File Number Entity Incorporation State Country Code Entity Tax Identification Number Entity Interactive Data Current Entity Address Address Line 1 Entity Address Address Line 2 Entity Address City Or Town Entity Address State Or Province Entity Address Postal Zip Code City Area Code Local Phone Number Auditor Name Auditor Location Auditor Firm Id Consolidated Balance Sheets Statement [Table] Statement [Line Items] Statement Equity Components [Axis] Series B Preferred Stock [Member] Assets Current Assets Cash Accounts and other receivables, net Inventory Total Current Assets [Assets, Current] Deposits Operating lease asset, net Goodwill [Goodwill] Total Assets [Assets] Liabilities and Stockholders' Deficit Current Liabilities Accounts payable and accrued liabilities Current portion of deferred revenue, net of contract assets Notes payable, current portion Convertible debentures, current portion, net of discount of $0 and $30,586, respectively Derivative liabilities Total Current Liabilities [Liabilities, Current] Notes payable, net of current portion Operating lease liability, net of current portion Deferred revenue, net of contract assets and current portion Total Liabilities [Liabilities] Redeemable convertible preferred stock - Series A: Authorized - 1,250,000 shares with $0.001 par value, 214,500 shares and 199,375 shares issued and outstanding as of December 31, 2022 and 2021, respectively, aggregate liquidation preference of $218,222 and $203,463 as of December 31, 2022 and 2021, respectively, and net of discount of $59,954 and $101,317 as of December 31, 2022 and 2021, respectively Stockholders' Deficit Series B preferred stock - Authorized - 5,000,000 shares with $0.001 par value, issued and outstanding - 3,750,000 and 5,000,000 shares, as of December 31, 2022 and 2021, respectively Common stock: Authorized - 2,190,000,000 shares with $0.001 par value issued and outstanding - 1,890,261,047 and 1,476,869,532 shares as of December 31, 2022 and 2021, respectively Additional paid-in capital Accumulated Deficit [Retained Earnings (Accumulated Deficit)] Total Stockholders' Deficit [Stockholders' Equity Attributable to Parent] Total Liabilities and Stockholders' Deficit [Liabilities and Equity] Redeemable Convertible Preferred Stock [Member] Convertible debentures, current portion, discount Common stock, shares par value Common stock, shares authorized Common stock, shares issued Common stock, shares outstanding Series A Preferred stock, shares par value Series A Preferred stock, shares authorized Series A Preferred stock, shares issued Series A Preferred stock, shares outstanding Series A Preferred stock, discount Series A Preferred stock, Aggregate liquidation preference Preferred stock, shares par value Preferred stock, shares authorized Preferred stock, shares issued Preferred stock, shares outstanding Consolidated Statements of Operations Revenues: Sales, services Total Revenues [Revenues] Cost of goods sold Gross (Loss) Profit [Gross Profit] Expenses: Selling, general and administrative expenses Payroll and related Management and consulting fees Stock-based director expense Total Expenses [Operating Expenses] Loss Before Other Income (Expense) [Operating Income (Loss)] Other Income (Expense): Accretion of discounts on convertible debentures Change in fair value of derivative liabilities Gain on extinguishment of debt, net Interest expense [Interest Expense] Total Other Income (Expense), net [Other Nonoperating Income (Expense)] Net Loss before Provision for Income Taxes [Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest] Provision for Income Taxes [Income Tax Expense (Benefit)] Net Loss [Net Income (Loss) Attributable to Parent] Accrued and deemed dividend on redeemable convertible preferred stock [Preferred Stock Dividends and Other Adjustments] Net loss attributable to common stockholders [Net Income (Loss) Available to Common Stockholders, Basic] Basic and Diluted Loss per Common Share Weighted Average Number of Common Shares Outstanding Consolidated Statements of Redeemable Convertible Preferred stock and Stockholders Deficit Equity Components [Axis] Redeemable Convertible Preferred Stock Series A [Member] Common Stock Additional Paid-In Capital Accumulated Deficit Retained Earnings [Member] Series B Preferred Stocks [Member] Balance, shares [Shares, Issued] Balance, amount Shares of Series A preferred stock for cash, net of costs and discounts, shares Shares of Series A preferred stock for cash, net of costs and discounts, amount Accrued dividends on Series A preferred stock Conversion of Series A preferred shares to common stock, shares Conversion of Series A preferred shares to common stock, amount Issuance of Series B preferred stock, shares Issuance of Series B preferred stock, amount Shares of common stock issued for cash, shares Shares of common stock issued for cash, amount Shares of common stock issued for exercise of convertible note, including fees, shares Shares of common stock issued for exercise of convertible note, including fees, amount Stock-based compensation, shares Stock-based compensation, amount Cashless exercise of warrants, shares Cashless exercise of warrants, amount Issuance of common stock for conversion of payables, shares Issuance of common stock for conversion of payables, amount Issuance of common stock for commitment fee on equity line, shares Issuance of common stock for commitment fee on equity line, amount Issuance of common stock for loan extension, shares Issuance of common stock for loan extension, amount Net loss Issuance of shares to directors, shares Issuance of shares to directors, amount Issuance of shares for services, shares Issuance of shares for services, amount Issuance of shares for cash, net of commitment fees, shares Issuance of shares for cash, net of commitment fees, amount Repurchase of Series B Preferred Stock, shares Repurchase of Series B Preferred Stock, amount Balance, shares Balance, amount Consolidated Statements of Cash Flows Cash Flows from Operating Activities Net loss [Net Income (Loss), Including Portion Attributable to Noncontrolling Interest] Adjustments to reconcile net loss to net cash used in operating activities: Accretion of discounts on convertible debentures and preferred stock Change in fair value of derivative liabilities Interest charge for derivative liabilities in excess of face amount of debt Gain on settlement of debt Amortization of right of use asset Stock-based compensation Changes in operating assets and liabilities: Accounts and other receivables [Increase (Decrease) in Accounts and Other Receivables] Inventory [Increase (Decrease) in Inventories] Prepaid expenses and deposits [Increase (Decrease) in Prepaid Expense and Other Assets] Accounts payable and accrued liabilities [Increase (Decrease) in Accounts Payable and Accrued Liabilities] Deferred revenue, net Net Cash Used in Operating Activities [Net Cash Provided by (Used in) Operating Activities] Cash Flows from Financing Activities Proceeds from issuance of preferred stock, net of offering costs Proceeds from notes payable Repayment of lease liability [Finance Lease, Principal Payments] Repayment of notes payable [Repayments of Notes Payable] Repurchase of Series B preferred stock [Payments for Repurchase of Redeemable Preferred Stock] Proceeds from issuance of common stock Net Cash Provided by Financing Activities [Net Cash Provided by (Used in) Financing Activities] Change in Cash [Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect] Cash, Beginning of Year [Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents] Cash, End of Year Supplemental Disclosures: Interest paid Income taxes paid Non-cash Investing and Financing Activities: Conversion of notes payable and accrued interest: Fair value of common shares issued Derecognition of notes payable and accrued interest Derecognition of unamortized discount Derecognition of derivative liabilities Conversion of preferred stock: Fair value of common stock issued Derecognition of preferred stock Derecognition of unamortized discount [Derecognition of unamortized discount] Derecognition of derivative liabilities [Derecognition of derivative liabilities] Deemed divided Discount related to issuance of preferred stock Deemed dividends on preferred stock (excluding conversions) Cashless exercise of warrants Issuance of common shares for commitment fee on equity line Right of use asset Reclassification of security deposit to accounts payable Organization and Description of Business Organization and Description of Business Business Description and Basis of Presentation [Text Block] Summary of Significant Accounting Policies Summary of Significant Accounting Policies Significant Accounting Policies [Text Block] Accounts and Other Receivables Accounts and Other Receivables Accounts and Nontrade Receivable [Text Block] Goodwill Goodwill Goodwill Disclosure [Text Block] Accounts Payable and Accrued Liabilities Accounts Payable and Accrued Liabilities Accounts Payable and Accrued Liabilities Disclosure [Text Block] Convertible Debentures and Notes Payable Convertible Debentures and Notes Payable Short-Term Debt [Text Block] Derivative Liabilities Derivative Liabilities Derivatives and Fair Value [Text Block] Related Party Transactions Related Party Transactions Related Party Transactions Disclosure [Text Block] Redeemable Preferred Stock and Stockholders Deficit Redeemable Preferred Stock and Stockholders' Deficit Share Purchase Warrants Share Purchase Warrants [Share Purchase Warrants] Stock Options Stock Options Share-Based Payment Arrangement [Text Block] Segments Segments Segment Reporting Disclosure [Text Block] Risk and Uncertainities Risk and Uncertainities Concentration Risk Disclosure [Text Block] Income Taxes Income Taxes Income Tax Disclosure [Text Block] Commitments and Contingencies Commitments and Contingencies Commitments and Contingencies Disclosure [Text Block] Subsequent Events Subsequent Events Subsequent Events [Text Block] Basic of Presentation and Consolidation Use of Estimates Cash and Cash Equivalents Accounts Receivable Inventory Inventory, Policy [Policy Text Block] Equipment Goodwill Goodwill and Intangible Assets, Goodwill, Policy [Policy Text Block] Impairment of Long-lived Assets Fair Value Measurements and Financial Instruments Revenue Recognition and Deferred Revenue Financing Costs and Debt Discount Income Taxes Income Tax, Policy [Policy Text Block] Stock-based Compensation Derivative Financial Instruments Loss Per Share Recent Accounting Pronouncements Summary of Property, Plant and Equipment Schedule of Accounts and Other Receivables Schedule of Accounts Payable and Accrued Liabilities Schedule of Maturities of Long-term Debt Schedule of Assumptions Used to Value Conversion Features Outstanding Summary of Fair Value of Derivative Liabilities on Recurring Basis Schedule of Derivative Liabilities Measured at Fair Value Schedule of Activity of Share Purchase Warrants Schedule of Share Purchase Warrants Outstanding Schedule of Stock Options Roll Forward Schedule of Income Tax Provision Schedule of Reconciliation of Income Tax Expense Schedule of Deferred Tax Assets Schedule of Unrecognized Tax Benefits Summary of Operating Lease Expense Schedule of Other Informatoin Related to Opearting Lease Schedule Future Payments Under Non Cancelable Operating Leases Working capital deficit Accumulated Deficit Long-Lived Tangible Asset [Axis] Computer Equipment [Member] Office Equipment [Member] Software [Member] Property, Plant and Equipment, Depreciation Methods Property, Plant and Equipment, Useful Life Operating Activities [Axis] Balance Sheet Location [Axis] Range [Axis] Deferred revenues outstanding [Member] Contract asset balance [Member] Minimum [Member] Maximum [Member] Additional deferred revenue Potentially dilutive shares outstanding Revenues recognized Deferred revenue Allowance for doubtful accounts Renewal fee term Trade accounts receivable Allowance for doubtful accounts [Accounts Receivable, Allowance for Credit Loss, Current] Accounts and other receivables Goodwill Trade accounts payable Accrued liabilities Lease liability, current portion Accrued interest payable Payroll and commissions payable Unrecognized tax position Accounts payable and accrued liabilities Short-Term Debt, Type [Axis] Convertible Notes [Member] Notes Payable [Member] 2023 2024 2025 2026 2027 Thereafter Total [Long-Term Debt] Debt Instrument [Axis] Plan Name [Axis] Related Party [Axis] Award Date [Axis] Promissory Note [Member] PPP Loan [Member] SBA Loans [Member] Convertible Promissory Note [Member] Crown Bridge Partners, LLC [Member] Minimum [Member] Investor [Member] Maximum [Member] July 10, 2020 [Member] Common Stock Purchase Warrant Agreement [Member] Securities Purchase Agreement [Member] Holder [Member] Proceeds from notes payable Proceeds from notes payable [Proceeds from notes payable] Debt conversion, converted instrument, principal, accrued interest, and fees Debt conversion, converted instrument, shares issued Changes in derivative liability Reduction in debt discount Interest expense Debt discount Interest rate Accrued interest Debt maturity Additional proceeding, description Note payble Borrowed additional under the note Weekly payments Three separate notes total principal Derivative liability, embedded conversion feature Variable conversion price percentage First tranche, principal amount Outstanding note Debt instrument decrease, forgiveness Monthly principal and interest payments Issuance of warrants to purchase common stock Exercise price Warrants [Member] Expected volatility Risk free interest rate Expected life (in years) Derivative liabilities Derivative Liability [Abstract] Derivative liabilities [Derivative liabilities] Embedded conversion feature - convertible debt Embedded conversion feature - preferred stock Embedded Conversion Features - Debt Instrument Balances, as of the beginning of the year Derivative liabilities recorded upon issuance of debt instrument Extinguishment due to conversion of debt instruments [Extinguishment of Debt, Amount] Net changes in fair value included in net loss Ending balance Embedded Conversion Features - Preferred Stock Balances, as of the beginning of the year [Balances, as of the beginning of the year] Derivative liabilities recorded upon issuance of preferred stock Extinguishment due to conversion of preferred stock Net changes in fair value included in net loss [Net changes in fair value included in net loss] Ending balance [Ending balance] Total ending balance Officer [Member] Director [Member] VP and General Manager [Member] CEO and VP [Member] Management and consulting fees Debt conversion, converted instrument, accrued interest Debt conversion, converted instrument, shares issued Due to Related Parties Rent and other office expenses Series B Super Voting Preferred Stock [Member] Holder [Member] Series A Convertible Preferred Stock [Member] Common Shares [Member] Series A Preferred Stock [Member] February 1 2021 [Member] March 1 2021 [Member] April 5 2021 [Member] April 30 2021 [Member] June 17 2021 [Member] August 11, 2021 [Member] September 13, 2021 [Member] December 27, 2021 [Member] February 2, 2022 [Member] March 24, 2022 [Member] April 26, 2022 [Member] May 20, 2022 [Member] August 23, 2022 [Member] September 26, 2022 [Member] November 2, 2022 [Member] December 14, 2022 [Member] Rights and Privileges of the Series A Preferred Stock [Member] Series A Preferred Stock Purchase Agreements [Member] Investor [Member] Preferred stock, par value Shares of common stock cashless exercise of warrants Common stock for services provided by a vendor Common stock for the exercise of a warrant on a cashless basis Common stock as a commitment fee for a new equity line of credit common stock for services provided by management and the board of directors Common stock shares issued upon conversion of preferred stock and accrued dividend Number of shares sold common stock Proceeds from issuance of stock Common stock shares issued upon conversion of preferred stock and accrued dividend [Stock Issued During Period, Shares, Conversion of Convertible Securities] Preferred stock shares converted Common stock for the conversion of debt and accrued interest Changes in derivative liability Deemed dividend Reduction of debt discount Preferred stock shares authorized Common stock shares issued in connection with convertible debt/equity Shares issued, shares Proceeds amount Voting right Repurchase share price Repurchased share Preferred stock, value Stock based compensation expense Proceeds from issuance of stock Shares issued for cash, shares Derivative liabilities [Derivative liabilities 1] Issued shares for the cashless exercise of warrants Dividend, percentage Dividend, percentage increased Mandatory Redemption, description Liquidation preference, description Stock conversion, description Warrants [Member] Number of warrants, beginning balance [Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Outstanding, Number] Number of warrants, issued Number of warrants, Adjusted for triggered down-round provisions Number of warrants, exercised [Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Exercised] Number of warrants, expired [Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Expirations] Number of warrants, ending balance Weighted average exercise price, beginning balance [Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price] Weighted average exercise price, issued Weighted average exercise price, adjusted for triggered down-round provisions Weighted average exercise price, exercised Weighted average exercise price, expired Weighted average exercise price, ending balance Financial Instrument [Axis] Warrants At 0.03 [Member] Warrants At 0.00 [Member] Number of warrants outstanding Exercise price (in Dollars per share) Expiry date Number of warrants, exercised [Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period] Issuance of shares of common stock Stock Option [Member] Number of options, beginning balance [Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number] Number of options, Granted Number of options, exercised Number of options, Cancelled / Forfeited [Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Expirations in Period] Number of options, ending balance Number of options, Vested Number of options, Unvested Weighted average exercise price, Granted Weighted average exercise price, Exercised Weighted average exercise price Cancelled / Forfeited Weighted average exercise price, Vested Weighted average exercise price, Unvested Aggregate intrinsic value, Nonvested Aggregate intrinsic value, beginning balance [Aggregate intrinsic value, beginning balance] Aggregate intrinsic value, ending balance Aggregate intrinsic value, unvasted Share Based Compensation Shares Authorized Under Stock Option Plans By Exercise Price Range Axis Options 0.04 [Member] Range of exercise prices Options Outstanding, Number of shares (in Shares) Options Outstanding, Weighted average remaining contractual life Options Outstanding, Weighted average exercise price Options Exercisable, Number of shares (in Shares) Options Exercisable, Weighted average exercise price Stock option plan [Member] Common stock shares reserved under plan Risks Uncertainties (Details Narrative) Concentration Risk Type [Axis] Customer Concentration Risk Sales Revenue, Net [Member] Accounts Receivable [Member] Concentration Risk, Percentage Current: Federal State Foreign Total Current Deferred: Federal [Deferred Federal Income Tax Expense (Benefit)] State [Deferred State and Local Income Tax Expense (Benefit)] Foreign [Deferred Foreign Income Tax Expense (Benefit)] Total Deferred Provision for Income Taxes [Provision for Income Taxes] Measurement Input Type Axis Reconciliation of income taxes [Member] Computed tax benefit at federal statutory rate State taxes Permanent items Stock-based compensation [Effective Income Tax Rate Reconciliation, Tax Expense (Benefit), Share-Based Payment Arrangement, Amount] Incentive stock options Conversion feature derivative liability Interest expense, derivative liability Uncertain tax positions Impact of difference related to foreign earnings Gain on extinguishment of debt Change in fair value of derivative liability Valuation allowance Provision for income taxes Deferred Tax Assets: Net operating loss carryforwards Stock-based compensation [Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-Based Compensation Cost] Accounts receivable and other timing differences Basis difference in assets and debt Total Deferred Tax Asset Valuation allowance [Valuation allowance] Net Deferred Tax Asset Geographic Distribution Axis Federal and State [Member] Unrecognized tax benefit, beginning Additions for tax positions related to current year Additions for tax positions related to prior years Unrecognized tax benefit, ending Net operating loss carryforwards, federal Net operating loss carryforwards, state Operating loss carry forward, expiry date, description Unrecognized tex benefit Operating lease cost Supplemental Cash Flows Information Cash paid for amounts included in the measurement of lease liability: Operating cash flows from operating lease Operating lease asset obtained in exchange for lease liability: Operating lease Remaining lease term Operating lease Discount rate Operating lease 2023 [Operating Leases, Future Minimum Payments Due, Next 12 Months] 2024 [Operating Leases, Future Minimum Payments, Due in Two Years] Total minimum lease payments Less imputed interest [Lessee, Operating Lease, Liability, Undiscounted Excess Amount] Present value of lease liabilities Less current portion of operating lease liability [Less current portion of operating lease liability] Non-current operating lease liability Obligation in accounts payable and liabilities Lease for office space under an operating lease Operating lease expired date Subsequent Event Type Axis Series A Preferred shares [Member] Subsequent Event [Member] CEO [Member] Preferred stock, shares converted into common stock Common stock shares issued duriing period shares Cash Proceeds Common stock shares issued duriing period, value The value of the financial instrument(s) that the original debt is being converted into in a noncash (or part noncash) transaction. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period. EX-101.CAL 7 igen-20221231_cal.xml XBRL TAXONOMY EXTENSION CALCULATION LINKBASE EX-101.PRE 8 igen-20221231_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE EX-101.DEF 9 igen-20221231_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE GRAPHIC 10 igen_10kimg7.jpg begin 644 igen_10kimg7.jpg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igen_10kimg17.jpg begin 644 igen_10kimg17.jpg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end XML 12 R1.htm IDEA: XBRL DOCUMENT v3.23.1
Cover - USD ($)
12 Months Ended
Dec. 31, 2022
Mar. 15, 2023
Jun. 30, 2022
Cover [Abstract]      
Entity Registrant Name IGEN Networks Corp.    
Entity Central Index Key 0001393540    
Document Type 10-K    
Amendment Flag false    
Entity Voluntary Filers No    
Current Fiscal Year End Date --12-31    
Entity Well Known Seasoned Issuer No    
Entity Small Business true    
Entity Shell Company false    
Entity Emerging Growth Company false    
Entity Current Reporting Status Yes    
Document Period End Date Dec. 31, 2022    
Entity Filer Category Non-accelerated Filer    
Document Fiscal Period Focus FY    
Document Fiscal Year Focus 2022    
Entity Common Stock Shares Outstanding   2,007,815,097  
Entity Public Float     $ 4,452,725
Document Annual Report true    
Document Transition Report false    
Entity File Number 333-141875    
Entity Incorporation State Country Code NV    
Entity Tax Identification Number 20-5879021    
Entity Interactive Data Current Yes    
Entity Address Address Line 1 31772 Casino Drive    
Entity Address Address Line 2 Suite C    
Entity Address City Or Town Lake Elsinore    
Entity Address State Or Province CA    
Entity Address Postal Zip Code 92530    
City Area Code 1    
Local Phone Number 855-912-5378    
Auditor Name GreenGrowthCPAs    
Auditor Location Los Angeles, California    
Auditor Firm Id 6580    
XML 13 R2.htm IDEA: XBRL DOCUMENT v3.23.1
Consolidated Balance Sheets - USD ($)
Dec. 31, 2022
Dec. 31, 2021
Current Assets    
Cash $ 0 $ 64,429
Accounts and other receivables, net 21,902 38,754
Inventory 30,141 71,183
Total Current Assets 52,043 174,366
Deposits 5,722 5,722
Operating lease asset, net 53,017 76,230
Goodwill 505,508 505,508
Total Assets 616,290 761,826
Current Liabilities    
Accounts payable and accrued liabilities 360,227 678,347
Current portion of deferred revenue, net of contract assets 81,066 65,715
Notes payable, current portion 596,746 114,338
Convertible debentures, current portion, net of discount of $0 and $30,586, respectively 37,000 89,064
Derivative liabilities 111,010 136,902
Total Current Liabilities 1,186,049 1,084,366
Notes payable, net of current portion 160,736 152,147
Operating lease liability, net of current portion 27,098 55,211
Deferred revenue, net of contract assets and current portion 81,632 79,770
Total Liabilities 1,455,515 1,371,494
Redeemable convertible preferred stock - Series A:    
Authorized - 1,250,000 shares with $0.001 par value, 214,500 shares and 199,375 shares issued and outstanding as of December 31, 2022 and 2021, respectively, aggregate liquidation preference of $218,222 and $203,463 as of December 31, 2022 and 2021, respectively, and net of discount of $59,954 and $101,317 as of December 31, 2022 and 2021, respectively 138,429 84,022
Stockholders' Deficit    
Common stock: Authorized - 2,190,000,000 shares with $0.001 par value issued and outstanding - 1,890,261,047 and 1,476,869,532 shares as of December 31, 2022 and 2021, respectively 1,890,262 1,476,870
Additional paid-in capital 17,298,474 16,900,962
Accumulated Deficit (20,170,140) (19,076,522)
Total Stockholders' Deficit (977,654) (693,690)
Total Liabilities and Stockholders' Deficit 616,290 761,826
Series B Preferred Stock [Member]    
Stockholders' Deficit    
Series B preferred stock - Authorized - 5,000,000 shares with $0.001 par value, issued and outstanding - 3,750,000 and 5,000,000 shares, as of December 31, 2022 and 2021, respectively $ 3,750 $ 5,000
XML 14 R3.htm IDEA: XBRL DOCUMENT v3.23.1
Consolidated Balance Sheets (Parenthetical) - USD ($)
Dec. 31, 2022
Dec. 31, 2021
Convertible debentures, current portion, discount $ 0 $ 30,586
Common stock, shares par value $ 0.001 $ 0.001
Common stock, shares authorized 2,190,000,000 2,190,000,000
Common stock, shares issued 1,890,261,047 1,476,869,532
Common stock, shares outstanding 1,890,261,047 1,476,869,532
Series B Preferred Stock [Member]    
Preferred stock, shares par value $ 0.001 $ 0.001
Preferred stock, shares authorized 5,000,000 5,000,000
Preferred stock, shares issued 3,750,000 5,000,000
Preferred stock, shares outstanding 3,750,000 5,000,000
Redeemable Convertible Preferred Stock [Member]    
Series A Preferred stock, shares par value $ 0.001 $ 0.001
Series A Preferred stock, shares authorized 1,250,000 1,250,000
Series A Preferred stock, shares issued 214,500 199,375
Series A Preferred stock, shares outstanding 214,500 199,375
Series A Preferred stock, discount $ 59,954 $ 101,317
Series A Preferred stock, Aggregate liquidation preference $ 218,222 $ 203,463
XML 15 R4.htm IDEA: XBRL DOCUMENT v3.23.1
Consolidated Statements of Operations - USD ($)
12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Revenues:    
Sales, services $ 318,016 $ 268,947
Total Revenues 318,016 268,947
Cost of goods sold 322,566 123,793
Gross (Loss) Profit (4,550) 145,154
Expenses:    
Selling, general and administrative expenses 400,860 423,288
Payroll and related 338,594 284,110
Management and consulting fees 192,350 193,647
Stock-based director expense 36,000 2,590,040
Total Expenses 967,804 3,491,085
Loss Before Other Income (Expense) (972,354) (3,345,931)
Other Income (Expense):    
Accretion of discounts on convertible debentures (35,201) (134,014)
Change in fair value of derivative liabilities (48,691) 79,337
Gain on extinguishment of debt, net 301,360 0
Interest expense (151,912) (27,521)
Total Other Income (Expense), net 65,556 (82,198)
Net Loss before Provision for Income Taxes (906,798) (3,428,129)
Provision for Income Taxes (800) (808)
Net Loss (907,598) (3,428,937)
Accrued and deemed dividend on redeemable convertible preferred stock (251,592) (371,926)
Net loss attributable to common stockholders $ (1,159,190) $ (3,800,863)
Basic and Diluted Loss per Common Share $ (0.00) $ (0.00)
Weighted Average Number of Common Shares Outstanding 1,613,852,078 1,263,939,724
XML 16 R5.htm IDEA: XBRL DOCUMENT v3.23.1
Consolidated Statements of Redeemable Convertible Preferred stock and Stockholders Deficit - USD ($)
Total
Redeemable Convertible Preferred Stock Series A [Member]
Common Stock
Additional Paid-In Capital
Accumulated Deficit
Series B Preferred Stocks [Member]
Balance, shares at Dec. 31, 2020   186,450 1,192,192,158     1,000,000
Balance, amount at Dec. 31, 2020 $ (923,017) $ 51,907 $ 1,192,192 $ 13,068,978 $ (15,185,187) $ 1,000
Shares of Series A preferred stock for cash, net of costs and discounts, shares   517,550        
Shares of Series A preferred stock for cash, net of costs and discounts, amount (76,304) $ 150,644 0 0 (76,304) 0
Accrued dividends on Series A preferred stock (147,652) $ 147,652 $ 0 0 (147,652) 0
Conversion of Series A preferred shares to common stock, shares   (504,625) 113,571,223      
Conversion of Series A preferred shares to common stock, amount 623,130 $ (266,181) $ 113,573 747,999 (238,442) $ 0
Issuance of Series B preferred stock, shares           4,000,000
Issuance of Series B preferred stock, amount 2,554,447 0 $ 0 2,550,447 0 $ 4,000
Shares of common stock issued for cash, shares     151,368,383      
Shares of common stock issued for cash, amount 621,745 0 $ 151,368 470,377 0 0
Shares of common stock issued for exercise of convertible note, including fees, shares     1,780,825      
Shares of common stock issued for exercise of convertible note, including fees, amount 18,610 0 $ 1,781 16,829 0 0
Stock-based compensation, shares     7,235,356      
Stock-based compensation, amount 42,045 0 $ 7,235 34,810 0 0
Cashless exercise of warrants, shares     498,260      
Cashless exercise of warrants, amount 0 0 $ 498 (498) 0 0
Issuance of common stock for conversion of payables, shares     3,243,875      
Issuance of common stock for conversion of payables, amount 16,543 0 $ 3,244 13,299 0 0
Issuance of common stock for commitment fee on equity line, shares     5,479,452      
Issuance of common stock for commitment fee on equity line, amount 0 0 $ 5,479 (5,479) 0 0
Issuance of common stock for loan extension, shares     1,500,000      
Issuance of common stock for loan extension, amount 5,700 0 $ 1,500 4,200 0 0
Net loss (3,428,937) $ 0 $ 0 0 (3,428,937) $ 0
Balance, shares at Dec. 31, 2021   199,375 1,476,869,532     5,000,000
Balance, amount at Dec. 31, 2021 (693,690) $ 84,022 $ 1,476,870 16,900,962 (19,076,522) $ 5,000
Shares of Series A preferred stock for cash, net of costs and discounts, shares   445,500        
Shares of Series A preferred stock for cash, net of costs and discounts, amount 0 $ 229,362 0 0 0 0
Accrued dividends on Series A preferred stock (126,186) $ 126,186 $ 0 0 (126,186) 0
Conversion of Series A preferred shares to common stock, shares   (430,375) 264,726,807      
Conversion of Series A preferred shares to common stock, amount 546,461 $ (301,141) $ 264,727 407,140 (125,406) 0
Cashless exercise of warrants, shares     19,560,705      
Cashless exercise of warrants, amount 0 0 $ 19,561 (19,561) 0 0
Net loss (907,598) 0 $ 0 0 (907,598) 0
Issuance of shares to directors, shares     20,000,000      
Issuance of shares to directors, amount 36,000 0 $ 20,000 16,000 0 0
Issuance of shares for services, shares     3,113,005      
Issuance of shares for services, amount 13,613 0 $ 3,113 10,500 0 0
Issuance of shares for cash, net of commitment fees, shares     105,990,998      
Issuance of shares for cash, net of commitment fees, amount 153,746 0 $ 105,991 47,755 0 $ 0
Repurchase of Series B Preferred Stock, shares           (1,250,000)
Repurchase of Series B Preferred Stock, amount 0 $ 0 $ 0 (64,322) 65,572 $ (1,250)
Balance, shares at Dec. 31, 2022   214,500 1,890,261,047     3,750,000
Balance, amount at Dec. 31, 2022 $ (977,654) $ 138,429 $ 1,890,262 $ 17,298,474 $ (20,170,140) $ 3,750
XML 17 R6.htm IDEA: XBRL DOCUMENT v3.23.1
Consolidated Statements of Cash Flows - USD ($)
12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Cash Flows from Operating Activities    
Net loss $ (907,598) $ (3,428,937)
Adjustments to reconcile net loss to net cash used in operating activities:    
Accretion of discounts on convertible debentures and preferred stock 35,201 134,014
Change in fair value of derivative liabilities 48,691 (79,337)
Interest charge for derivative liabilities in excess of face amount of debt   0
Gain on settlement of debt (301,360) 0
Amortization of right of use asset 23,213 5,438
Stock-based compensation 49,613 2,602,191
Changes in operating assets and liabilities:    
Accounts and other receivables 16,852 (3,924)
Inventory 41,042 (50,727)
Prepaid expenses and deposits 0 (5,722)
Accounts payable and accrued liabilities (923) (142,629)
Deferred revenue, net 17,213 6,673
Net Cash Used in Operating Activities (978,056) (962,960)
Cash Flows from Financing Activities    
Proceeds from issuance of preferred stock, net of offering costs 390,000 470,500
Proceeds from notes payable 527,000 49,965
Repayment of lease liability (28,113) (5,438)
Repayment of notes payable (127,756) (136,115)
Repurchase of Series B preferred stock (1,250) 0
Proceeds from issuance of common stock 153,746 621,746
Net Cash Provided by Financing Activities 913,627 1,000,658
Change in Cash (64,429) 37,698
Cash, Beginning of Year 64,429 26,731
Cash, End of Year 0 64,429
Supplemental Disclosures:    
Interest paid 104,164 18,593
Income taxes paid 0 808
Conversion of notes payable and accrued interest:    
Fair value of common shares issued 0 18,610
Derecognition of notes payable and accrued interest 0 (9,616)
Derecognition of unamortized discount 0 0
Derecognition of derivative liabilities 0 (9,013)
Conversion of preferred stock:    
Fair value of common stock issued 671,866 861,574
Derecognition of preferred stock (437,139) (472,810)
Derecognition of unamortized discount 146,448 206,629
Derecognition of derivative liabilities (241,490) (356,951)
Deemed divided (125,406) (251,187)
Discount related to issuance of preferred stock 175,638 319,856
Deemed dividends on preferred stock (excluding conversions) 126,186 (147,653)
Cashless exercise of warrants 19,561 498
Issuance of common shares for commitment fee on equity line 12,500 5,481
Right of use asset 0 81,668
Reclassification of security deposit to accounts payable $ 0 $ 4,013
XML 18 R7.htm IDEA: XBRL DOCUMENT v3.23.1
Organization and Description of Business
12 Months Ended
Dec. 31, 2022
Organization and Description of Business  
Organization and Description of Business

1. Organization and Description of Business

 

IGEN Networks Corp. (“IGEN”, the “Company”, “we”, “our”) was incorporated in the State of Nevada on November 14, 2006, under the name of Nurse Solutions Inc. On September 19, 2008, the Company changed its name to Sync2 Entertainment Corporation and traded under the symbol SYTO. On September 15, 2008, the Company became a reporting issuer in British Columbia, Canada. On May 26, 2009, the Company changed its name to IGEN Networks Corp. On March 25, 2015, the Company was listed on the Canadian Securities Exchange (CSE) under the trading symbol IGN and the Company became a reporting Venture Issuer in British Columbia and Ontario, Canada.

 

The Company’s principal business is the development and marketing of software services for the automotive industry. The Company works with wireless carriers, hardware suppliers and software developers to provide direct and secure access to information on the vehicle and the driver’s behavior. The software services are delivered from the AWS Cloud to the consumer and their families over the wireless networks and accessed from any mobile or desktop device. The software services are marketed to automotive dealers, financial institutions, and direct-to-consumer through various commercial and consumer brands.

 

Going Concern

 

The consolidated financial statements as of and for the year ended December 31, 2022 have been prepared assuming that the Company will continue as a going concern. The Company has experienced recurring losses from operations and has negative operating cash flows since inception, has a working capital deficit of $1,134,006 and an accumulated deficit of $20,170,140 as of December 31, 2022, and is dependent on its ability to raise capital from stockholders or other sources to sustain operations. These factors raise substantial doubt about the Company’s ability to continue as a going concern. Ultimately, the Company plans to achieve profitable operations through the increase in revenue base and successfully growing its operations organically or through acquisitions. The consolidated financial statements do not include any adjustments that might result from the outcome of these uncertainties.

XML 19 R8.htm IDEA: XBRL DOCUMENT v3.23.1
Summary of Significant Accounting Policies
12 Months Ended
Dec. 31, 2022
Summary of Significant Accounting Policies  
Summary of Significant Accounting Policies

2. Summary of Significant Accounting Policies

 

Basic of Presentation and Consolidation

 

These consolidated financial statements and related notes include the records of the Company and the Company’s wholly-owned subsidiary, Nimbo Tracking LLC, which is based in the USA.

 

All intercompany transactions and balances have been eliminated. These consolidated financial statements are presented in accordance with accounting principles generally accepted in the United States (“U.S. GAAP”), are expressed in U.S. dollars, and, in management’s opinion, have been properly prepared within reasonable limits of materiality and within the framework of the significant accounting policies summarized below.

 

Use of Estimates

 

The preparation of these consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements, and the reported amounts of revenues and expenses during the reporting period. The Company regularly evaluates estimates and assumptions related to allowance for doubtful accounts, valuation of inventory, the useful life and recoverability of equipment, impairment of goodwill, valuation of notes payable and convertible debentures, fair value of stock-based compensation and derivative liabilities, and deferred income tax asset valuation allowances. The Company bases its estimates and assumptions on current facts, historical experience and various other factors that it believes to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities and the accrual of costs and expenses that are not readily apparent from other sources. The actual results experienced by the Company may differ materially and adversely from the Company’s estimates. To the extent there are material differences between the estimates and the actual results, future results of operations will be affected.

 

Cash and Cash Equivalents

 

The Company considers all highly liquid instruments purchased with an original maturity of three months or less at the time of acquisition to be cash equivalents.

 Accounts Receivable

 

Accounts receivable are recognized and carried at the original invoice amount less an allowance for expected uncollectible amounts. Inherent in the assessment of the allowance for doubtful accounts are certain judgments and estimates including, among others, the customer’s willingness or ability to pay, the Company’s compliance with customer invoicing requirements, the effect of general economic conditions and the ongoing relationship with the customer. Accounts with outstanding balances longer than the payment terms are considered past due. We do not charge interest on past due balances. The Company writes off trade receivables when all reasonable collection efforts have been exhausted. Bad debt expense is reflected as a component of general and administrative expenses in the consolidated statements of operations. As of December 31, 2022 and 2021, the allowance for doubtful accounts was approximately $16,000 and $11,000, respectively.

 

Inventory

 

Inventory consists of vehicle tracking and recovery devices and is comprised entirely of finished goods that can be resold. Inventory is stated at the lower of cost or net realizable value. Cost is determined on a first-in, first-out (FIFO) basis. Net realizable value is the estimated selling price in the ordinary course of business, less estimated costs of completion and selling costs. There was no provision for inventory recorded during the years ended December 31, 2022 and 2021.

 

Equipment

 

Office equipment, computer equipment, and software are recorded at cost. Depreciation is provided annually at rates and methods over their estimated useful lives. Management reviews the estimates of useful lives of the assets every year and adjusts them on prospective basis, if needed. All equipment was fully depreciated as of December 31, 2022 and 2021. For purposes of computing depreciation, the method of depreciating equipment is as follows:

 

Computer equipment

3 years straight-line

Office equipment

5 years straight-line

Software

3 years straight-line

 

Goodwill

 

Goodwill represents the excess of the acquisition price over the fair value of identifiable net assets acquired. Goodwill is allocated at the date of the business combination. Goodwill is not amortized, but is tested for impairment annually on December 31 of each year or more frequently if events or changes in circumstances indicate the asset may be impaired. These events and circumstances may include a significant change in legal factors or in the business climate, a significant decline in the Company’s share price, an adverse action of assessment by a regulator, unanticipated competition, a loss of key personnel, significant disposal activity and the testing of recoverability for a significant asset group.

 

Goodwill impairment is measured as the amount by which a reporting unit’s carrying value exceeds its fair value.

 

The Company has only one reporting unit. Therefore, all of the Company’s goodwill relates to that reporting unit, and at December 31, 2022 and 2021, the carrying value for that reporting unit is negative.

 

Impairment of Long-lived Assets

 

The Company reviews long-lived assets, such as equipment, for impairment whenever events or changes in the circumstances indicate that the carrying value may not be recoverable. If the total of the estimated undiscounted future cash flows is less than the carrying value of the asset, an impairment loss is recognized for the excess of the carrying value over the fair value of the asset during the year the impairment occurs.

 

Fair Value Measurements and Financial Instruments

 

In accordance with Financial Accounting Standard Board (“FASB”) Accounting Standards Codification (“ASC”) 820, “Fair Value Measurements and Disclosures,” the Company is to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. ASC 820 establishes a fair value hierarchy based on the level of independent, objective evidence surrounding the inputs used to measure fair value. A financial instrument’s categorization within the fair value hierarchy is based upon the lowest level of input that is significant to the fair value measurement. ASC 820 prioritizes the inputs into three levels that may be used to measure fair value:

 

Level 1

 

Level 1 applies to assets or liabilities for which there are quoted prices in active markets for identical assets or liabilities.

 

Level 2

 

Level 2 applies to assets or liabilities for which there are inputs other than quoted prices that are observable for the asset or liability such as quoted prices for similar assets or liabilities in active markets; quoted prices for identical assets or liabilities in markets with insufficient volume or infrequent transactions (less active markets); or model-derived valuations in which significant inputs are observable or can be derived principally from, or corroborated by, observable market data.

 

Level 3

 

Level 3 applies to assets or liabilities for which there are unobservable inputs to the valuation methodology that are significant to the measurement of the fair value of the assets or liabilities.

See Note 7 for fair value measurement information related to the Company’s derivative liabilities.

 

The fair values of cash and cash equivalents, accounts and other receivables, restricted cash, and accounts payable and accrued liabilities, approximate their carrying values due to the immediate or short-term maturity of these financial instruments. Foreign currency transactions are primarily undertaken in Canadian dollars. The fair value of cash is determined based on “Level 1” inputs and the fair value of derivative liabilities is determined based on “Level 3” inputs. The recorded values of notes payable, approximate their current fair values because of their nature and respective maturity dates or durations. The financial risk is the risk to the Company’s operations that arise from fluctuations in foreign exchange rates and the degree of volatility to these rates. Currently, the Company does not use derivative instruments to reduce its exposure to foreign currency risk. Financial instruments that potentially subject the Company to concentrations of credit risk consists of cash and accounts receivable. The Company places its cash and cash equivalents in what it believes to be credit-worthy financial institutions.

 

Revenue Recognition and Deferred Revenue

 

We recognize revenue in accordance with ASC 606, “Revenue from Contracts with Customers”, using the five-step model, including (1) identify the contract with the customer, (2) identify the performance obligations in the contract, (3) determine the transaction price, (4) allocate the transaction price to the performance obligations in the contract, and (5) recognize revenue in accordance with U.S. GAAP. Title and risk of loss generally pass to our customers upon delivery, as we have insurance for lost shipments. In limited circumstances where either title or risk of loss pass upon destination or acceptance or when collection is not reasonably assured, we defer revenue recognition until such events occur. We derive substantially all our revenues from the sale of products and services combined into one performance obligation. Product revenue includes the shipment of product according to the agreement with our customers. Service revenue include vehicle tracking services and customer support (technical support), installations and consulting. A contract usually includes both product and services. For these contracts, the Company accounts for individual performance obligations separately if they are distinct. Performance obligations include, but are not limited to, pass-thru harnesses and vehicle tracking services. Almost all of our revenues are derived from customers located in United States of America in the auto industry. The transaction price is allocated to the separate performance obligations on a relative standalone selling price basis. Standalone selling prices are typically estimated based on observable transactions when these services are not sold on a standalone basis. At contract inception, an assessment of the goods and services promised in the contracts with customers is performed and a performance obligation is identified for each distinct promise to transfer to the customer a good or service (or bundle of goods or services). To identify the performance obligations, the Company considers all of the goods or services promised in the contract regardless of whether they are explicitly stated or are implied by customary business practices. Revenue is recognized when our performance obligation has been met. The Company has insignificant revenues related to product sales. For these revenues, the Company considers control to have transferred upon delivery because the Company has a present right to payment at that time, the Company has transferred use of the asset, and the customer is able to direct the use of, and obtain substantially all of the remaining benefits from, the asset. For arrangements under which the Company provides vehicle tracking services, which account for the substantial portion of the Company’s revenues, the Company satisfies its performance obligations as those services are performed whereby the customer simultaneously receives and consumes the benefits of such services under the agreement. Revenues are recognized net of any taxes collected from customers, which are subsequently remitted to governmental authorities.

 

The Company provides product warranties with varying lengths of time and terms. The product warranties are considered to be assurance-type in nature and do not cover anything beyond ensuring that the product is functioning as intended. Based on the guidance in ASC 606, assurance-type warranties do not represent separate performance obligations. The Company has historically experienced a low rate of product returns under the warranty program.

 

Management assesses the business environment, customers’ financial condition, historical collection experience, accounts receivable aging, and customer disputes to determine whether collectability is reasonably assured.

 

Revenue relating to the sale of service fees on its vehicle tracking and recovery services is recognized over the life of the contact. The service renewal fees are offered in terms ranging from 12 to 36 months and are generally payable upon delivery of the vehicle tracking devices or in full upon renewal.

 

Deferred revenues are recorded net of contract assets when cash payments are received from customers in advance of the Company’s performance. Contract assets represent the costs of (1) commission costs, (2) installation costs, and (3) the underlying hardware to enable the Company to perform on its contracts with customers and are amortized using the same method and term as deferred revenues. As of December 31, 2022 and 2021, deferred revenues, net of contract assets totaled $162,698 and $145,485, respectively, and contract assets totaled $73,450 and $71,441, respectively. Any revenue that has been deferred and is expected to be recognized beyond one year is classified as deferred revenue, net of current portion.

 

During the year ended December 31, 2022, the Company recorded additions to deferred revenues of $238,284 and recognized total revenues of $210,222 through the amortization of deferred revenues. During the year ended December 31, 2022, the Company recognized revenues of $112,323 related to deferred revenues outstanding as of December 31, 2021 as the services were performed.

Financing Costs and Debt Discount

 

Financing costs and debt discounts are recorded net of notes payable and convertible debentures in the consolidated balance sheets. Amortization of financing costs and the debt discounts is calculated using the effective interest method over the term of the debt and is recorded as interest expense in the consolidated statements of operations.

 

Income Taxes

 

Deferred income taxes are provided on the asset and liability method whereby deferred income tax assets are recognized for deductible temporary differences and operating loss and tax credit carryforwards and deferred tax liabilities are recognized for taxable temporary differences. Temporary differences are the differences between the reported amounts of assets and liabilities and their tax bases. Deferred income tax assets are reduced by a valuation allowance when, in the opinion of management, it is more likely than not that some portion or all of the deferred income tax assets will not be realized. Deferred income tax assets and liabilities are adjusted for the effects of changes in tax laws and rates on the date of enactment.

 

Stock-based Compensation

 

The Company accounts for stock-based payments in accordance with stock-based payment accounting guidance which requires all stock-based payments to be recognized based upon their fair values. The fair value of stock-based awards is estimated at the grant date using the Black-Scholes Option Pricing Model and the portion that is ultimately expected to vest is recognized as compensation cost over the requisite service period. The determination of fair value using the Black-Scholes Option Pricing Model is affected by the Company’s stock price as well as assumptions regarding a number of complex and subjective variables, including expected stock price volatility, risk-free interest rate, expected dividends and projected employee stock option exercise behaviors. The Company accounts for forfeitures of unvested awards as they occur.

 

Derivative Financial Instruments

 

The Company classifies as equity any contracts that require physical settlement or net-share settlement or provide us a choice of net cash settlement or settlement in our own shares (physical settlement or net-share settlement) provided that such contracts are indexed to our own stock as defined in ASC Topic 815-40 “Contracts in Entity’s Own Equity.” The Company classifies as assets or liabilities any contracts (including embedded conversion features) that require net-cash settlement including a requirement to net cash settle the contract if an event occurs and if that event is outside our control or give the counterparty a choice of net-cash settlement or settlement in shares. The Company assesses classification of its derivatives at each reporting date to determine whether a change in classification between assets and liabilities is required.

 

Loss Per Share

 

Basic earnings (loss) per share are computed by dividing net income (loss) available to common shareholders (numerator) by the weighted average number of shares outstanding (denominator) during the period. Diluted earnings per share give effect to all dilutive potential common shares outstanding during the period including stock options, using the treasury stock method, and convertible debentures, using the if-converted method. In computing diluted earnings (loss) per share, the average stock price for the period is used in determining the number of shares assumed to be purchased from the exercise of stock options or warrants. Diluted earnings (loss) per share exclude all potentially issuable shares if their effect is anti-dilutive. Because the effect of conversion of the Company’s dilutive securities is anti-dilutive, diluted loss per share is the same as basic loss per share for the periods presented. As of December 31, 2022 and 2021, the Company has 442,441,431 and 239,950,260 potentially dilutive shares outstanding, respectively.

 

Recent Accounting Pronouncement

 

In August 2020, the FASB issued ASU 2020-06, “Debt - Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging - Contracts in Entity’s Own Equity (Subtopic 815 - 40)” (“ASU 2020-06”). ASU 2020-06 simplifies the accounting for certain financial instruments with characteristics of liabilities and equity, including convertible instruments and contracts on an entity’s own equity. The ASU is part of the FASB’s simplification initiative, which aims to reduce unnecessary complexity in U.S. GAAP. The ASU’s amendments are effective for fiscal years beginning after December 15, 2023, and interim periods within those fiscal years. The Company is currently evaluating the impact ASU 2020-06 will have on its financial statements.

The Company does not believe that there are any other new accounting pronouncements that have been issued that might have a material impact on its consolidated financial position or results of operations.

XML 20 R9.htm IDEA: XBRL DOCUMENT v3.23.1
Accounts and Other Receivables
12 Months Ended
Dec. 31, 2022
Accounts and Other Receivables  
Accounts and Other Receivables

3. Accounts and Other Receivables

 

 

 

December 31,

2022

 

 

December 31,

2021

 

Trade accounts receivable

 

$38,190

 

 

$49,462

 

Allowance for doubtful accounts

 

 

(16,288 )

 

 

(10,708 )

 

 

$21,902

 

 

$38,754

 

XML 21 R10.htm IDEA: XBRL DOCUMENT v3.23.1
Goodwill
12 Months Ended
Dec. 31, 2022
Goodwill  
Goodwill

4. Goodwill

 

As of December 31, 2022 and 2021, the Company had goodwill of $505,508 related to the acquisition of Nimbo Tracking, LLC.

XML 22 R11.htm IDEA: XBRL DOCUMENT v3.23.1
Accounts Payable and Accrued Liabilities
12 Months Ended
Dec. 31, 2022
Accounts Payable and Accrued Liabilities  
Accounts Payable and Accrued Liabilities

5. Accounts Payable and Accrued Liabilities

 

 

 

December 31,

2022

 

 

December 31,

2021

 

Trade accounts payable

 

$174,319

 

 

$540,288

 

Accrued liabilities

 

 

49,723

 

 

 

5,740

 

Lease liability, current portion

 

 

28,110

 

 

 

21,019

 

Accrued interest payable

 

 

2,386

 

 

 

6,097

 

Payroll and commissions payable

 

 

15,689

 

 

 

15,203

 

Unrecognized tax position

 

 

90,000

 

 

 

90,000

 

 

 

$360,227

 

 

$678,347

 

XML 23 R12.htm IDEA: XBRL DOCUMENT v3.23.1
Convertible Debentures and Notes Payable
12 Months Ended
Dec. 31, 2022
Convertible Debentures and Notes Payable  
Convertible Debentures and Notes Payable

6. Convertible Debentures and Notes Payable

 

On May 17, 2019, the Company entered into a Convertible Promissory Note (“Promissory Note”) with Crown Bridge Partners, LLC (the “Holder”). The Promissory Note bears interest at 7% per annum (with the understanding that the first 12 months of interest of each tranche will be guaranteed). The maturity date is 18 months from the effective date of each payment.

 

The Conversion Price, as defined in the agreement, is the lesser of (i) the lowest Trading Price (as defined below) during the previous 25 trading day period ending on the latest complete trading day prior to the date of this Promissory Note or (ii) the Variable Conversion Price (as defined below). The Variable Conversion Price means the lowest one Trading Price (as defined below) for the common stock during the 25 Trading Day period ending on the last complete Trading Day prior to the Conversion Date. Trading Price means, for any security as of any date, the lesser of the (i) lowest traded price and (ii) lowest closing bid price. Based on the Company’s examination of the conversion feature and the relative accounting guidance, the Company has determined that the conversion feature should be treated as a derivative liability for accounting purposes.

 

Additionally, if at any time while the Promissory Note is outstanding, the Conversion Price is equal to or lower than $0.025, then an additional $10,000 will be automatically added to the principal balance of each tranche funded under the Note.

 

In connection with the Promissory Note, the Company also entered into a Securities Purchase Agreement with the Holder which states that the Company will also issue to the Holder a warrant to purchase an amount of shares of its common stock equal to 50% of the face value of each respective tranche divided by $0.10.

 

Per the terms of the Common Stock Purchase Warrant agreement, on May 17, 2019, the Company issued a warrant to purchase 250,000 shares of common stock with an Exercise Price of $0.10 subject to adjustment (standard anti-dilution features). The agreement contains a down-round provision that automatically resets the exercise price of the warrant to a new exercise price that is equal to the per share price of common stock subsequently issued (including conversions of debt and preferred stock). Upon the lowing of the exercise price, the number of warrants will be increased such that the total proceeds upon exercise is the same amount (see Note 7). If the Market Price of one shares of common stock is greater than the Exercise Price, the Holder may elect to receive Warrant Shares pursuant to cashless exercise, in lieu of cash exercise, per a defined formula in the agreement.

 

On June 19, 2020, the Company received $19,250 in net cash proceeds from a note holder under the same terms as the Promissory Note. The related principal amount due for the convertible debt instrument was $25,000 and the note matures on December 19, 2021. Using the Binomial Lattice Model, the Company computed the estimated fair value of the embedded conversion feature to be approximately $142,000 and recorded a related derivative liability for that amount and a charge to interest expense of approximately $122,000. Related to the derivative liability, the shares issued, the bonus interest, and the direct financing costs, the Company recorded a debt discount totaling $25,000 for the note, which is being amortized to interest expense over the term of the note using the effective interest method. As of December 31, 2022, the principal and interest owed under this note totaled $12,000.

 

On July 10, 2020, the Company received $19,250 in net cash proceeds from a note holder under the same terms as the Promissory Note. The related principal amount due for the convertible debt instrument was $25,000 and the note matures on January 10, 2022. Using the Binomial Lattice Model, the Company computed the estimated fair value of the embedded conversion feature to be approximately $61,000 and recorded a related derivative liability for that amount and a charge to interest expense of approximately $42,000. Related to the derivative liability, the shares issued, the bonus interest, and the direct financing costs, the Company recorded a debt discount totaling $25,000 for the note, which is being amortized to interest expense over the term of the note using the effective interest method. As of December 31, 2022, the principal and interest owed under this note totaled $25,000.

 

On May 4, 2020, the Company entered into a Paycheck Protection Program (“PPP”) Loan with a principal amount of $59,949 through a financial institution under the PPP administered by the SBA and established as part of the CARES Act. The PPP Loan bears interest at 1.0% per annum and matures on May 4, 2022 with the first six months of interest and principal payments deferred. The amount borrowed under the PPP Loan is guaranteed by the U.S. Small Business Administration (“SBA”) and is eligible for forgiveness in an amount equal to the sum of the eligible costs, including payroll, benefits, rent and utilities, incurred by the Company during the 24-week period beginning on the date the Company received the proceeds. The PPP Loan contains customary events of default, and the occurrence of an event of default may result in a claim for the immediate repayment of all amounts outstanding under the PPP Loan. As of December 31, 2022, the balance of the PPP Loan, including accrued interest was $60,948.

 

On July 7, 2020, the Company entered into a secured disaster loan with the SBA with a principal amount of $150,000. The SBA loan bears interest at 3.75% per annum and matures in July 2050. The Company is required to make monthly principal and interest payments of $731 beginning in July 2021. As of December 31, 2022, the balance on the SBA loan, including interest was $164,063.

 

On November 2, 2020, the Company received $146,500 in net cash proceeds from a note holder under an Inventory Financing Promissory Note. The related principal amount due for the convertible debt instrument was $168,000. The note bears interest at 12% per annum and matures on May 2, 2022. Principal and accrued interest are convertible into common stock at a variable conversion price, which is 80% of the average two lowest traded prices for common stock during a 10-day trading period prior to conversion. Using the Binomial Lattice Model, the Company computed the estimated fair value of the embedded conversion feature to be approximately $99,000 and recorded a related derivative liability for that amount. The Company also issued 2,000,000 shares of common stock to the note holder as additional compensation. The value of the shares, $14,800. Related to the derivative liability, the shares issued, the bonus interest, and the direct financing costs, the Company recorded a debt discount totaling approximately $135,000 for the note, which is being amortized to interest expense over the term of the note using the effective interest method. During the year ended December 31, 2022, the Company received forgiveness of the note totaling $45,148 and paid down the remaining balance and accrued interest. As of December 31, 2022 the balance on the note is $0.

 

On December 13, 2021, the Company received $50,000 in net cash proceeds from a note holder under a short-term bridge note. During the year ended December 31, 2022, the Company borrowed an additional $127,000 under the note. The note matures on February 13, 2023. The Company is required to make 34 weekly payments of $4,633. As of December 31, 2022, the balance on the note was $130,355.

 

During the year ended December 31, 2021, the holders of the convertible notes converted a total of $9,616 of principal, interest and fees for a total of 1,780,825 shares of common stock. Related to these conversions during the year ended December 31, 2021, the Company recorded a reduction of the associated derivative liability for the conversion features of $9,013 and a reduction of the debt discount of $0 as components of the loss on settlement of debt. During the year ended December 31, 2021, the Company recorded $134,014 of interest expense related to the amortization of the debt discounts.

During the year ended December 31, 2022, the Company entered into four separate notes with an investor, for total principal of $400,000. The notes mature through March 2023 and bear interest between 6% and 12% per annum. As of December 31, 2022, the principal and interest owed on these notes totaled $401,516.

 

As of December 31, 2022 long-term debt matures as follows: 

 

Year Ending

 

Notes Payable

 

 

Convertible Notes

 

 

Total

 

2023

 

$596,745

 

 

$37,000

 

 

$633,745

 

2024

 

 

3,454

 

 

 

-

 

 

 

3,454

 

2025

 

 

3,586

 

 

 

-

 

 

 

3,586

 

2026

 

 

3,718

 

 

 

-

 

 

 

3,718

 

2027

 

 

3,900

 

 

 

-

 

 

 

3,900

 

Thereafter

 

 

146,078

 

 

 

-

 

 

 

146,078

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

$757,482

 

 

$37,000

 

 

$794,482

 

XML 24 R13.htm IDEA: XBRL DOCUMENT v3.23.1
Derivative Liabilities
12 Months Ended
Dec. 31, 2022
Derivative Liabilities  
Derivative Liabilities

7. Derivative Liabilities

 

During the years ended December 31, 2022 and 2021, the Company had outstanding convertible debentures with variable exercise prices based on market rates (see Note 6) and convertible series A preferred stock with variable exercise prices based on market rates (see Note 9). The Company records the fair value of the conversion features with variable exercise prices based on future market rates in accordance with ASC 815. The fair value of the derivative liabilities is revalued on each balance sheet date with corresponding gains and losses recorded in the consolidated statements of operations. The Company uses a multi-nominal lattice model to fair value the derivative liabilities. The following inputs and assumptions were used to value the conversion features outstanding during the years ended December 31, 2022 and 2021, assuming no expected dividends:

 

 

 

2022

 

 

2021

 

Expected volatility

 

 

145-166

%

 

 

135-275

%

Risk free interest rate

 

 

1.34-4.68

%

 

 

0.05-0.15

%

Expected life (in years)

 

 

0-1.5

 

 

 

0-1.5

 

 

The following table presents the Company’s embedded conversion features of its convertible debt and preferred stock measured at fair value on a recurring basis as of December 31, 2022 and 2021.

 

 

 

Level 3

Carrying

Value as of

December 31,

2022

 

 

Level 3

Carrying

Value as of

December 31,

2021

 

Derivative liabilities:

 

 

 

 

 

 

Embedded conversion feature – convertible debt

 

$-

 

 

$51,131

 

Embedded conversion feature – preferred stock

 

 

111,010

 

 

 

85,771

 

 

 

$111,010

 

 

$136,902

 

 

The following table provides a reconciliation of the beginning and ending balances for the Company’s derivative liabilities measured at fair value using Level 3 inputs:

 

 

 

For The

Year

Ended

December 31,

2022

 

 

For The

Year

Ended

December 31,

2021

 

Embedded Conversion Features – Debt Instruments

 

 

 

 

 

 

Balances, as of the beginning of the year

 

$51,131

 

 

$97,024

 

Derivative liabilities recorded upon issuance of debt instruments

 

 

-

 

 

 

-

 

Extinguishment due to conversion of debt instruments

 

 

-

 

 

 

(8,994 )

Net changes in fair value included in net loss

 

 

(51,131 )

 

 

(36,989 )

Ending balance

 

$-

 

 

$51,131

 

 

 

 

 

 

 

 

 

 

Embedded Conversion Features – Preferred Stock

 

 

 

 

 

 

 

 

Balances, as of the beginning of the year

 

$85,771

 

 

$92,751

 

Derivative liabilities recorded upon issuance of preferred stock

 

 

175,639

 

 

 

392,410

 

Extinguishment due to conversion of preferred stock

 

 

(241,490 )

 

 

(356,951 )

Net changes in fair value included in net loss

 

 

91,090

 

 

 

(42,439 )

Ending balance

 

$111,010

 

 

$85,771

 

 

 

 

 

 

 

 

 

 

Total ending balance

 

$111,010

 

 

$136,902

 

XML 25 R14.htm IDEA: XBRL DOCUMENT v3.23.1
Related Party Transactions
12 Months Ended
Dec. 31, 2022
Related Party Transactions  
Related Party Transactions

8. Related Party Transactions

 

(a)

During the years ended December 31, 2022 and 2021, the Company incurred approximately $145,000 and $147,000, respectively, in management and consulting fees with an officer and an entity controlled by him. As of December 31, 2022 and 2021, the Company owed approximately $5,000 and $9,000, respectively, to directors and officers and a company controlled by a director, which is included in accounts payable and accrued liabilities. The amounts owed are unsecured, non-interest bearing, and due on demand.

 

 

(b)

During the years ended December 31, 2022 and 2021, the Company issued 0 and 4,608,173 shares of common stock for the conversion of $0 and $24,729, respectively of accrued expenses owed to the CEO and VP of Operations.

 

 

(c)

During the year ended December 31, 2022 and 2021, the Company recorded approximately $0 and $8,000, respectively to the VP and General Manager for rent and other office expenses.

XML 26 R15.htm IDEA: XBRL DOCUMENT v3.23.1
Redeemable Preferred Stock and Stockholders Deficit
12 Months Ended
Dec. 31, 2022
Redeemable Preferred Stock and Stockholders Deficit  
Redeemable Preferred Stock and Stockholders' Deficit

9. Redeemable Preferred Stock and Stockholders’ Deficit

 

Preferred Stock

 

The Company is authorized to issue 10,000,000 shares of preferred stock with a par value of $0.001 per share. The Company has designated 1,250,000 of these shares as Series A Convertible Preferred Stock (“Series A Preferred Stock”).

 

On February 1, 2021, the Company entered into a Series A Preferred Stock Purchase Agreement with an investor. The Company issued 58,850 shares for proceeds of $53,500.

 

On March 1, 2021, the Company entered into a Series A Preferred Stock Purchase Agreements with an investor. The Company issued 80,850 shares for proceeds of $73,500.

 

On April 5, 2021, the Company entered into a Series A Preferred Stock Purchase Agreements with an investor. The Company issued 58,850 shares for proceeds of $53,500.

 

On April 30, 2021, the Company entered into a Series A Preferred Stock Purchase Agreements with an investor. The Company issued 59,125 shares for proceeds of $53,750.

 

On June 17, 2021, the Company entered into a Series A Preferred Stock Purchase Agreements with an investor. The Company issued 60,500 shares for proceeds of $55,000.

 

On August 11, 2021, the Company entered into a Series A Preferred Stock Purchase Agreements with an investor. The Company issued 59,125 shares for proceeds of $53,750.

 

On September 13, 2021, the Company entered into a Series A Preferred Stock Purchase Agreements with an investor. The Company issued 59,125 shares for proceeds of $53,750.

 

On December 27, 2021, the Company entered into a Series A Preferred Stock Purchase Agreement with an investor. The Company issued 81,125 shares for proceeds of $73,750.

 

On February 2, 2022, the Company entered into a Series A Preferred Stock Purchase Agreement with an investor. The Company issued 59,125 shares for proceeds of $53,500.

 

On March 24, 2022, the Company entered into a Series A Preferred Stock Purchase Agreement with an investor. The Company issued 59,125 shares for proceeds of $53,500.

 

On April 26, 2022, the Company entered into a Series A Preferred Stock Purchase Agreement with an investor. The Company issued 59,125 shares for proceeds of $53,500.

 

On May 20, 2022, the Company entered into a Series A Preferred Stock Purchase Agreement with an investor. The Company issued 53,625 shares for proceeds of $48,750.

 

On August 23, 2022, the Company entered into a Series A Preferred Stock Purchase Agreement with an investor. The Company issued 59,125 shares for proceeds of $53,500.

 

On September 26, 2022, the Company entered into a Series A Preferred Stock Purchase Agreement with an investor. The Company issued 59,125 shares for proceeds of $53,500.

 

On November 2, 2022, the Company entered into a Series A Preferred Stock Purchase Agreement with an investor. The Company issued 48,125 shares for proceeds of $43,750.

 

On December 14, 2022, the Company entered into a Series A Preferred Stock Purchase Agreement with an investor. The Company issued 48,125 shares for proceeds of $43,750.

 

Rights and Privileges of the Series A Preferred Stock

 

 

·

Voting – Series A Preferred Stockholders have no voting rights

 

·

Dividends – 8% cumulative dividend, compounded daily, payable solely upon redemption, liquidation, or conversion. (increases to 22% for an event of default)

 

·

Liquidation Preference – equal to the then Stated Value (initially $1.00 per share) as adjusted pursuant to the terms in the agreement (including but not limited to the additional of any accrued unpaid dividends and the Default Adjustment (as defined), if applicable.

 

·

Redemption – Company has the right to redeem the shares from the issuance date through 270 days following the issuance date using the table noted in the Certificate of Designations, Preferences, Rights and Limitations of Series A Convertible Preferred Stock agreement. After 270 days, except for the Mandatory Redemption, the Company does not have the right to redeem the shares.

 

·

Mandatory Redemption – 18 months after the Issuance Date or upon the occurrence of an Event of Default, the Company is required to redeem all of the shares of Series A Preferred Stock of the Holder. The Company shall make a cash payment in an amount equal to the total number of shares of Series A Preferred Stock held by the Holder multiplied by the then current Stated Value as adjusted (including but not limited to the addition of any accrued unpaid dividends and the Default Adjustment

 

·

Conversion – At any time after 6 months following the Issuance Date, the Holder may convert all or any part of the outstanding Series A Preferred Stock into shares of Common Stock. The Variable Conversion Price is defined as 75% of the Market Price. The Market Price is defined as the average of the 3 lowest Trading Prices for the Common Stock during the 15 day Trading Period ending on the last complete Trading Day prior to the Conversion Date.

 

·

Default Adjustments – Upon the occurrence of any Event of Default, the Stated Value will be increased between 150% and 200%, depending on the Event of Default.

Based on the terms of the conversion feature, the Company could be required to issue an infinite number of shares of common stock. As such, the Company has determined the conversion feature to be a derivative liability under relevant accounting guidance. The Company estimated the fair value of the conversion feature using the Binomial Lattice Model on the date of issuance, on the date of each conversion notice, and remeasures the fair value at each reporting period. During the year ended December 31, 2022, the Company issued 445,500 shares of series A preferred stock for proceeds of $405,000. Related to these issuances, the Company recorded derivative liabilities of $175,638 and discounts to the preferred stock of $175,638, which is being amortized to deemed dividends over the redemption period. Also related to these issuances the Company recorded deemed dividends of $126,186.

 

During the year ended December 31, 2022, the holder of the Series A preferred stock converted 430,375 shares of Series A preferred stock and accrued dividends into 264,726,807 shares of common stock. Related to these conversions during the year ended December 31, 2022, the Company recorded a reduction of the associated derivative liability for the conversion features of $241,490 and a reduction of the preferred stock discount of $142,620 and $125,406 of deemed dividend.

 

Rights and Privileges of the Series B Preferred Stock

 

In February 2021, the Company issued 500,000 shares of its Series B Super Voting Preferred Stock. Each share of Series B preferred stock has voting rights equal to 500 shares of common stock, is not entitled to receive dividends, is not convertible into shares of common stock. If the holder of the Series B preferred stock ceases to be a Board Member, the Company will repurchase any Series B preferred stock from the holder for a price of $0.001 per share. If the holder of the Series B preferred stock proposes to transfer any shares of Series B preferred stock, the Company will have 90 days to repurchase the shares for a price of $0.001 per share. The grant date fair value of the Series B preferred stock issued during the nine months ended September 30, 2021 was $278,447 and was recorded to stock-based compensation expense in the accompanying condensed consolidated statements of operations.

 

During the year ended December 31, 2022, the Company repurchased 1,250,000 shares of its Series B Super Voting Preferred Stock, valued at $65,572 and $1,250 cash, per the terms of the Series B shareholder agreement.

 

Common Stock

 

2022 

 

During the year ended December 31, 2022, the Company issued 3,113,005 shares of common stock for services provided by a vendor.

 

During the year ended December 31, 2022, the Company issued 19,560,705 shares of common stock for the exercise of a warrant on a cashless basis.

 

During the year ended December 31, 2022, the Company issued 264,726,807 shares of common stock for the conversion of Series A preferred stock and accrued dividends.

 

During the year ended December 31, 2022, the Company issued 12,500,000 shares of common stock as a commitment fee for a new equity line of credit.

 

During the year ended December 31, 2022, the Company issued 93,490,998 shares of common stock for cash proceeds of $153,746.

 

During the year ended December 31, 2022, the Company issued 20,000,000 shares of common stock for services provided by management and the board of directors.

 

2021

 

During the year ended December 31, 2021, the Company sold a total of 151,368,383 shares of common stock for proceeds of $621,745.

 

During the year ended December 31, 2021, the Company issued a total of 10,479,231 shares of common stock for the conversion of $58,588 of accrued expenses owed to the VP and General Manager and another employee.

 

During the year ended December 31, 2021, the Company issued 498,260 shares for the cashless exercise of warrants.

 

During the year ended December 31, 2021, the Company issued 113,571,223 shares of common stock for the conversion of Series A preferred stock and accrued dividends.

 

During the year ended December 31, 2021, the Company issued 1,780,825 shares of common stock for the conversion of debt and accrued interest.

 

During the year ended December 31, 2021, the Company issued a total of 6,979,452 shares of common stock for a loan commitment fee and a loan extension fee.

XML 27 R16.htm IDEA: XBRL DOCUMENT v3.23.1
Share Purchase Warrants
12 Months Ended
Dec. 31, 2022
Share Purchase Warrants  
Share Purchase Warrants

10. Share Purchase Warrants

 

The following table summarizes the activity of the Company’s share purchase warrants:

 

 

 

Number of

warrants

 

 

Weighted

average

exercise

price

 

 

 

 

 

 

 

 

Balance, January 1, 2021

 

 

166,517,918

 

 

$0.00

 

Issued

 

 

-

 

 

 

-

 

Adjusted for triggered down-round provisions

 

 

 

 

 

 

0.00

 

Exercised

 

 

 

 

 

 

0.00

 

Expired

 

 

(980,392 )

 

 

0.00

 

Balance, December 31, 2021

 

 

165,537,526

 

 

 

0.00

 

Issued

 

 

-

 

 

 

-

 

Adjusted for triggered down-round provisions

 

 

-

 

 

 

0.00

 

Exercised

 

 

(20,408,163 )

 

 

0.00

 

Expired

 

 

(50,000 )

 

 

0.00

 

Balance, December 31, 2022

 

 

145,079,363

 

 

$0.00

 

 

As of December 31, 2022, the following share purchase warrants were outstanding:

 

Number of warrants outstanding

 

 

Exercise price

 

 

Expiration date

 

2,222,222

 

 

$

0.03

 

 

December 2, 2024

 

142,857,141

 

 

$

0.00

 

 

September 23, 2024

 

145,079,363

 

 

 

 

 

 

 

 

 

During the year ended December 31, 2022, a warrant holder exercised 20,408,163 warrants on a cashless basis resulting in the issuance of 19,560,705 shares of common stock.

XML 28 R17.htm IDEA: XBRL DOCUMENT v3.23.1
Stock Options
12 Months Ended
Dec. 31, 2022
Stock Options  
Stock Options

11. Stock Options

 

The Company established a stock option plan for directors, officers, employees and consultants of the Company (the “Plan”). The purpose of the Plan is to give to directors, officers, employees and consultants of the Company, as additional compensation, the opportunity to participate in the profitability of the Company by granting to such individuals options, exercisable over periods of up to ten (10) years as determined by the board of directors of the Company, to buy shares of the Company at a price equal to the Market Price (as defined) prevailing on the date the option is granted. As of December 31, 2022, there were 6,440,000 shares available under the Plan.

 

The following table summarizes the activity of the Company’s stock options:

 

 

 

Number of

options

 

 

Weighted

average

exercise

price

 

 

Aggregate

intrinsic value

 

 

 

 

 

 

 

 

 

 

 

Balance, January 1, 2021

 

 

3,250,000

 

 

$0.09

 

 

 

 

Granted

 

 

-

 

 

 

-

 

 

 

 

Exercised

 

 

-

 

 

 

-

 

 

 

 

Cancelled / forfeited

 

 

(75,000 )

 

 

0.16

 

 

 

 

Balance, December 31, 2021

 

 

3,175,000

 

 

$0.08

 

 

$-

 

Granted

 

 

-

 

 

 

-

 

 

 

 

 

Cancelled / forfeited

 

 

(1,675,000 )

 

 

0.12

 

 

 

 

 

Balance, December 31, 2022

 

 

1,500,000

 

 

$0.04

 

 

$-

 

Vested as of December 31, 2022

 

 

1,500,000

 

 

$0.04

 

 

$-

 

Unvested as of December 31, 2022

 

 

-

 

 

$-

 

 

$-

 

 

 

 

 

Outstanding

 

 

Exercisable

 

Range of

exercise prices

 

 

Number of

shares

 

 

Weighted average

remaining

contractual

life (years)

 

 

Weighted

average

exercise

price

 

 

Number of

shares

 

 

Weighted

average

exercise

price

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

$0.04

 

 

 

1,500,000

 

 

 

1.4

 

 

 

0.04

 

 

 

1,500,000

 

 

 

0.04

 

 

 

 

 

 

1,500,000

 

 

 

1.4

 

 

$0.04

 

 

 

1,500,000

 

 

$0.04

 

 

During the years ended December 31, 2022 and 2021, the Company did not issue any options to employees. As of December 31, 2022, the Company had no unrecognized compensation expense.

XML 29 R18.htm IDEA: XBRL DOCUMENT v3.23.1
Segments
12 Months Ended
Dec. 31, 2022
Segments  
Segments

12. Segments

 

The Company has one reportable segment: vehicle tracking and recovery solutions. The Company allocates resources to and assesses the performance of each reportable segment using information about its revenue and operating income (loss). The Company does not evaluate operating segments using discrete asset information.

 

Segmentation by geographical location is not presented as all revenues are earned in the U.S. Total assets by segment are not presented as that information is not used to allocate resources or assess performance at the segment level and is not reviewed by the Chief Operating Decision Maker of the Company.

XML 30 R19.htm IDEA: XBRL DOCUMENT v3.23.1
Risk and Uncertainities
12 Months Ended
Dec. 31, 2022
Risk and Uncertainities  
Risk and Uncertainities

13. Risks and Uncertainties

 

The Company extends credit to customers on an unsecured basis in the normal course of business. The Company’s policy is to perform an analysis of the recoverability of its receivables at the end of each reporting period and to establish allowances where appropriate. The Company analyzes historical bad debts and contract losses, customer concentrations, and customer credit-worthiness when evaluating the adequacy of the allowances.

 

During the year ended December 31, 2022 and 2021, the Company had four and two customers which accounted for 77% and 56%, respectively, of total invoiced amounts, which are recorded as deferred revenues and amortized over the related service period to revenues.

 

As of December 31, 2022 and 2021, the Company had three and one customers, respectively, which accounted for 99% and 99%, respectively, of the gross accounts receivable balance.

XML 31 R20.htm IDEA: XBRL DOCUMENT v3.23.1
Income Taxes
12 Months Ended
Dec. 31, 2022
Income Taxes  
Income Taxes

14. Income Taxes

 

The Company’s income tax provision consists of the following:

 

 

 

2022

 

 

2021

 

Current:

 

 

 

 

 

 

Federal

 

$-

 

 

$-

 

State

 

 

800

 

 

 

808

 

Foreign

 

 

-

 

 

 

-

 

Total Current

 

 

800

 

 

 

808

 

Deferred:

 

 

 

 

 

 

 

 

Federal

 

 

-

 

 

 

-

 

State

 

 

-

 

 

 

-

 

Foreign

 

 

-

 

 

 

-

 

Total Deferred

 

 

-

 

 

 

-

 

Provision for income taxes

 

$800

 

 

$808

 

 

A reconciliation of income taxes computed by applying the statutory U.S. income tax rate to the Company’s loss before income taxes to the income tax provision is as follows:

 

 

 

2022

 

 

2021

 

Computed tax benefit at federal statutory rate

 

$(190,596 )

 

$764,147

 

State taxes

 

 

632

 

 

 

638

 

Permanent items

 

 

75

 

 

 

75

 

Stock-based compensation

 

 

175,196

 

 

 

8,829

 

Incentive stock options

 

 

-

 

 

 

-

 

Conversion feature derivative liability

 

 

-

 

 

 

-

 

Interest expense, derivative liability

 

 

-

 

 

 

-

 

Uncertain tax positions

 

 

-

 

 

 

-

 

Impact of difference related to foreign earnings

 

 

-

 

 

 

-

 

Gain on extinguishment of debt

 

 

-

 

 

 

-

 

Change in fair value of derivative liability

 

 

10,225

 

 

 

16,661

 

Valuation allowance

 

 

5,268

 

 

 

(789,542 )

Provision for income taxes

 

$800

 

 

$808

 

 

Deferred tax assets and liabilities reflect the net tax effects of temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes. Significant components of the Company’s deferred tax assets are as follows:

 

 

 

2022

 

 

2021

 

Deferred Tax Assets:

 

 

 

 

 

 

Net operating loss carryforwards

 

$2,967,000

 

 

$604,000

 

Stock-based compensation

 

 

529,000

 

 

 

767,000

 

Accounts receivable and other timing differences

 

 

140,000

 

 

 

138,000

 

Basis difference in assets and debt

 

 

(80,000 )

 

 

(71,000 )

Total Deferred Tax Asset

 

 

3,556,000

 

 

 

1,438,000

 

Valuation allowance

 

 

(3,556,000 )

 

 

(1,438,000 )

Net Deferred Tax Asset

 

$-

 

 

$-

 

 

Realization of deferred tax assets is dependent upon future earnings, if any, the timing and amount of which are uncertain. Accordingly, the net deferred tax assets for the U.S. federal and state have been fully offset by a valuation allowance.

 

As of December 31, 2022, the Company had net operating loss carryforwards for federal and state income tax purposes of $9,970,000 and $9,739,000, respectively, which expire beginning in the year 2029.

The Company is required to file US federal and California tax returns, however the Company has not filed its federal or state returns since 2009 Due to the Company’s loss position the statute remains open for any losses carried over into the current year which means all years from 2007 remain open to examination.

 

The Company has adopted FASB ASC 740, “Income Taxes” to account for income taxes. ASC 740 clarifies the accounting for uncertainty in income taxes recognized in an enterprise’s financial statement. This standard prescribes a recognition threshold and measurement attribute for the financial statement recognition and measurement of a tax position taken or expected to be taken in the tax return. ASC 740 also provides guidance on derecognition of tax benefits, classification on the balance sheet, interest and penalties, accounting in interim periods, disclosure and transaction. In accordance with ASC 740-10-50, the Company is classifying interest and penalties as a component of tax expense.

 

The Company has a reserve related to unrecognized tax positions of $90,000 as of December 31, 2022, which is presented as part of accounts payable and accrued liabilities. These unrecognized tax positions, if recognized, would affect the effective tax rate. A reconciliation of the change in the unrecognized tax positions for the year ended December 31, 2022 is as follows:

 

 

 

Federal

and

State

 

Balance at January 1, 2022

 

$90,000

 

Additions for tax positions related to current year

 

 

-

 

Additions for tax positions related to prior years

 

 

-

 

Balance at December 31, 2022

 

$90,000

 

XML 32 R21.htm IDEA: XBRL DOCUMENT v3.23.1
Commitments and Contingencies
12 Months Ended
Dec. 31, 2022
Commitments and Contingencies  
Commitments and Contingencies

15. Commitments and Contingencies

 

Withheld Payroll Taxes

 

Since its inception, the Company has made several payments to employees for wages, net of state and federal income taxes. Due to cash constraints, the Company has not yet remitted all of these withheld amounts to the appropriate government agency. Accordingly, as of December 31, 2022 and 2021 the Company has recorded $37,984 and $37,984, respectively, related to this obligation in accounts payable and accrued liabilities, including estimated penalties and interest.

 

Operating Lease

 

On September 1, 2021 the Company entered into a lease for office space under an operating lease for approximately 2,500 square feet in Lake Elsinore, California, which is set to expire on October 31, 2024.

 

Operating lease assets and liabilities are recognized at the lease commencement date. Operating lease liabilities represent the present value of lease payments not yet paid. Operating lease assets represent our right to use an underlying asset and are based upon the operating lease liabilities as adjusted for prepayments or accrued lease payments, initial direct costs, lease incentives, and impairment of operating lease assets. To determine the present value of lease payments not yet paid, the Company estimates incremental secured borrowing rates corresponding to the maturities of the leases.

 

The Company’s lease contains rent escalations over the lease term. The Company recognizes expense for these leases on a straight-line basis over the lease term. Additionally, tenant incentives used to fund leasehold improvements are recognized when earned and reduce our right-of-use asset related to the lease. These are amortized through the right-of-use asset as reductions of expense over the lease term. The Company’s lease agreements do not contain any material residual value guarantees or material restrictive covenants.

 

The Company has elected the short-term lease recognition exemption for all applicable classes of underlying assets. Short-term disclosures include only those leases with a term greater than one month and 12 months or less, and expense is recognized on a straight-line basis over the lease term. Leases with an initial term of 12 months or less, that do not include an option to purchase the underlying asset that the Company is reasonably certain to exercise, are not recorded on the consolidated balance sheet.

 

The components of lease expense were as follows:

 

 

 

Year Ended

December 31,

 

 

 

2022

 

 

2021

 

Operating lease cost

 

$31,129

 

 

$5,438

 

Other information related to leases was as follows:

 

 

 

Year Ended

December 31,

 

 

 

2021

 

 

2020

 

Supplemental Cash Flows Information

 

 

 

 

 

 

Cash paid for amounts included in the measurement of lease liability:

 

 

 

 

 

 

Operating cash flows from operating lease

 

$26,210

 

 

$7,785

 

Operating lease asset obtained in exchange for lease liability:

 

 

 

 

 

 

 

 

Operating lease

 

$-

 

 

$81,668

 

Remaining lease term

 

 

 

 

 

 

 

 

Operating lease

 

1.83 years

 

 

2.83 years

 

Discount rate

 

 

 

 

 

 

 

 

Operating lease

 

 

12.00%

 

 

12.00%

 

Future payments under noncancelable operating leases having initial or remaining terms of one year or more are as follows for the succeeding fiscal year and thereafter:

 

 

 

For the Years Ended

December 31,

 

 

 

 

 

2023

 

$33,244

 

2024

 

 

28,610

 

Total minimum lease payments

 

 

61,854

 

Less imputed interest

 

 

(6,646 )

Present value of lease liabilities

 

 

55,208

 

Less current portion of operating lease liability (included in accounts payable and accrued expenses)

 

 

(28,110 )

Non-current operating lease liability

 

$27,098

 

 

Indemnities and Guarantees

 

We have made certain indemnities and guarantees, under which we may be required to make payments to a guaranteed or indemnified party, in relation to certain transactions. We indemnify our officers and directors to the maximum extent permitted under the laws of the State of Nevada. The duration of these indemnities and guarantees varies and, in certain cases, is indefinite. These indemnities and guarantees do not provide for any limitation of the maximum potential future payments we could be obligated to make. Historically, we have not been obligated to make any payments for these obligations and no liabilities have been recorded for these indemnities and guarantees in the accompanying consolidated balance sheets.

 

Legal Matters

 

In the ordinary course of business, we may face various claims brought by third parties and may, from time to time, make claims or take legal actions to assert our rights, including intellectual property disputes, contractual disputes and other commercial disputes. Any of these claims could subject us to litigation. Management believes there are currently no claims that are likely to have a material effect on our consolidated financial position and results of operations.

XML 33 R22.htm IDEA: XBRL DOCUMENT v3.23.1
Subsequent Events
12 Months Ended
Dec. 31, 2022
Subsequent Events  
Subsequent Events

16. Subsequent Events

 

On February 15, 2023, the Company issued 20,000,000 shares of common stock to its CEO, valued at $21,000.

 

On February 22, 2023, the Company issued 34,064,050 shares of common stock for cash proceeds of $32,974.

 

On March 1, 2023, the Company issued 26,000,000 shares of common stock for the conversion of 25,000 shares of its Series A preferred stock.

 

On March 3, 2023, the Company issued 35,490,000 shares of common stock for the conversion of 34,125 shares of its Series A preferred stock.

 

The Company evaluates subsequent events and transactions that occur after the balance sheet date up to the date that the consolidated financial statements are available to be issued. Any material events that occur between the balance sheet date and the date that the consolidated financial statements were available for issuance are disclosed as subsequent events, while the consolidated financial statements are adjusted to reflect any conditions that existed at the balance sheet date. Based upon this review, except as disclosed within the footnotes or as discussed below, the Company did not identify any subsequent events that require adjustment or disclosure in the consolidated financial statements.

XML 34 R23.htm IDEA: XBRL DOCUMENT v3.23.1
Summary of Significant Accounting Policies (Policies)
12 Months Ended
Dec. 31, 2022
Summary of Significant Accounting Policies  
Basic of Presentation and Consolidation

These consolidated financial statements and related notes include the records of the Company and the Company’s wholly-owned subsidiary, Nimbo Tracking LLC, which is based in the USA.

 

All intercompany transactions and balances have been eliminated. These consolidated financial statements are presented in accordance with accounting principles generally accepted in the United States (“U.S. GAAP”), are expressed in U.S. dollars, and, in management’s opinion, have been properly prepared within reasonable limits of materiality and within the framework of the significant accounting policies summarized below.

Use of Estimates

The preparation of these consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements, and the reported amounts of revenues and expenses during the reporting period. The Company regularly evaluates estimates and assumptions related to allowance for doubtful accounts, valuation of inventory, the useful life and recoverability of equipment, impairment of goodwill, valuation of notes payable and convertible debentures, fair value of stock-based compensation and derivative liabilities, and deferred income tax asset valuation allowances. The Company bases its estimates and assumptions on current facts, historical experience and various other factors that it believes to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities and the accrual of costs and expenses that are not readily apparent from other sources. The actual results experienced by the Company may differ materially and adversely from the Company’s estimates. To the extent there are material differences between the estimates and the actual results, future results of operations will be affected.

Cash and Cash Equivalents

The Company considers all highly liquid instruments purchased with an original maturity of three months or less at the time of acquisition to be cash equivalents.

Accounts Receivable

Accounts receivable are recognized and carried at the original invoice amount less an allowance for expected uncollectible amounts. Inherent in the assessment of the allowance for doubtful accounts are certain judgments and estimates including, among others, the customer’s willingness or ability to pay, the Company’s compliance with customer invoicing requirements, the effect of general economic conditions and the ongoing relationship with the customer. Accounts with outstanding balances longer than the payment terms are considered past due. We do not charge interest on past due balances. The Company writes off trade receivables when all reasonable collection efforts have been exhausted. Bad debt expense is reflected as a component of general and administrative expenses in the consolidated statements of operations. As of December 31, 2022 and 2021, the allowance for doubtful accounts was approximately $16,000 and $11,000, respectively.

Inventory

Inventory consists of vehicle tracking and recovery devices and is comprised entirely of finished goods that can be resold. Inventory is stated at the lower of cost or net realizable value. Cost is determined on a first-in, first-out (FIFO) basis. Net realizable value is the estimated selling price in the ordinary course of business, less estimated costs of completion and selling costs. There was no provision for inventory recorded during the years ended December 31, 2022 and 2021.

Equipment

Office equipment, computer equipment, and software are recorded at cost. Depreciation is provided annually at rates and methods over their estimated useful lives. Management reviews the estimates of useful lives of the assets every year and adjusts them on prospective basis, if needed. All equipment was fully depreciated as of December 31, 2022 and 2021. For purposes of computing depreciation, the method of depreciating equipment is as follows:

 

Computer equipment

3 years straight-line

Office equipment

5 years straight-line

Software

3 years straight-line

Goodwill

Goodwill represents the excess of the acquisition price over the fair value of identifiable net assets acquired. Goodwill is allocated at the date of the business combination. Goodwill is not amortized, but is tested for impairment annually on December 31 of each year or more frequently if events or changes in circumstances indicate the asset may be impaired. These events and circumstances may include a significant change in legal factors or in the business climate, a significant decline in the Company’s share price, an adverse action of assessment by a regulator, unanticipated competition, a loss of key personnel, significant disposal activity and the testing of recoverability for a significant asset group.

 

Goodwill impairment is measured as the amount by which a reporting unit’s carrying value exceeds its fair value.

 

The Company has only one reporting unit. Therefore, all of the Company’s goodwill relates to that reporting unit, and at December 31, 2022 and 2021, the carrying value for that reporting unit is negative.

Impairment of Long-lived Assets

The Company reviews long-lived assets, such as equipment, for impairment whenever events or changes in the circumstances indicate that the carrying value may not be recoverable. If the total of the estimated undiscounted future cash flows is less than the carrying value of the asset, an impairment loss is recognized for the excess of the carrying value over the fair value of the asset during the year the impairment occurs.

Fair Value Measurements and Financial Instruments

In accordance with Financial Accounting Standard Board (“FASB”) Accounting Standards Codification (“ASC”) 820, “Fair Value Measurements and Disclosures,” the Company is to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. ASC 820 establishes a fair value hierarchy based on the level of independent, objective evidence surrounding the inputs used to measure fair value. A financial instrument’s categorization within the fair value hierarchy is based upon the lowest level of input that is significant to the fair value measurement. ASC 820 prioritizes the inputs into three levels that may be used to measure fair value:

 

Level 1

 

Level 1 applies to assets or liabilities for which there are quoted prices in active markets for identical assets or liabilities.

 

Level 2

 

Level 2 applies to assets or liabilities for which there are inputs other than quoted prices that are observable for the asset or liability such as quoted prices for similar assets or liabilities in active markets; quoted prices for identical assets or liabilities in markets with insufficient volume or infrequent transactions (less active markets); or model-derived valuations in which significant inputs are observable or can be derived principally from, or corroborated by, observable market data.

 

Level 3

 

Level 3 applies to assets or liabilities for which there are unobservable inputs to the valuation methodology that are significant to the measurement of the fair value of the assets or liabilities.

See Note 7 for fair value measurement information related to the Company’s derivative liabilities.

 

The fair values of cash and cash equivalents, accounts and other receivables, restricted cash, and accounts payable and accrued liabilities, approximate their carrying values due to the immediate or short-term maturity of these financial instruments. Foreign currency transactions are primarily undertaken in Canadian dollars. The fair value of cash is determined based on “Level 1” inputs and the fair value of derivative liabilities is determined based on “Level 3” inputs. The recorded values of notes payable, approximate their current fair values because of their nature and respective maturity dates or durations. The financial risk is the risk to the Company’s operations that arise from fluctuations in foreign exchange rates and the degree of volatility to these rates. Currently, the Company does not use derivative instruments to reduce its exposure to foreign currency risk. Financial instruments that potentially subject the Company to concentrations of credit risk consists of cash and accounts receivable. The Company places its cash and cash equivalents in what it believes to be credit-worthy financial institutions.

Revenue Recognition and Deferred Revenue

We recognize revenue in accordance with ASC 606, “Revenue from Contracts with Customers”, using the five-step model, including (1) identify the contract with the customer, (2) identify the performance obligations in the contract, (3) determine the transaction price, (4) allocate the transaction price to the performance obligations in the contract, and (5) recognize revenue in accordance with U.S. GAAP. Title and risk of loss generally pass to our customers upon delivery, as we have insurance for lost shipments. In limited circumstances where either title or risk of loss pass upon destination or acceptance or when collection is not reasonably assured, we defer revenue recognition until such events occur. We derive substantially all our revenues from the sale of products and services combined into one performance obligation. Product revenue includes the shipment of product according to the agreement with our customers. Service revenue include vehicle tracking services and customer support (technical support), installations and consulting. A contract usually includes both product and services. For these contracts, the Company accounts for individual performance obligations separately if they are distinct. Performance obligations include, but are not limited to, pass-thru harnesses and vehicle tracking services. Almost all of our revenues are derived from customers located in United States of America in the auto industry. The transaction price is allocated to the separate performance obligations on a relative standalone selling price basis. Standalone selling prices are typically estimated based on observable transactions when these services are not sold on a standalone basis. At contract inception, an assessment of the goods and services promised in the contracts with customers is performed and a performance obligation is identified for each distinct promise to transfer to the customer a good or service (or bundle of goods or services). To identify the performance obligations, the Company considers all of the goods or services promised in the contract regardless of whether they are explicitly stated or are implied by customary business practices. Revenue is recognized when our performance obligation has been met. The Company has insignificant revenues related to product sales. For these revenues, the Company considers control to have transferred upon delivery because the Company has a present right to payment at that time, the Company has transferred use of the asset, and the customer is able to direct the use of, and obtain substantially all of the remaining benefits from, the asset. For arrangements under which the Company provides vehicle tracking services, which account for the substantial portion of the Company’s revenues, the Company satisfies its performance obligations as those services are performed whereby the customer simultaneously receives and consumes the benefits of such services under the agreement. Revenues are recognized net of any taxes collected from customers, which are subsequently remitted to governmental authorities.

 

The Company provides product warranties with varying lengths of time and terms. The product warranties are considered to be assurance-type in nature and do not cover anything beyond ensuring that the product is functioning as intended. Based on the guidance in ASC 606, assurance-type warranties do not represent separate performance obligations. The Company has historically experienced a low rate of product returns under the warranty program.

 

Management assesses the business environment, customers’ financial condition, historical collection experience, accounts receivable aging, and customer disputes to determine whether collectability is reasonably assured.

 

Revenue relating to the sale of service fees on its vehicle tracking and recovery services is recognized over the life of the contact. The service renewal fees are offered in terms ranging from 12 to 36 months and are generally payable upon delivery of the vehicle tracking devices or in full upon renewal.

 

Deferred revenues are recorded net of contract assets when cash payments are received from customers in advance of the Company’s performance. Contract assets represent the costs of (1) commission costs, (2) installation costs, and (3) the underlying hardware to enable the Company to perform on its contracts with customers and are amortized using the same method and term as deferred revenues. As of December 31, 2022 and 2021, deferred revenues, net of contract assets totaled $162,698 and $145,485, respectively, and contract assets totaled $73,450 and $71,441, respectively. Any revenue that has been deferred and is expected to be recognized beyond one year is classified as deferred revenue, net of current portion.

 

During the year ended December 31, 2022, the Company recorded additions to deferred revenues of $238,284 and recognized total revenues of $210,222 through the amortization of deferred revenues. During the year ended December 31, 2022, the Company recognized revenues of $112,323 related to deferred revenues outstanding as of December 31, 2021 as the services were performed.

Financing Costs and Debt Discount

Financing costs and debt discounts are recorded net of notes payable and convertible debentures in the consolidated balance sheets. Amortization of financing costs and the debt discounts is calculated using the effective interest method over the term of the debt and is recorded as interest expense in the consolidated statements of operations.

Income Taxes

Deferred income taxes are provided on the asset and liability method whereby deferred income tax assets are recognized for deductible temporary differences and operating loss and tax credit carryforwards and deferred tax liabilities are recognized for taxable temporary differences. Temporary differences are the differences between the reported amounts of assets and liabilities and their tax bases. Deferred income tax assets are reduced by a valuation allowance when, in the opinion of management, it is more likely than not that some portion or all of the deferred income tax assets will not be realized. Deferred income tax assets and liabilities are adjusted for the effects of changes in tax laws and rates on the date of enactment.

Stock-based Compensation

The Company accounts for stock-based payments in accordance with stock-based payment accounting guidance which requires all stock-based payments to be recognized based upon their fair values. The fair value of stock-based awards is estimated at the grant date using the Black-Scholes Option Pricing Model and the portion that is ultimately expected to vest is recognized as compensation cost over the requisite service period. The determination of fair value using the Black-Scholes Option Pricing Model is affected by the Company’s stock price as well as assumptions regarding a number of complex and subjective variables, including expected stock price volatility, risk-free interest rate, expected dividends and projected employee stock option exercise behaviors. The Company accounts for forfeitures of unvested awards as they occur.

Derivative Financial Instruments

The Company classifies as equity any contracts that require physical settlement or net-share settlement or provide us a choice of net cash settlement or settlement in our own shares (physical settlement or net-share settlement) provided that such contracts are indexed to our own stock as defined in ASC Topic 815-40 “Contracts in Entity’s Own Equity.” The Company classifies as assets or liabilities any contracts (including embedded conversion features) that require net-cash settlement including a requirement to net cash settle the contract if an event occurs and if that event is outside our control or give the counterparty a choice of net-cash settlement or settlement in shares. The Company assesses classification of its derivatives at each reporting date to determine whether a change in classification between assets and liabilities is required.

Loss Per Share

Basic earnings (loss) per share are computed by dividing net income (loss) available to common shareholders (numerator) by the weighted average number of shares outstanding (denominator) during the period. Diluted earnings per share give effect to all dilutive potential common shares outstanding during the period including stock options, using the treasury stock method, and convertible debentures, using the if-converted method. In computing diluted earnings (loss) per share, the average stock price for the period is used in determining the number of shares assumed to be purchased from the exercise of stock options or warrants. Diluted earnings (loss) per share exclude all potentially issuable shares if their effect is anti-dilutive. Because the effect of conversion of the Company’s dilutive securities is anti-dilutive, diluted loss per share is the same as basic loss per share for the periods presented. As of December 31, 2022 and 2021, the Company has 442,441,431 and 239,950,260 potentially dilutive shares outstanding, respectively.

Recent Accounting Pronouncements

In August 2020, the FASB issued ASU 2020-06, “Debt - Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging - Contracts in Entity’s Own Equity (Subtopic 815 - 40)” (“ASU 2020-06”). ASU 2020-06 simplifies the accounting for certain financial instruments with characteristics of liabilities and equity, including convertible instruments and contracts on an entity’s own equity. The ASU is part of the FASB’s simplification initiative, which aims to reduce unnecessary complexity in U.S. GAAP. The ASU’s amendments are effective for fiscal years beginning after December 15, 2023, and interim periods within those fiscal years. The Company is currently evaluating the impact ASU 2020-06 will have on its financial statements.

The Company does not believe that there are any other new accounting pronouncements that have been issued that might have a material impact on its consolidated financial position or results of operations.

XML 35 R24.htm IDEA: XBRL DOCUMENT v3.23.1
Summary of Significant Accounting Policies (Tables)
12 Months Ended
Dec. 31, 2022
Summary of Significant Accounting Policies  
Summary of Property, Plant and Equipment

Computer equipment

3 years straight-line

Office equipment

5 years straight-line

Software

3 years straight-line

XML 36 R25.htm IDEA: XBRL DOCUMENT v3.23.1
Accounts and Other Receivables (Tables)
12 Months Ended
Dec. 31, 2022
Accounts and Other Receivables  
Schedule of Accounts and Other Receivables

 

 

December 31,

2022

 

 

December 31,

2021

 

Trade accounts receivable

 

$38,190

 

 

$49,462

 

Allowance for doubtful accounts

 

 

(16,288 )

 

 

(10,708 )

 

 

$21,902

 

 

$38,754

 

XML 37 R26.htm IDEA: XBRL DOCUMENT v3.23.1
Accounts Payable and Accrued Liabilities (Tables)
12 Months Ended
Dec. 31, 2022
Accounts Payable and Accrued Liabilities  
Schedule of Accounts Payable and Accrued Liabilities

 

 

December 31,

2022

 

 

December 31,

2021

 

Trade accounts payable

 

$174,319

 

 

$540,288

 

Accrued liabilities

 

 

49,723

 

 

 

5,740

 

Lease liability, current portion

 

 

28,110

 

 

 

21,019

 

Accrued interest payable

 

 

2,386

 

 

 

6,097

 

Payroll and commissions payable

 

 

15,689

 

 

 

15,203

 

Unrecognized tax position

 

 

90,000

 

 

 

90,000

 

 

 

$360,227

 

 

$678,347

 

XML 38 R27.htm IDEA: XBRL DOCUMENT v3.23.1
Convertible Debentures and Notes Payable (Tables)
12 Months Ended
Dec. 31, 2022
Convertible Debentures and Notes Payable  
Schedule of Maturities of Long-term Debt

Year Ending

 

Notes Payable

 

 

Convertible Notes

 

 

Total

 

2023

 

$596,745

 

 

$37,000

 

 

$633,745

 

2024

 

 

3,454

 

 

 

-

 

 

 

3,454

 

2025

 

 

3,586

 

 

 

-

 

 

 

3,586

 

2026

 

 

3,718

 

 

 

-

 

 

 

3,718

 

2027

 

 

3,900

 

 

 

-

 

 

 

3,900

 

Thereafter

 

 

146,078

 

 

 

-

 

 

 

146,078

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

$757,482

 

 

$37,000

 

 

$794,482

 

XML 39 R28.htm IDEA: XBRL DOCUMENT v3.23.1
Derivative Liabilities (Tables)
12 Months Ended
Dec. 31, 2022
Derivative Liabilities  
Schedule of Assumptions Used to Value Conversion Features Outstanding

 

 

2022

 

 

2021

 

Expected volatility

 

 

145-166

%

 

 

135-275

%

Risk free interest rate

 

 

1.34-4.68

%

 

 

0.05-0.15

%

Expected life (in years)

 

 

0-1.5

 

 

 

0-1.5

 

Summary of Fair Value of Derivative Liabilities on Recurring Basis

 

 

Level 3

Carrying

Value as of

December 31,

2022

 

 

Level 3

Carrying

Value as of

December 31,

2021

 

Derivative liabilities:

 

 

 

 

 

 

Embedded conversion feature – convertible debt

 

$-

 

 

$51,131

 

Embedded conversion feature – preferred stock

 

 

111,010

 

 

 

85,771

 

 

 

$111,010

 

 

$136,902

 

Schedule of Derivative Liabilities Measured at Fair Value

 

 

For The

Year

Ended

December 31,

2022

 

 

For The

Year

Ended

December 31,

2021

 

Embedded Conversion Features – Debt Instruments

 

 

 

 

 

 

Balances, as of the beginning of the year

 

$51,131

 

 

$97,024

 

Derivative liabilities recorded upon issuance of debt instruments

 

 

-

 

 

 

-

 

Extinguishment due to conversion of debt instruments

 

 

-

 

 

 

(8,994 )

Net changes in fair value included in net loss

 

 

(51,131 )

 

 

(36,989 )

Ending balance

 

$-

 

 

$51,131

 

 

 

 

 

 

 

 

 

 

Embedded Conversion Features – Preferred Stock

 

 

 

 

 

 

 

 

Balances, as of the beginning of the year

 

$85,771

 

 

$92,751

 

Derivative liabilities recorded upon issuance of preferred stock

 

 

175,639

 

 

 

392,410

 

Extinguishment due to conversion of preferred stock

 

 

(241,490 )

 

 

(356,951 )

Net changes in fair value included in net loss

 

 

91,090

 

 

 

(42,439 )

Ending balance

 

$111,010

 

 

$85,771

 

 

 

 

 

 

 

 

 

 

Total ending balance

 

$111,010

 

 

$136,902

 

XML 40 R29.htm IDEA: XBRL DOCUMENT v3.23.1
Share Purchase Warrants (Tables)
12 Months Ended
Dec. 31, 2022
Share Purchase Warrants  
Schedule of Activity of Share Purchase Warrants

 

 

Number of

warrants

 

 

Weighted

average

exercise

price

 

 

 

 

 

 

 

 

Balance, January 1, 2021

 

 

166,517,918

 

 

$0.00

 

Issued

 

 

-

 

 

 

-

 

Adjusted for triggered down-round provisions

 

 

 

 

 

 

0.00

 

Exercised

 

 

 

 

 

 

0.00

 

Expired

 

 

(980,392 )

 

 

0.00

 

Balance, December 31, 2021

 

 

165,537,526

 

 

 

0.00

 

Issued

 

 

-

 

 

 

-

 

Adjusted for triggered down-round provisions

 

 

-

 

 

 

0.00

 

Exercised

 

 

(20,408,163 )

 

 

0.00

 

Expired

 

 

(50,000 )

 

 

0.00

 

Balance, December 31, 2022

 

 

145,079,363

 

 

$0.00

 

Schedule of Share Purchase Warrants Outstanding

Number of warrants outstanding

 

 

Exercise price

 

 

Expiration date

 

2,222,222

 

 

$

0.03

 

 

December 2, 2024

 

142,857,141

 

 

$

0.00

 

 

September 23, 2024

 

145,079,363

 

 

 

 

 

 

 

 

XML 41 R30.htm IDEA: XBRL DOCUMENT v3.23.1
Stock Options (Tables)
12 Months Ended
Dec. 31, 2022
Stock Options  
Schedule of Stock Options Roll Forward

 

 

Number of

options

 

 

Weighted

average

exercise

price

 

 

Aggregate

intrinsic value

 

 

 

 

 

 

 

 

 

 

 

Balance, January 1, 2021

 

 

3,250,000

 

 

$0.09

 

 

 

 

Granted

 

 

-

 

 

 

-

 

 

 

 

Exercised

 

 

-

 

 

 

-

 

 

 

 

Cancelled / forfeited

 

 

(75,000 )

 

 

0.16

 

 

 

 

Balance, December 31, 2021

 

 

3,175,000

 

 

$0.08

 

 

$-

 

Granted

 

 

-

 

 

 

-

 

 

 

 

 

Cancelled / forfeited

 

 

(1,675,000 )

 

 

0.12

 

 

 

 

 

Balance, December 31, 2022

 

 

1,500,000

 

 

$0.04

 

 

$-

 

Vested as of December 31, 2022

 

 

1,500,000

 

 

$0.04

 

 

$-

 

Unvested as of December 31, 2022

 

 

-

 

 

$-

 

 

$-

 

 

 

 

Outstanding

 

 

Exercisable

 

Range of

exercise prices

 

 

Number of

shares

 

 

Weighted average

remaining

contractual

life (years)

 

 

Weighted

average

exercise

price

 

 

Number of

shares

 

 

Weighted

average

exercise

price

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

$0.04

 

 

 

1,500,000

 

 

 

1.4

 

 

 

0.04

 

 

 

1,500,000

 

 

 

0.04

 

 

 

 

 

 

1,500,000

 

 

 

1.4

 

 

$0.04

 

 

 

1,500,000

 

 

$0.04

 

XML 42 R31.htm IDEA: XBRL DOCUMENT v3.23.1
Income Taxes (Tables)
12 Months Ended
Dec. 31, 2022
Income Taxes  
Schedule of Income Tax Provision

 

 

2022

 

 

2021

 

Current:

 

 

 

 

 

 

Federal

 

$-

 

 

$-

 

State

 

 

800

 

 

 

808

 

Foreign

 

 

-

 

 

 

-

 

Total Current

 

 

800

 

 

 

808

 

Deferred:

 

 

 

 

 

 

 

 

Federal

 

 

-

 

 

 

-

 

State

 

 

-

 

 

 

-

 

Foreign

 

 

-

 

 

 

-

 

Total Deferred

 

 

-

 

 

 

-

 

Provision for income taxes

 

$800

 

 

$808

 

Schedule of Reconciliation of Income Tax Expense

 

 

2022

 

 

2021

 

Computed tax benefit at federal statutory rate

 

$(190,596 )

 

$764,147

 

State taxes

 

 

632

 

 

 

638

 

Permanent items

 

 

75

 

 

 

75

 

Stock-based compensation

 

 

175,196

 

 

 

8,829

 

Incentive stock options

 

 

-

 

 

 

-

 

Conversion feature derivative liability

 

 

-

 

 

 

-

 

Interest expense, derivative liability

 

 

-

 

 

 

-

 

Uncertain tax positions

 

 

-

 

 

 

-

 

Impact of difference related to foreign earnings

 

 

-

 

 

 

-

 

Gain on extinguishment of debt

 

 

-

 

 

 

-

 

Change in fair value of derivative liability

 

 

10,225

 

 

 

16,661

 

Valuation allowance

 

 

5,268

 

 

 

(789,542 )

Provision for income taxes

 

$800

 

 

$808

 

Schedule of Deferred Tax Assets

 

 

2022

 

 

2021

 

Deferred Tax Assets:

 

 

 

 

 

 

Net operating loss carryforwards

 

$2,967,000

 

 

$604,000

 

Stock-based compensation

 

 

529,000

 

 

 

767,000

 

Accounts receivable and other timing differences

 

 

140,000

 

 

 

138,000

 

Basis difference in assets and debt

 

 

(80,000 )

 

 

(71,000 )

Total Deferred Tax Asset

 

 

3,556,000

 

 

 

1,438,000

 

Valuation allowance

 

 

(3,556,000 )

 

 

(1,438,000 )

Net Deferred Tax Asset

 

$-

 

 

$-

 

Schedule of Unrecognized Tax Benefits

 

 

Federal

and

State

 

Balance at January 1, 2022

 

$90,000

 

Additions for tax positions related to current year

 

 

-

 

Additions for tax positions related to prior years

 

 

-

 

Balance at December 31, 2022

 

$90,000

 

XML 43 R32.htm IDEA: XBRL DOCUMENT v3.23.1
Commitments and Contingencies (Tables)
12 Months Ended
Dec. 31, 2022
Commitments and Contingencies  
Summary of Operating Lease Expense

 

 

Year Ended

December 31,

 

 

 

2022

 

 

2021

 

Operating lease cost

 

$31,129

 

 

$5,438

 

Schedule of Other Informatoin Related to Opearting Lease

 

 

Year Ended

December 31,

 

 

 

2021

 

 

2020

 

Supplemental Cash Flows Information

 

 

 

 

 

 

Cash paid for amounts included in the measurement of lease liability:

 

 

 

 

 

 

Operating cash flows from operating lease

 

$26,210

 

 

$7,785

 

Operating lease asset obtained in exchange for lease liability:

 

 

 

 

 

 

 

 

Operating lease

 

$-

 

 

$81,668

 

Remaining lease term

 

 

 

 

 

 

 

 

Operating lease

 

1.83 years

 

 

2.83 years

 

Discount rate

 

 

 

 

 

 

 

 

Operating lease

 

 

12.00%

 

 

12.00%
Schedule Future Payments Under Non Cancelable Operating Leases

 

 

For the Years Ended

December 31,

 

 

 

 

 

2023

 

$33,244

 

2024

 

 

28,610

 

Total minimum lease payments

 

 

61,854

 

Less imputed interest

 

 

(6,646 )

Present value of lease liabilities

 

 

55,208

 

Less current portion of operating lease liability (included in accounts payable and accrued expenses)

 

 

(28,110 )

Non-current operating lease liability

 

$27,098

 

 

Indemnities and Guarantees

XML 44 R33.htm IDEA: XBRL DOCUMENT v3.23.1
Organization and Description of Business (Details Narrative) - USD ($)
Dec. 31, 2022
Dec. 31, 2021
Organization and Description of Business    
Working capital deficit $ (1,134,006)  
Accumulated Deficit $ (20,170,140) $ (19,076,522)
XML 45 R34.htm IDEA: XBRL DOCUMENT v3.23.1
Summary of Significant Accounting Policies (Details)
12 Months Ended
Dec. 31, 2022
Computer Equipment [Member]  
Property, Plant and Equipment, Depreciation Methods straight-line
Property, Plant and Equipment, Useful Life 3 years
Office Equipment [Member]  
Property, Plant and Equipment, Depreciation Methods straight-line
Property, Plant and Equipment, Useful Life 5 years
Software [Member]  
Property, Plant and Equipment, Depreciation Methods straight-line
Property, Plant and Equipment, Useful Life 3 years
XML 46 R35.htm IDEA: XBRL DOCUMENT v3.23.1
Summary of Significant Accounting Policies (Details Narrative) - USD ($)
12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Additional deferred revenue $ 238,284  
Potentially dilutive shares outstanding 442,441,431 239,950,260
Revenues recognized $ 210,222  
Deferred revenue 162,698 $ 145,485
Allowance for doubtful accounts $ 16,000 11,000
Minimum [Member]    
Renewal fee term 12 years  
Maximum [Member]    
Renewal fee term 36 years  
Contract asset balance [Member]    
Deferred revenue $ 73,450 $ 71,441
Deferred revenues outstanding [Member]    
Revenues recognized $ 112,323  
XML 47 R36.htm IDEA: XBRL DOCUMENT v3.23.1
Accounts and Other Receivables (Details) - USD ($)
Dec. 31, 2022
Dec. 31, 2021
Accounts and Other Receivables    
Trade accounts receivable $ 38,190 $ 49,462
Allowance for doubtful accounts (16,288) (10,708)
Accounts and other receivables $ 21,902 $ 38,754
XML 48 R37.htm IDEA: XBRL DOCUMENT v3.23.1
Goodwill (Details Narrative) - USD ($)
Dec. 31, 2022
Dec. 31, 2021
Goodwill    
Goodwill $ 505,508 $ 505,508
XML 49 R38.htm IDEA: XBRL DOCUMENT v3.23.1
Accounts Payable and Accrued Liabilities (Details) - USD ($)
Dec. 31, 2022
Dec. 31, 2021
Accounts Payable and Accrued Liabilities    
Trade accounts payable $ 174,319 $ 540,288
Accrued liabilities 49,723 5,740
Lease liability, current portion 28,110 21,019
Accrued interest payable 2,386 6,097
Payroll and commissions payable 15,689 15,203
Unrecognized tax position 90,000 90,000
Accounts payable and accrued liabilities $ 360,227 $ 678,347
XML 50 R39.htm IDEA: XBRL DOCUMENT v3.23.1
Convertible Debentures and Notes Payable (Details)
Dec. 31, 2022
USD ($)
2023 $ 633,745
2024 3,454
2025 3,586
2026 3,718
2027 3,900
Thereafter 146,078
Total 794,482
Convertible Notes [Member]  
2023 37,000
2024 0
2025 0
2026 0
2027 0
Thereafter 0
Total 37,000
Notes Payable [Member]  
2023 596,745
2024 3,454
2025 3,586
2026 3,718
2027 3,900
Thereafter 146,078
Total $ 757,482
XML 51 R40.htm IDEA: XBRL DOCUMENT v3.23.1
Convertible Debentures and Notes Payable (Details Narrative) - USD ($)
1 Months Ended 12 Months Ended
Dec. 13, 2021
Nov. 02, 2020
Jul. 10, 2020
Jul. 07, 2020
May 04, 2020
Jun. 19, 2020
May 17, 2019
Dec. 31, 2022
Dec. 31, 2021
Proceeds from notes payable               $ 527,000 $ 49,965
Interest expense               $ 151,912 27,521
Investor [Member]                  
Debt maturity               mature through March 2023  
Note payble               $ 401,516  
Three separate notes total principal               $ 400,000  
Investor [Member] | Minimum [Member]                  
Interest rate               6.00%  
Investor [Member] | Maximum [Member]                  
Interest rate               12.00%  
PPP Loan [Member]                  
Proceeds from notes payable         $ 59,949        
Interest rate         1.00%        
Accrued interest               $ 60,948  
Debt maturity         matures on May 4, 2022        
SBA Loans [Member]                  
Proceeds from notes payable       $ 150,000          
Interest rate       3.75%          
Accrued interest               164,063  
Debt maturity       July 2050          
Monthly principal and interest payments       $ 731          
Common Stock Purchase Warrant Agreement [Member]                  
Issuance of warrants to purchase common stock             250,000    
Exercise price             $ 0.10    
Securities Purchase Agreement [Member] | Holder [Member]                  
Exercise price             $ 0.10    
Promissory Note [Member]                  
Proceeds from notes payable   $ 146,500 $ 19,250     $ 19,250      
Interest expense   14,800 42,000     122,000      
Debt discount   $ 135,000 25,000     25,000      
Interest rate   12.00%              
Debt maturity   matures on May 2, 2022              
Note payble               0  
Derivative liability, embedded conversion feature     61,000     142,000      
Variable conversion price percentage   80.00%              
First tranche, principal amount   $ 168,000 $ 25,000     $ 25,000      
Outstanding note               12,000  
Debt instrument decrease, forgiveness               45,148  
Promissory Note [Member] | July 10, 2020 [Member]                  
Outstanding note               25,000  
Convertible Promissory Note [Member]                  
Debt conversion, converted instrument, principal, accrued interest, and fees                 $ 9,616
Debt conversion, converted instrument, shares issued                 1,780,825
Changes in derivative liability                 $ 9,013
Reduction in debt discount                 0
Interest expense                 $ 134,014
Convertible Promissory Note [Member] | Crown Bridge Partners, LLC [Member]                  
Proceeds from notes payable $ 50,000                
Interest rate             7.00%    
Debt maturity The note matures on February 13, 2023           The maturity date is 18 months from the effective date of each payment    
Additional proceeding, description             Additionally, if at any time while the Promissory Note is outstanding, the Conversion Price is equal to or lower than $0.025, then an additional $10,000 will be automatically added to the principal balance of each tranche funded under the Note    
Note payble               130,355  
Borrowed additional under the note               $ 127,000  
Weekly payments $ 4,633                
Computer Equipment [Member]                  
Debt conversion, converted instrument, shares issued   2,000,000              
Derivative liability, embedded conversion feature   $ 99,000              
XML 52 R41.htm IDEA: XBRL DOCUMENT v3.23.1
Derivative Liabilities (Details) - Warrants [Member]
12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Minimum [Member]    
Expected volatility 145.00% 135.00%
Risk free interest rate 1.34% 0.05%
Expected life (in years) 0 years 0 years
Maximum [Member]    
Expected volatility 166.00% 275.00%
Risk free interest rate 4.68% 0.15%
Expected life (in years) 1 year 6 months 1 year 6 months
XML 53 R42.htm IDEA: XBRL DOCUMENT v3.23.1
Derivative Liabilities (Details 1) - USD ($)
Dec. 31, 2022
Dec. 31, 2021
Derivative liabilities    
Derivative liabilities $ 0 $ 51,131
Embedded conversion feature - convertible debt 111,010 85,771
Embedded conversion feature - preferred stock $ 111,010 $ 136,902
XML 54 R43.htm IDEA: XBRL DOCUMENT v3.23.1
Derivative Liabilities (Details 2) - USD ($)
12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Embedded Conversion Features - Debt Instrument    
Balances, as of the beginning of the year $ 51,131 $ 97,024
Derivative liabilities recorded upon issuance of debt instrument 0 0
Extinguishment due to conversion of debt instruments 0 (8,994)
Net changes in fair value included in net loss (51,131) (36,989)
Ending balance 0 51,131
Embedded Conversion Features - Preferred Stock    
Balances, as of the beginning of the year 85,771 92,751
Derivative liabilities recorded upon issuance of preferred stock 175,639 392,410
Extinguishment due to conversion of preferred stock (241,490) (356,951)
Net changes in fair value included in net loss 91,090 (42,439)
Ending balance 111,010 85,771
Total ending balance $ 111,010 $ 136,902
XML 55 R44.htm IDEA: XBRL DOCUMENT v3.23.1
Related Party Transactions (Details Narrative) - USD ($)
12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Management and consulting fees $ 192,350 $ 193,647
Officer [Member]    
Management and consulting fees 145,000 147,000
Director [Member]    
Due to Related Parties 5,000 9,000
VP and General Manager [Member]    
Rent and other office expenses 0 8,000
CEO and VP [Member]    
Debt conversion, converted instrument, accrued interest $ 0 $ 24,729
Debt conversion, converted instrument, shares issued 0 4,608,173
XML 56 R45.htm IDEA: XBRL DOCUMENT v3.23.1
Redeemable Preferred Stock and Stockholders Deficit (Details Narrative) - USD ($)
1 Months Ended 12 Months Ended
Feb. 10, 2021
Sep. 30, 2021
Dec. 31, 2022
Dec. 31, 2021
Shares of common stock cashless exercise of warrants       6,979,452
Common stock for services provided by a vendor     3,113,005  
Common stock for the exercise of a warrant on a cashless basis     19,560,705  
Common stock as a commitment fee for a new equity line of credit     12,500,000  
common stock for services provided by management and the board of directors     20,000,000  
Common stock shares issued upon conversion of preferred stock and accrued dividend     264,726,807 113,571,223
Number of shares sold common stock       151,368,383
Proceeds from issuance of stock       $ 621,745
Shares issued, shares     93,490,998  
Proceeds amount     $ 153,746  
Stock based compensation expense     36,000 2,590,040
Proceeds from issuance of stock     $ 390,000 470,500
Rights and Privileges of the Series A Preferred Stock [Member]        
Voting right     Stockholders have no voting rights  
Dividend, percentage     8.00%  
Dividend, percentage increased     22.00%  
Mandatory Redemption, description     18 months after the Issuance Date  
Liquidation preference, description     equal to the then Stated Value (initially $1.00 per share) as adjusted pursuant to the terms in the agreement (including but not limited to the additional of any accrued unpaid dividends and the Default Adjustment (as defined), if applicable  
Stock conversion, description     At any time after 6 months following the Issuance Date  
February 1 2021 [Member]        
Shares issued, shares     58,850  
Proceeds amount     $ 53,500  
March 1 2021 [Member]        
Shares issued, shares     80,850  
Proceeds amount     $ 73,500  
April 5 2021 [Member]        
Shares issued, shares     58,850  
Proceeds amount     $ 53,500  
April 30 2021 [Member]        
Shares issued, shares     59,125  
Proceeds amount     $ 53,750  
June 17 2021 [Member]        
Shares issued, shares     60,500  
Proceeds amount     $ 55,000  
August 11, 2021 [Member]        
Shares issued, shares     59,125  
Proceeds amount     $ 53,750  
September 13, 2021 [Member]        
Shares issued, shares     59,125  
Proceeds amount     $ 53,750  
December 27, 2021 [Member]        
Shares issued, shares     81,125  
Proceeds amount     $ 73,750  
February 2, 2022 [Member]        
Shares issued, shares     59,125  
Proceeds amount     $ 53,500  
March 24, 2022 [Member]        
Shares issued, shares     59,125  
Proceeds amount     $ 53,500  
April 26, 2022 [Member]        
Shares issued, shares     59,125  
Proceeds amount     $ 53,500  
May 20, 2022 [Member]        
Shares issued, shares     53,625  
Proceeds amount     $ 48,750  
August 23, 2022 [Member]        
Shares issued, shares     59,125  
Proceeds amount     $ 53,500  
September 26, 2022 [Member]        
Shares issued, shares     59,125  
Proceeds amount     $ 53,500  
November 2, 2022 [Member]        
Shares issued, shares     48,125  
Proceeds amount     $ 43,750  
December 14, 2022 [Member]        
Shares issued, shares     48,125  
Proceeds amount     $ 43,750  
Investor [Member] | Series A Preferred Stock Purchase Agreements [Member]        
Deemed dividend     126,186  
Reduction of debt discount     175,638  
Proceeds from issuance of stock     $ 405,000  
Shares issued for cash, shares     44,550  
Derivative liabilities     $ 175,638  
Series B Super Voting Preferred Stock [Member]        
Preferred stock, par value $ 0.001      
Preferred stock shares authorized 500,000      
Voting right Each share of Series B preferred stock has voting rights equal to 500 shares of common stock      
Repurchase share price $ 0.001      
Repurchased share     1,250,000  
Preferred stock, value     $ 65,572 $ 1,250
Stock based compensation expense   $ 278,447    
Series A Convertible Preferred Stock [Member] | Holder [Member]        
Common stock shares issued upon conversion of preferred stock and accrued dividend     264,726,807  
Preferred stock shares converted     430,375  
Common stock for the conversion of debt and accrued interest       1,780,825
Changes in derivative liability     $ 241,490  
Deemed dividend     142,620  
Reduction of debt discount     $ 125,406  
Common Shares [Member]        
Proceeds from issuance of stock       $ 58,588
Shares issued for cash, shares       10,479,231
Issued shares for the cashless exercise of warrants       498,260
Series A Preferred Stock [Member]        
Preferred stock, par value     $ 0.001  
Preferred stock shares authorized     10,000,000  
Common stock shares issued in connection with convertible debt/equity     1,250,000  
XML 57 R46.htm IDEA: XBRL DOCUMENT v3.23.1
Share Purchase Warrants (Details) - Warrants [Member] - $ / shares
12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Number of warrants, beginning balance 165,537,526 166,517,918
Number of warrants, exercised (20,408,163)  
Number of warrants, expired (50,000) (980,392)
Number of warrants, ending balance 145,079,363 165,537,526
Weighted average exercise price, beginning balance $ 0.00 $ 0.00
Weighted average exercise price, issued 0 0
Weighted average exercise price, adjusted for triggered down-round provisions 0.00 0.00
Weighted average exercise price, exercised 0.00 0.00
Weighted average exercise price, expired 0.00 0.00
Weighted average exercise price, ending balance $ 0.00 $ 0.00
XML 58 R47.htm IDEA: XBRL DOCUMENT v3.23.1
Share Purchase Warrants (Details 1)
12 Months Ended
Dec. 31, 2022
$ / shares
shares
Number of warrants outstanding 145,079,363
Warrants At 0.03 [Member]  
Number of warrants outstanding 2,222,222
Exercise price (in Dollars per share) | $ / shares $ 0.03
Expiry date December 2, 2024
Warrants At 0.00 [Member]  
Number of warrants outstanding 142,857,141
Exercise price (in Dollars per share) | $ / shares $ 0.00
Expiry date September 23, 2024
XML 59 R48.htm IDEA: XBRL DOCUMENT v3.23.1
Share Purchase Warrants (Details Narrative) - Warrants [Member]
12 Months Ended
Dec. 31, 2022
shares
Number of warrants, exercised 20,408,163
Issuance of shares of common stock 19,560,705
XML 60 R49.htm IDEA: XBRL DOCUMENT v3.23.1
Stock Options (Details) - Stock Option [Member] - USD ($)
12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Number of options, beginning balance 3,175,000 3,250,000
Number of options, exercised 0  
Number of options, Cancelled / Forfeited (1,675,000) (75,000)
Number of options, ending balance 1,500,000 3,175,000
Number of options, Vested   0
Number of options, Unvested 1,500,000 0
Weighted average exercise price, beginning balance $ 0.08 $ 0.09
Weighted average exercise price, Granted 0 0
Weighted average exercise price, Exercised   0
Weighted average exercise price Cancelled / Forfeited 0.12 0.16
Weighted average exercise price, ending balance 0.04 $ 0.08
Weighted average exercise price, Vested 0.04  
Weighted average exercise price, Unvested $ 0  
Aggregate intrinsic value, Nonvested $ 0  
Aggregate intrinsic value, beginning balance 0  
Aggregate intrinsic value, ending balance 0 $ 0
Aggregate intrinsic value, unvasted $ 0  
XML 61 R50.htm IDEA: XBRL DOCUMENT v3.23.1
Stock Options (Details 1) - $ / shares
12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Options 0.04 [Member]      
Range of exercise prices $ 0.04    
Options Outstanding, Number of shares (in Shares) 1,500,000    
Options Outstanding, Weighted average remaining contractual life 1 year 4 months 24 days    
Options Outstanding, Weighted average exercise price $ 0.04    
Options Exercisable, Number of shares (in Shares) 1,500,000    
Options Exercisable, Weighted average exercise price $ 0.04    
Stock Option [Member]      
Options Outstanding, Number of shares (in Shares) 1,500,000 3,175,000 3,250,000
Options Outstanding, Weighted average remaining contractual life 1 year 4 months 24 days    
Options Outstanding, Weighted average exercise price $ 0.04    
Options Exercisable, Number of shares (in Shares) 1,500,000    
Options Exercisable, Weighted average exercise price $ 0.04    
XML 62 R51.htm IDEA: XBRL DOCUMENT v3.23.1
Stock Options (Details Narrative)
Dec. 31, 2022
shares
Stock option plan [Member]  
Common stock shares reserved under plan 6,440,000
XML 63 R52.htm IDEA: XBRL DOCUMENT v3.23.1
Risks Uncertainties (Details Narrative) - Customer Concentration Risk
12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Sales Revenue, Net [Member]    
Concentration Risk, Percentage 77.00% 56.00%
Accounts Receivable [Member]    
Concentration Risk, Percentage 99.00% 99.00%
XML 64 R53.htm IDEA: XBRL DOCUMENT v3.23.1
Income Taxes (Details) - USD ($)
12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Current:    
Federal $ 0 $ 0
State 800 808
Foreign 0 0
Total Current 800 808
Deferred:    
Federal 0 0
State 0 0
Foreign 0 0
Total Deferred 0 0
Provision for Income Taxes $ 800 $ 808
XML 65 R54.htm IDEA: XBRL DOCUMENT v3.23.1
Income Taxes (Details 1) - USD ($)
12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Gain on extinguishment of debt $ 301,360 $ 0
Provision for income taxes 800 808
Reconciliation of income taxes [Member]    
Computed tax benefit at federal statutory rate (190,596) 764,147
State taxes 632 638
Permanent items 75 75
Stock-based compensation 175,196 8,829
Incentive stock options 0 0
Conversion feature derivative liability 0 0
Interest expense, derivative liability 0 0
Uncertain tax positions 0 0
Impact of difference related to foreign earnings 0 0
Gain on extinguishment of debt 0 0
Change in fair value of derivative liability 10,225 16,661
Valuation allowance 5,268 (789,542)
Provision for income taxes $ 800 $ 808
XML 66 R55.htm IDEA: XBRL DOCUMENT v3.23.1
Income Taxes (Details 2) - USD ($)
Dec. 31, 2022
Dec. 31, 2021
Deferred Tax Assets:    
Net operating loss carryforwards $ 2,967,000 $ 604,000
Stock-based compensation 529,000 767,000
Accounts receivable and other timing differences 140,000 138,000
Basis difference in assets and debt (80,000) (71,000)
Total Deferred Tax Asset 3,556,000 1,438,000
Valuation allowance (3,556,000) (1,438,000)
Net Deferred Tax Asset $ 0 $ 0
XML 67 R56.htm IDEA: XBRL DOCUMENT v3.23.1
Income Taxes (Details 3) - Federal and State [Member]
12 Months Ended
Dec. 31, 2022
USD ($)
Unrecognized tax benefit, beginning $ 90,000
Additions for tax positions related to current year 0
Additions for tax positions related to prior years 0
Unrecognized tax benefit, ending $ 90,000
XML 68 R57.htm IDEA: XBRL DOCUMENT v3.23.1
Income Taxes (Details Narrative) - USD ($)
12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Income Taxes    
Net operating loss carryforwards, federal $ 9,970,000  
Net operating loss carryforwards, state $ 9,739,000  
Operating loss carry forward, expiry date, description expire beginning in the year 2029  
Unrecognized tex benefit $ 90,000 $ 90,000
XML 69 R58.htm IDEA: XBRL DOCUMENT v3.23.1
Commitments and Contingencies (Details) - USD ($)
12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Commitments and Contingencies    
Operating lease cost $ 31,129 $ 5,438
XML 70 R59.htm IDEA: XBRL DOCUMENT v3.23.1
Commitments and Contingencies (Details 1) - USD ($)
12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Cash paid for amounts included in the measurement of lease liability:    
Operating cash flows from operating lease $ 26,210 $ 7,785
Operating lease asset obtained in exchange for lease liability:    
Operating lease $ 0 $ 81,668
Remaining lease term Operating lease 1.83 2.83
Discount rate Operating lease 12.00% 12.00%
XML 71 R60.htm IDEA: XBRL DOCUMENT v3.23.1
Commitments and Contingencies (Details 2)
Dec. 31, 2021
USD ($)
Commitments and Contingencies  
2023 $ 33,244
2024 28,610
Total minimum lease payments 61,854
Less imputed interest (6,646)
Present value of lease liabilities 55,208
Less current portion of operating lease liability (28,110)
Non-current operating lease liability $ 27,098
XML 72 R61.htm IDEA: XBRL DOCUMENT v3.23.1
Commitments and Contingencies (Details Narrative)
12 Months Ended
Dec. 31, 2022
USD ($)
ft²
Dec. 31, 2021
USD ($)
Commitments and Contingencies    
Obligation in accounts payable and liabilities | $ $ 37,984 $ 37,984
Lease for office space under an operating lease | ft² 2,500  
Operating lease expired date Oct. 31, 2024  
XML 73 R62.htm IDEA: XBRL DOCUMENT v3.23.1
Subsequent Events (Details Narrative) - USD ($)
1 Months Ended 2 Months Ended
Mar. 03, 2023
Mar. 02, 2023
Feb. 22, 2023
Feb. 15, 2023
Mar. 01, 2023
Common stock shares issued duriing period shares     34,064,050    
Cash Proceeds     $ 32,974    
Subsequent Event [Member] | CEO [Member]          
Common stock shares issued duriing period shares       20,000,000  
Common stock shares issued duriing period, value       $ 21,000  
Series A Preferred shares [Member] | Subsequent Event [Member]          
Preferred stock, shares converted into common stock 34,125       25,000
Common stock shares issued duriing period shares 35,490,000 26,000,000      
XML 74 igen_10k_htm.xml IDEA: XBRL DOCUMENT 0001393540 2022-01-01 2022-12-31 0001393540 2023-02-01 2023-02-22 0001393540 igen:CEOMember us-gaap:SubsequentEventMember 2023-01-01 2023-02-15 0001393540 igen:SeriesAPreferredSharesMember us-gaap:SubsequentEventMember 2023-03-01 2023-03-02 0001393540 igen:SeriesAPreferredSharesMember us-gaap:SubsequentEventMember 2023-03-01 2023-03-03 0001393540 igen:SeriesAPreferredSharesMember us-gaap:SubsequentEventMember 2023-03-01 0001393540 igen:SeriesAPreferredSharesMember us-gaap:SubsequentEventMember 2023-03-03 0001393540 igen:FederalAndStateMember 2022-01-01 2022-12-31 0001393540 igen:ReconciliationOfIncomeTaxesMember 2021-01-01 2021-12-31 0001393540 igen:ReconciliationOfIncomeTaxesMember 2022-01-01 2022-12-31 0001393540 us-gaap:CreditConcentrationRiskMember igen:AccountReceivableMember 2022-01-01 2022-12-31 0001393540 us-gaap:CreditConcentrationRiskMember igen:AccountReceivableMember 2021-01-01 2021-12-31 0001393540 us-gaap:CreditConcentrationRiskMember igen:SaleRevenueNetMember 2021-01-01 2021-12-31 0001393540 us-gaap:CreditConcentrationRiskMember igen:SaleRevenueNetMember 2022-01-01 2022-12-31 0001393540 igen:StockOptionPlanMember 2022-12-31 0001393540 igen:OptionsOneMember 2022-01-01 2022-12-31 0001393540 igen:OptionsOneMember 2022-12-31 0001393540 us-gaap:StockOptionMember 2022-12-31 0001393540 us-gaap:StockOptionMember 2021-01-01 2021-12-31 0001393540 us-gaap:StockOptionMember 2022-01-01 2022-12-31 0001393540 us-gaap:StockOptionMember 2021-12-31 0001393540 us-gaap:StockOptionMember 2020-12-31 0001393540 igen:WarrantsAt000Member 2022-01-01 2022-12-31 0001393540 igen:WarrantsAt003Member 2022-01-01 2022-12-31 0001393540 igen:WarrantsAt000Member 2022-12-31 0001393540 igen:WarrantsAt003Member 2022-12-31 0001393540 igen:WarrantsMember 2022-12-31 0001393540 igen:WarrantsMember 2021-12-31 0001393540 igen:WarrantsMember 2021-01-01 2021-12-31 0001393540 igen:WarrantsMember 2022-01-01 2022-12-31 0001393540 igen:WarrantsMember 2020-12-31 0001393540 igen:SeriesAPreferredStockPurchaseAgreementsMember us-gaap:InvestorMember 2022-12-31 0001393540 igen:CommonStockSharesMember 2021-01-01 2021-12-31 0001393540 igen:SeriesBSuperVotingPreferredStockMember 2021-09-02 2021-09-30 0001393540 igen:SeriesBSuperVotingPreferredStockMember 2021-12-31 0001393540 igen:SeriesBSuperVotingPreferredStockMember 2022-12-31 0001393540 igen:SeriesBSuperVotingPreferredStockMember 2022-01-01 2022-12-31 0001393540 igen:SeriesBSuperVotingPreferredStockMember 2021-02-01 2021-02-10 0001393540 igen:RightsAndPrivilegesOfTheSeriesAPreferredStockMember 2022-01-01 2022-12-31 0001393540 igen:DecemberFourteenTwentyTwentyTwoMember 2022-01-01 2022-12-31 0001393540 igen:NovemberTwoTwentyTwentyTwoMember 2022-01-01 2022-12-31 0001393540 igen:SeptemberTwentySixTwentyTwentyTwoMember 2022-01-01 2022-12-31 0001393540 igen:AugustTwentyThreeTwentyTwentyTwoMember 2022-01-01 2022-12-31 0001393540 igen:MayTwentyTwentyTwentyTwoMember 2022-01-01 2022-12-31 0001393540 igen:AprilTwentySixTwentyTwentyTwoMember 2022-01-01 2022-12-31 0001393540 igen:MarchTwentyFourTwentyTwentyTwoMember 2022-01-01 2022-12-31 0001393540 igen:FebruaryTwoTwentyTwentyTwoMember 2022-01-01 2022-12-31 0001393540 igen:DecemberTwentySevenTwentyTwentyOneMember 2022-01-01 2022-12-31 0001393540 igen:SeptemberThirteenTwentyTwentyOneMember 2022-01-01 2022-12-31 0001393540 igen:AugustElevenTwentyTwentyOneMember 2022-01-01 2022-12-31 0001393540 igen:JuneSeventeenTwentyTwentyOneMember 2022-01-01 2022-12-31 0001393540 igen:AprilThirtyTwentyTwentyOneMember 2022-01-01 2022-12-31 0001393540 igen:AprilFiveTwentyTwentyOneMember 2022-01-01 2022-12-31 0001393540 igen:MarchOneTwentyTwentyOneMember 2022-01-01 2022-12-31 0001393540 igen:FebruaryOneTwentyTwentyOneMember 2022-01-01 2022-12-31 0001393540 us-gaap:SeriesAPreferredStockMember 2022-01-01 2022-12-31 0001393540 igen:SeriesAPreferredStockPurchaseAgreementsMember us-gaap:InvestorMember 2022-01-01 2022-12-31 0001393540 igen:HolderMember igen:SeriesAConvertiblePreferredStockMember 2021-01-01 2021-12-31 0001393540 igen:HolderMember igen:SeriesAConvertiblePreferredStockMember 2022-01-01 2022-12-31 0001393540 us-gaap:SeriesAPreferredStockMember 2022-12-31 0001393540 igen:SeriesBSuperVotingPreferredStockMember 2021-02-10 0001393540 igen:VPAndGeneralManagerMember 2021-01-01 2021-12-31 0001393540 igen:VPAndGeneralManagerMember 2022-01-01 2022-12-31 0001393540 srt:DirectorMember 2021-12-31 0001393540 srt:DirectorMember 2022-12-31 0001393540 igen:CEOAndVPMember 2021-01-01 2021-12-31 0001393540 igen:CEOAndVPMember 2022-01-01 2022-12-31 0001393540 srt:OfficerMember 2021-01-01 2021-12-31 0001393540 srt:OfficerMember 2022-01-01 2022-12-31 0001393540 srt:MaximumMember igen:WarrantsMember 2021-01-01 2021-12-31 0001393540 srt:MinimumMember igen:WarrantsMember 2021-01-01 2021-12-31 0001393540 srt:MaximumMember igen:WarrantsMember 2022-01-01 2022-12-31 0001393540 srt:MinimumMember igen:WarrantsMember 2022-01-01 2022-12-31 0001393540 igen:SecuritiesPurchaseAgreementMember igen:HolderMember 2019-05-17 0001393540 igen:CommonStockPurchaseWarrantAgreementMember 2019-05-17 0001393540 us-gaap:ComputerEquipmentMember 2020-11-01 2020-11-02 0001393540 igen:PromissoryNoteMember 2022-01-01 2022-12-31 0001393540 igen:TenJuliMember igen:PromissoryNoteMember 2022-12-31 0001393540 us-gaap:ComputerEquipmentMember 2020-11-02 0001393540 igen:ConvertiblePromissoryNoteMember igen:CrownBridgePartnersLLCMember 2022-01-01 2022-12-31 0001393540 us-gaap:InvestorMember 2022-12-31 0001393540 igen:ConvertiblePromissoryNoteMember igen:CrownBridgePartnersLLCMember 2022-12-31 0001393540 igen:PromissoryNoteMember 2022-12-31 0001393540 us-gaap:InvestorMember 2022-01-01 2022-12-31 0001393540 igen:ConvertiblePromissoryNoteMember igen:CrownBridgePartnersLLCMember 2019-05-01 2019-05-17 0001393540 srt:MaximumMember us-gaap:InvestorMember 2022-12-31 0001393540 srt:MinimumMember us-gaap:InvestorMember 2022-12-31 0001393540 igen:SBALoansMember 2022-12-31 0001393540 igen:SBALoansMember 2020-07-07 0001393540 igen:PPPLoanMember 2022-12-31 0001393540 igen:PPPLoanMember 2020-05-04 0001393540 igen:ConvertiblePromissoryNoteMember igen:CrownBridgePartnersLLCMember 2019-05-17 0001393540 igen:PromissoryNoteMember 2020-11-02 0001393540 igen:PromissoryNoteMember 2020-07-10 0001393540 igen:PromissoryNoteMember 2020-06-19 0001393540 igen:ConvertiblePromissoryNoteMember 2021-01-01 2021-12-31 0001393540 igen:ConvertiblePromissoryNoteMember igen:CrownBridgePartnersLLCMember 2021-12-01 2021-12-13 0001393540 igen:PromissoryNoteMember 2020-11-01 2020-11-02 0001393540 igen:SBALoansMember 2020-07-01 2020-07-07 0001393540 igen:PPPLoanMember 2020-04-28 2020-05-04 0001393540 igen:PromissoryNoteMember 2020-07-01 2020-07-10 0001393540 igen:PromissoryNoteMember 2020-06-01 2020-06-19 0001393540 us-gaap:ConvertibleNotesPayableMember 2022-12-31 0001393540 igen:NotesPayableMember 2022-12-31 0001393540 srt:MaximumMember 2022-01-01 2022-12-31 0001393540 srt:MinimumMember 2022-01-01 2022-12-31 0001393540 igen:ContractAssetBalanceMember 2021-12-31 0001393540 igen:ContractAssetBalanceMember 2022-12-31 0001393540 igen:DeferredRevenuesOutstandingMember 2022-01-01 2022-12-31 0001393540 us-gaap:SoftwareAndSoftwareDevelopmentCostsMember 2022-01-01 2022-12-31 0001393540 us-gaap:OfficeEquipmentMember 2022-01-01 2022-12-31 0001393540 us-gaap:ComputerEquipmentMember 2022-01-01 2022-12-31 0001393540 us-gaap:RetainedEarningsMember 2022-12-31 0001393540 us-gaap:AdditionalPaidInCapitalMember 2022-12-31 0001393540 igen:SeriesBPreferredStocksMember 2022-12-31 0001393540 us-gaap:CommonStockMember 2022-12-31 0001393540 igen:RedeemableConvertiblePreferredStocksSeriesAMember 2022-12-31 0001393540 us-gaap:RetainedEarningsMember 2022-01-01 2022-12-31 0001393540 us-gaap:AdditionalPaidInCapitalMember 2022-01-01 2022-12-31 0001393540 igen:SeriesBPreferredStocksMember 2022-01-01 2022-12-31 0001393540 us-gaap:CommonStockMember 2022-01-01 2022-12-31 0001393540 igen:RedeemableConvertiblePreferredStocksSeriesAMember 2022-01-01 2022-12-31 0001393540 us-gaap:RetainedEarningsMember 2021-12-31 0001393540 us-gaap:AdditionalPaidInCapitalMember 2021-12-31 0001393540 igen:SeriesBPreferredStocksMember 2021-12-31 0001393540 us-gaap:CommonStockMember 2021-12-31 0001393540 igen:RedeemableConvertiblePreferredStocksSeriesAMember 2021-12-31 0001393540 us-gaap:RetainedEarningsMember 2021-01-01 2021-12-31 0001393540 us-gaap:AdditionalPaidInCapitalMember 2021-01-01 2021-12-31 0001393540 igen:SeriesBPreferredStocksMember 2021-01-01 2021-12-31 0001393540 us-gaap:CommonStockMember 2021-01-01 2021-12-31 0001393540 igen:RedeemableConvertiblePreferredStocksSeriesAMember 2021-01-01 2021-12-31 0001393540 2020-12-31 0001393540 us-gaap:RetainedEarningsMember 2020-12-31 0001393540 us-gaap:AdditionalPaidInCapitalMember 2020-12-31 0001393540 igen:SeriesBPreferredStocksMember 2020-12-31 0001393540 us-gaap:CommonStockMember 2020-12-31 0001393540 igen:RedeemableConvertiblePreferredStocksSeriesAMember 2020-12-31 0001393540 2021-01-01 2021-12-31 0001393540 us-gaap:RedeemableConvertiblePreferredStockMember 2022-12-31 0001393540 us-gaap:RedeemableConvertiblePreferredStockMember 2021-12-31 0001393540 us-gaap:SeriesBPreferredStockMember 2021-12-31 0001393540 us-gaap:SeriesBPreferredStockMember 2022-12-31 0001393540 2021-12-31 0001393540 2022-12-31 0001393540 2023-03-15 0001393540 2022-06-30 iso4217:USD shares iso4217:USD shares pure utr:sqft 0001393540 false --12-31 FY 2022 0.001 2190000000 1476869532 1890261047 0.001 1250000 199375 214500 0.001 5000000 5000000 3750000 251592 371926 P3Y 25000 44550 0 0 0 10-K true 2022-12-31 false 333-141875 IGEN Networks Corp. NV 20-5879021 31772 Casino Drive Suite C Lake Elsinore CA 92530 1 855-912-5378 No No Yes Yes Non-accelerated Filer true false false 4452725 2007815097 GreenGrowthCPAs Los Angeles, California 6580 0 64429 21902 38754 30141 71183 52043 174366 5722 5722 53017 76230 505508 505508 616290 761826 360227 678347 81066 65715 596746 114338 0 30586 37000 89064 111010 136902 1186049 1084366 160736 152147 27098 55211 81632 79770 1455515 1371494 1250000 0.001 214500 199375 218222 203463 59954 101317 138429 84022 5000000 0.001 3750000 5000000 3750 5000 2190000000 0.001 1890261047 1476869532 1890262 1476870 17298474 16900962 -20170140 -19076522 -977654 -693690 616290 761826 318016 268947 318016 268947 322566 123793 -4550 145154 400860 423288 338594 284110 192350 193647 36000 2590040 967804 3491085 -972354 -3345931 -35201 -134014 -48691 79337 301360 0 151912 27521 65556 -82198 -906798 -3428129 800 808 -907598 -3428937 -1159190 -3800863 -0.00 -0.00 1613852078 1263939724 186450 51907 1000000 1000 1192192158 1192192 13068978 -15185187 -923017 517550 150644 0 0 0 -76304 -76304 147652 0 0 0 -147652 -147652 -504625 -266181 0 113571223 113573 747999 -238442 623130 0 4000000 4000 0 2550447 0 2554447 0 0 151368383 151368 470377 0 621745 0 0 1780825 1781 16829 0 18610 0 0 7235356 7235 34810 0 42045 0 0 498260 498 -498 0 0 0 0 3243875 3244 13299 0 16543 0 0 5479452 5479 -5479 0 0 0 0 1500000 1500 4200 0 5700 0 0 0 0 -3428937 -3428937 199375 84022 5000000 5000 1476869532 1476870 16900962 -19076522 -693690 0 0 20000000 20000 16000 0 36000 0 0 3113005 3113 10500 0 13613 0 0 105990998 105991 47755 0 153746 0 0 19560705 19561 -19561 0 0 445500 229362 0 0 0 0 0 126186 0 0 0 -126186 -126186 -430375 -301141 0 264726807 264727 407140 -125406 546461 0 -1250000 -1250 0 -64322 65572 0 0 0 0 0 -907598 -907598 214500 138429 3750000 3750 1890261047 1890262 17298474 -20170140 -977654 907598 3428937 35201 134014 -48691 79337 0 301360 0 23213 5438 49613 2602191 -16852 3924 -41042 50727 0 5722 -923 -142629 17213 6673 -978056 -962960 390000 470500 527000 49965 28113 5438 127756 136115 1250 0 153746 621746 913627 1000658 -64429 37698 64429 26731 0 64429 104164 18593 0 808 0 18610 0 -9616 0 0 0 -9013 671866 861574 -437139 -472810 146448 206629 -241490 -356951 -125406 -251187 175638 319856 126186 -147653 19561 498 12500 5481 0 81668 0 4013 <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;"><strong>1.</strong> <strong>Organization and Description of Business</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">IGEN Networks Corp. (“IGEN”, the “Company”, “we”, “our”) was incorporated in the State of Nevada on November 14, 2006, under the name of Nurse Solutions Inc. On September 19, 2008, the Company changed its name to Sync2 Entertainment Corporation and traded under the symbol SYTO. On September 15, 2008, the Company became a reporting issuer in British Columbia, Canada. On May 26, 2009, the Company changed its name to IGEN Networks Corp. On March 25, 2015, the Company was listed on the Canadian Securities Exchange (CSE) under the trading symbol IGN and the Company became a reporting Venture Issuer in British Columbia and Ontario, Canada.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">The Company’s principal business is the development and marketing of software services for the automotive industry. The Company works with wireless carriers, hardware suppliers and software developers to provide direct and secure access to information on the vehicle and the driver’s behavior. The software services are delivered from the AWS Cloud to the consumer and their families over the wireless networks and accessed from any mobile or desktop device. The software services are marketed to automotive dealers, financial institutions, and direct-to-consumer through various commercial and consumer brands.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;"><strong><em>Going Concern</em></strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">The consolidated financial statements as of and for the year ended December 31, 2022 have been prepared assuming that the Company will continue as a going concern. The Company has experienced recurring losses from operations and has negative operating cash flows since inception, has a working capital deficit of $1,134,006 and an accumulated deficit of $20,170,140 as of December 31, 2022, and is dependent on its ability to raise capital from stockholders or other sources to sustain operations. These factors raise substantial doubt about the Company’s ability to continue as a going concern. Ultimately, the Company plans to achieve profitable operations through the increase in revenue base and successfully growing its operations organically or through acquisitions. The consolidated financial statements do not include any adjustments that might result from the outcome of these uncertainties.</p> -1134006 -20170140 <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;"><strong>2.</strong> <strong>Summary of Significant Accounting Policies</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;"><strong><em>Basic of Presentation and Consolidation</em></strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">These consolidated financial statements and related notes include the records of the Company and the Company’s wholly-owned subsidiary, Nimbo Tracking LLC, which is based in the USA.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">All intercompany transactions and balances have been eliminated. These consolidated financial statements are presented in accordance with accounting principles generally accepted in the United States (“U.S. GAAP”), are expressed in U.S. dollars, and, in management’s opinion, have been properly prepared within reasonable limits of materiality and within the framework of the significant accounting policies summarized below.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;"><strong><em>Use of Estimates</em></strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">The preparation of these consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements, and the reported amounts of revenues and expenses during the reporting period. The Company regularly evaluates estimates and assumptions related to allowance for doubtful accounts, valuation of inventory, the useful life and recoverability of equipment, impairment of goodwill, valuation of notes payable and convertible debentures, fair value of stock-based compensation and derivative liabilities, and deferred income tax asset valuation allowances. The Company bases its estimates and assumptions on current facts, historical experience and various other factors that it believes to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities and the accrual of costs and expenses that are not readily apparent from other sources. The actual results experienced by the Company may differ materially and adversely from the Company’s estimates. To the extent there are material differences between the estimates and the actual results, future results of operations will be affected.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;"><strong><em>Cash and Cash Equivalents</em></strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">The Company considers all highly liquid instruments purchased with an original maturity of three months or less at the time of acquisition to be cash equivalents.</p><p style="font-size:10pt;font-family:times new roman;margin:0px"> <strong><em>Accounts Receivable</em></strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">Accounts receivable are recognized and carried at the original invoice amount less an allowance for expected uncollectible amounts. Inherent in the assessment of the allowance for doubtful accounts are certain judgments and estimates including, among others, the customer’s willingness or ability to pay, the Company’s compliance with customer invoicing requirements, the effect of general economic conditions and the ongoing relationship with the customer. Accounts with outstanding balances longer than the payment terms are considered past due. We do not charge interest on past due balances. The Company writes off trade receivables when all reasonable collection efforts have been exhausted. Bad debt expense is reflected as a component of general and administrative expenses in the consolidated statements of operations. As of December 31, 2022 and 2021, the allowance for doubtful accounts was approximately $16,000 and $11,000, respectively.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;"><strong><em>Inventory</em></strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">Inventory consists of vehicle tracking and recovery devices and is comprised entirely of finished goods that can be resold. Inventory is stated at the lower of cost or net realizable value. Cost is determined on a first-in, first-out (FIFO) basis. Net realizable value is the estimated selling price in the ordinary course of business, less estimated costs of completion and selling costs. There was no provision for inventory recorded during the years ended December 31, 2022 and 2021.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;"><strong><em>Equipment</em></strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">Office equipment, computer equipment, and software are recorded at cost. Depreciation is provided annually at rates and methods over their estimated useful lives. Management reviews the estimates of useful lives of the assets every year and adjusts them on prospective basis, if needed. All equipment was fully depreciated as of December 31, 2022 and 2021. For purposes of computing depreciation, the method of depreciating equipment is as follows:</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><table cellpadding="0" style="border-spacing:0;font-size:10pt;width:100%"><tbody><tr style="height:15px;background-color:#cceeff"><td style="width:17%;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">Computer equipment</p></td><td style="width:71%;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">3 years straight-line</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="width:17%;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">Office equipment</p></td><td style="width:71%;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">5 years straight-line</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="width:17%;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">Software</p></td><td style="width:71%;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">3 years straight-line</p></td></tr></tbody></table><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;"><strong><em>Goodwill</em></strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">Goodwill represents the excess of the acquisition price over the fair value of identifiable net assets acquired. Goodwill is allocated at the date of the business combination. Goodwill is not amortized, but is tested for impairment annually on December 31 of each year or more frequently if events or changes in circumstances indicate the asset may be impaired. These events and circumstances may include a significant change in legal factors or in the business climate, a significant decline in the Company’s share price, an adverse action of assessment by a regulator, unanticipated competition, a loss of key personnel, significant disposal activity and the testing of recoverability for a significant asset group.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">Goodwill impairment is measured as the amount by which a reporting unit’s carrying value exceeds its fair value.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">The Company has only one reporting unit. Therefore, all of the Company’s goodwill relates to that reporting unit, and at December 31, 2022 and 2021, the carrying value for that reporting unit is negative.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;"><strong><em>Impairment of Long-lived Assets</em></strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">The Company reviews long-lived assets, such as equipment, for impairment whenever events or changes in the circumstances indicate that the carrying value may not be recoverable. If the total of the estimated undiscounted future cash flows is less than the carrying value of the asset, an impairment loss is recognized for the excess of the carrying value over the fair value of the asset during the year the impairment occurs.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;"><strong><em>Fair Value Measurements and Financial Instruments</em></strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">In accordance with Financial Accounting Standard Board (“FASB”) Accounting Standards Codification (“ASC”) 820, “Fair Value Measurements and Disclosures,” the Company is to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. ASC 820 establishes a fair value hierarchy based on the level of independent, objective evidence surrounding the inputs used to measure fair value. A financial instrument’s categorization within the fair value hierarchy is based upon the lowest level of input that is significant to the fair value measurement. ASC 820 prioritizes the inputs into three levels that may be used to measure fair value:</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;"><em>Level 1</em></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">Level 1 applies to assets or liabilities for which there are quoted prices in active markets for identical assets or liabilities.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;"><em>Level 2</em></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">Level 2 applies to assets or liabilities for which there are inputs other than quoted prices that are observable for the asset or liability such as quoted prices for similar assets or liabilities in active markets; quoted prices for identical assets or liabilities in markets with insufficient volume or infrequent transactions (less active markets); or model-derived valuations in which significant inputs are observable or can be derived principally from, or corroborated by, observable market data.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;"><em>Level 3</em></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">Level 3 applies to assets or liabilities for which there are unobservable inputs to the valuation methodology that are significant to the measurement of the fair value of the assets or liabilities.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">See Note 7 for fair value measurement information related to the Company’s derivative liabilities.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">The fair values of cash and cash equivalents, accounts and other receivables, restricted cash, and accounts payable and accrued liabilities, approximate their carrying values due to the immediate or short-term maturity of these financial instruments. Foreign currency transactions are primarily undertaken in Canadian dollars. The fair value of cash is determined based on “Level 1” inputs and the fair value of derivative liabilities is determined based on “Level 3” inputs. The recorded values of notes payable, approximate their current fair values because of their nature and respective maturity dates or durations. The financial risk is the risk to the Company’s operations that arise from fluctuations in foreign exchange rates and the degree of volatility to these rates. Currently, the Company does not use derivative instruments to reduce its exposure to foreign currency risk. Financial instruments that potentially subject the Company to concentrations of credit risk consists of cash and accounts receivable. The Company places its cash and cash equivalents in what it believes to be credit-worthy financial institutions.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;"><strong><em>Revenue Recognition and Deferred Revenue</em></strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">We recognize revenue in accordance with ASC 606, “Revenue from Contracts with Customers”, using the five-step model, including (1) identify the contract with the customer, (2) identify the performance obligations in the contract, (3) determine the transaction price, (4) allocate the transaction price to the performance obligations in the contract, and (5) recognize revenue in accordance with U.S. GAAP. Title and risk of loss generally pass to our customers upon delivery, as we have insurance for lost shipments. In limited circumstances where either title or risk of loss pass upon destination or acceptance or when collection is not reasonably assured, we defer revenue recognition until such events occur. We derive substantially all our revenues from the sale of products and services combined into one performance obligation. Product revenue includes the shipment of product according to the agreement with our customers. Service revenue include vehicle tracking services and customer support (technical support), installations and consulting. A contract usually includes both product and services. For these contracts, the Company accounts for individual performance obligations separately if they are distinct. Performance obligations include, but are not limited to, pass-thru harnesses and vehicle tracking services. Almost all of our revenues are derived from customers located in United States of America in the auto industry. The transaction price is allocated to the separate performance obligations on a relative standalone selling price basis. Standalone selling prices are typically estimated based on observable transactions when these services are not sold on a standalone basis. At contract inception, an assessment of the goods and services promised in the contracts with customers is performed and a performance obligation is identified for each distinct promise to transfer to the customer a good or service (or bundle of goods or services). To identify the performance obligations, the Company considers all of the goods or services promised in the contract regardless of whether they are explicitly stated or are implied by customary business practices. Revenue is recognized when our performance obligation has been met. The Company has insignificant revenues related to product sales. For these revenues, the Company considers control to have transferred upon delivery because the Company has a present right to payment at that time, the Company has transferred use of the asset, and the customer is able to direct the use of, and obtain substantially all of the remaining benefits from, the asset. For arrangements under which the Company provides vehicle tracking services, which account for the substantial portion of the Company’s revenues, the Company satisfies its performance obligations as those services are performed whereby the customer simultaneously receives and consumes the benefits of such services under the agreement. Revenues are recognized net of any taxes collected from customers, which are subsequently remitted to governmental authorities.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">The Company provides product warranties with varying lengths of time and terms. The product warranties are considered to be assurance-type in nature and do not cover anything beyond ensuring that the product is functioning as intended. Based on the guidance in ASC 606, assurance-type warranties do not represent separate performance obligations. The Company has historically experienced a low rate of product returns under the warranty program.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">Management assesses the business environment, customers’ financial condition, historical collection experience, accounts receivable aging, and customer disputes to determine whether collectability is reasonably assured.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">Revenue relating to the sale of service fees on its vehicle tracking and recovery services is recognized over the life of the contact. The service renewal fees are offered in terms ranging from 12 to 36 months and are generally payable upon delivery of the vehicle tracking devices or in full upon renewal.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">Deferred revenues are recorded net of contract assets when cash payments are received from customers in advance of the Company’s performance. Contract assets represent the costs of (1) commission costs, (2) installation costs, and (3) the underlying hardware to enable the Company to perform on its contracts with customers and are amortized using the same method and term as deferred revenues. As of December 31, 2022 and 2021, deferred revenues, net of contract assets totaled $162,698 and $145,485, respectively, and contract assets totaled $73,450 and $71,441, respectively. Any revenue that has been deferred and is expected to be recognized beyond one year is classified as deferred revenue, net of current portion.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">During the year ended December 31, 2022, the Company recorded additions to deferred revenues of $238,284 and recognized total revenues of $210,222 through the amortization of deferred revenues. During the year ended December 31, 2022, the Company recognized revenues of $112,323 related to deferred revenues outstanding as of December 31, 2021 as the services were performed.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;"><strong><em>Financing Costs and Debt Discount</em></strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">Financing costs and debt discounts are recorded net of notes payable and convertible debentures in the consolidated balance sheets. Amortization of financing costs and the debt discounts is calculated using the effective interest method over the term of the debt and is recorded as interest expense in the consolidated statements of operations.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;"><strong><em>Income Taxes</em></strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">Deferred income taxes are provided on the asset and liability method whereby deferred income tax assets are recognized for deductible temporary differences and operating loss and tax credit carryforwards and deferred tax liabilities are recognized for taxable temporary differences. Temporary differences are the differences between the reported amounts of assets and liabilities and their tax bases. Deferred income tax assets are reduced by a valuation allowance when, in the opinion of management, it is more likely than not that some portion or all of the deferred income tax assets will not be realized. Deferred income tax assets and liabilities are adjusted for the effects of changes in tax laws and rates on the date of enactment.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;"><strong><em>Stock-based Compensation</em></strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">The Company accounts for stock-based payments in accordance with stock-based payment accounting guidance which requires all stock-based payments to be recognized based upon their fair values. The fair value of stock-based awards is estimated at the grant date using the Black-Scholes Option Pricing Model and the portion that is ultimately expected to vest is recognized as compensation cost over the requisite service period. The determination of fair value using the Black-Scholes Option Pricing Model is affected by the Company’s stock price as well as assumptions regarding a number of complex and subjective variables, including expected stock price volatility, risk-free interest rate, expected dividends and projected employee stock option exercise behaviors. The Company accounts for forfeitures of unvested awards as they occur.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;"><strong><em>Derivative Financial Instruments</em></strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">The Company classifies as equity any contracts that require physical settlement or net-share settlement or provide us a choice of net cash settlement or settlement in our own shares (physical settlement or net-share settlement) provided that such contracts are indexed to our own stock as defined in ASC Topic 815-40 “Contracts in Entity’s Own Equity.” The Company classifies as assets or liabilities any contracts (including embedded conversion features) that require net-cash settlement including a requirement to net cash settle the contract if an event occurs and if that event is outside our control or give the counterparty a choice of net-cash settlement or settlement in shares. The Company assesses classification of its derivatives at each reporting date to determine whether a change in classification between assets and liabilities is required.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;"><strong><em>Loss Per Share</em></strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">Basic earnings (loss) per share are computed by dividing net income (loss) available to common shareholders (numerator) by the weighted average number of shares outstanding (denominator) during the period. Diluted earnings per share give effect to all dilutive potential common shares outstanding during the period including stock options, using the treasury stock method, and convertible debentures, using the if-converted method. In computing diluted earnings (loss) per share, the average stock price for the period is used in determining the number of shares assumed to be purchased from the exercise of stock options or warrants. Diluted earnings (loss) per share exclude all potentially issuable shares if their effect is anti-dilutive. Because the effect of conversion of the Company’s dilutive securities is anti-dilutive, diluted loss per share is the same as basic loss per share for the periods presented. As of December 31, 2022 and 2021, the Company has 442,441,431 and 239,950,260 potentially dilutive shares outstanding, respectively.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;"><strong><em>Recent Accounting Pronouncement</em></strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">In August 2020, the FASB issued ASU 2020-06, <em>“Debt - Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging - Contracts in Entity’s Own Equity (Subtopic 815 - 40)”</em> (“ASU 2020-06”). ASU 2020-06 simplifies the accounting for certain financial instruments with characteristics of liabilities and equity, including convertible instruments and contracts on an entity’s own equity. The ASU is part of the FASB’s simplification initiative, which aims to reduce unnecessary complexity in U.S. GAAP. The ASU’s amendments are effective for fiscal years beginning after December 15, 2023, and interim periods within those fiscal years. The Company is currently evaluating the impact ASU 2020-06 will have on its financial statements.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">The Company does not believe that there are any other new accounting pronouncements that have been issued that might have a material impact on its consolidated financial position or results of operations.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">These consolidated financial statements and related notes include the records of the Company and the Company’s wholly-owned subsidiary, Nimbo Tracking LLC, which is based in the USA.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">All intercompany transactions and balances have been eliminated. These consolidated financial statements are presented in accordance with accounting principles generally accepted in the United States (“U.S. GAAP”), are expressed in U.S. dollars, and, in management’s opinion, have been properly prepared within reasonable limits of materiality and within the framework of the significant accounting policies summarized below.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">The preparation of these consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements, and the reported amounts of revenues and expenses during the reporting period. The Company regularly evaluates estimates and assumptions related to allowance for doubtful accounts, valuation of inventory, the useful life and recoverability of equipment, impairment of goodwill, valuation of notes payable and convertible debentures, fair value of stock-based compensation and derivative liabilities, and deferred income tax asset valuation allowances. The Company bases its estimates and assumptions on current facts, historical experience and various other factors that it believes to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities and the accrual of costs and expenses that are not readily apparent from other sources. The actual results experienced by the Company may differ materially and adversely from the Company’s estimates. To the extent there are material differences between the estimates and the actual results, future results of operations will be affected.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">The Company considers all highly liquid instruments purchased with an original maturity of three months or less at the time of acquisition to be cash equivalents.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">Accounts receivable are recognized and carried at the original invoice amount less an allowance for expected uncollectible amounts. Inherent in the assessment of the allowance for doubtful accounts are certain judgments and estimates including, among others, the customer’s willingness or ability to pay, the Company’s compliance with customer invoicing requirements, the effect of general economic conditions and the ongoing relationship with the customer. Accounts with outstanding balances longer than the payment terms are considered past due. We do not charge interest on past due balances. The Company writes off trade receivables when all reasonable collection efforts have been exhausted. Bad debt expense is reflected as a component of general and administrative expenses in the consolidated statements of operations. As of December 31, 2022 and 2021, the allowance for doubtful accounts was approximately $16,000 and $11,000, respectively.</p> 16000 11000 <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">Inventory consists of vehicle tracking and recovery devices and is comprised entirely of finished goods that can be resold. Inventory is stated at the lower of cost or net realizable value. Cost is determined on a first-in, first-out (FIFO) basis. Net realizable value is the estimated selling price in the ordinary course of business, less estimated costs of completion and selling costs. There was no provision for inventory recorded during the years ended December 31, 2022 and 2021.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">Office equipment, computer equipment, and software are recorded at cost. Depreciation is provided annually at rates and methods over their estimated useful lives. Management reviews the estimates of useful lives of the assets every year and adjusts them on prospective basis, if needed. All equipment was fully depreciated as of December 31, 2022 and 2021. For purposes of computing depreciation, the method of depreciating equipment is as follows:</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><table cellpadding="0" style="border-spacing:0;font-size:10pt;width:100%"><tbody><tr style="height:15px;background-color:#cceeff"><td style="width:17%;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">Computer equipment</p></td><td style="width:71%;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">3 years straight-line</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="width:17%;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">Office equipment</p></td><td style="width:71%;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">5 years straight-line</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="width:17%;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">Software</p></td><td style="width:71%;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">3 years straight-line</p></td></tr></tbody></table> <table cellpadding="0" style="border-spacing:0;font-size:10pt;width:100%"><tbody><tr style="height:15px;background-color:#cceeff"><td style="width:17%;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">Computer equipment</p></td><td style="width:71%;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">3 years straight-line</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="width:17%;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">Office equipment</p></td><td style="width:71%;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">5 years straight-line</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="width:17%;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">Software</p></td><td style="width:71%;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">3 years straight-line</p></td></tr></tbody></table> P3Y straight-line P5Y straight-line straight-line <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">Goodwill represents the excess of the acquisition price over the fair value of identifiable net assets acquired. Goodwill is allocated at the date of the business combination. Goodwill is not amortized, but is tested for impairment annually on December 31 of each year or more frequently if events or changes in circumstances indicate the asset may be impaired. These events and circumstances may include a significant change in legal factors or in the business climate, a significant decline in the Company’s share price, an adverse action of assessment by a regulator, unanticipated competition, a loss of key personnel, significant disposal activity and the testing of recoverability for a significant asset group.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">Goodwill impairment is measured as the amount by which a reporting unit’s carrying value exceeds its fair value.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">The Company has only one reporting unit. Therefore, all of the Company’s goodwill relates to that reporting unit, and at December 31, 2022 and 2021, the carrying value for that reporting unit is negative.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">The Company reviews long-lived assets, such as equipment, for impairment whenever events or changes in the circumstances indicate that the carrying value may not be recoverable. If the total of the estimated undiscounted future cash flows is less than the carrying value of the asset, an impairment loss is recognized for the excess of the carrying value over the fair value of the asset during the year the impairment occurs.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">In accordance with Financial Accounting Standard Board (“FASB”) Accounting Standards Codification (“ASC”) 820, “Fair Value Measurements and Disclosures,” the Company is to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. ASC 820 establishes a fair value hierarchy based on the level of independent, objective evidence surrounding the inputs used to measure fair value. A financial instrument’s categorization within the fair value hierarchy is based upon the lowest level of input that is significant to the fair value measurement. ASC 820 prioritizes the inputs into three levels that may be used to measure fair value:</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;"><em>Level 1</em></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">Level 1 applies to assets or liabilities for which there are quoted prices in active markets for identical assets or liabilities.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;"><em>Level 2</em></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">Level 2 applies to assets or liabilities for which there are inputs other than quoted prices that are observable for the asset or liability such as quoted prices for similar assets or liabilities in active markets; quoted prices for identical assets or liabilities in markets with insufficient volume or infrequent transactions (less active markets); or model-derived valuations in which significant inputs are observable or can be derived principally from, or corroborated by, observable market data.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;"><em>Level 3</em></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">Level 3 applies to assets or liabilities for which there are unobservable inputs to the valuation methodology that are significant to the measurement of the fair value of the assets or liabilities.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">See Note 7 for fair value measurement information related to the Company’s derivative liabilities.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">The fair values of cash and cash equivalents, accounts and other receivables, restricted cash, and accounts payable and accrued liabilities, approximate their carrying values due to the immediate or short-term maturity of these financial instruments. Foreign currency transactions are primarily undertaken in Canadian dollars. The fair value of cash is determined based on “Level 1” inputs and the fair value of derivative liabilities is determined based on “Level 3” inputs. The recorded values of notes payable, approximate their current fair values because of their nature and respective maturity dates or durations. The financial risk is the risk to the Company’s operations that arise from fluctuations in foreign exchange rates and the degree of volatility to these rates. Currently, the Company does not use derivative instruments to reduce its exposure to foreign currency risk. Financial instruments that potentially subject the Company to concentrations of credit risk consists of cash and accounts receivable. The Company places its cash and cash equivalents in what it believes to be credit-worthy financial institutions.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">We recognize revenue in accordance with ASC 606, “Revenue from Contracts with Customers”, using the five-step model, including (1) identify the contract with the customer, (2) identify the performance obligations in the contract, (3) determine the transaction price, (4) allocate the transaction price to the performance obligations in the contract, and (5) recognize revenue in accordance with U.S. GAAP. Title and risk of loss generally pass to our customers upon delivery, as we have insurance for lost shipments. In limited circumstances where either title or risk of loss pass upon destination or acceptance or when collection is not reasonably assured, we defer revenue recognition until such events occur. We derive substantially all our revenues from the sale of products and services combined into one performance obligation. Product revenue includes the shipment of product according to the agreement with our customers. Service revenue include vehicle tracking services and customer support (technical support), installations and consulting. A contract usually includes both product and services. For these contracts, the Company accounts for individual performance obligations separately if they are distinct. Performance obligations include, but are not limited to, pass-thru harnesses and vehicle tracking services. Almost all of our revenues are derived from customers located in United States of America in the auto industry. The transaction price is allocated to the separate performance obligations on a relative standalone selling price basis. Standalone selling prices are typically estimated based on observable transactions when these services are not sold on a standalone basis. At contract inception, an assessment of the goods and services promised in the contracts with customers is performed and a performance obligation is identified for each distinct promise to transfer to the customer a good or service (or bundle of goods or services). To identify the performance obligations, the Company considers all of the goods or services promised in the contract regardless of whether they are explicitly stated or are implied by customary business practices. Revenue is recognized when our performance obligation has been met. The Company has insignificant revenues related to product sales. For these revenues, the Company considers control to have transferred upon delivery because the Company has a present right to payment at that time, the Company has transferred use of the asset, and the customer is able to direct the use of, and obtain substantially all of the remaining benefits from, the asset. For arrangements under which the Company provides vehicle tracking services, which account for the substantial portion of the Company’s revenues, the Company satisfies its performance obligations as those services are performed whereby the customer simultaneously receives and consumes the benefits of such services under the agreement. Revenues are recognized net of any taxes collected from customers, which are subsequently remitted to governmental authorities.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">The Company provides product warranties with varying lengths of time and terms. The product warranties are considered to be assurance-type in nature and do not cover anything beyond ensuring that the product is functioning as intended. Based on the guidance in ASC 606, assurance-type warranties do not represent separate performance obligations. The Company has historically experienced a low rate of product returns under the warranty program.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">Management assesses the business environment, customers’ financial condition, historical collection experience, accounts receivable aging, and customer disputes to determine whether collectability is reasonably assured.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">Revenue relating to the sale of service fees on its vehicle tracking and recovery services is recognized over the life of the contact. The service renewal fees are offered in terms ranging from 12 to 36 months and are generally payable upon delivery of the vehicle tracking devices or in full upon renewal.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">Deferred revenues are recorded net of contract assets when cash payments are received from customers in advance of the Company’s performance. Contract assets represent the costs of (1) commission costs, (2) installation costs, and (3) the underlying hardware to enable the Company to perform on its contracts with customers and are amortized using the same method and term as deferred revenues. As of December 31, 2022 and 2021, deferred revenues, net of contract assets totaled $162,698 and $145,485, respectively, and contract assets totaled $73,450 and $71,441, respectively. Any revenue that has been deferred and is expected to be recognized beyond one year is classified as deferred revenue, net of current portion.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">During the year ended December 31, 2022, the Company recorded additions to deferred revenues of $238,284 and recognized total revenues of $210,222 through the amortization of deferred revenues. During the year ended December 31, 2022, the Company recognized revenues of $112,323 related to deferred revenues outstanding as of December 31, 2021 as the services were performed.</p> P12Y P36Y 162698 145485 73450 71441 238284 210222 112323 <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">Financing costs and debt discounts are recorded net of notes payable and convertible debentures in the consolidated balance sheets. Amortization of financing costs and the debt discounts is calculated using the effective interest method over the term of the debt and is recorded as interest expense in the consolidated statements of operations.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">Deferred income taxes are provided on the asset and liability method whereby deferred income tax assets are recognized for deductible temporary differences and operating loss and tax credit carryforwards and deferred tax liabilities are recognized for taxable temporary differences. Temporary differences are the differences between the reported amounts of assets and liabilities and their tax bases. Deferred income tax assets are reduced by a valuation allowance when, in the opinion of management, it is more likely than not that some portion or all of the deferred income tax assets will not be realized. Deferred income tax assets and liabilities are adjusted for the effects of changes in tax laws and rates on the date of enactment.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">The Company accounts for stock-based payments in accordance with stock-based payment accounting guidance which requires all stock-based payments to be recognized based upon their fair values. The fair value of stock-based awards is estimated at the grant date using the Black-Scholes Option Pricing Model and the portion that is ultimately expected to vest is recognized as compensation cost over the requisite service period. The determination of fair value using the Black-Scholes Option Pricing Model is affected by the Company’s stock price as well as assumptions regarding a number of complex and subjective variables, including expected stock price volatility, risk-free interest rate, expected dividends and projected employee stock option exercise behaviors. The Company accounts for forfeitures of unvested awards as they occur.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">The Company classifies as equity any contracts that require physical settlement or net-share settlement or provide us a choice of net cash settlement or settlement in our own shares (physical settlement or net-share settlement) provided that such contracts are indexed to our own stock as defined in ASC Topic 815-40 “Contracts in Entity’s Own Equity.” The Company classifies as assets or liabilities any contracts (including embedded conversion features) that require net-cash settlement including a requirement to net cash settle the contract if an event occurs and if that event is outside our control or give the counterparty a choice of net-cash settlement or settlement in shares. The Company assesses classification of its derivatives at each reporting date to determine whether a change in classification between assets and liabilities is required.</p> <p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">Basic earnings (loss) per share are computed by dividing net income (loss) available to common shareholders (numerator) by the weighted average number of shares outstanding (denominator) during the period. Diluted earnings per share give effect to all dilutive potential common shares outstanding during the period including stock options, using the treasury stock method, and convertible debentures, using the if-converted method. In computing diluted earnings (loss) per share, the average stock price for the period is used in determining the number of shares assumed to be purchased from the exercise of stock options or warrants. Diluted earnings (loss) per share exclude all potentially issuable shares if their effect is anti-dilutive. Because the effect of conversion of the Company’s dilutive securities is anti-dilutive, diluted loss per share is the same as basic loss per share for the periods presented. As of December 31, 2022 and 2021, the Company has 442,441,431 and 239,950,260 potentially dilutive shares outstanding, respectively.</p> 442441431 239950260 <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">In August 2020, the FASB issued ASU 2020-06, <em>“Debt - Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging - Contracts in Entity’s Own Equity (Subtopic 815 - 40)”</em> (“ASU 2020-06”). ASU 2020-06 simplifies the accounting for certain financial instruments with characteristics of liabilities and equity, including convertible instruments and contracts on an entity’s own equity. The ASU is part of the FASB’s simplification initiative, which aims to reduce unnecessary complexity in U.S. GAAP. The ASU’s amendments are effective for fiscal years beginning after December 15, 2023, and interim periods within those fiscal years. The Company is currently evaluating the impact ASU 2020-06 will have on its financial statements.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">The Company does not believe that there are any other new accounting pronouncements that have been issued that might have a material impact on its consolidated financial position or results of operations.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;"><strong>3.</strong> <strong>Accounts and Other Receivables</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"><tbody><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>December 31,</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>2022</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>December 31,</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>2021</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">Trade accounts receivable</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">38,190</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">49,462</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">Allowance for doubtful accounts</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">(16,288 </td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">(10,708 </td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td></tr><tr style="height:15px;background-color:#cceeff"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;">21,902</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;">38,754</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr></tbody></table> <table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"><tbody><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>December 31,</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>2022</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>December 31,</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>2021</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">Trade accounts receivable</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">38,190</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">49,462</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">Allowance for doubtful accounts</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">(16,288 </td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">(10,708 </td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td></tr><tr style="height:15px;background-color:#cceeff"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;">21,902</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;">38,754</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr></tbody></table> 38190 49462 16288 10708 21902 38754 <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;"><strong>4.</strong> <strong>Goodwill</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">As of December 31, 2022 and 2021, the Company had goodwill of $505,508 related to the acquisition of Nimbo Tracking, LLC.</p> 505508 <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;"><strong>5.</strong> <strong>Accounts Payable and Accrued Liabilities</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"><tbody><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>December 31,</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>2022</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>December 31,</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>2021</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">Trade accounts payable</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">174,319</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">540,288</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">Accrued liabilities</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">49,723</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">5,740</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">Lease liability, current portion</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">28,110</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">21,019</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">Accrued interest payable</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">2,386</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">6,097</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">Payroll and commissions payable</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">15,689</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">15,203</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">Unrecognized tax position</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">90,000</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">90,000</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;">360,227</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;">678,347</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr></tbody></table> <table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"><tbody><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>December 31,</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>2022</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>December 31,</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>2021</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">Trade accounts payable</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">174,319</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">540,288</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">Accrued liabilities</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">49,723</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">5,740</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">Lease liability, current portion</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">28,110</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">21,019</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">Accrued interest payable</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">2,386</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">6,097</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">Payroll and commissions payable</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">15,689</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">15,203</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">Unrecognized tax position</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">90,000</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">90,000</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;">360,227</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;">678,347</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr></tbody></table> 174319 540288 49723 5740 28110 21019 2386 6097 15689 15203 90000 90000 360227 678347 <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;"><strong>6.</strong> <strong>Convertible Debentures and Notes Payable</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">On May 17, 2019, the Company entered into a Convertible Promissory Note (“Promissory Note”) with Crown Bridge Partners, LLC (the “Holder”). The Promissory Note bears interest at 7% per annum (with the understanding that the first 12 months of interest of each tranche will be guaranteed). The maturity date is 18 months from the effective date of each payment.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">The Conversion Price, as defined in the agreement, is the lesser of (i) the lowest Trading Price (as defined below) during the previous 25 trading day period ending on the latest complete trading day prior to the date of this Promissory Note or (ii) the Variable Conversion Price (as defined below). The Variable Conversion Price means the lowest one Trading Price (as defined below) for the common stock during the 25 Trading Day period ending on the last complete Trading Day prior to the Conversion Date. Trading Price means, for any security as of any date, the lesser of the (i) lowest traded price and (ii) lowest closing bid price. Based on the Company’s examination of the conversion feature and the relative accounting guidance, the Company has determined that the conversion feature should be treated as a derivative liability for accounting purposes.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">Additionally, if at any time while the Promissory Note is outstanding, the Conversion Price is equal to or lower than $0.025, then an additional $10,000 will be automatically added to the principal balance of each tranche funded under the Note.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">In connection with the Promissory Note, the Company also entered into a Securities Purchase Agreement with the Holder which states that the Company will also issue to the Holder a warrant to purchase an amount of shares of its common stock equal to 50% of the face value of each respective tranche divided by $0.10.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">Per the terms of the Common Stock Purchase Warrant agreement, on May 17, 2019, the Company issued a warrant to purchase 250,000 shares of common stock with an Exercise Price of $0.10 subject to adjustment (standard anti-dilution features). The agreement contains a down-round provision that automatically resets the exercise price of the warrant to a new exercise price that is equal to the per share price of common stock subsequently issued (including conversions of debt and preferred stock). Upon the lowing of the exercise price, the number of warrants will be increased such that the total proceeds upon exercise is the same amount (see Note 7). If the Market Price of one shares of common stock is greater than the Exercise Price, the Holder may elect to receive Warrant Shares pursuant to cashless exercise, in lieu of cash exercise, per a defined formula in the agreement.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">On June 19, 2020, the Company received $19,250 in net cash proceeds from a note holder under the same terms as the Promissory Note. The related principal amount due for the convertible debt instrument was $25,000 and the note matures on December 19, 2021. Using the Binomial Lattice Model, the Company computed the estimated fair value of the embedded conversion feature to be approximately $142,000 and recorded a related derivative liability for that amount and a charge to interest expense of approximately $122,000. Related to the derivative liability, the shares issued, the bonus interest, and the direct financing costs, the Company recorded a debt discount totaling $25,000 for the note, which is being amortized to interest expense over the term of the note using the effective interest method. As of December 31, 2022, the principal and interest owed under this note totaled $12,000.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">On July 10, 2020, the Company received $19,250 in net cash proceeds from a note holder under the same terms as the Promissory Note. The related principal amount due for the convertible debt instrument was $25,000 and the note matures on January 10, 2022. Using the Binomial Lattice Model, the Company computed the estimated fair value of the embedded conversion feature to be approximately $61,000 and recorded a related derivative liability for that amount and a charge to interest expense of approximately $42,000. Related to the derivative liability, the shares issued, the bonus interest, and the direct financing costs, the Company recorded a debt discount totaling $25,000 for the note, which is being amortized to interest expense over the term of the note using the effective interest method. As of December 31, 2022, the principal and interest owed under this note totaled $25,000.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">On May 4, 2020, the Company entered into a Paycheck Protection Program (“PPP”) Loan with a principal amount of $59,949 through a financial institution under the PPP administered by the SBA and established as part of the CARES Act. The PPP Loan bears interest at 1.0% per annum and matures on May 4, 2022 with the first six months of interest and principal payments deferred. The amount borrowed under the PPP Loan is guaranteed by the U.S. Small Business Administration (“SBA”) and is eligible for forgiveness in an amount equal to the sum of the eligible costs, including payroll, benefits, rent and utilities, incurred by the Company during the 24-week period beginning on the date the Company received the proceeds. The PPP Loan contains customary events of default, and the occurrence of an event of default may result in a claim for the immediate repayment of all amounts outstanding under the PPP Loan. As of December 31, 2022, the balance of the PPP Loan, including accrued interest was $60,948.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">On July 7, 2020, the Company entered into a secured disaster loan with the SBA with a principal amount of $150,000. The SBA loan bears interest at 3.75% per annum and matures in July 2050. The Company is required to make monthly principal and interest payments of $731 beginning in July 2021. As of December 31, 2022, the balance on the SBA loan, including interest was $164,063.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">On November 2, 2020, the Company received $146,500 in net cash proceeds from a note holder under an Inventory Financing Promissory Note. The related principal amount due for the convertible debt instrument was $168,000. The note bears interest at 12% per annum and matures on May 2, 2022. Principal and accrued interest are convertible into common stock at a variable conversion price, which is 80% of the average two lowest traded prices for common stock during a 10-day trading period prior to conversion. Using the Binomial Lattice Model, the Company computed the estimated fair value of the embedded conversion feature to be approximately $99,000 and recorded a related derivative liability for that amount. The Company also issued 2,000,000 shares of common stock to the note holder as additional compensation. The value of the shares, $14,800. Related to the derivative liability, the shares issued, the bonus interest, and the direct financing costs, the Company recorded a debt discount totaling approximately $135,000 for the note, which is being amortized to interest expense over the term of the note using the effective interest method. During the year ended December 31, 2022, the Company received forgiveness of the note totaling $45,148 and paid down the remaining balance and accrued interest. As of December 31, 2022 the balance on the note is $0.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">On December 13, 2021, the Company received $50,000 in net cash proceeds from a note holder under a short-term bridge note. During the year ended December 31, 2022, the Company borrowed an additional $127,000 under the note. The note matures on February 13, 2023. The Company is required to make 34 weekly payments of $4,633. As of December 31, 2022, the balance on the note was $130,355.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">During the year ended December 31, 2021, the holders of the convertible notes converted a total of $9,616 of principal, interest and fees for a total of 1,780,825 shares of common stock. Related to these conversions during the year ended December 31, 2021, the Company recorded a reduction of the associated derivative liability for the conversion features of $9,013 and a reduction of the debt discount of $0 as components of the loss on settlement of debt. During the year ended December 31, 2021, the Company recorded $134,014 of interest expense related to the amortization of the debt discounts.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">During the year ended December 31, 2022, the Company entered into four separate notes with an investor, for total principal of $400,000. The notes mature through March 2023 and bear interest between 6% and 12% per annum. As of December 31, 2022, the principal and interest owed on these notes totaled $401,516.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">As of December 31, 2022 long-term debt matures as follows: </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"><tbody><tr style="height:15px"><td style="BORDER-BOTTOM: #000000 1px solid;vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in"><strong>Year Ending</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>Notes Payable</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>Convertible Notes</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>Total</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">2023</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">596,745</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">37,000</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">633,745</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">2024</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">3,454</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">3,454</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">2025</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">3,586</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">3,586</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">2026</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">3,718</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">3,718</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">2027</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">3,900</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">3,900</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">Thereafter</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">146,078</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">-</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">146,078</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;">757,482</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;">37,000</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;">794,482</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr></tbody></table> 0.07 The maturity date is 18 months from the effective date of each payment Additionally, if at any time while the Promissory Note is outstanding, the Conversion Price is equal to or lower than $0.025, then an additional $10,000 will be automatically added to the principal balance of each tranche funded under the Note 0.10 250000 0.10 19250 25000 142000 122000 25000 12000 19250 25000 61000 42000 25000 59949 0.010 matures on May 4, 2022 60948 150000 0.0375 July 2050 731 164063 146500 168000 0.12 matures on May 2, 2022 0.80 99000 2000000 14800 135000 45148 0 50000 127000 The note matures on February 13, 2023 4633 130355 9616 1780825 9013 0 134014 400000 mature through March 2023 0.06 0.12 401516 <table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"><tbody><tr style="height:15px"><td style="BORDER-BOTTOM: #000000 1px solid;vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in"><strong>Year Ending</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>Notes Payable</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>Convertible Notes</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>Total</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">2023</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">596,745</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">37,000</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">633,745</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">2024</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">3,454</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">3,454</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">2025</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">3,586</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">3,586</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">2026</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">3,718</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">3,718</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">2027</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">3,900</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">3,900</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">Thereafter</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">146,078</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">-</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">146,078</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;">757,482</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;">37,000</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;">794,482</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr></tbody></table> 596745 37000 633745 3454 0 3454 3586 0 3586 3718 0 3718 3900 0 3900 146078 0 146078 757482 37000 794482 <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;"><strong>7.</strong> <strong>Derivative Liabilities</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">During the years ended December 31, 2022 and 2021, the Company had outstanding convertible debentures with variable exercise prices based on market rates (see Note 6) and convertible series A preferred stock with variable exercise prices based on market rates (see Note 9). The Company records the fair value of the conversion features with variable exercise prices based on future market rates in accordance with ASC 815. The fair value of the derivative liabilities is revalued on each balance sheet date with corresponding gains and losses recorded in the consolidated statements of operations. The Company uses a multi-nominal lattice model to fair value the derivative liabilities. The following inputs and assumptions were used to value the conversion features outstanding during the years ended December 31, 2022 and 2021, assuming no expected dividends:</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><table cellpadding="0" style="border-spacing:0;font-size:10pt;width:100%"><tbody><tr style="height:15px"><td style="width:64%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td colspan="2" style="BORDER-BOTTOM: 1px solid;width:10%;vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>2022</strong></p></td><td style="width:2%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td colspan="2" style="BORDER-BOTTOM: 1px solid;width:10%;vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>2021</strong></p></td><td style="width:2%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="width:64%;vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">Expected volatility</p></td><td style="width:1%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:8%;vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:right;">145-166</p></td><td style="width:2%;vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">%</p></td><td style="width:1%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:8%;vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:right;">135-275</p></td><td style="width:2%;vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">%</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="width:64%;vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">Risk free interest rate</p></td><td style="width:1%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:8%;vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:right;">1.34-4.68</p></td><td style="width:2%;vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">%</p></td><td style="width:1%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:8%;vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:right;">0.05-0.15</p></td><td style="width:2%;vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">%</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="width:64%;vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">Expected life (in years)</p></td><td style="width:1%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:8%;vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:right;">0-1.5</p></td><td style="width:2%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:8%;vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:right;">0-1.5</p></td><td style="width:2%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">The following table presents the Company’s embedded conversion features of its convertible debt and preferred stock measured at fair value on a recurring basis as of December 31, 2022 and 2021.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"><tbody><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>Level 3</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>Carrying</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>Value as of</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>December 31,</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>2022</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>Level 3</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>Carrying</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>Value as of</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>December 31,</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>2021</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">Derivative liabilities:</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" colspan="2" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" colspan="2" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">Embedded conversion feature – convertible debt</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">51,131</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">Embedded conversion feature – preferred stock</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">111,010</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">85,771</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;">111,010</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;">136,902</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">The following table provides a reconciliation of the beginning and ending balances for the Company’s derivative liabilities measured at fair value using Level 3 inputs:</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"><tbody><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>For The</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>Year</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>Ended</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>December 31,</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>2022</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>For The</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>Year</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>Ended</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>December 31,</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>2021</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">Embedded Conversion Features – Debt Instruments</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" colspan="2" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" colspan="2" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">Balances, as of the beginning of the year</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">51,131</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">97,024</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">Derivative liabilities recorded upon issuance of debt instruments</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">Extinguishment due to conversion of debt instruments</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(8,994 </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">Net changes in fair value included in net loss</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">(51,131 </td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">(36,989 </td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">Ending balance</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;">-</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;">51,131</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">Embedded Conversion Features – Preferred Stock</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">Balances, as of the beginning of the year</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">85,771</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">92,751</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">Derivative liabilities recorded upon issuance of preferred stock</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">175,639</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">392,410</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">Extinguishment due to conversion of preferred stock</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(241,490 </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(356,951 </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">Net changes in fair value included in net loss</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">91,090</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">(42,439 </td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">Ending balance</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;">111,010</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;">85,771</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">Total ending balance</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;">111,010</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;">136,902</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr></tbody></table> <table cellpadding="0" style="border-spacing:0;font-size:10pt;width:100%"><tbody><tr style="height:15px"><td style="width:64%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td colspan="2" style="BORDER-BOTTOM: 1px solid;width:10%;vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>2022</strong></p></td><td style="width:2%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td colspan="2" style="BORDER-BOTTOM: 1px solid;width:10%;vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>2021</strong></p></td><td style="width:2%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="width:64%;vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">Expected volatility</p></td><td style="width:1%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:8%;vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:right;">145-166</p></td><td style="width:2%;vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">%</p></td><td style="width:1%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:8%;vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:right;">135-275</p></td><td style="width:2%;vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">%</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="width:64%;vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">Risk free interest rate</p></td><td style="width:1%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:8%;vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:right;">1.34-4.68</p></td><td style="width:2%;vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">%</p></td><td style="width:1%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:8%;vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:right;">0.05-0.15</p></td><td style="width:2%;vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">%</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="width:64%;vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">Expected life (in years)</p></td><td style="width:1%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:8%;vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:right;">0-1.5</p></td><td style="width:2%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:8%;vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:right;">0-1.5</p></td><td style="width:2%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr></tbody></table> 1.45 1.66 1.35 2.75 0.0134 0.0468 0.0005 0.0015 P0Y P1Y6M P0Y P1Y6M <table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"><tbody><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>Level 3</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>Carrying</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>Value as of</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>December 31,</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>2022</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>Level 3</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>Carrying</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>Value as of</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>December 31,</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>2021</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">Derivative liabilities:</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" colspan="2" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" colspan="2" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">Embedded conversion feature – convertible debt</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">51,131</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">Embedded conversion feature – preferred stock</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">111,010</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">85,771</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;">111,010</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;">136,902</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr></tbody></table> 0 51131 111010 85771 111010 136902 <table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"><tbody><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>For The</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>Year</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>Ended</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>December 31,</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>2022</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>For The</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>Year</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>Ended</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>December 31,</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>2021</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">Embedded Conversion Features – Debt Instruments</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" colspan="2" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" colspan="2" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">Balances, as of the beginning of the year</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">51,131</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">97,024</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">Derivative liabilities recorded upon issuance of debt instruments</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">Extinguishment due to conversion of debt instruments</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(8,994 </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">Net changes in fair value included in net loss</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">(51,131 </td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">(36,989 </td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">Ending balance</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;">-</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;">51,131</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">Embedded Conversion Features – Preferred Stock</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">Balances, as of the beginning of the year</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">85,771</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">92,751</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">Derivative liabilities recorded upon issuance of preferred stock</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">175,639</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">392,410</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">Extinguishment due to conversion of preferred stock</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(241,490 </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(356,951 </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">Net changes in fair value included in net loss</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">91,090</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">(42,439 </td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">Ending balance</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;">111,010</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;">85,771</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">Total ending balance</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;">111,010</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;">136,902</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr></tbody></table> 51131 97024 0 0 0 8994 -51131 -36989 0 51131 85771 92751 175639 392410 -241490 -356951 91090 -42439 111010 85771 111010 136902 <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;"><strong>8.</strong> <strong>Related Party Transactions</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><table cellpadding="0" style="border-spacing:0;font-size:10pt;width:100%"><tbody><tr style="height:15px"><td style="width:4%;vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">(a)</p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">During the years ended December 31, 2022 and 2021, the Company incurred approximately $145,000 and $147,000, respectively, in management and consulting fees with an officer and an entity controlled by him. As of December 31, 2022 and 2021, the Company owed approximately $5,000 and $9,000, respectively, to directors and officers and a company controlled by a director, which is included in accounts payable and accrued liabilities. The amounts owed are unsecured, non-interest bearing, and due on demand.</p></td></tr><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p></td></tr><tr style="height:15px"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">(b)</p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">During the years ended December 31, 2022 and 2021, the Company issued 0 and 4,608,173 shares of common stock for the conversion of $0 and $24,729, respectively of accrued expenses owed to the CEO and VP of Operations.</p></td></tr><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p></td></tr><tr style="height:15px"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">(c)</p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">During the year ended December 31, 2022 and 2021, the Company recorded approximately $0 and $8,000, respectively to the VP and General Manager for rent and other office expenses.</p></td></tr></tbody></table> 145000 147000 5000 9000 0 4608173 0 24729 0 8000 <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;"><strong>9.</strong> <strong>Redeemable Preferred Stock and</strong> <strong>Stockholders’ Deficit</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;"><strong><em>Preferred Stock</em></strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">The Company is authorized to issue 10,000,000 shares of preferred stock with a par value of $0.001 per share. The Company has designated 1,250,000 of these shares as Series A Convertible Preferred Stock (“Series A Preferred Stock”).</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">On February 1, 2021, the Company entered into a Series A Preferred Stock Purchase Agreement with an investor. The Company issued 58,850 shares for proceeds of $53,500.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">On March 1, 2021, the Company entered into a Series A Preferred Stock Purchase Agreements with an investor. The Company issued 80,850 shares for proceeds of $73,500.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">On April 5, 2021, the Company entered into a Series A Preferred Stock Purchase Agreements with an investor. The Company issued 58,850 shares for proceeds of $53,500.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">On April 30, 2021, the Company entered into a Series A Preferred Stock Purchase Agreements with an investor. The Company issued 59,125 shares for proceeds of $53,750.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">On June 17, 2021, the Company entered into a Series A Preferred Stock Purchase Agreements with an investor. The Company issued 60,500 shares for proceeds of $55,000.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">On August 11, 2021, the Company entered into a Series A Preferred Stock Purchase Agreements with an investor. The Company issued 59,125 shares for proceeds of $53,750.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">On September 13, 2021, the Company entered into a Series A Preferred Stock Purchase Agreements with an investor. The Company issued 59,125 shares for proceeds of $53,750.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">On December 27, 2021, the Company entered into a Series A Preferred Stock Purchase Agreement with an investor. The Company issued 81,125 shares for proceeds of $73,750.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">On February 2, 2022, the Company entered into a Series A Preferred Stock Purchase Agreement with an investor. The Company issued 59,125 shares for proceeds of $53,500.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">On March 24, 2022, the Company entered into a Series A Preferred Stock Purchase Agreement with an investor. The Company issued 59,125 shares for proceeds of $53,500.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">On April 26, 2022, the Company entered into a Series A Preferred Stock Purchase Agreement with an investor. The Company issued 59,125 shares for proceeds of $53,500.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">On May 20, 2022, the Company entered into a Series A Preferred Stock Purchase Agreement with an investor. The Company issued 53,625 shares for proceeds of $48,750.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">On August 23, 2022, the Company entered into a Series A Preferred Stock Purchase Agreement with an investor. The Company issued 59,125 shares for proceeds of $53,500.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">On September 26, 2022, the Company entered into a Series A Preferred Stock Purchase Agreement with an investor. The Company issued 59,125 shares for proceeds of $53,500.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">On November 2, 2022, the Company entered into a Series A Preferred Stock Purchase Agreement with an investor. The Company issued 48,125 shares for proceeds of $43,750.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">On December 14, 2022, the Company entered into a Series A Preferred Stock Purchase Agreement with an investor. The Company issued 48,125 shares for proceeds of $43,750.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;"><strong><span style="text-decoration:underline">Rights and Privileges of the Series A Preferred Stock</span></strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><table cellpadding="0" style="border-spacing:0;font-size:10pt;width:100%"><tbody><tr style="height:15px"><td style="width:4%;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p></td><td style="width:4%;vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;"><span style="font-family:symbol">·</span></p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;"><strong><span style="text-decoration:underline">Voting</span></strong> – Series A Preferred Stockholders have no voting rights</p></td></tr><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;"><span style="font-family:symbol">·</span></p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;"><strong><span style="text-decoration:underline">Dividends</span></strong> – 8% cumulative dividend, compounded daily, payable solely upon redemption, liquidation, or conversion. (increases to 22% for an event of default)</p></td></tr><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;"><span style="font-family:symbol">·</span></p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;"><strong><span style="text-decoration:underline">Liquidation Preference</span></strong> – equal to the then Stated Value (initially $1.00 per share) as adjusted pursuant to the terms in the agreement (including but not limited to the additional of any accrued unpaid dividends and the Default Adjustment (as defined), if applicable.</p></td></tr><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;"><span style="font-family:symbol">·</span></p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;"><strong><span style="text-decoration:underline">Redemption</span></strong> – Company has the right to redeem the shares from the issuance date through 270 days following the issuance date using the table noted in the Certificate of Designations, Preferences, Rights and Limitations of Series A Convertible Preferred Stock agreement. After 270 days, except for the Mandatory Redemption, the Company does not have the right to redeem the shares.</p></td></tr><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;"><span style="font-family:symbol">·</span></p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;"><strong><span style="text-decoration:underline">Mandatory Redemption</span></strong> – 18 months after the Issuance Date or upon the occurrence of an Event of Default, the Company is required to redeem all of the shares of Series A Preferred Stock of the Holder. The Company shall make a cash payment in an amount equal to the total number of shares of Series A Preferred Stock held by the Holder multiplied by the then current Stated Value as adjusted (including but not limited to the addition of any accrued unpaid dividends and the Default Adjustment</p></td></tr><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;"><span style="font-family:symbol">·</span></p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;"><strong><span style="text-decoration:underline">Conversion</span></strong> – At any time after 6 months following the Issuance Date, the Holder may convert all or any part of the outstanding Series A Preferred Stock into shares of Common Stock. The Variable Conversion Price is defined as 75% of the Market Price. The Market Price is defined as the average of the 3 lowest Trading Prices for the Common Stock during the 15 day Trading Period ending on the last complete Trading Day prior to the Conversion Date.</p></td></tr><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;"><span style="font-family:symbol">·</span></p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;"><strong><span style="text-decoration:underline">Default Adjustments</span></strong> – Upon the occurrence of any Event of Default, the Stated Value will be increased between 150% and 200%, depending on the Event of Default.</p></td></tr></tbody></table><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">Based on the terms of the conversion feature, the Company could be required to issue an infinite number of shares of common stock. As such, the Company has determined the conversion feature to be a derivative liability under relevant accounting guidance. The Company estimated the fair value of the conversion feature using the Binomial Lattice Model on the date of issuance, on the date of each conversion notice, and remeasures the fair value at each reporting period. During the year ended December 31, 2022, the Company issued 445,500 shares of series A preferred stock for proceeds of $405,000. Related to these issuances, the Company recorded derivative liabilities of $175,638 and discounts to the preferred stock of $175,638, which is being amortized to deemed dividends over the redemption period. Also related to these issuances the Company recorded deemed dividends of $126,186.</p><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">During the year ended December 31, 2022, the holder of the Series A preferred stock converted 430,375 shares of Series A preferred stock and accrued dividends into 264,726,807 shares of common stock. Related to these conversions during the year ended December 31, 2022, the Company recorded a reduction of the associated derivative liability for the conversion features of $241,490 and a reduction of the preferred stock discount of $142,620 and $125,406 of deemed dividend.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;"><strong>Rights and Privileges of the Series B Preferred Stock</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">In February 2021, the Company issued 500,000 shares of its Series B Super Voting Preferred Stock. Each share of Series B preferred stock has voting rights equal to 500 shares of common stock, is not entitled to receive dividends, is not convertible into shares of common stock. If the holder of the Series B preferred stock ceases to be a Board Member, the Company will repurchase any Series B preferred stock from the holder for a price of $0.001 per share. If the holder of the Series B preferred stock proposes to transfer any shares of Series B preferred stock, the Company will have 90 days to repurchase the shares for a price of $0.001 per share. The grant date fair value of the Series B preferred stock issued during the nine months ended September 30, 2021 was $278,447 and was recorded to stock-based compensation expense in the accompanying condensed consolidated statements of operations.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">During the year ended December 31, 2022, the Company repurchased 1,250,000 shares of its Series B Super Voting Preferred Stock, valued at $65,572 and $1,250 cash, per the terms of the Series B shareholder agreement.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;"><strong><em>Common Stock</em></strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;"><strong>2022 </strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">During the year ended December 31, 2022, the Company issued 3,113,005 shares of common stock for services provided by a vendor.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">During the year ended December 31, 2022, the Company issued 19,560,705 shares of common stock for the exercise of a warrant on a cashless basis.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">During the year ended December 31, 2022, the Company issued 264,726,807 shares of common stock for the conversion of Series A preferred stock and accrued dividends.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">During the year ended December 31, 2022, the Company issued 12,500,000 shares of common stock as a commitment fee for a new equity line of credit.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">During the year ended December 31, 2022, the Company issued 93,490,998 shares of common stock for cash proceeds of $153,746.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">During the year ended December 31, 2022, the Company issued 20,000,000 shares of common stock for services provided by management and the board of directors.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;"><strong>2021</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">During the year ended December 31, 2021, the Company sold a total of 151,368,383 shares of common stock for proceeds of $621,745.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">During the year ended December 31, 2021, the Company issued a total of 10,479,231 shares of common stock for the conversion of $58,588 of accrued expenses owed to the VP and General Manager and another employee.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">During the year ended December 31, 2021, the Company issued 498,260 shares for the cashless exercise of warrants.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">During the year ended December 31, 2021, the Company issued 113,571,223 shares of common stock for the conversion of Series A preferred stock and accrued dividends.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">During the year ended December 31, 2021, the Company issued 1,780,825 shares of common stock for the conversion of debt and accrued interest.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">During the year ended December 31, 2021, the Company issued a total of 6,979,452 shares of common stock for a loan commitment fee and a loan extension fee.</p> 10000000 0.001 1250000 58850 53500 80850 73500 58850 53500 59125 53750 60500 55000 59125 53750 59125 53750 81125 73750 59125 53500 59125 53500 59125 53500 53625 48750 59125 53500 59125 53500 48125 43750 48125 43750 Stockholders have no voting rights 0.08 0.22 equal to the then Stated Value (initially $1.00 per share) as adjusted pursuant to the terms in the agreement (including but not limited to the additional of any accrued unpaid dividends and the Default Adjustment (as defined), if applicable 18 months after the Issuance Date At any time after 6 months following the Issuance Date 405000 175638 175638 126186 430375 264726807 241490 142620 125406 500000 Each share of Series B preferred stock has voting rights equal to 500 shares of common stock 0.001 0.001 278447 1250000 65572 1250 3113005 19560705 264726807 12500000 93490998 153746 20000000 151368383 621745 10479231 58588 498260 113571223 1780825 6979452 <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;"><strong>10.</strong> <strong>Share Purchase Warrants</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">The following table summarizes the activity of the Company’s share purchase warrants:</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"><tbody><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>Number of</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>warrants</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>Weighted</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>average</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>exercise</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>price</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" colspan="2" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" colspan="2" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">Balance, January 1, 2021</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">166,517,918</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">0.00</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">Issued</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">Adjusted for triggered down-round provisions</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">0.00</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">Exercised</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">0.00</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">Expired</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">(980,392 </td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">0.00</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">Balance, December 31, 2021</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">165,537,526</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">0.00</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">Issued</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">Adjusted for triggered down-round provisions</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">0.00</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">Exercised</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(20,408,163 </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">0.00</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">Expired</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">(50,000 </td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">0.00</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">Balance, December 31, 2022</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 3px double;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;">145,079,363</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;">0.00</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">As of December 31, 2022, the following share purchase warrants were outstanding:</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><table cellpadding="0" style="border-spacing:0;font-size:10pt;width:100%"><tbody><tr style="height:15px"><td style="BORDER-BOTTOM: 1px solid;vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>Number of warrants outstanding</strong></p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td colspan="2" style="BORDER-BOTTOM: 1px solid;vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>Exercise price</strong></p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>Expiration date</strong></p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="width:15%;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:right;">2,222,222</p></td><td style="width:1%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:2%;vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">$</p></td><td style="width:15%;vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:right;">0.03</p></td><td style="width:1%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:15%;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;">December 2, 2024</p></td><td style="width:1%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="BORDER-BOTTOM: 1px solid;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:right;">142,857,141</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">$</p></td><td style="vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:right;">0.00</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;">September 23, 2024</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="BORDER-BOTTOM: 3px double;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:right;">145,079,363</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">During the year ended December 31, 2022, a warrant holder exercised 20,408,163 warrants on a cashless basis resulting in the issuance of 19,560,705 shares of common stock.</p> <table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"><tbody><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>Number of</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>warrants</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>Weighted</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>average</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>exercise</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>price</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" colspan="2" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" colspan="2" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">Balance, January 1, 2021</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">166,517,918</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">0.00</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">Issued</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">Adjusted for triggered down-round provisions</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">0.00</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">Exercised</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">0.00</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">Expired</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">(980,392 </td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">0.00</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">Balance, December 31, 2021</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">165,537,526</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">0.00</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">Issued</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">Adjusted for triggered down-round provisions</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">0.00</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">Exercised</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(20,408,163 </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">0.00</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">Expired</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">(50,000 </td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">0.00</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">Balance, December 31, 2022</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 3px double;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;">145,079,363</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;">0.00</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr></tbody></table> 166517918 0.00 0 0.00 0.00 980392 0.00 165537526 0.00 0 0.00 20408163 0.00 50000 0.00 145079363 0.00 <table cellpadding="0" style="border-spacing:0;font-size:10pt;width:100%"><tbody><tr style="height:15px"><td style="BORDER-BOTTOM: 1px solid;vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>Number of warrants outstanding</strong></p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td colspan="2" style="BORDER-BOTTOM: 1px solid;vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>Exercise price</strong></p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>Expiration date</strong></p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="width:15%;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:right;">2,222,222</p></td><td style="width:1%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:2%;vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">$</p></td><td style="width:15%;vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:right;">0.03</p></td><td style="width:1%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:15%;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;">December 2, 2024</p></td><td style="width:1%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="BORDER-BOTTOM: 1px solid;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:right;">142,857,141</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">$</p></td><td style="vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:right;">0.00</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;">September 23, 2024</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="BORDER-BOTTOM: 3px double;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:right;">145,079,363</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr></tbody></table> 2222222 0.03 December 2, 2024 142857141 0.00 September 23, 2024 145079363 20408163 19560705 <p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in"><strong>11.</strong> <strong>Stock Options</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">The Company established a stock option plan for directors, officers, employees and consultants of the Company (the “Plan”). The purpose of the Plan is to give to directors, officers, employees and consultants of the Company, as additional compensation, the opportunity to participate in the profitability of the Company by granting to such individuals options, exercisable over periods of up to ten (10) years as determined by the board of directors of the Company, to buy shares of the Company at a price equal to the Market Price (as defined) prevailing on the date the option is granted. As of December 31, 2022, there were 6,440,000 shares available under the Plan.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">The following table summarizes the activity of the Company’s stock options:</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"><tbody><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>Number of</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>options</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>Weighted</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>average</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>exercise</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>price</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>Aggregate</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>intrinsic value</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" colspan="2" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" colspan="2" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" colspan="2" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">Balance, January 1, 2021</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">3,250,000</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">0.09</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" colspan="2" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">Granted</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" colspan="2" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">Exercised</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" colspan="2" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">Cancelled / forfeited</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">(75,000 </td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">0.16</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" colspan="2" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">Balance, December 31, 2021</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">3,175,000</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">0.08</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">Granted</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">Cancelled / forfeited</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">(1,675,000 </td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">0.12</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">Balance, December 31, 2022</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">1,500,000</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">0.04</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">Vested as of December 31, 2022</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">1,500,000</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">0.04</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">Unvested as of December 31, 2022</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 3px double;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;">-</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;">-</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"><tbody><tr style="height:15px"><td colspan="2"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="10" style="BORDER-BOTTOM: 1px solid;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>Outstanding</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="6" style="BORDER-BOTTOM: 1px solid;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>Exercisable</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px"><td colspan="2" style="BORDER-BOTTOM: 1px solid;vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>Range of</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>exercise prices</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>Number of</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>shares</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>Weighted average</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>remaining</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>contractual</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>life (years)</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>Weighted</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>average</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>exercise</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>price</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>Number of</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>shares</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>Weighted</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>average</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>exercise</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>price</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px"><td colspan="2"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" colspan="2"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" colspan="2"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" colspan="2"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" colspan="2"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" colspan="2"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td style="width:9%;">0.04</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">1,500,000</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">1.4</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">0.04</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">1,500,000</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">0.04</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 3px double;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 3px double;vertical-align:bottom;text-align:right;">1,500,000</td><td style="PADDING-BOTTOM: 3px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 3px double;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 3px double;vertical-align:bottom;text-align:right;">1.4</td><td style="PADDING-BOTTOM: 3px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 3px double;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 3px double;vertical-align:bottom;text-align:right;">0.04</td><td style="PADDING-BOTTOM: 3px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 3px double;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 3px double;vertical-align:bottom;text-align:right;">1,500,000</td><td style="PADDING-BOTTOM: 3px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 3px double;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 3px double;vertical-align:bottom;text-align:right;">0.04</td><td style="PADDING-BOTTOM: 3px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">During the years ended December 31, 2022 and 2021, the Company did not issue any options to employees. As of December 31, 2022, the Company had no unrecognized compensation expense.</p> 6440000 <table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"><tbody><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>Number of</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>options</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>Weighted</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>average</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>exercise</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>price</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>Aggregate</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>intrinsic value</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" colspan="2" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" colspan="2" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" colspan="2" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">Balance, January 1, 2021</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">3,250,000</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">0.09</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" colspan="2" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">Granted</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" colspan="2" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">Exercised</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" colspan="2" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">Cancelled / forfeited</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">(75,000 </td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">0.16</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" colspan="2" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">Balance, December 31, 2021</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">3,175,000</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">0.08</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">Granted</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">Cancelled / forfeited</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">(1,675,000 </td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">0.12</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">Balance, December 31, 2022</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">1,500,000</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">0.04</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">Vested as of December 31, 2022</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">1,500,000</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">0.04</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">Unvested as of December 31, 2022</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 3px double;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;">-</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;">-</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr></tbody></table><table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"><tbody><tr style="height:15px"><td colspan="2"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="10" style="BORDER-BOTTOM: 1px solid;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>Outstanding</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="6" style="BORDER-BOTTOM: 1px solid;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>Exercisable</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px"><td colspan="2" style="BORDER-BOTTOM: 1px solid;vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>Range of</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>exercise prices</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>Number of</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>shares</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>Weighted average</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>remaining</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>contractual</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>life (years)</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>Weighted</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>average</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>exercise</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>price</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>Number of</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>shares</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>Weighted</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>average</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>exercise</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>price</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px"><td colspan="2"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" colspan="2"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" colspan="2"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" colspan="2"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" colspan="2"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" colspan="2"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td style="width:9%;">0.04</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">1,500,000</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">1.4</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">0.04</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">1,500,000</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">0.04</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 3px double;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 3px double;vertical-align:bottom;text-align:right;">1,500,000</td><td style="PADDING-BOTTOM: 3px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 3px double;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 3px double;vertical-align:bottom;text-align:right;">1.4</td><td style="PADDING-BOTTOM: 3px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 3px double;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 3px double;vertical-align:bottom;text-align:right;">0.04</td><td style="PADDING-BOTTOM: 3px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 3px double;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 3px double;vertical-align:bottom;text-align:right;">1,500,000</td><td style="PADDING-BOTTOM: 3px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 3px double;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 3px double;vertical-align:bottom;text-align:right;">0.04</td><td style="PADDING-BOTTOM: 3px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr></tbody></table> 3250000 0.09 0 0 75000 0.16 3175000 0.08 0 0 1675000 0.12 1500000 0.04 0 1500000 0.04 0 0 0 0.04 1500000 P1Y4M24D 0.04 1500000 0.04 1500000 P1Y4M24D 0.04 1500000 0.04 <p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in"><strong>12.</strong> <strong>Segments</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">The Company has one reportable segment: vehicle tracking and recovery solutions. The Company allocates resources to and assesses the performance of each reportable segment using information about its revenue and operating income (loss). The Company does not evaluate operating segments using discrete asset information.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">Segmentation by geographical location is not presented as all revenues are earned in the U.S. Total assets by segment are not presented as that information is not used to allocate resources or assess performance at the segment level and is not reviewed by the Chief Operating Decision Maker of the Company.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;"><strong>13.</strong> <strong>Risks and Uncertainties</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">The Company extends credit to customers on an unsecured basis in the normal course of business. The Company’s policy is to perform an analysis of the recoverability of its receivables at the end of each reporting period and to establish allowances where appropriate. The Company analyzes historical bad debts and contract losses, customer concentrations, and customer credit-worthiness when evaluating the adequacy of the allowances.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">During the year ended December 31, 2022 and 2021, the Company had four and two customers which accounted for 77% and 56%, respectively, of total invoiced amounts, which are recorded as deferred revenues and amortized over the related service period to revenues.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">As of December 31, 2022 and 2021, the Company had three and one customers, respectively, which accounted for 99% and 99%, respectively, of the gross accounts receivable balance.</p> 0.77 0.56 0.99 0.99 <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;"><strong>14.</strong> <strong>Income Taxes</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">The Company’s income tax provision consists of the following:</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"><tbody><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>2022</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>2021</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">Current:</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" colspan="2" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" colspan="2" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in;text-indent:10.1pt">Federal</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in;text-indent:10.1pt">State</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">800</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">808</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">Foreign</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">-</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">-</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">Total Current</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">800</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">808</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">Deferred:</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in;text-indent:10.1pt">Federal</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in;text-indent:10.1pt">State</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in;text-indent:10.1pt">Foreign</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">Total Deferred</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">-</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">-</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">Provision for income taxes</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;">800</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;">808</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">A reconciliation of income taxes computed by applying the statutory U.S. income tax rate to the Company’s loss before income taxes to the income tax provision is as follows:</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"><tbody><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>2022</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>2021</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">Computed tax benefit at federal statutory rate</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(190,596 </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">764,147</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">State taxes</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">632</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">638</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">Permanent items</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">75</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">75</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">Stock-based compensation</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">175,196</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">8,829</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">Incentive stock options</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">Conversion feature derivative liability</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">Interest expense, derivative liability</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">Uncertain tax positions</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">Impact of difference related to foreign earnings</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">Gain on extinguishment of debt</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">Change in fair value of derivative liability</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">10,225</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">16,661</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">Valuation allowance</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">5,268</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">(789,542 </td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">Provision for income taxes</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;">800</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;">808</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">Deferred tax assets and liabilities reflect the net tax effects of temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes. Significant components of the Company’s deferred tax assets are as follows:</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"><tbody><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>2022</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>2021</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">Deferred Tax Assets:</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" colspan="2" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" colspan="2" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in;text-indent:10.1pt">Net operating loss carryforwards</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">2,967,000</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">604,000</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in;text-indent:10.1pt">Stock-based compensation</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">529,000</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">767,000</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in;text-indent:10.1pt">Accounts receivable and other timing differences</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">140,000</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">138,000</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in;text-indent:10.1pt">Basis difference in assets and debt</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">(80,000 </td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">(71,000 </td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">Total Deferred Tax Asset</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">3,556,000</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">1,438,000</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">Valuation allowance</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">(3,556,000 </td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">(1,438,000 </td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">Net Deferred Tax Asset</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;">-</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;">-</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">Realization of deferred tax assets is dependent upon future earnings, if any, the timing and amount of which are uncertain. Accordingly, the net deferred tax assets for the U.S. federal and state have been fully offset by a valuation allowance.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">As of December 31, 2022, the Company had net operating loss carryforwards for federal and state income tax purposes of $9,970,000 and $9,739,000, respectively, which expire beginning in the year 2029.</p><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">The Company is required to file US federal and California tax returns, however the Company has not filed its federal or state returns since 2009 Due to the Company’s loss position the statute remains open for any losses carried over into the current year which means all years from 2007 remain open to examination.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">The Company has adopted FASB ASC 740, “Income Taxes” to account for income taxes. ASC 740 clarifies the accounting for uncertainty in income taxes recognized in an enterprise’s financial statement. This standard prescribes a recognition threshold and measurement attribute for the financial statement recognition and measurement of a tax position taken or expected to be taken in the tax return. ASC 740 also provides guidance on derecognition of tax benefits, classification on the balance sheet, interest and penalties, accounting in interim periods, disclosure and transaction. In accordance with ASC 740-10-50, the Company is classifying interest and penalties as a component of tax expense.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">The Company has a reserve related to unrecognized tax positions of $90,000 as of December 31, 2022, which is presented as part of accounts payable and accrued liabilities. These unrecognized tax positions, if recognized, would affect the effective tax rate. A reconciliation of the change in the unrecognized tax positions for the year ended December 31, 2022 is as follows:</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"><tbody><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>Federal</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>and</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>State</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">Balance at January 1, 2022</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">90,000</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">Additions for tax positions related to current year</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">Additions for tax positions related to prior years</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">-</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">Balance at December 31, 2022</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;">90,000</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr></tbody></table> <table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"><tbody><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>2022</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>2021</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">Current:</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" colspan="2" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" colspan="2" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in;text-indent:10.1pt">Federal</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in;text-indent:10.1pt">State</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">800</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">808</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">Foreign</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">-</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">-</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">Total Current</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">800</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">808</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">Deferred:</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in;text-indent:10.1pt">Federal</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in;text-indent:10.1pt">State</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in;text-indent:10.1pt">Foreign</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">Total Deferred</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">-</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">-</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">Provision for income taxes</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;">800</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;">808</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr></tbody></table> 0 0 800 808 0 0 800 808 0 0 0 0 0 0 0 0 800 808 <table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"><tbody><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>2022</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>2021</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">Computed tax benefit at federal statutory rate</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(190,596 </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">764,147</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">State taxes</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">632</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">638</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">Permanent items</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">75</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">75</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">Stock-based compensation</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">175,196</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">8,829</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">Incentive stock options</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">Conversion feature derivative liability</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">Interest expense, derivative liability</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">Uncertain tax positions</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">Impact of difference related to foreign earnings</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">Gain on extinguishment of debt</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">Change in fair value of derivative liability</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">10,225</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">16,661</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">Valuation allowance</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">5,268</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">(789,542 </td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">Provision for income taxes</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;">800</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;">808</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr></tbody></table> -190596 764147 632 638 75 75 175196 8829 0 0 0 0 0 0 0 0 0 0 0 0 10225 16661 5268 -789542 800 808 <table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"><tbody><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>2022</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>2021</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">Deferred Tax Assets:</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" colspan="2" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" colspan="2" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in;text-indent:10.1pt">Net operating loss carryforwards</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">2,967,000</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">604,000</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in;text-indent:10.1pt">Stock-based compensation</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">529,000</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">767,000</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in;text-indent:10.1pt">Accounts receivable and other timing differences</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">140,000</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">138,000</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in;text-indent:10.1pt">Basis difference in assets and debt</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">(80,000 </td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">(71,000 </td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">Total Deferred Tax Asset</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">3,556,000</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">1,438,000</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">Valuation allowance</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">(3,556,000 </td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">(1,438,000 </td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">Net Deferred Tax Asset</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;">-</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;">-</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr></tbody></table> 2967000 604000 529000 767000 140000 138000 -80000 -71000 3556000 1438000 -3556000 -1438000 0 0 9970000 9739000 expire beginning in the year 2029 90000 <table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"><tbody><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>Federal</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>and</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>State</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">Balance at January 1, 2022</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">90,000</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">Additions for tax positions related to current year</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">Additions for tax positions related to prior years</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">-</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">Balance at December 31, 2022</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;">90,000</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr></tbody></table> 90000 0 0 90000 <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;"><strong>15.</strong> <strong>Commitments and Contingencies</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;"><strong><em>Withheld Payroll Taxes</em></strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">Since its inception, the Company has made several payments to employees for wages, net of state and federal income taxes. Due to cash constraints, the Company has not yet remitted all of these withheld amounts to the appropriate government agency. Accordingly, as of December 31, 2022 and 2021 the Company has recorded $37,984 and $37,984, respectively, related to this obligation in accounts payable and accrued liabilities, including estimated penalties and interest.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;"><strong><em>Operating Lease</em></strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">On September 1, 2021 the Company entered into a lease for office space under an operating lease for approximately 2,500 square feet in Lake Elsinore, California, which is set to expire on October 31, 2024.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">Operating lease assets and liabilities are recognized at the lease commencement date. Operating lease liabilities represent the present value of lease payments not yet paid. Operating lease assets represent our right to use an underlying asset and are based upon the operating lease liabilities as adjusted for prepayments or accrued lease payments, initial direct costs, lease incentives, and impairment of operating lease assets. To determine the present value of lease payments not yet paid, the Company estimates incremental secured borrowing rates corresponding to the maturities of the leases.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">The Company’s lease contains rent escalations over the lease term. The Company recognizes expense for these leases on a straight-line basis over the lease term. Additionally, tenant incentives used to fund leasehold improvements are recognized when earned and reduce our right-of-use asset related to the lease. These are amortized through the right-of-use asset as reductions of expense over the lease term. The Company’s lease agreements do not contain any material residual value guarantees or material restrictive covenants.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">The Company has elected the short-term lease recognition exemption for all applicable classes of underlying assets. Short-term disclosures include only those leases with a term greater than one month and 12 months or less, and expense is recognized on a straight-line basis over the lease term. Leases with an initial term of 12 months or less, that do not include an option to purchase the underlying asset that the Company is reasonably certain to exercise, are not recorded on the consolidated balance sheet.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">The components of lease expense were as follows:</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"><tbody><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="6" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>Year Ended</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>December 31,</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>2022</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>2021</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">Operating lease cost</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">31,129</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">5,438</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Other information related to leases was as follows:</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"><tbody><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="6" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>Year Ended</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>December 31,</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>2021</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>2020</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in"><strong>Supplemental Cash Flows Information</strong></p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" colspan="2" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" colspan="2" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">Cash paid for amounts included in the measurement of lease liability:</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" colspan="2" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" colspan="2" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in;text-indent:10.1pt">Operating cash flows from operating lease</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">26,210</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">7,785</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">Operating lease asset obtained in exchange for lease liability:</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in;text-indent:10.1pt">Operating lease</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">81,668</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in"><strong>Remaining lease term</strong></p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in;text-indent:10.1pt">Operating lease</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td colspan="2"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:right;">1.83 years</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td colspan="2"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:right;">2.83 years</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in"><strong>Discount rate</strong></p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in;text-indent:10.1pt">Operating lease</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">12.00</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">%</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">12.00</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">%</td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">Future payments under noncancelable operating leases having initial or remaining terms of one year or more are as follows for the succeeding fiscal year and thereafter:</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"><tbody><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>For the Years Ended</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>December 31,</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">2023</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">33,244</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">2024</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">28,610</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in;text-indent:10.1pt">Total minimum lease payments</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">61,854</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">Less imputed interest</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">(6,646 </td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in;text-indent:10.1pt">Present value of lease liabilities</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">55,208</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">Less current portion of operating lease liability (included in accounts payable and accrued expenses)</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">(28,110 </td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in;text-indent:10.1pt">Non-current operating lease liability</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;">27,098</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;"><strong><em>Indemnities and Guarantees</em></strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">We have made certain indemnities and guarantees, under which we may be required to make payments to a guaranteed or indemnified party, in relation to certain transactions. We indemnify our officers and directors to the maximum extent permitted under the laws of the State of Nevada. The duration of these indemnities and guarantees varies and, in certain cases, is indefinite. These indemnities and guarantees do not provide for any limitation of the maximum potential future payments we could be obligated to make. Historically, we have not been obligated to make any payments for these obligations and no liabilities have been recorded for these indemnities and guarantees in the accompanying consolidated balance sheets.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;"><strong><em>Legal Matters</em></strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">In the ordinary course of business, we may face various claims brought by third parties and may, from time to time, make claims or take legal actions to assert our rights, including intellectual property disputes, contractual disputes and other commercial disputes. Any of these claims could subject us to litigation. Management believes there are currently no claims that are likely to have a material effect on our consolidated financial position and results of operations.</p> 37984 37984 2500 2024-10-31 <table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"><tbody><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="6" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>Year Ended</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>December 31,</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>2022</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>2021</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">Operating lease cost</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">31,129</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">5,438</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr></tbody></table> 31129 5438 <table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"><tbody><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="6" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>Year Ended</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>December 31,</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>2021</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>2020</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in"><strong>Supplemental Cash Flows Information</strong></p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" colspan="2" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" colspan="2" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">Cash paid for amounts included in the measurement of lease liability:</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" colspan="2" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" colspan="2" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in;text-indent:10.1pt">Operating cash flows from operating lease</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">26,210</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">7,785</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">Operating lease asset obtained in exchange for lease liability:</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in;text-indent:10.1pt">Operating lease</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">81,668</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in"><strong>Remaining lease term</strong></p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in;text-indent:10.1pt">Operating lease</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td colspan="2"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:right;">1.83 years</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td colspan="2"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:right;">2.83 years</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in"><strong>Discount rate</strong></p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in;text-indent:10.1pt">Operating lease</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">12.00</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">%</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">12.00</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">%</td></tr></tbody></table> 26210 7785 0 81668 1.83 2.83 0.12 0.12 <table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"><tbody><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>For the Years Ended</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>December 31,</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">2023</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">33,244</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">2024</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">28,610</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in;text-indent:10.1pt">Total minimum lease payments</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">61,854</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">Less imputed interest</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">(6,646 </td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in;text-indent:10.1pt">Present value of lease liabilities</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">55,208</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">Less current portion of operating lease liability (included in accounts payable and accrued expenses)</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">(28,110 </td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in;text-indent:10.1pt">Non-current operating lease liability</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;">27,098</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;"><strong><em>Indemnities and Guarantees</em></strong></p> 33244 28610 61854 6646 55208 28110 27098 <p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>16. Subsequent Events</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">On February 15, 2023, the Company issued 20,000,000 shares of common stock to its CEO, valued at $21,000.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">On February 22, 2023, the Company issued 34,064,050 shares of common stock for cash proceeds of $32,974.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">On March 1, 2023, the Company issued 26,000,000 shares of common stock for the conversion of 25,000 shares of its Series A preferred stock.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">On March 3, 2023, the Company issued 35,490,000 shares of common stock for the conversion of 34,125 shares of its Series A preferred stock.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">The Company evaluates subsequent events and transactions that occur after the balance sheet date up to the date that the consolidated financial statements are available to be issued. Any material events that occur between the balance sheet date and the date that the consolidated financial statements were available for issuance are disclosed as subsequent events, while the consolidated financial statements are adjusted to reflect any conditions that existed at the balance sheet date. Based upon this review, except as disclosed within the footnotes or as discussed below, the Company did not identify any subsequent events that require adjustment or disclosure in the consolidated financial statements.</p> 20000000 21000 34064050 32974 26000000 25000 35490000 34125 EXCEL 75 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 76 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 77 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 78 FilingSummary.xml IDEA: XBRL DOCUMENT 3.23.1 html 147 383 1 false 66 0 false 5 false false R1.htm 000001 - Document - Cover Sheet http://igen.com/role/Cover Cover Cover 1 false false R2.htm 000002 - Statement - Consolidated Balance Sheets Sheet http://igen.com/role/ConsolidatedBalanceSheets Consolidated Balance Sheets Statements 2 false false R3.htm 000003 - Statement - Consolidated Balance Sheets (Parenthetical) Sheet http://igen.com/role/ConsolidatedBalanceSheetsParenthetical Consolidated Balance Sheets (Parenthetical) Statements 3 false false R4.htm 000004 - Statement - Consolidated Statements of Operations Sheet http://igen.com/role/ConsolidatedStatementsOfOperations Consolidated Statements of Operations Statements 4 false false R5.htm 000005 - Statement - Consolidated Statements of Redeemable Convertible Preferred stock and Stockholders Deficit Sheet http://igen.com/role/ConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholdersDeficit Consolidated Statements of Redeemable Convertible Preferred stock and Stockholders Deficit Statements 5 false false R6.htm 000006 - Statement - Consolidated Statements of Cash Flows Sheet http://igen.com/role/ConsolidatedStatementsOfCashFlows Consolidated Statements of Cash Flows Statements 6 false false R7.htm 000007 - Disclosure - Organization and Description of Business Sheet http://igen.com/role/OrganizationAndDescriptionOfBusiness Organization and Description of Business Notes 7 false false R8.htm 000008 - Disclosure - Summary of Significant Accounting Policies Sheet http://igen.com/role/SummaryOfSignificantAccountingPolicies Summary of Significant Accounting Policies Notes 8 false false R9.htm 000009 - Disclosure - Accounts and Other Receivables Sheet http://igen.com/role/AccountsAndOtherReceivables Accounts and Other Receivables Notes 9 false false R10.htm 000010 - Disclosure - Goodwill Sheet http://igen.com/role/Goodwill Goodwill Notes 10 false false R11.htm 000011 - Disclosure - Accounts Payable and Accrued Liabilities Sheet http://igen.com/role/AccountsPayableAndAccruedLiabilities Accounts Payable and Accrued Liabilities Notes 11 false false R12.htm 000012 - Disclosure - Convertible Debentures and Notes Payable Notes http://igen.com/role/ConvertibleDebenturesAndNotesPayable Convertible Debentures and Notes Payable Notes 12 false false R13.htm 000013 - Disclosure - Derivative Liabilities Sheet http://igen.com/role/DerivativeLiabilities Derivative Liabilities Notes 13 false false R14.htm 000014 - Disclosure - Related Party Transactions Sheet http://igen.com/role/RelatedPartyTransactions Related Party Transactions Notes 14 false false R15.htm 000015 - Disclosure - Redeemable Preferred Stock and Stockholders Deficit Sheet http://igen.com/role/RedeemablePreferredStockAndStockholdersDeficit Redeemable Preferred Stock and Stockholders Deficit Notes 15 false false R16.htm 000016 - Disclosure - Share Purchase Warrants Sheet http://igen.com/role/SharePurchaseWarrants Share Purchase Warrants Notes 16 false false R17.htm 000017 - Disclosure - Stock Options Sheet http://igen.com/role/StockOptions Stock Options Notes 17 false false R18.htm 000018 - Disclosure - Segments Sheet http://igen.com/role/Segments Segments Notes 18 false false R19.htm 000019 - Disclosure - Risk and Uncertainities Sheet http://igen.com/role/RiskAndUncertainities Risk and Uncertainities Notes 19 false false R20.htm 000020 - Disclosure - Income Taxes Sheet http://igen.com/role/IncomeTaxes Income Taxes Notes 20 false false R21.htm 000021 - Disclosure - Commitments and Contingencies Sheet http://igen.com/role/CommitmentsAndContingencies Commitments and Contingencies Notes 21 false false R22.htm 000022 - Disclosure - Subsequent Events Sheet http://igen.com/role/SubsequentEvents Subsequent Events Notes 22 false false R23.htm 000023 - Disclosure - Summary of Significant Accounting Policies (Policies) Sheet http://igen.com/role/SummaryOfSignificantAccountingPoliciesPolicies Summary of Significant Accounting Policies (Policies) Policies http://igen.com/role/SummaryOfSignificantAccountingPolicies 23 false false R24.htm 000024 - Disclosure - Summary of Significant Accounting Policies (Tables) Sheet http://igen.com/role/SummaryOfSignificantAccountingPoliciesTables Summary of Significant Accounting Policies (Tables) Tables http://igen.com/role/SummaryOfSignificantAccountingPolicies 24 false false R25.htm 000025 - Disclosure - Accounts and Other Receivables (Tables) Sheet http://igen.com/role/AccountsAndOtherReceivablesTables Accounts and Other Receivables (Tables) Tables http://igen.com/role/AccountsAndOtherReceivables 25 false false R26.htm 000026 - Disclosure - Accounts Payable and Accrued Liabilities (Tables) Sheet http://igen.com/role/AccountsPayableAndAccruedLiabilitiesTables Accounts Payable and Accrued Liabilities (Tables) Tables http://igen.com/role/AccountsPayableAndAccruedLiabilities 26 false false R27.htm 000027 - Disclosure - Convertible Debentures and Notes Payable (Tables) Notes http://igen.com/role/ConvertibleDebenturesAndNotesPayableTables Convertible Debentures and Notes Payable (Tables) Tables http://igen.com/role/ConvertibleDebenturesAndNotesPayable 27 false false R28.htm 000028 - Disclosure - Derivative Liabilities (Tables) Sheet http://igen.com/role/DerivativeLiabilitiesTables Derivative Liabilities (Tables) Tables http://igen.com/role/DerivativeLiabilities 28 false false R29.htm 000029 - Disclosure - Share Purchase Warrants (Tables) Sheet http://igen.com/role/SharePurchaseWarrantsTables Share Purchase Warrants (Tables) Tables http://igen.com/role/SharePurchaseWarrants 29 false false R30.htm 000030 - Disclosure - Stock Options (Tables) Sheet http://igen.com/role/StockOptionsTables Stock Options (Tables) Tables http://igen.com/role/StockOptions 30 false false R31.htm 000031 - Disclosure - Income Taxes (Tables) Sheet http://igen.com/role/IncomeTaxesTables Income Taxes (Tables) Tables http://igen.com/role/IncomeTaxes 31 false false R32.htm 000032 - Disclosure - Commitments and Contingencies (Tables) Sheet http://igen.com/role/CommitmentsAndContingenciesTables Commitments and Contingencies (Tables) Tables http://igen.com/role/CommitmentsAndContingencies 32 false false R33.htm 000033 - Disclosure - Organization and Description of Business (Details Narrative) Sheet http://igen.com/role/OrganizationAndDescriptionOfBusinessDetailsNarrative Organization and Description of Business (Details Narrative) Details http://igen.com/role/OrganizationAndDescriptionOfBusiness 33 false false R34.htm 000034 - Disclosure - Summary of Significant Accounting Policies (Details) Sheet http://igen.com/role/SummaryOfSignificantAccountingPoliciesDetails Summary of Significant Accounting Policies (Details) Details http://igen.com/role/SummaryOfSignificantAccountingPoliciesTables 34 false false R35.htm 000035 - Disclosure - Summary of Significant Accounting Policies (Details Narrative) Sheet http://igen.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative Summary of Significant Accounting Policies (Details Narrative) Details http://igen.com/role/SummaryOfSignificantAccountingPoliciesTables 35 false false R36.htm 000036 - Disclosure - Accounts and Other Receivables (Details) Sheet http://igen.com/role/AccountsAndOtherReceivablesDetails Accounts and Other Receivables (Details) Details http://igen.com/role/AccountsAndOtherReceivablesTables 36 false false R37.htm 000037 - Disclosure - Goodwill (Details Narrative) Sheet http://igen.com/role/GoodwillDetailsNarrative Goodwill (Details Narrative) Details http://igen.com/role/Goodwill 37 false false R38.htm 000038 - Disclosure - Accounts Payable and Accrued Liabilities (Details) Sheet http://igen.com/role/AccountsPayableAndAccruedLiabilitiesDetails Accounts Payable and Accrued Liabilities (Details) Details http://igen.com/role/AccountsPayableAndAccruedLiabilitiesTables 38 false false R39.htm 000039 - Disclosure - Convertible Debentures and Notes Payable (Details) Notes http://igen.com/role/ConvertibleDebenturesAndNotesPayableDetails Convertible Debentures and Notes Payable (Details) Details http://igen.com/role/ConvertibleDebenturesAndNotesPayableTables 39 false false R40.htm 000040 - Disclosure - Convertible Debentures and Notes Payable (Details Narrative) Notes http://igen.com/role/ConvertibleDebenturesAndNotesPayableDetailsNarrative Convertible Debentures and Notes Payable (Details Narrative) Details http://igen.com/role/ConvertibleDebenturesAndNotesPayableTables 40 false false R41.htm 000041 - Disclosure - Derivative Liabilities (Details) Sheet http://igen.com/role/DerivativeLiabilitiesDetails Derivative Liabilities (Details) Details http://igen.com/role/DerivativeLiabilitiesTables 41 false false R42.htm 000042 - Disclosure - Derivative Liabilities (Details 1) Sheet http://igen.com/role/DerivativeLiabilitiesDetails1 Derivative Liabilities (Details 1) Details http://igen.com/role/DerivativeLiabilitiesTables 42 false false R43.htm 000043 - Disclosure - Derivative Liabilities (Details 2) Sheet http://igen.com/role/DerivativeLiabilitiesDetails2 Derivative Liabilities (Details 2) Details http://igen.com/role/DerivativeLiabilitiesTables 43 false false R44.htm 000044 - Disclosure - Related Party Transactions (Details Narrative) Sheet http://igen.com/role/RelatedPartyTransactionsDetailsNarrative Related Party Transactions (Details Narrative) Details http://igen.com/role/RelatedPartyTransactions 44 false false R45.htm 000045 - Disclosure - Redeemable Preferred Stock and Stockholders Deficit (Details Narrative) Sheet http://igen.com/role/RedeemablePreferredStockAndStockholdersDeficitDetailsNarrative Redeemable Preferred Stock and Stockholders Deficit (Details Narrative) Details http://igen.com/role/RedeemablePreferredStockAndStockholdersDeficit 45 false false R46.htm 000046 - Disclosure - Share Purchase Warrants (Details) Sheet http://igen.com/role/SharePurchaseWarrantsDetails Share Purchase Warrants (Details) Details http://igen.com/role/SharePurchaseWarrantsTables 46 false false R47.htm 000047 - Disclosure - Share Purchase Warrants (Details 1) Sheet http://igen.com/role/SharePurchaseWarrantsDetails1 Share Purchase Warrants (Details 1) Details http://igen.com/role/SharePurchaseWarrantsTables 47 false false R48.htm 000048 - Disclosure - Share Purchase Warrants (Details Narrative) Sheet http://igen.com/role/SharePurchaseWarrantsDetailsNarrative Share Purchase Warrants (Details Narrative) Details http://igen.com/role/SharePurchaseWarrantsTables 48 false false R49.htm 000049 - Disclosure - Stock Options (Details) Sheet http://igen.com/role/StockOptionsDetails Stock Options (Details) Details http://igen.com/role/StockOptionsTables 49 false false R50.htm 000050 - Disclosure - Stock Options (Details 1) Sheet http://igen.com/role/StockOptionsDetails1 Stock Options (Details 1) Details http://igen.com/role/StockOptionsTables 50 false false R51.htm 000051 - Disclosure - Stock Options (Details Narrative) Sheet http://igen.com/role/StockOptionsDetailsNarrative Stock Options (Details Narrative) Details http://igen.com/role/StockOptionsTables 51 false false R52.htm 000052 - Disclosure - Risks Uncertainties (Details Narrative) Sheet http://igen.com/role/RisksUncertaintiesDetailsNarrative Risks Uncertainties (Details Narrative) Details 52 false false R53.htm 000053 - Disclosure - Income Taxes (Details) Sheet http://igen.com/role/IncomeTaxesDetails Income Taxes (Details) Details http://igen.com/role/IncomeTaxesTables 53 false false R54.htm 000054 - Disclosure - Income Taxes (Details 1) Sheet http://igen.com/role/IncomeTaxesDetails1 Income Taxes (Details 1) Details http://igen.com/role/IncomeTaxesTables 54 false false R55.htm 000055 - Disclosure - Income Taxes (Details 2) Sheet http://igen.com/role/IncomeTaxesDetails2 Income Taxes (Details 2) Details http://igen.com/role/IncomeTaxesTables 55 false false R56.htm 000056 - Disclosure - Income Taxes (Details 3) Sheet http://igen.com/role/IncomeTaxesDetails3 Income Taxes (Details 3) Details http://igen.com/role/IncomeTaxesTables 56 false false R57.htm 000057 - Disclosure - Income Taxes (Details Narrative) Sheet http://igen.com/role/IncomeTaxesDetailsNarrative Income Taxes (Details Narrative) Details http://igen.com/role/IncomeTaxesTables 57 false false R58.htm 000058 - Disclosure - Commitments and Contingencies (Details) Sheet http://igen.com/role/CommitmentsAndContingenciesDetails Commitments and Contingencies (Details) Details http://igen.com/role/CommitmentsAndContingenciesTables 58 false false R59.htm 000059 - Disclosure - Commitments and Contingencies (Details 1) Sheet http://igen.com/role/CommitmentsAndContingenciesDetails1 Commitments and Contingencies (Details 1) Details http://igen.com/role/CommitmentsAndContingenciesTables 59 false false R60.htm 000060 - Disclosure - Commitments and Contingencies (Details 2) Sheet http://igen.com/role/CommitmentsAndContingenciesDetails2 Commitments and Contingencies (Details 2) Details http://igen.com/role/CommitmentsAndContingenciesTables 60 false false R61.htm 000061 - Disclosure - Commitments and Contingencies (Details Narrative) Sheet http://igen.com/role/CommitmentsAndContingenciesDetailsNarrative Commitments and Contingencies (Details Narrative) Details http://igen.com/role/CommitmentsAndContingenciesTables 61 false false R62.htm 000062 - Disclosure - Subsequent Events (Details Narrative) Sheet http://igen.com/role/SubsequentEventsDetailsNarrative Subsequent Events (Details Narrative) Details http://igen.com/role/SubsequentEvents 62 false false All Reports Book All Reports [dq-0542-Deprecated-Concept] Concept PropertyPlantAndEquipmentDepreciationMethods in us-gaap/2022 used in 3 facts was deprecated in us-gaap/2023 as of 2023 and should not be used. igen_10k.htm 1 [dq-0542-Deprecated-Concept] Concept DueToRelatedPartiesCurrent in us-gaap/2022 used in 2 facts was deprecated in us-gaap/2023 as of 2023 and should not be used. igen_10k.htm 1 [ix-0514-Hidden-Fact-Eligible-For-Transform] WARN: 21 fact(s) appearing in ix:hidden were eligible for transformation: dei:CurrentFiscalYearEndDate, igen:OutstandingNote, igen:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsUnvestedNumberOfShares, igen:SharesIssuedForCashShares, us-gaap:CommonStockParOrStatedValuePerShare, us-gaap:CommonStockSharesAuthorized, us-gaap:CommonStockSharesIssued, us-gaap:CommonStockSharesOutstanding, us-gaap:PreferredStockDividendsAndOtherAdjustments, us-gaap:PreferredStockParOrStatedValuePerShare, us-gaap:PreferredStockSharesAuthorized, us-gaap:PreferredStockSharesIssued, us-gaap:PreferredStockSharesOutstanding, us-gaap:PropertyPlantAndEquipmentUsefulLife, us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares, us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised, us-gaap:TemporaryEquityParOrStatedValuePerShare, us-gaap:TemporaryEquitySharesAuthorized, us-gaap:TemporaryEquitySharesIssued, us-gaap:TemporaryEquitySharesOutstanding - igen_10k.htm 1 igen_10k.htm igen-20221231.xsd igen-20221231_cal.xml igen-20221231_def.xml igen-20221231_lab.xml igen-20221231_pre.xml igen_ex21.htm igen_ex311.htm igen_ex321.htm igen_10kimg17.jpg igen_10kimg7.jpg http://fasb.org/us-gaap/2022 http://xbrl.sec.gov/dei/2022 true true JSON 81 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "igen_10k.htm": { "axisCustom": 0, "axisStandard": 17, "baseTaxonomies": { "http://fasb.org/us-gaap/2022": 498, "http://xbrl.sec.gov/dei/2022": 33 }, "contextCount": 147, "dts": { "calculationLink": { "local": [ "igen-20221231_cal.xml" ] }, "definitionLink": { "local": [ "igen-20221231_def.xml" ] }, "inline": { "local": [ "igen_10k.htm" ] }, "labelLink": { "local": [ "igen-20221231_lab.xml" ] }, "presentationLink": { "local": [ "igen-20221231_pre.xml" ] }, "schema": { "local": [ "igen-20221231.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd", "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd", "http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd", "https://xbrl.fasb.org/srt/2022/elts/srt-roles-2022.xsd", "https://xbrl.fasb.org/srt/2022/elts/srt-types-2022.xsd", "https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd", "https://xbrl.fasb.org/us-gaap/2022/elts/us-roles-2022.xsd", "https://xbrl.fasb.org/us-gaap/2022/elts/us-types-2022.xsd", "https://xbrl.sec.gov/country/2022/country-2022.xsd", "https://xbrl.sec.gov/currency/2022/currency-2022.xsd", "https://xbrl.sec.gov/dei/2022/dei-2022.xsd", "https://xbrl.sec.gov/exch/2022/exch-2022.xsd", "https://xbrl.sec.gov/naics/2022/naics-2022.xsd", "https://xbrl.sec.gov/sic/2022/sic-2022.xsd", "https://xbrl.sec.gov/stpr/2022/stpr-2022.xsd" ] } }, "elementCount": 535, "entityCount": 1, "hidden": { "http://fasb.org/us-gaap/2022": 17, "http://igen.com/20221231": 3, "http://xbrl.sec.gov/dei/2022": 5, "total": 25 }, "keyCustom": 128, "keyStandard": 255, "memberCustom": 48, "memberStandard": 18, "nsprefix": "igen", "nsuri": "http://igen.com/20221231", "report": { "R1": { "firstAnchor": { "ancestors": [ "span", "strong", "p", "td", "tr", "tbody", "table", "body", "html" ], "baseRef": "igen_10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "dei:EntityRegistrantName", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "000001 - Document - Cover", "menuCat": "Cover", "order": "1", "role": "http://igen.com/role/Cover", "shortName": "Cover", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "strong", "p", "td", "tr", "tbody", "table", "body", "html" ], "baseRef": "igen_10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "dei:EntityRegistrantName", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R10": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "igen_10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:GoodwillDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "000010 - Disclosure - Goodwill", "menuCat": "Notes", "order": "10", "role": "http://igen.com/role/Goodwill", "shortName": "Goodwill", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "igen_10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:GoodwillDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R11": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "igen_10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "000011 - Disclosure - Accounts Payable and Accrued Liabilities", "menuCat": "Notes", "order": "11", "role": "http://igen.com/role/AccountsPayableAndAccruedLiabilities", "shortName": "Accounts Payable and Accrued Liabilities", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "igen_10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R12": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "igen_10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ShortTermDebtTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "000012 - Disclosure - Convertible Debentures and Notes Payable", "menuCat": "Notes", "order": "12", "role": "http://igen.com/role/ConvertibleDebenturesAndNotesPayable", "shortName": "Convertible Debentures and Notes Payable", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "igen_10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ShortTermDebtTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R13": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "igen_10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DerivativesAndFairValueTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "000013 - Disclosure - Derivative Liabilities", "menuCat": "Notes", "order": "13", "role": "http://igen.com/role/DerivativeLiabilities", "shortName": "Derivative Liabilities", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "igen_10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DerivativesAndFairValueTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R14": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "igen_10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "000014 - Disclosure - Related Party Transactions", "menuCat": "Notes", "order": "14", "role": "http://igen.com/role/RelatedPartyTransactions", "shortName": "Related Party Transactions", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "igen_10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R15": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "igen_10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "000015 - Disclosure - Redeemable Preferred Stock and Stockholders Deficit", "menuCat": "Notes", "order": "15", "role": "http://igen.com/role/RedeemablePreferredStockAndStockholdersDeficit", "shortName": "Redeemable Preferred Stock and Stockholders Deficit", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "igen_10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R16": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "igen_10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "igen:SharePurchaseWarrantDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "000016 - Disclosure - Share Purchase Warrants", "menuCat": "Notes", "order": "16", "role": "http://igen.com/role/SharePurchaseWarrants", "shortName": "Share Purchase Warrants", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "igen_10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "igen:SharePurchaseWarrantDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R17": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "igen_10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "000017 - Disclosure - Stock Options", "menuCat": "Notes", "order": "17", "role": "http://igen.com/role/StockOptions", "shortName": "Stock Options", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "igen_10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R18": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "igen_10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SegmentReportingDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "000018 - Disclosure - Segments", "menuCat": "Notes", "order": "18", "role": "http://igen.com/role/Segments", "shortName": "Segments", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "igen_10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SegmentReportingDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R19": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "igen_10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ConcentrationRiskDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "000019 - Disclosure - Risk and Uncertainities", "menuCat": "Notes", "order": "19", "role": "http://igen.com/role/RiskAndUncertainities", "shortName": "Risk and Uncertainities", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "igen_10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ConcentrationRiskDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R2": { "firstAnchor": { "ancestors": [ "td", "tr", "tbody", "table", "body", "html" ], "baseRef": "igen_10k.htm", "contextRef": "AsOf2022-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "000002 - Statement - Consolidated Balance Sheets", "menuCat": "Statements", "order": "2", "role": "http://igen.com/role/ConsolidatedBalanceSheets", "shortName": "Consolidated Balance Sheets", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "td", "tr", "tbody", "table", "body", "html" ], "baseRef": "igen_10k.htm", "contextRef": "AsOf2022-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R20": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "igen_10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:IncomeTaxDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "000020 - Disclosure - Income Taxes", "menuCat": "Notes", "order": "20", "role": "http://igen.com/role/IncomeTaxes", "shortName": "Income Taxes", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "igen_10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:IncomeTaxDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R21": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "igen_10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "000021 - Disclosure - Commitments and Contingencies", "menuCat": "Notes", "order": "21", "role": "http://igen.com/role/CommitmentsAndContingencies", "shortName": "Commitments and Contingencies", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "igen_10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R22": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "igen_10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SubsequentEventsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "000022 - Disclosure - Subsequent Events", "menuCat": "Notes", "order": "22", "role": "http://igen.com/role/SubsequentEvents", "shortName": "Subsequent Events", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "igen_10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SubsequentEventsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R23": { "firstAnchor": { "ancestors": [ "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "igen_10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "000023 - Disclosure - Summary of Significant Accounting Policies (Policies)", "menuCat": "Policies", "order": "23", "role": "http://igen.com/role/SummaryOfSignificantAccountingPoliciesPolicies", "shortName": "Summary of Significant Accounting Policies (Policies)", "subGroupType": "policies", "uniqueAnchor": { "ancestors": [ "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "igen_10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R24": { "firstAnchor": { "ancestors": [ "us-gaap:PropertyPlantAndEquipmentPolicyTextBlock", "ix:continuation", "body", "html" ], "baseRef": "igen_10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:PropertyPlantAndEquipmentTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "000024 - Disclosure - Summary of Significant Accounting Policies (Tables)", "menuCat": "Tables", "order": "24", "role": "http://igen.com/role/SummaryOfSignificantAccountingPoliciesTables", "shortName": "Summary of Significant Accounting Policies (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:PropertyPlantAndEquipmentPolicyTextBlock", "ix:continuation", "body", "html" ], "baseRef": "igen_10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:PropertyPlantAndEquipmentTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R25": { "firstAnchor": { "ancestors": [ "us-gaap:AccountsAndNontradeReceivableTextBlock", "body", "html" ], "baseRef": "igen_10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfOtherAssetsTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "000025 - Disclosure - Accounts and Other Receivables (Tables)", "menuCat": "Tables", "order": "25", "role": "http://igen.com/role/AccountsAndOtherReceivablesTables", "shortName": "Accounts and Other Receivables (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:AccountsAndNontradeReceivableTextBlock", "body", "html" ], "baseRef": "igen_10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfOtherAssetsTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R26": { "firstAnchor": { "ancestors": [ "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock", "body", "html" ], "baseRef": "igen_10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "000026 - Disclosure - Accounts Payable and Accrued Liabilities (Tables)", "menuCat": "Tables", "order": "26", "role": "http://igen.com/role/AccountsPayableAndAccruedLiabilitiesTables", "shortName": "Accounts Payable and Accrued Liabilities (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock", "body", "html" ], "baseRef": "igen_10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R27": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "igen_10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "000027 - Disclosure - Convertible Debentures and Notes Payable (Tables)", "menuCat": "Tables", "order": "27", "role": "http://igen.com/role/ConvertibleDebenturesAndNotesPayableTables", "shortName": "Convertible Debentures and Notes Payable (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "igen_10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R28": { "firstAnchor": { "ancestors": [ "us-gaap:DerivativesAndFairValueTextBlock", "body", "html" ], "baseRef": "igen_10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfAssumptionsUsedTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "000028 - Disclosure - Derivative Liabilities (Tables)", "menuCat": "Tables", "order": "28", "role": "http://igen.com/role/DerivativeLiabilitiesTables", "shortName": "Derivative Liabilities (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:DerivativesAndFairValueTextBlock", "body", "html" ], "baseRef": "igen_10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfAssumptionsUsedTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R29": { "firstAnchor": { "ancestors": [ "igen:SharePurchaseWarrantDisclosureTextBlock", "body", "html" ], "baseRef": "igen_10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "000029 - Disclosure - Share Purchase Warrants (Tables)", "menuCat": "Tables", "order": "29", "role": "http://igen.com/role/SharePurchaseWarrantsTables", "shortName": "Share Purchase Warrants (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "igen:SharePurchaseWarrantDisclosureTextBlock", "body", "html" ], "baseRef": "igen_10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R3": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "tbody", "table", "body", "html" ], "baseRef": "igen_10k.htm", "contextRef": "AsOf2022-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:ConvertibleDebtCurrent", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "000003 - Statement - Consolidated Balance Sheets (Parenthetical)", "menuCat": "Statements", "order": "3", "role": "http://igen.com/role/ConsolidatedBalanceSheetsParenthetical", "shortName": "Consolidated Balance Sheets (Parenthetical)", "subGroupType": "parenthetical", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "tbody", "table", "body", "html" ], "baseRef": "igen_10k.htm", "contextRef": "AsOf2022-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:ConvertibleDebtCurrent", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R30": { "firstAnchor": { "ancestors": [ "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "body", "html" ], "baseRef": "igen_10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfStockOptionsRollForwardTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "000030 - Disclosure - Stock Options (Tables)", "menuCat": "Tables", "order": "30", "role": "http://igen.com/role/StockOptionsTables", "shortName": "Stock Options (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "body", "html" ], "baseRef": "igen_10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfStockOptionsRollForwardTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R31": { "firstAnchor": { "ancestors": [ "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "baseRef": "igen_10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SummaryOfIncomeTaxContingenciesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "000031 - Disclosure - Income Taxes (Tables)", "menuCat": "Tables", "order": "31", "role": "http://igen.com/role/IncomeTaxesTables", "shortName": "Income Taxes (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "baseRef": "igen_10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SummaryOfIncomeTaxContingenciesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R32": { "firstAnchor": { "ancestors": [ "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "body", "html" ], "baseRef": "igen_10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:LeaseCostTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "000032 - Disclosure - Commitments and Contingencies (Tables)", "menuCat": "Tables", "order": "32", "role": "http://igen.com/role/CommitmentsAndContingenciesTables", "shortName": "Commitments and Contingencies (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "body", "html" ], "baseRef": "igen_10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:LeaseCostTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R33": { "firstAnchor": { "ancestors": [ "p", "us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock", "body", "html" ], "baseRef": "igen_10k.htm", "contextRef": "AsOf2022-12-31", "decimals": "0", "first": true, "lang": null, "name": "igen:WorkingCapitalDeficit", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "000033 - Disclosure - Organization and Description of Business (Details Narrative)", "menuCat": "Details", "order": "33", "role": "http://igen.com/role/OrganizationAndDescriptionOfBusinessDetailsNarrative", "shortName": "Organization and Description of Business (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock", "body", "html" ], "baseRef": "igen_10k.htm", "contextRef": "AsOf2022-12-31", "decimals": "0", "first": true, "lang": null, "name": "igen:WorkingCapitalDeficit", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R34": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "tbody", "table", "us-gaap:PropertyPlantAndEquipmentTextBlock", "us-gaap:PropertyPlantAndEquipmentPolicyTextBlock", "ix:continuation", "body", "html" ], "baseRef": "igen_10k.htm", "contextRef": "From2022-01-01to2022-12-31_us-gaap_ComputerEquipmentMember", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:PropertyPlantAndEquipmentDepreciationMethods", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "000034 - Disclosure - Summary of Significant Accounting Policies (Details)", "menuCat": "Details", "order": "34", "role": "http://igen.com/role/SummaryOfSignificantAccountingPoliciesDetails", "shortName": "Summary of Significant Accounting Policies (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "tbody", "table", "us-gaap:PropertyPlantAndEquipmentTextBlock", "us-gaap:PropertyPlantAndEquipmentPolicyTextBlock", "ix:continuation", "body", "html" ], "baseRef": "igen_10k.htm", "contextRef": "From2022-01-01to2022-12-31_us-gaap_ComputerEquipmentMember", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:PropertyPlantAndEquipmentDepreciationMethods", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R35": { "firstAnchor": { "ancestors": [ "p", "us-gaap:RevenueRecognitionDeferredRevenue", "ix:continuation", "body", "html" ], "baseRef": "igen_10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:DeferredRevenueAdditions", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "000035 - Disclosure - Summary of Significant Accounting Policies (Details Narrative)", "menuCat": "Details", "order": "35", "role": "http://igen.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative", "shortName": "Summary of Significant Accounting Policies (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "us-gaap:RevenueRecognitionDeferredRevenue", "ix:continuation", "body", "html" ], "baseRef": "igen_10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:DeferredRevenueAdditions", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R36": { "firstAnchor": { "ancestors": [ "td", "tr", "tbody", "table", "us-gaap:ScheduleOfOtherAssetsTableTextBlock", "us-gaap:AccountsAndNontradeReceivableTextBlock", "body", "html" ], "baseRef": "igen_10k.htm", "contextRef": "AsOf2022-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:TradeReceivablesHeldForSaleAmount", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "000036 - Disclosure - Accounts and Other Receivables (Details)", "menuCat": "Details", "order": "36", "role": "http://igen.com/role/AccountsAndOtherReceivablesDetails", "shortName": "Accounts and Other Receivables (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "tbody", "table", "us-gaap:ScheduleOfOtherAssetsTableTextBlock", "us-gaap:AccountsAndNontradeReceivableTextBlock", "body", "html" ], "baseRef": "igen_10k.htm", "contextRef": "AsOf2022-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:TradeReceivablesHeldForSaleAmount", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R37": { "firstAnchor": { "ancestors": [ "p", "us-gaap:GoodwillDisclosureTextBlock", "body", "html" ], "baseRef": "igen_10k.htm", "contextRef": "AsOf2022-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:Goodwill", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "000037 - Disclosure - Goodwill (Details Narrative)", "menuCat": "Details", "order": "37", "role": "http://igen.com/role/GoodwillDetailsNarrative", "shortName": "Goodwill (Details Narrative)", "subGroupType": "details", "uniqueAnchor": null }, "R38": { "firstAnchor": { "ancestors": [ "td", "tr", "tbody", "table", "us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock", "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock", "body", "html" ], "baseRef": "igen_10k.htm", "contextRef": "AsOf2022-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:AccountsPayableCurrent", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "000038 - Disclosure - Accounts Payable and Accrued Liabilities (Details)", "menuCat": "Details", "order": "38", "role": "http://igen.com/role/AccountsPayableAndAccruedLiabilitiesDetails", "shortName": "Accounts Payable and Accrued Liabilities (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "tbody", "table", "us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock", "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock", "body", "html" ], "baseRef": "igen_10k.htm", "contextRef": "AsOf2022-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:AccountsPayableCurrent", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R39": { "firstAnchor": { "ancestors": [ "td", "tr", "tbody", "table", "us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "igen_10k.htm", "contextRef": "AsOf2022-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "000039 - Disclosure - Convertible Debentures and Notes Payable (Details)", "menuCat": "Details", "order": "39", "role": "http://igen.com/role/ConvertibleDebenturesAndNotesPayableDetails", "shortName": "Convertible Debentures and Notes Payable (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "tbody", "table", "us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "igen_10k.htm", "contextRef": "AsOf2022-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R4": { "firstAnchor": { "ancestors": [ "td", "tr", "tbody", "table", "body", "html" ], "baseRef": "igen_10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": "0", "first": true, "lang": null, "name": "igen:SalesServices", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "000004 - Statement - Consolidated Statements of Operations", "menuCat": "Statements", "order": "4", "role": "http://igen.com/role/ConsolidatedStatementsOfOperations", "shortName": "Consolidated Statements of Operations", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "td", "tr", "tbody", "table", "body", "html" ], "baseRef": "igen_10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": "0", "first": true, "lang": null, "name": "igen:SalesServices", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R40": { "firstAnchor": { "ancestors": [ "td", "tr", "tbody", "table", "body", "html" ], "baseRef": "igen_10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:ProceedsFromNotesPayable", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "000040 - Disclosure - Convertible Debentures and Notes Payable (Details Narrative)", "menuCat": "Details", "order": "40", "role": "http://igen.com/role/ConvertibleDebenturesAndNotesPayableDetailsNarrative", "shortName": "Convertible Debentures and Notes Payable (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "ix:continuation", "body", "html" ], "baseRef": "igen_10k.htm", "contextRef": "From2022-01-01to2022-12-31_us-gaap_InvestorMember", "decimals": null, "lang": "en-US", "name": "us-gaap:DebtInstrumentMaturityDateDescription", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R41": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "tbody", "table", "us-gaap:ScheduleOfAssumptionsUsedTableTextBlock", "us-gaap:DerivativesAndFairValueTextBlock", "body", "html" ], "baseRef": "igen_10k.htm", "contextRef": "From2022-01-01to2022-12-31_srt_MinimumMember_igen_WarrantsMember", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate", "reportCount": 1, "unique": true, "unitRef": "Pure", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "000041 - Disclosure - Derivative Liabilities (Details)", "menuCat": "Details", "order": "41", "role": "http://igen.com/role/DerivativeLiabilitiesDetails", "shortName": "Derivative Liabilities (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "tbody", "table", "us-gaap:ScheduleOfAssumptionsUsedTableTextBlock", "us-gaap:DerivativesAndFairValueTextBlock", "body", "html" ], "baseRef": "igen_10k.htm", "contextRef": "From2022-01-01to2022-12-31_srt_MinimumMember_igen_WarrantsMember", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate", "reportCount": 1, "unique": true, "unitRef": "Pure", "xsiNil": "false" } }, "R42": { "firstAnchor": { "ancestors": [ "td", "tr", "tbody", "table", "us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock", "us-gaap:DerivativesAndFairValueTextBlock", "body", "html" ], "baseRef": "igen_10k.htm", "contextRef": "AsOf2022-12-31", "decimals": "0", "first": true, "lang": null, "name": "igen:DerivativeCurrentLiabilities", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "000042 - Disclosure - Derivative Liabilities (Details 1)", "menuCat": "Details", "order": "42", "role": "http://igen.com/role/DerivativeLiabilitiesDetails1", "shortName": "Derivative Liabilities (Details 1)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "tbody", "table", "us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock", "us-gaap:DerivativesAndFairValueTextBlock", "body", "html" ], "baseRef": "igen_10k.htm", "contextRef": "AsOf2022-12-31", "decimals": "0", "first": true, "lang": null, "name": "igen:DerivativeCurrentLiabilities", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R43": { "firstAnchor": { "ancestors": [ "td", "tr", "tbody", "table", "us-gaap:ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock", "us-gaap:DerivativesAndFairValueTextBlock", "body", "html" ], "baseRef": "igen_10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": "0", "first": true, "lang": null, "name": "igen:BalancesAsOfTheBeginningOfTheYear", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "000043 - Disclosure - Derivative Liabilities (Details 2)", "menuCat": "Details", "order": "43", "role": "http://igen.com/role/DerivativeLiabilitiesDetails2", "shortName": "Derivative Liabilities (Details 2)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "tbody", "table", "us-gaap:ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock", "us-gaap:DerivativesAndFairValueTextBlock", "body", "html" ], "baseRef": "igen_10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": "0", "first": true, "lang": null, "name": "igen:BalancesAsOfTheBeginningOfTheYear", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R44": { "firstAnchor": { "ancestors": [ "td", "tr", "tbody", "table", "body", "html" ], "baseRef": "igen_10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:ManagementFeeExpense", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "000044 - Disclosure - Related Party Transactions (Details Narrative)", "menuCat": "Details", "order": "44", "role": "http://igen.com/role/RelatedPartyTransactionsDetailsNarrative", "shortName": "Related Party Transactions (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "tbody", "table", "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "body", "html" ], "baseRef": "igen_10k.htm", "contextRef": "From2022-01-01to2022-12-31_srt_OfficerMember", "decimals": "0", "lang": null, "name": "us-gaap:ManagementFeeExpense", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R45": { "firstAnchor": { "ancestors": [ "p", "ix:continuation", "body", "html" ], "baseRef": "igen_10k.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": "0", "first": true, "lang": null, "name": "igen:SharesOfCommonStockCashlessExerciseOfWarrants", "reportCount": 1, "unique": true, "unitRef": "Shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "000045 - Disclosure - Redeemable Preferred Stock and Stockholders Deficit (Details Narrative)", "menuCat": "Details", "order": "45", "role": "http://igen.com/role/RedeemablePreferredStockAndStockholdersDeficitDetailsNarrative", "shortName": "Redeemable Preferred Stock and Stockholders Deficit (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "ix:continuation", "body", "html" ], "baseRef": "igen_10k.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": "0", "first": true, "lang": null, "name": "igen:SharesOfCommonStockCashlessExerciseOfWarrants", "reportCount": 1, "unique": true, "unitRef": "Shares", "xsiNil": "false" } }, "R46": { "firstAnchor": { "ancestors": [ "td", "tr", "tbody", "table", "us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock", "igen:SharePurchaseWarrantDisclosureTextBlock", "body", "html" ], "baseRef": "igen_10k.htm", "contextRef": "AsOf2021-12-31_igen_WarrantsMember", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber", "reportCount": 1, "unitRef": "Shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "000046 - Disclosure - Share Purchase Warrants (Details)", "menuCat": "Details", "order": "46", "role": "http://igen.com/role/SharePurchaseWarrantsDetails", "shortName": "Share Purchase Warrants (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "tbody", "table", "us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock", "igen:SharePurchaseWarrantDisclosureTextBlock", "body", "html" ], "baseRef": "igen_10k.htm", "contextRef": "AsOf2020-12-31_igen_WarrantsMember", "decimals": "0", "lang": null, "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber", "reportCount": 1, "unique": true, "unitRef": "Shares", "xsiNil": "false" } }, "R47": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "tbody", "table", "igen:ScheduleOfSharePurchaseWarrantsOutstandingTableTextBlock", "igen:SharePurchaseWarrantDisclosureTextBlock", "body", "html" ], "baseRef": "igen_10k.htm", "contextRef": "AsOf2022-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:ClassOfWarrantOrRightOutstanding", "reportCount": 1, "unique": true, "unitRef": "Shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "000047 - Disclosure - Share Purchase Warrants (Details 1)", "menuCat": "Details", "order": "47", "role": "http://igen.com/role/SharePurchaseWarrantsDetails1", "shortName": "Share Purchase Warrants (Details 1)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "tbody", "table", "igen:ScheduleOfSharePurchaseWarrantsOutstandingTableTextBlock", "igen:SharePurchaseWarrantDisclosureTextBlock", "body", "html" ], "baseRef": "igen_10k.htm", "contextRef": "AsOf2022-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:ClassOfWarrantOrRightOutstanding", "reportCount": 1, "unique": true, "unitRef": "Shares", "xsiNil": "false" } }, "R48": { "firstAnchor": { "ancestors": [ "p", "igen:SharePurchaseWarrantDisclosureTextBlock", "body", "html" ], "baseRef": "igen_10k.htm", "contextRef": "From2022-01-01to2022-12-31_igen_WarrantsMember", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised", "reportCount": 1, "unique": true, "unitRef": "Shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "000048 - Disclosure - Share Purchase Warrants (Details Narrative)", "menuCat": "Details", "order": "48", "role": "http://igen.com/role/SharePurchaseWarrantsDetailsNarrative", "shortName": "Share Purchase Warrants (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "igen:SharePurchaseWarrantDisclosureTextBlock", "body", "html" ], "baseRef": "igen_10k.htm", "contextRef": "From2022-01-01to2022-12-31_igen_WarrantsMember", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised", "reportCount": 1, "unique": true, "unitRef": "Shares", "xsiNil": "false" } }, "R49": { "firstAnchor": { "ancestors": [ "td", "tr", "tbody", "table", "us-gaap:ScheduleOfStockOptionsRollForwardTableTextBlock", "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "body", "html" ], "baseRef": "igen_10k.htm", "contextRef": "AsOf2021-12-31_us-gaap_StockOptionMember", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber", "reportCount": 1, "unitRef": "Shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "000049 - Disclosure - Stock Options (Details)", "menuCat": "Details", "order": "49", "role": "http://igen.com/role/StockOptionsDetails", "shortName": "Stock Options (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "tbody", "table", "us-gaap:ScheduleOfStockOptionsRollForwardTableTextBlock", "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "body", "html" ], "baseRef": "igen_10k.htm", "contextRef": "From2022-01-01to2022-12-31_us-gaap_StockOptionMember", "decimals": "0", "lang": null, "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod", "reportCount": 1, "unique": true, "unitRef": "Shares", "xsiNil": "false" } }, "R5": { "firstAnchor": { "ancestors": [ "td", "tr", "tbody", "table", "body", "html" ], "baseRef": "igen_10k.htm", "contextRef": "AsOf2020-12-31_igen_RedeemableConvertiblePreferredStocksSeriesAMember", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:SharesIssued", "reportCount": 1, "unique": true, "unitRef": "Shares", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "000005 - Statement - Consolidated Statements of Redeemable Convertible Preferred stock and Stockholders Deficit", "menuCat": "Statements", "order": "5", "role": "http://igen.com/role/ConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholdersDeficit", "shortName": "Consolidated Statements of Redeemable Convertible Preferred stock and Stockholders Deficit", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "td", "tr", "tbody", "table", "body", "html" ], "baseRef": "igen_10k.htm", "contextRef": "AsOf2020-12-31_igen_RedeemableConvertiblePreferredStocksSeriesAMember", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:SharesIssued", "reportCount": 1, "unique": true, "unitRef": "Shares", "xsiNil": "false" } }, "R50": { "firstAnchor": { "ancestors": [ "td", "tr", "tbody", "table", "ix:continuation", "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "body", "html" ], "baseRef": "igen_10k.htm", "contextRef": "AsOf2022-12-31_igen_OptionsOneMember", "decimals": "INF", "first": true, "lang": null, "name": "igen:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisePrice", "reportCount": 1, "unique": true, "unitRef": "USDPShares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "000050 - Disclosure - Stock Options (Details 1)", "menuCat": "Details", "order": "50", "role": "http://igen.com/role/StockOptionsDetails1", "shortName": "Stock Options (Details 1)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "tbody", "table", "ix:continuation", "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "body", "html" ], "baseRef": "igen_10k.htm", "contextRef": "AsOf2022-12-31_igen_OptionsOneMember", "decimals": "INF", "first": true, "lang": null, "name": "igen:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisePrice", "reportCount": 1, "unique": true, "unitRef": "USDPShares", "xsiNil": "false" } }, "R51": { "firstAnchor": { "ancestors": [ "p", "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "body", "html" ], "baseRef": "igen_10k.htm", "contextRef": "AsOf2022-12-31_igen_StockOptionPlanMember", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:CommonStockCapitalSharesReservedForFutureIssuance", "reportCount": 1, "unique": true, "unitRef": "Shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "000051 - Disclosure - Stock Options (Details Narrative)", "menuCat": "Details", "order": "51", "role": "http://igen.com/role/StockOptionsDetailsNarrative", "shortName": "Stock Options (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "body", "html" ], "baseRef": "igen_10k.htm", "contextRef": "AsOf2022-12-31_igen_StockOptionPlanMember", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:CommonStockCapitalSharesReservedForFutureIssuance", "reportCount": 1, "unique": true, "unitRef": "Shares", "xsiNil": "false" } }, "R52": { "firstAnchor": { "ancestors": [ "p", "us-gaap:ConcentrationRiskDisclosureTextBlock", "body", "html" ], "baseRef": "igen_10k.htm", "contextRef": "From2022-01-01to2022-12-31_us-gaap_CreditConcentrationRiskMember_igen_SaleRevenueNetMember", "decimals": "INF", "first": true, "lang": null, "name": "igen:ConcentrationRisksPercentage", "reportCount": 1, "unique": true, "unitRef": "Pure", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "000052 - Disclosure - Risks Uncertainties (Details Narrative)", "menuCat": "Details", "order": "52", "role": "http://igen.com/role/RisksUncertaintiesDetailsNarrative", "shortName": "Risks Uncertainties (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "us-gaap:ConcentrationRiskDisclosureTextBlock", "body", "html" ], "baseRef": "igen_10k.htm", "contextRef": "From2022-01-01to2022-12-31_us-gaap_CreditConcentrationRiskMember_igen_SaleRevenueNetMember", "decimals": "INF", "first": true, "lang": null, "name": "igen:ConcentrationRisksPercentage", "reportCount": 1, "unique": true, "unitRef": "Pure", "xsiNil": "false" } }, "R53": { "firstAnchor": { "ancestors": [ "td", "tr", "tbody", "table", "us-gaap:SummaryOfIncomeTaxContingenciesTextBlock", "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "baseRef": "igen_10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:CurrentFederalTaxExpenseBenefit", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "000053 - Disclosure - Income Taxes (Details)", "menuCat": "Details", "order": "53", "role": "http://igen.com/role/IncomeTaxesDetails", "shortName": "Income Taxes (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "tbody", "table", "us-gaap:SummaryOfIncomeTaxContingenciesTextBlock", "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "baseRef": "igen_10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:CurrentFederalTaxExpenseBenefit", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R54": { "firstAnchor": { "ancestors": [ "td", "tr", "tbody", "table", "body", "html" ], "baseRef": "igen_10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:GainsLossesOnExtinguishmentOfDebt", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "000054 - Disclosure - Income Taxes (Details 1)", "menuCat": "Details", "order": "54", "role": "http://igen.com/role/IncomeTaxesDetails1", "shortName": "Income Taxes (Details 1)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "tbody", "table", "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock", "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "baseRef": "igen_10k.htm", "contextRef": "From2022-01-01to2022-12-31_igen_ReconciliationOfIncomeTaxesMember", "decimals": "0", "lang": null, "name": "us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R55": { "firstAnchor": { "ancestors": [ "td", "tr", "tbody", "table", "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock", "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "baseRef": "igen_10k.htm", "contextRef": "AsOf2022-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:DeferredTaxAssetsOperatingLossCarryforwards", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "000055 - Disclosure - Income Taxes (Details 2)", "menuCat": "Details", "order": "55", "role": "http://igen.com/role/IncomeTaxesDetails2", "shortName": "Income Taxes (Details 2)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "tbody", "table", "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock", "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "baseRef": "igen_10k.htm", "contextRef": "AsOf2022-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:DeferredTaxAssetsOperatingLossCarryforwards", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R56": { "firstAnchor": { "ancestors": [ "td", "tr", "tbody", "table", "us-gaap:ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "igen_10k.htm", "contextRef": "From2022-01-01to2022-12-31_igen_FederalAndStateMember", "decimals": "0", "first": true, "lang": null, "name": "igen:UnrecognizedTaxBenefitBeginning", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "000056 - Disclosure - Income Taxes (Details 3)", "menuCat": "Details", "order": "56", "role": "http://igen.com/role/IncomeTaxesDetails3", "shortName": "Income Taxes (Details 3)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "tbody", "table", "us-gaap:ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "igen_10k.htm", "contextRef": "From2022-01-01to2022-12-31_igen_FederalAndStateMember", "decimals": "0", "first": true, "lang": null, "name": "igen:UnrecognizedTaxBenefitBeginning", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R57": { "firstAnchor": { "ancestors": [ "p", "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "baseRef": "igen_10k.htm", "contextRef": "AsOf2022-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsForeign", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "000057 - Disclosure - Income Taxes (Details Narrative)", "menuCat": "Details", "order": "57", "role": "http://igen.com/role/IncomeTaxesDetailsNarrative", "shortName": "Income Taxes (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "baseRef": "igen_10k.htm", "contextRef": "AsOf2022-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsForeign", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R58": { "firstAnchor": { "ancestors": [ "td", "tr", "tbody", "table", "us-gaap:LeaseCostTableTextBlock", "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "body", "html" ], "baseRef": "igen_10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:OperatingLeaseCost", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "000058 - Disclosure - Commitments and Contingencies (Details)", "menuCat": "Details", "order": "58", "role": "http://igen.com/role/CommitmentsAndContingenciesDetails", "shortName": "Commitments and Contingencies (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "tbody", "table", "us-gaap:LeaseCostTableTextBlock", "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "body", "html" ], "baseRef": "igen_10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:OperatingLeaseCost", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R59": { "firstAnchor": { "ancestors": [ "td", "tr", "tbody", "table", "igen:ScheduleOfOtherInformatoinRelatedToOpeartingLeasetabletextblock", "ix:continuation", "body", "html" ], "baseRef": "igen_10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": "0", "first": true, "lang": null, "name": "igen:OperatingCashFlowsFromOperatingLease", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "000059 - Disclosure - Commitments and Contingencies (Details 1)", "menuCat": "Details", "order": "59", "role": "http://igen.com/role/CommitmentsAndContingenciesDetails1", "shortName": "Commitments and Contingencies (Details 1)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "tbody", "table", "igen:ScheduleOfOtherInformatoinRelatedToOpeartingLeasetabletextblock", "ix:continuation", "body", "html" ], "baseRef": "igen_10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": "0", "first": true, "lang": null, "name": "igen:OperatingCashFlowsFromOperatingLease", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R6": { "firstAnchor": { "ancestors": [ "td", "tr", "tbody", "table", "body", "html" ], "baseRef": "igen_10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:ProfitLoss", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "000006 - Statement - Consolidated Statements of Cash Flows", "menuCat": "Statements", "order": "6", "role": "http://igen.com/role/ConsolidatedStatementsOfCashFlows", "shortName": "Consolidated Statements of Cash Flows", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "td", "tr", "tbody", "table", "body", "html" ], "baseRef": "igen_10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:ProfitLoss", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R60": { "firstAnchor": { "ancestors": [ "td", "tr", "tbody", "table", "igen:ScheduleOfFutureMinimumRentalPaymentsForOperatingLeaseTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "igen_10k.htm", "contextRef": "AsOf2021-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:OperatingLeasesFutureMinimumPaymentsDueCurrent", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "000060 - Disclosure - Commitments and Contingencies (Details 2)", "menuCat": "Details", "order": "60", "role": "http://igen.com/role/CommitmentsAndContingenciesDetails2", "shortName": "Commitments and Contingencies (Details 2)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "tbody", "table", "igen:ScheduleOfFutureMinimumRentalPaymentsForOperatingLeaseTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "igen_10k.htm", "contextRef": "AsOf2021-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:OperatingLeasesFutureMinimumPaymentsDueCurrent", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R61": { "firstAnchor": { "ancestors": [ "p", "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "body", "html" ], "baseRef": "igen_10k.htm", "contextRef": "AsOf2022-12-31", "decimals": "0", "first": true, "lang": null, "name": "igen:ObligationInAccountsPayableAndLiabilities", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "000061 - Disclosure - Commitments and Contingencies (Details Narrative)", "menuCat": "Details", "order": "61", "role": "http://igen.com/role/CommitmentsAndContingenciesDetailsNarrative", "shortName": "Commitments and Contingencies (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "body", "html" ], "baseRef": "igen_10k.htm", "contextRef": "AsOf2022-12-31", "decimals": "0", "first": true, "lang": null, "name": "igen:ObligationInAccountsPayableAndLiabilities", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R62": { "firstAnchor": { "ancestors": [ "p", "us-gaap:SubsequentEventsTextBlock", "body", "html" ], "baseRef": "igen_10k.htm", "contextRef": "From2023-02-01to2023-02-22", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:StockIssuedDuringPeriodSharesOther", "reportCount": 1, "unique": true, "unitRef": "Shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "000062 - Disclosure - Subsequent Events (Details Narrative)", "menuCat": "Details", "order": "62", "role": "http://igen.com/role/SubsequentEventsDetailsNarrative", "shortName": "Subsequent Events (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "us-gaap:SubsequentEventsTextBlock", "body", "html" ], "baseRef": "igen_10k.htm", "contextRef": "From2023-02-01to2023-02-22", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:StockIssuedDuringPeriodSharesOther", "reportCount": 1, "unique": true, "unitRef": "Shares", "xsiNil": "false" } }, "R7": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "igen_10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "000007 - Disclosure - Organization and Description of Business", "menuCat": "Notes", "order": "7", "role": "http://igen.com/role/OrganizationAndDescriptionOfBusiness", "shortName": "Organization and Description of Business", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "igen_10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R8": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "igen_10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SignificantAccountingPoliciesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "000008 - Disclosure - Summary of Significant Accounting Policies", "menuCat": "Notes", "order": "8", "role": "http://igen.com/role/SummaryOfSignificantAccountingPolicies", "shortName": "Summary of Significant Accounting Policies", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "igen_10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SignificantAccountingPoliciesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R9": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "igen_10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:AccountsAndNontradeReceivableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "000009 - Disclosure - Accounts and Other Receivables", "menuCat": "Notes", "order": "9", "role": "http://igen.com/role/AccountsAndOtherReceivables", "shortName": "Accounts and Other Receivables", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "igen_10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:AccountsAndNontradeReceivableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } } }, "segmentCount": 66, "tag": { "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://igen.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_AuditorFirmId": { "auth_ref": [ "r508", "r509", "r510" ], "lang": { "en-us": { "role": { "documentation": "PCAOB issued Audit Firm Identifier", "label": "Auditor Firm Id" } } }, "localname": "AuditorFirmId", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://igen.com/role/Cover" ], "xbrltype": "nonemptySequenceNumberItemType" }, "dei_AuditorLocation": { "auth_ref": [ "r508", "r509", "r510" ], "lang": { "en-us": { "role": { "label": "Auditor Location" } } }, "localname": "AuditorLocation", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://igen.com/role/Cover" ], "xbrltype": "internationalNameItemType" }, "dei_AuditorName": { "auth_ref": [ "r508", "r509", "r510" ], "lang": { "en-us": { "role": { "label": "Auditor Name" } } }, "localname": "AuditorName", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://igen.com/role/Cover" ], "xbrltype": "internationalNameItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Area code of city", "label": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://igen.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_CoverAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Cover page.", "label": "Cover [Abstract]" } } }, "localname": "CoverAbstract", "nsuri": "http://xbrl.sec.gov/dei/2022", "xbrltype": "stringItemType" }, "dei_CurrentFiscalYearEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "End date of current fiscal year in the format --MM-DD.", "label": "Current Fiscal Year End Date" } } }, "localname": "CurrentFiscalYearEndDate", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://igen.com/role/Cover" ], "xbrltype": "gMonthDayItemType" }, "dei_DocumentAnnualReport": { "auth_ref": [ "r508", "r509", "r510" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as an annual report.", "label": "Document Annual Report" } } }, "localname": "DocumentAnnualReport", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://igen.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentFiscalPeriodFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.", "label": "Document Fiscal Period Focus" } } }, "localname": "DocumentFiscalPeriodFocus", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://igen.com/role/Cover" ], "xbrltype": "fiscalPeriodItemType" }, "dei_DocumentFiscalYearFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.", "label": "Document Fiscal Year Focus" } } }, "localname": "DocumentFiscalYearFocus", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://igen.com/role/Cover" ], "xbrltype": "gYearItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.", "label": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://igen.com/role/Cover" ], "xbrltype": "dateItemType" }, "dei_DocumentTransitionReport": { "auth_ref": [ "r511" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as a transition report.", "label": "Document Transition Report" } } }, "localname": "DocumentTransitionReport", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://igen.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://igen.com/role/Cover" ], "xbrltype": "submissionTypeItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address Address Line 1" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://igen.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine2": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 2 such as Street or Suite number", "label": "Entity Address Address Line 2" } } }, "localname": "EntityAddressAddressLine2", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://igen.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address City Or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://igen.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://igen.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressStateOrProvince": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the state or province.", "label": "Entity Address State Or Province" } } }, "localname": "EntityAddressStateOrProvince", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://igen.com/role/Cover" ], "xbrltype": "stateOrProvinceItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r507" ], "lang": { "en-us": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://igen.com/role/Cover" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityCommonStockSharesOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.", "label": "Entity Common Stock Shares Outstanding" } } }, "localname": "EntityCommonStockSharesOutstanding", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://igen.com/role/Cover" ], "xbrltype": "sharesItemType" }, "dei_EntityCurrentReportingStatus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Current Reporting Status" } } }, "localname": "EntityCurrentReportingStatus", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://igen.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r507" ], "lang": { "en-us": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://igen.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://igen.com/role/Cover" ], "xbrltype": "fileNumberItemType" }, "dei_EntityFilerCategory": { "auth_ref": [ "r507" ], "lang": { "en-us": { "role": { "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Filer Category" } } }, "localname": "EntityFilerCategory", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://igen.com/role/Cover" ], "xbrltype": "filerCategoryItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation State Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://igen.com/role/Cover" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityInteractiveDataCurrent": { "auth_ref": [ "r512" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).", "label": "Entity Interactive Data Current" } } }, "localname": "EntityInteractiveDataCurrent", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://igen.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityPublicFloat": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.", "label": "Entity Public Float" } } }, "localname": "EntityPublicFloat", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://igen.com/role/Cover" ], "xbrltype": "monetaryItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r507" ], "lang": { "en-us": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://igen.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityShellCompany": { "auth_ref": [ "r507" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.", "label": "Entity Shell Company" } } }, "localname": "EntityShellCompany", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://igen.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntitySmallBusiness": { "auth_ref": [ "r507" ], "lang": { "en-us": { "role": { "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).", "label": "Entity Small Business" } } }, "localname": "EntitySmallBusiness", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://igen.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r507" ], "lang": { "en-us": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity Tax Identification Number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://igen.com/role/Cover" ], "xbrltype": "employerIdItemType" }, "dei_EntityVoluntaryFilers": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.", "label": "Entity Voluntary Filers" } } }, "localname": "EntityVoluntaryFilers", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://igen.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityWellKnownSeasonedIssuer": { "auth_ref": [ "r513" ], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.", "label": "Entity Well Known Seasoned Issuer" } } }, "localname": "EntityWellKnownSeasonedIssuer", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://igen.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://igen.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "igen_AccountReceivableMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Accounts Receivable [Member]" } } }, "localname": "AccountReceivableMember", "nsuri": "http://igen.com/20221231", "presentation": [ "http://igen.com/role/RisksUncertaintiesDetailsNarrative" ], "xbrltype": "domainItemType" }, "igen_AccretionOfDiscountsOnConvertibleDebenturesAndPreferredStock": { "auth_ref": [], "calculation": { "http://igen.com/role/ConsolidatedStatementsOfCashFlows": { "order": 3.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "label": "Accretion of discounts on convertible debentures and preferred stock" } } }, "localname": "AccretionOfDiscountsOnConvertibleDebenturesAndPreferredStock", "nsuri": "http://igen.com/20221231", "presentation": [ "http://igen.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "igen_AccruedDividendsOnSeriesAPreferredStock": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Accrued dividends on Series A preferred stock" } } }, "localname": "AccruedDividendsOnSeriesAPreferredStock", "nsuri": "http://igen.com/20221231", "presentation": [ "http://igen.com/role/ConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholdersDeficit" ], "xbrltype": "monetaryItemType" }, "igen_AccruedInterest": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Accrued interest" } } }, "localname": "AccruedInterest", "nsuri": "http://igen.com/20221231", "presentation": [ "http://igen.com/role/ConvertibleDebenturesAndNotesPayableDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "igen_AggregateIntrinsicValue": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "[Aggregate intrinsic value, beginning balance]", "periodEndLabel": "Aggregate intrinsic value, ending balance", "periodStartLabel": "Aggregate intrinsic value, beginning balance" } } }, "localname": "AggregateIntrinsicValue", "nsuri": "http://igen.com/20221231", "presentation": [ "http://igen.com/role/StockOptionsDetails" ], "xbrltype": "monetaryItemType" }, "igen_AggregateIntrinsicValueNonvested": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Aggregate intrinsic value, Nonvested" } } }, "localname": "AggregateIntrinsicValueNonvested", "nsuri": "http://igen.com/20221231", "presentation": [ "http://igen.com/role/StockOptionsDetails" ], "xbrltype": "monetaryItemType" }, "igen_AggregateIntrinsicValueUnvasted": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Aggregate intrinsic value, unvasted" } } }, "localname": "AggregateIntrinsicValueUnvasted", "nsuri": "http://igen.com/20221231", "presentation": [ "http://igen.com/role/StockOptionsDetails" ], "xbrltype": "monetaryItemType" }, "igen_AprilFiveTwentyTwentyOneMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "April 5 2021 [Member]" } } }, "localname": "AprilFiveTwentyTwentyOneMember", "nsuri": "http://igen.com/20221231", "presentation": [ "http://igen.com/role/RedeemablePreferredStockAndStockholdersDeficitDetailsNarrative" ], "xbrltype": "domainItemType" }, "igen_AprilThirtyTwentyTwentyOneMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "April 30 2021 [Member]" } } }, "localname": "AprilThirtyTwentyTwentyOneMember", "nsuri": "http://igen.com/20221231", "presentation": [ "http://igen.com/role/RedeemablePreferredStockAndStockholdersDeficitDetailsNarrative" ], "xbrltype": "domainItemType" }, "igen_AprilTwentySixTwentyTwentyTwoMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "April 26, 2022 [Member]" } } }, "localname": "AprilTwentySixTwentyTwentyTwoMember", "nsuri": "http://igen.com/20221231", "presentation": [ "http://igen.com/role/RedeemablePreferredStockAndStockholdersDeficitDetailsNarrative" ], "xbrltype": "domainItemType" }, "igen_AssetsDeposits": { "auth_ref": [], "calculation": { "http://igen.com/role/ConsolidatedBalanceSheets": { "order": 5.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "label": "Deposits" } } }, "localname": "AssetsDeposits", "nsuri": "http://igen.com/20221231", "presentation": [ "http://igen.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "igen_AugustElevenTwentyTwentyOneMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "August 11, 2021 [Member]" } } }, "localname": "AugustElevenTwentyTwentyOneMember", "nsuri": "http://igen.com/20221231", "presentation": [ "http://igen.com/role/RedeemablePreferredStockAndStockholdersDeficitDetailsNarrative" ], "xbrltype": "domainItemType" }, "igen_AugustTwentyThreeTwentyTwentyTwoMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "August 23, 2022 [Member]" } } }, "localname": "AugustTwentyThreeTwentyTwentyTwoMember", "nsuri": "http://igen.com/20221231", "presentation": [ "http://igen.com/role/RedeemablePreferredStockAndStockholdersDeficitDetailsNarrative" ], "xbrltype": "domainItemType" }, "igen_BalancesAsOfTheBeginningOfTheYear": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Balances, as of the beginning of the year" } } }, "localname": "BalancesAsOfTheBeginningOfTheYear", "nsuri": "http://igen.com/20221231", "presentation": [ "http://igen.com/role/DerivativeLiabilitiesDetails2" ], "xbrltype": "monetaryItemType" }, "igen_BasisDifferenceInAssetsAndDebt": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "Basis difference in assets and debt" } } }, "localname": "BasisDifferenceInAssetsAndDebt", "nsuri": "http://igen.com/20221231", "presentation": [ "http://igen.com/role/IncomeTaxesDetails2" ], "xbrltype": "monetaryItemType" }, "igen_BorrowedAdditionalUnderTheNote": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Borrowed additional under the note" } } }, "localname": "BorrowedAdditionalUnderTheNote", "nsuri": "http://igen.com/20221231", "presentation": [ "http://igen.com/role/ConvertibleDebenturesAndNotesPayableDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "igen_CEOAndVPMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "CEO and VP [Member]" } } }, "localname": "CEOAndVPMember", "nsuri": "http://igen.com/20221231", "presentation": [ "http://igen.com/role/RelatedPartyTransactionsDetailsNarrative" ], "xbrltype": "domainItemType" }, "igen_CEOMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "CEO [Member]" } } }, "localname": "CEOMember", "nsuri": "http://igen.com/20221231", "presentation": [ "http://igen.com/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "domainItemType" }, "igen_CashPaidForAmountsIncludedInTheMeasurementOfLeaseLiabilityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Cash paid for amounts included in the measurement of lease liability:" } } }, "localname": "CashPaidForAmountsIncludedInTheMeasurementOfLeaseLiabilityAbstract", "nsuri": "http://igen.com/20221231", "presentation": [ "http://igen.com/role/CommitmentsAndContingenciesDetails1" ], "xbrltype": "stringItemType" }, "igen_CashlessExerciseOfWarrants": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Cashless exercise of warrants" } } }, "localname": "CashlessExerciseOfWarrants", "nsuri": "http://igen.com/20221231", "presentation": [ "http://igen.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "igen_CashlessExerciseOfWarrantsAmount": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Cashless exercise of warrants, amount" } } }, "localname": "CashlessExerciseOfWarrantsAmount", "nsuri": "http://igen.com/20221231", "presentation": [ "http://igen.com/role/ConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholdersDeficit" ], "xbrltype": "monetaryItemType" }, "igen_CashlessExerciseOfWarrantsShares": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Cashless exercise of warrants, shares" } } }, "localname": "CashlessExerciseOfWarrantsShares", "nsuri": "http://igen.com/20221231", "presentation": [ "http://igen.com/role/ConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholdersDeficit" ], "xbrltype": "sharesItemType" }, "igen_CommonStockAsACommitmentFee": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Common stock as a commitment fee for a new equity line of credit" } } }, "localname": "CommonStockAsACommitmentFee", "nsuri": "http://igen.com/20221231", "presentation": [ "http://igen.com/role/RedeemablePreferredStockAndStockholdersDeficitDetailsNarrative" ], "xbrltype": "sharesItemType" }, "igen_CommonStockForServices": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Common stock for services provided by a vendor" } } }, "localname": "CommonStockForServices", "nsuri": "http://igen.com/20221231", "presentation": [ "http://igen.com/role/RedeemablePreferredStockAndStockholdersDeficitDetailsNarrative" ], "xbrltype": "sharesItemType" }, "igen_CommonStockForServicesProvidedByManagement": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "common stock for services provided by management and the board of directors" } } }, "localname": "CommonStockForServicesProvidedByManagement", "nsuri": "http://igen.com/20221231", "presentation": [ "http://igen.com/role/RedeemablePreferredStockAndStockholdersDeficitDetailsNarrative" ], "xbrltype": "sharesItemType" }, "igen_CommonStockForTheConversionOfDebtAndAccruedInterest": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Common stock for the conversion of debt and accrued interest" } } }, "localname": "CommonStockForTheConversionOfDebtAndAccruedInterest", "nsuri": "http://igen.com/20221231", "presentation": [ "http://igen.com/role/RedeemablePreferredStockAndStockholdersDeficitDetailsNarrative" ], "xbrltype": "sharesItemType" }, "igen_CommonStockForTheExerciseOfAWarrant": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Common stock for the exercise of a warrant on a cashless basis" } } }, "localname": "CommonStockForTheExerciseOfAWarrant", "nsuri": "http://igen.com/20221231", "presentation": [ "http://igen.com/role/RedeemablePreferredStockAndStockholdersDeficitDetailsNarrative" ], "xbrltype": "sharesItemType" }, "igen_CommonStockPurchaseWarrantAgreementMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Common Stock Purchase Warrant Agreement [Member]" } } }, "localname": "CommonStockPurchaseWarrantAgreementMember", "nsuri": "http://igen.com/20221231", "presentation": [ "http://igen.com/role/ConvertibleDebenturesAndNotesPayableDetailsNarrative" ], "xbrltype": "domainItemType" }, "igen_CommonStockSharesIssuedUponConversionOfPreferredStockAndAccruedDividend": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Common stock shares issued upon conversion of preferred stock and accrued dividend" } } }, "localname": "CommonStockSharesIssuedUponConversionOfPreferredStockAndAccruedDividend", "nsuri": "http://igen.com/20221231", "presentation": [ "http://igen.com/role/RedeemablePreferredStockAndStockholdersDeficitDetailsNarrative" ], "xbrltype": "sharesItemType" }, "igen_CommonStockSharesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Common Shares [Member]" } } }, "localname": "CommonStockSharesMember", "nsuri": "http://igen.com/20221231", "presentation": [ "http://igen.com/role/RedeemablePreferredStockAndStockholdersDeficitDetailsNarrative" ], "xbrltype": "domainItemType" }, "igen_ConcentrationRisksPercentage": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Concentration Risk, Percentage" } } }, "localname": "ConcentrationRisksPercentage", "nsuri": "http://igen.com/20221231", "presentation": [ "http://igen.com/role/RisksUncertaintiesDetailsNarrative" ], "xbrltype": "percentItemType" }, "igen_ContractAssetBalanceMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Contract asset balance [Member]" } } }, "localname": "ContractAssetBalanceMember", "nsuri": "http://igen.com/20221231", "presentation": [ "http://igen.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "domainItemType" }, "igen_ConversionFeatureDerivativeLiability": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Conversion feature derivative liability" } } }, "localname": "ConversionFeatureDerivativeLiability", "nsuri": "http://igen.com/20221231", "presentation": [ "http://igen.com/role/IncomeTaxesDetails1" ], "xbrltype": "monetaryItemType" }, "igen_ConversionOfNotesPayableAndAccruedInterestAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Conversion of notes payable and accrued interest:" } } }, "localname": "ConversionOfNotesPayableAndAccruedInterestAbstract", "nsuri": "http://igen.com/20221231", "presentation": [ "http://igen.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "igen_ConversionOfPreferredStockAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Conversion of preferred stock:" } } }, "localname": "ConversionOfPreferredStockAbstract", "nsuri": "http://igen.com/20221231", "presentation": [ "http://igen.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "igen_ConversionOfPreferredStockDeemedDividend": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Deemed divided" } } }, "localname": "ConversionOfPreferredStockDeemedDividend", "nsuri": "http://igen.com/20221231", "presentation": [ "http://igen.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "igen_ConversionOfPreferredStockDerecognitionOfDerivativeLiabilities": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "[Derecognition of derivative liabilities]", "verboseLabel": "Derecognition of derivative liabilities" } } }, "localname": "ConversionOfPreferredStockDerecognitionOfDerivativeLiabilities", "nsuri": "http://igen.com/20221231", "presentation": [ "http://igen.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "igen_ConversionOfPreferredStockDerecognitionOfPreferredStock": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Derecognition of preferred stock" } } }, "localname": "ConversionOfPreferredStockDerecognitionOfPreferredStock", "nsuri": "http://igen.com/20221231", "presentation": [ "http://igen.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "igen_ConversionOfPreferredStockDerecognitionOfUnamortizedDiscount": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "[Derecognition of unamortized discount]", "verboseLabel": "Derecognition of unamortized discount" } } }, "localname": "ConversionOfPreferredStockDerecognitionOfUnamortizedDiscount", "nsuri": "http://igen.com/20221231", "presentation": [ "http://igen.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "igen_ConversionOfPreferredStockDerecognitionOfUnamortizedDiscountOther": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Derecognition of unamortized discount" } } }, "localname": "ConversionOfPreferredStockDerecognitionOfUnamortizedDiscountOther", "nsuri": "http://igen.com/20221231", "presentation": [ "http://igen.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "igen_ConversionOfPreferredStockFairValueOfCommonSharesIssued": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Fair value of common stock issued" } } }, "localname": "ConversionOfPreferredStockFairValueOfCommonSharesIssued", "nsuri": "http://igen.com/20221231", "presentation": [ "http://igen.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "igen_ConversionOfSeriesAPreferredSharesToCommonStockAmount": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Conversion of Series A preferred shares to common stock, amount" } } }, "localname": "ConversionOfSeriesAPreferredSharesToCommonStockAmount", "nsuri": "http://igen.com/20221231", "presentation": [ "http://igen.com/role/ConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholdersDeficit" ], "xbrltype": "monetaryItemType" }, "igen_ConversionOfSeriesAPreferredSharesToCommonStockShares": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Conversion of Series A preferred shares to common stock, shares" } } }, "localname": "ConversionOfSeriesAPreferredSharesToCommonStockShares", "nsuri": "http://igen.com/20221231", "presentation": [ "http://igen.com/role/ConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholdersDeficit" ], "xbrltype": "sharesItemType" }, "igen_ConversionOfStockAmountConverted": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "Extinguishment due to conversion of preferred stock" } } }, "localname": "ConversionOfStockAmountConverted", "nsuri": "http://igen.com/20221231", "presentation": [ "http://igen.com/role/DerivativeLiabilitiesDetails2" ], "xbrltype": "monetaryItemType" }, "igen_ConvertibleDebenturesAndNotesPayableAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Convertible Debentures and Notes Payable" } } }, "localname": "ConvertibleDebenturesAndNotesPayableAbstract", "nsuri": "http://igen.com/20221231", "xbrltype": "stringItemType" }, "igen_ConvertibleDebenturesCurrent": { "auth_ref": [], "calculation": { "http://igen.com/role/ConsolidatedBalanceSheets": { "order": 13.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "label": "Convertible debentures, current portion, net of discount of $0 and $30,586, respectively" } } }, "localname": "ConvertibleDebenturesCurrent", "nsuri": "http://igen.com/20221231", "presentation": [ "http://igen.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "igen_ConvertiblePromissoryNoteMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Convertible Promissory Note [Member]" } } }, "localname": "ConvertiblePromissoryNoteMember", "nsuri": "http://igen.com/20221231", "presentation": [ "http://igen.com/role/ConvertibleDebenturesAndNotesPayableDetailsNarrative" ], "xbrltype": "domainItemType" }, "igen_CrownBridgePartnersLLCMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Crown Bridge Partners, LLC [Member]" } } }, "localname": "CrownBridgePartnersLLCMember", "nsuri": "http://igen.com/20221231", "presentation": [ "http://igen.com/role/ConvertibleDebenturesAndNotesPayableDetailsNarrative" ], "xbrltype": "domainItemType" }, "igen_DebtConversionConvertedInstrumentAccruedInterest": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The value of the financial instrument(s) that the original debt is being converted into in a noncash (or part noncash) transaction. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.", "label": "Debt conversion, converted instrument, accrued interest" } } }, "localname": "DebtConversionConvertedInstrumentAccruedInterest", "nsuri": "http://igen.com/20221231", "presentation": [ "http://igen.com/role/RelatedPartyTransactionsDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "igen_DecemberFourteenTwentyTwentyTwoMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "December 14, 2022 [Member]" } } }, "localname": "DecemberFourteenTwentyTwentyTwoMember", "nsuri": "http://igen.com/20221231", "presentation": [ "http://igen.com/role/RedeemablePreferredStockAndStockholdersDeficitDetailsNarrative" ], "xbrltype": "domainItemType" }, "igen_DecemberTwentySevenTwentyTwentyOneMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "December 27, 2021 [Member]" } } }, "localname": "DecemberTwentySevenTwentyTwentyOneMember", "nsuri": "http://igen.com/20221231", "presentation": [ "http://igen.com/role/RedeemablePreferredStockAndStockholdersDeficitDetailsNarrative" ], "xbrltype": "domainItemType" }, "igen_DeemedDividend": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Deemed dividend" } } }, "localname": "DeemedDividend", "nsuri": "http://igen.com/20221231", "presentation": [ "http://igen.com/role/RedeemablePreferredStockAndStockholdersDeficitDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "igen_DeemedDividendsOnPreferredStockExcludingConversions": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Deemed dividends on preferred stock (excluding conversions)" } } }, "localname": "DeemedDividendsOnPreferredStockExcludingConversions", "nsuri": "http://igen.com/20221231", "presentation": [ "http://igen.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "igen_DeferredRevenuesOutstandingMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Deferred revenues outstanding [Member]" } } }, "localname": "DeferredRevenuesOutstandingMember", "nsuri": "http://igen.com/20221231", "presentation": [ "http://igen.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "domainItemType" }, "igen_DerecognitionOfNotesPayableAndAccruedInterest": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Derecognition of notes payable and accrued interest" } } }, "localname": "DerecognitionOfNotesPayableAndAccruedInterest", "nsuri": "http://igen.com/20221231", "presentation": [ "http://igen.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "igen_DerivativeCurrentLiabilities": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "[Derivative liabilities]", "verboseLabel": "Derivative liabilities" } } }, "localname": "DerivativeCurrentLiabilities", "nsuri": "http://igen.com/20221231", "presentation": [ "http://igen.com/role/DerivativeLiabilitiesDetails1" ], "xbrltype": "monetaryItemType" }, "igen_DerivativeLiabilities1": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "[Derivative liabilities 1]", "verboseLabel": "Derivative liabilities" } } }, "localname": "DerivativeLiabilities1", "nsuri": "http://igen.com/20221231", "presentation": [ "http://igen.com/role/RedeemablePreferredStockAndStockholdersDeficitDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "igen_DerivativeLiabilitiesRecordedUponIssuanceOfConvertibleDebt": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Derivative liabilities recorded upon issuance of debt instrument" } } }, "localname": "DerivativeLiabilitiesRecordedUponIssuanceOfConvertibleDebt", "nsuri": "http://igen.com/20221231", "presentation": [ "http://igen.com/role/DerivativeLiabilitiesDetails2" ], "xbrltype": "monetaryItemType" }, "igen_DerivativeLiabilitiesRecordedUponIssuanceOfPreferredStock": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Derivative liabilities recorded upon issuance of preferred stock" } } }, "localname": "DerivativeLiabilitiesRecordedUponIssuanceOfPreferredStock", "nsuri": "http://igen.com/20221231", "presentation": [ "http://igen.com/role/DerivativeLiabilitiesDetails2" ], "xbrltype": "monetaryItemType" }, "igen_DiscountRelatedToIssuanceOfPreferredStock": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Discount related to issuance of preferred stock" } } }, "localname": "DiscountRelatedToIssuanceOfPreferredStock", "nsuri": "http://igen.com/20221231", "presentation": [ "http://igen.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "igen_DividendPercentageIncreased": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Dividend, percentage increased" } } }, "localname": "DividendPercentageIncreased", "nsuri": "http://igen.com/20221231", "presentation": [ "http://igen.com/role/RedeemablePreferredStockAndStockholdersDeficitDetailsNarrative" ], "xbrltype": "percentItemType" }, "igen_EarningsPerShareBasicAndDiluted1": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Basic and Diluted Loss per Common Share" } } }, "localname": "EarningsPerShareBasicAndDiluted1", "nsuri": "http://igen.com/20221231", "presentation": [ "http://igen.com/role/ConsolidatedStatementsOfOperations" ], "xbrltype": "perShareItemType" }, "igen_EmbeddedConversionFeatureConvertibleDebt": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "Embedded conversion feature - convertible debt" } } }, "localname": "EmbeddedConversionFeatureConvertibleDebt", "nsuri": "http://igen.com/20221231", "presentation": [ "http://igen.com/role/DerivativeLiabilitiesDetails1" ], "xbrltype": "monetaryItemType" }, "igen_EmbeddedConversionFeaturePreferredStock": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "Embedded conversion feature - preferred stock" } } }, "localname": "EmbeddedConversionFeaturePreferredStock", "nsuri": "http://igen.com/20221231", "presentation": [ "http://igen.com/role/DerivativeLiabilitiesDetails1" ], "xbrltype": "monetaryItemType" }, "igen_EmbeddedConversionFeaturesBeginningBalance": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "[Balances, as of the beginning of the year]", "verboseLabel": "Balances, as of the beginning of the year" } } }, "localname": "EmbeddedConversionFeaturesBeginningBalance", "nsuri": "http://igen.com/20221231", "presentation": [ "http://igen.com/role/DerivativeLiabilitiesDetails2" ], "xbrltype": "monetaryItemType" }, "igen_EmbeddedConversionFeaturesConvertibleDebtAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Embedded Conversion Features - Debt Instrument" } } }, "localname": "EmbeddedConversionFeaturesConvertibleDebtAbstract", "nsuri": "http://igen.com/20221231", "presentation": [ "http://igen.com/role/DerivativeLiabilitiesDetails2" ], "xbrltype": "stringItemType" }, "igen_EmbeddedConversionFeaturesEndingBalance": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "[Ending balance]", "verboseLabel": "Ending balance" } } }, "localname": "EmbeddedConversionFeaturesEndingBalance", "nsuri": "http://igen.com/20221231", "presentation": [ "http://igen.com/role/DerivativeLiabilitiesDetails2" ], "xbrltype": "monetaryItemType" }, "igen_EmbeddedConversionFeaturesPreferredStockAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Embedded Conversion Features - Preferred Stock" } } }, "localname": "EmbeddedConversionFeaturesPreferredStockAbstract", "nsuri": "http://igen.com/20221231", "presentation": [ "http://igen.com/role/DerivativeLiabilitiesDetails2" ], "xbrltype": "stringItemType" }, "igen_EndingBalanceConvertibleDebt": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "Ending balance" } } }, "localname": "EndingBalanceConvertibleDebt", "nsuri": "http://igen.com/20221231", "presentation": [ "http://igen.com/role/DerivativeLiabilitiesDetails2" ], "xbrltype": "monetaryItemType" }, "igen_FairValueAssetsMeasuredOnRecurringBasisChangeInRealizedGainLoss": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Net changes in fair value included in net loss" } } }, "localname": "FairValueAssetsMeasuredOnRecurringBasisChangeInRealizedGainLoss", "nsuri": "http://igen.com/20221231", "presentation": [ "http://igen.com/role/DerivativeLiabilitiesDetails2" ], "xbrltype": "monetaryItemType" }, "igen_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisChangeInRealizedGainLoss": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Derecognition of derivative liabilities" } } }, "localname": "FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisChangeInRealizedGainLoss", "nsuri": "http://igen.com/20221231", "presentation": [ "http://igen.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "igen_FebruaryOneTwentyTwentyOneMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "February 1 2021 [Member]" } } }, "localname": "FebruaryOneTwentyTwentyOneMember", "nsuri": "http://igen.com/20221231", "presentation": [ "http://igen.com/role/RedeemablePreferredStockAndStockholdersDeficitDetailsNarrative" ], "xbrltype": "domainItemType" }, "igen_FebruaryTwoTwentyTwentyTwoMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "February 2, 2022 [Member]" } } }, "localname": "FebruaryTwoTwentyTwentyTwoMember", "nsuri": "http://igen.com/20221231", "presentation": [ "http://igen.com/role/RedeemablePreferredStockAndStockholdersDeficitDetailsNarrative" ], "xbrltype": "domainItemType" }, "igen_FederalAndStateMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Federal and State [Member]" } } }, "localname": "FederalAndStateMember", "nsuri": "http://igen.com/20221231", "presentation": [ "http://igen.com/role/IncomeTaxesDetails3" ], "xbrltype": "domainItemType" }, "igen_FinancingCostsAndDebtDiscountPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Financing Costs and Debt Discount" } } }, "localname": "FinancingCostsAndDebtDiscountPolicyTextBlock", "nsuri": "http://igen.com/20221231", "presentation": [ "http://igen.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "igen_FirstTranchePrincipalAmount": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "First tranche, principal amount" } } }, "localname": "FirstTranchePrincipalAmount", "nsuri": "http://igen.com/20221231", "presentation": [ "http://igen.com/role/ConvertibleDebenturesAndNotesPayableDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "igen_HolderMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Holder [Member]", "verboseLabel": "Holder [Member]" } } }, "localname": "HolderMember", "nsuri": "http://igen.com/20221231", "presentation": [ "http://igen.com/role/ConvertibleDebenturesAndNotesPayableDetailsNarrative", "http://igen.com/role/RedeemablePreferredStockAndStockholdersDeficitDetailsNarrative" ], "xbrltype": "domainItemType" }, "igen_ImpactOfDifferenceRelatedToForeignEarnings": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Impact of difference related to foreign earnings" } } }, "localname": "ImpactOfDifferenceRelatedToForeignEarnings", "nsuri": "http://igen.com/20221231", "presentation": [ "http://igen.com/role/IncomeTaxesDetails1" ], "xbrltype": "monetaryItemType" }, "igen_IncentiveStockOptions": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "Incentive stock options" } } }, "localname": "IncentiveStockOptions", "nsuri": "http://igen.com/20221231", "presentation": [ "http://igen.com/role/IncomeTaxesDetails1" ], "xbrltype": "monetaryItemType" }, "igen_InterestChargeForDerivativeLiabilitiesInExcessOfFaceAmountOfDebt": { "auth_ref": [], "calculation": { "http://igen.com/role/ConsolidatedStatementsOfCashFlows": { "order": 4.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "label": "Interest charge for derivative liabilities in excess of face amount of debt" } } }, "localname": "InterestChargeForDerivativeLiabilitiesInExcessOfFaceAmountOfDebt", "nsuri": "http://igen.com/20221231", "presentation": [ "http://igen.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "igen_IssuanceOfCommonSharesForCommitmentFeeOnEquityLine": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Issuance of common shares for commitment fee on equity line" } } }, "localname": "IssuanceOfCommonSharesForCommitmentFeeOnEquityLine", "nsuri": "http://igen.com/20221231", "presentation": [ "http://igen.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "igen_IssuanceOfCommonStockForCommitmentFeeOnEquityLineAmount": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Issuance of common stock for commitment fee on equity line, amount" } } }, "localname": "IssuanceOfCommonStockForCommitmentFeeOnEquityLineAmount", "nsuri": "http://igen.com/20221231", "presentation": [ "http://igen.com/role/ConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholdersDeficit" ], "xbrltype": "monetaryItemType" }, "igen_IssuanceOfCommonStockForCommitmentFeeOnEquityLineShares": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Issuance of common stock for commitment fee on equity line, shares" } } }, "localname": "IssuanceOfCommonStockForCommitmentFeeOnEquityLineShares", "nsuri": "http://igen.com/20221231", "presentation": [ "http://igen.com/role/ConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholdersDeficit" ], "xbrltype": "sharesItemType" }, "igen_IssuanceOfCommonStockForConversionOfPayablesAmount": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "Issuance of common stock for conversion of payables, amount" } } }, "localname": "IssuanceOfCommonStockForConversionOfPayablesAmount", "nsuri": "http://igen.com/20221231", "presentation": [ "http://igen.com/role/ConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholdersDeficit" ], "xbrltype": "monetaryItemType" }, "igen_IssuanceOfCommonStockForConversionOfPayablesShares": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Issuance of common stock for conversion of payables, shares" } } }, "localname": "IssuanceOfCommonStockForConversionOfPayablesShares", "nsuri": "http://igen.com/20221231", "presentation": [ "http://igen.com/role/ConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholdersDeficit" ], "xbrltype": "sharesItemType" }, "igen_IssuanceOfCommonStockForLoanExtensionAmount": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "Issuance of common stock for loan extension, amount" } } }, "localname": "IssuanceOfCommonStockForLoanExtensionAmount", "nsuri": "http://igen.com/20221231", "presentation": [ "http://igen.com/role/ConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholdersDeficit" ], "xbrltype": "monetaryItemType" }, "igen_IssuanceOfCommonStockForLoanExtensionShares": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Issuance of common stock for loan extension, shares" } } }, "localname": "IssuanceOfCommonStockForLoanExtensionShares", "nsuri": "http://igen.com/20221231", "presentation": [ "http://igen.com/role/ConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholdersDeficit" ], "xbrltype": "sharesItemType" }, "igen_IssuanceOfSeriesBPreferredStockAmount": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Issuance of Series B preferred stock, amount" } } }, "localname": "IssuanceOfSeriesBPreferredStockAmount", "nsuri": "http://igen.com/20221231", "presentation": [ "http://igen.com/role/ConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholdersDeficit" ], "xbrltype": "monetaryItemType" }, "igen_IssuanceOfSeriesBPreferredStockShares": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Issuance of Series B preferred stock, shares" } } }, "localname": "IssuanceOfSeriesBPreferredStockShares", "nsuri": "http://igen.com/20221231", "presentation": [ "http://igen.com/role/ConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholdersDeficit" ], "xbrltype": "sharesItemType" }, "igen_IssuanceOfSharesForCashNetOfCommitmentFeesAmount": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "Issuance of shares for cash, net of commitment fees, amount" } } }, "localname": "IssuanceOfSharesForCashNetOfCommitmentFeesAmount", "nsuri": "http://igen.com/20221231", "presentation": [ "http://igen.com/role/ConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholdersDeficit" ], "xbrltype": "monetaryItemType" }, "igen_IssuanceOfSharesForCashNetOfCommitmentFeesShares": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Issuance of shares for cash, net of commitment fees, shares" } } }, "localname": "IssuanceOfSharesForCashNetOfCommitmentFeesShares", "nsuri": "http://igen.com/20221231", "presentation": [ "http://igen.com/role/ConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholdersDeficit" ], "xbrltype": "sharesItemType" }, "igen_IssuanceOfSharesForServicesAmount": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "Issuance of shares for services, amount" } } }, "localname": "IssuanceOfSharesForServicesAmount", "nsuri": "http://igen.com/20221231", "presentation": [ "http://igen.com/role/ConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholdersDeficit" ], "xbrltype": "monetaryItemType" }, "igen_IssuanceOfSharesForServicesShares": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Issuance of shares for services, shares" } } }, "localname": "IssuanceOfSharesForServicesShares", "nsuri": "http://igen.com/20221231", "presentation": [ "http://igen.com/role/ConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholdersDeficit" ], "xbrltype": "sharesItemType" }, "igen_IssuanceOfSharesOfCommonStock": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Issuance of shares of common stock" } } }, "localname": "IssuanceOfSharesOfCommonStock", "nsuri": "http://igen.com/20221231", "presentation": [ "http://igen.com/role/SharePurchaseWarrantsDetailsNarrative" ], "xbrltype": "sharesItemType" }, "igen_IssuanceOfSharesToDirectorsAmount": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "Issuance of shares to directors, amount" } } }, "localname": "IssuanceOfSharesToDirectorsAmount", "nsuri": "http://igen.com/20221231", "presentation": [ "http://igen.com/role/ConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholdersDeficit" ], "xbrltype": "monetaryItemType" }, "igen_IssuanceOfSharesToDirectorsShares": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Issuance of shares to directors, shares" } } }, "localname": "IssuanceOfSharesToDirectorsShares", "nsuri": "http://igen.com/20221231", "presentation": [ "http://igen.com/role/ConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholdersDeficit" ], "xbrltype": "sharesItemType" }, "igen_IssuedSharesForTheCashlessExerciseOfWarrants": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Issued shares for the cashless exercise of warrants" } } }, "localname": "IssuedSharesForTheCashlessExerciseOfWarrants", "nsuri": "http://igen.com/20221231", "presentation": [ "http://igen.com/role/RedeemablePreferredStockAndStockholdersDeficitDetailsNarrative" ], "xbrltype": "sharesItemType" }, "igen_JuneSeventeenTwentyTwentyOneMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "June 17 2021 [Member]" } } }, "localname": "JuneSeventeenTwentyTwentyOneMember", "nsuri": "http://igen.com/20221231", "presentation": [ "http://igen.com/role/RedeemablePreferredStockAndStockholdersDeficitDetailsNarrative" ], "xbrltype": "domainItemType" }, "igen_LeaseLiabilityCurrentPortion": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Lease liability, current portion" } } }, "localname": "LeaseLiabilityCurrentPortion", "nsuri": "http://igen.com/20221231", "presentation": [ "http://igen.com/role/AccountsPayableAndAccruedLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "igen_LessCurrentPortionOfOperatingLeaseLiability": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "[Less current portion of operating lease liability]", "negatedLabel": "Less current portion of operating lease liability" } } }, "localname": "LessCurrentPortionOfOperatingLeaseLiability", "nsuri": "http://igen.com/20221231", "presentation": [ "http://igen.com/role/CommitmentsAndContingenciesDetails2" ], "xbrltype": "monetaryItemType" }, "igen_LiquidationPreferenceDescription": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Liquidation preference, description" } } }, "localname": "LiquidationPreferenceDescription", "nsuri": "http://igen.com/20221231", "presentation": [ "http://igen.com/role/RedeemablePreferredStockAndStockholdersDeficitDetailsNarrative" ], "xbrltype": "stringItemType" }, "igen_MarchOneTwentyTwentyOneMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "March 1 2021 [Member]" } } }, "localname": "MarchOneTwentyTwentyOneMember", "nsuri": "http://igen.com/20221231", "presentation": [ "http://igen.com/role/RedeemablePreferredStockAndStockholdersDeficitDetailsNarrative" ], "xbrltype": "domainItemType" }, "igen_MarchTwentyFourTwentyTwentyTwoMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "March 24, 2022 [Member]" } } }, "localname": "MarchTwentyFourTwentyTwentyTwoMember", "nsuri": "http://igen.com/20221231", "presentation": [ "http://igen.com/role/RedeemablePreferredStockAndStockholdersDeficitDetailsNarrative" ], "xbrltype": "domainItemType" }, "igen_MayTwentyTwentyTwentyTwoMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "May 20, 2022 [Member]" } } }, "localname": "MayTwentyTwentyTwentyTwoMember", "nsuri": "http://igen.com/20221231", "presentation": [ "http://igen.com/role/RedeemablePreferredStockAndStockholdersDeficitDetailsNarrative" ], "xbrltype": "domainItemType" }, "igen_MonthlyPrincipalAndInterestPayments": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "Monthly principal and interest payments" } } }, "localname": "MonthlyPrincipalAndInterestPayments", "nsuri": "http://igen.com/20221231", "presentation": [ "http://igen.com/role/ConvertibleDebenturesAndNotesPayableDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "igen_NetChangesInFairValueIncludedInNetLoss": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "[Net changes in fair value included in net loss]", "verboseLabel": "Net changes in fair value included in net loss" } } }, "localname": "NetChangesInFairValueIncludedInNetLoss", "nsuri": "http://igen.com/20221231", "presentation": [ "http://igen.com/role/DerivativeLiabilitiesDetails2" ], "xbrltype": "monetaryItemType" }, "igen_NonCurrentOperatingLeaseLiability": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Non-current operating lease liability" } } }, "localname": "NonCurrentOperatingLeaseLiability", "nsuri": "http://igen.com/20221231", "presentation": [ "http://igen.com/role/CommitmentsAndContingenciesDetails2" ], "xbrltype": "monetaryItemType" }, "igen_NotesPayableMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Notes Payable [Member]" } } }, "localname": "NotesPayableMember", "nsuri": "http://igen.com/20221231", "presentation": [ "http://igen.com/role/ConvertibleDebenturesAndNotesPayableDetails" ], "xbrltype": "domainItemType" }, "igen_NovemberTwoTwentyTwentyTwoMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "November 2, 2022 [Member]" } } }, "localname": "NovemberTwoTwentyTwentyTwoMember", "nsuri": "http://igen.com/20221231", "presentation": [ "http://igen.com/role/RedeemablePreferredStockAndStockholdersDeficitDetailsNarrative" ], "xbrltype": "domainItemType" }, "igen_NumberOfSharesSoldCommonStock": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Number of shares sold common stock" } } }, "localname": "NumberOfSharesSoldCommonStock", "nsuri": "http://igen.com/20221231", "presentation": [ "http://igen.com/role/RedeemablePreferredStockAndStockholdersDeficitDetailsNarrative" ], "xbrltype": "sharesItemType" }, "igen_NumberOfWarrantsAdjustedForTriggeredDownRoundProvisions": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Number of warrants, Adjusted for triggered down-round provisions" } } }, "localname": "NumberOfWarrantsAdjustedForTriggeredDownRoundProvisions", "nsuri": "http://igen.com/20221231", "presentation": [ "http://igen.com/role/SharePurchaseWarrantsDetails" ], "xbrltype": "sharesItemType" }, "igen_ObligationInAccountsPayableAndLiabilities": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Obligation in accounts payable and liabilities" } } }, "localname": "ObligationInAccountsPayableAndLiabilities", "nsuri": "http://igen.com/20221231", "presentation": [ "http://igen.com/role/CommitmentsAndContingenciesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "igen_OperatingCashFlowsFromOperatingLease": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Operating cash flows from operating lease" } } }, "localname": "OperatingCashFlowsFromOperatingLease", "nsuri": "http://igen.com/20221231", "presentation": [ "http://igen.com/role/CommitmentsAndContingenciesDetails1" ], "xbrltype": "monetaryItemType" }, "igen_OperatingLeaseAssetObtainedInExchangeForLeaseLiabilityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Operating lease asset obtained in exchange for lease liability:" } } }, "localname": "OperatingLeaseAssetObtainedInExchangeForLeaseLiabilityAbstract", "nsuri": "http://igen.com/20221231", "presentation": [ "http://igen.com/role/CommitmentsAndContingenciesDetails1" ], "xbrltype": "stringItemType" }, "igen_OptionsExercisableWeightedAverageExercisePrice": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Options Exercisable, Weighted average exercise price" } } }, "localname": "OptionsExercisableWeightedAverageExercisePrice", "nsuri": "http://igen.com/20221231", "presentation": [ "http://igen.com/role/StockOptionsDetails1" ], "xbrltype": "perShareItemType" }, "igen_OptionsOneMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Options 0.04 [Member]" } } }, "localname": "OptionsOneMember", "nsuri": "http://igen.com/20221231", "presentation": [ "http://igen.com/role/StockOptionsDetails1" ], "xbrltype": "domainItemType" }, "igen_OutstandingNote": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Outstanding note" } } }, "localname": "OutstandingNote", "nsuri": "http://igen.com/20221231", "presentation": [ "http://igen.com/role/ConvertibleDebenturesAndNotesPayableDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "igen_PPPLoanMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "PPP Loan [Member]" } } }, "localname": "PPPLoanMember", "nsuri": "http://igen.com/20221231", "presentation": [ "http://igen.com/role/ConvertibleDebenturesAndNotesPayableDetailsNarrative" ], "xbrltype": "domainItemType" }, "igen_PotentiallyDilutiveSharesOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Potentially dilutive shares outstanding" } } }, "localname": "PotentiallyDilutiveSharesOutstanding", "nsuri": "http://igen.com/20221231", "presentation": [ "http://igen.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "sharesItemType" }, "igen_PreferredStockSharesConvertedIntoCommonStock": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Preferred stock, shares converted into common stock" } } }, "localname": "PreferredStockSharesConvertedIntoCommonStock", "nsuri": "http://igen.com/20221231", "presentation": [ "http://igen.com/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "sharesItemType" }, "igen_ProceedsAmount": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Proceeds amount" } } }, "localname": "ProceedsAmount", "nsuri": "http://igen.com/20221231", "presentation": [ "http://igen.com/role/RedeemablePreferredStockAndStockholdersDeficitDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "igen_ProceedsFromIssuanceOfStock": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Proceeds from issuance of stock" } } }, "localname": "ProceedsFromIssuanceOfStock", "nsuri": "http://igen.com/20221231", "presentation": [ "http://igen.com/role/RedeemablePreferredStockAndStockholdersDeficitDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "igen_ProceedsFromNotesPayables": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "[Proceeds from notes payable]", "verboseLabel": "Proceeds from notes payable" } } }, "localname": "ProceedsFromNotesPayables", "nsuri": "http://igen.com/20221231", "presentation": [ "http://igen.com/role/ConvertibleDebenturesAndNotesPayableDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "igen_ProceedsFromRepaymentsOfRestrictedCashFinancingActivities1": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "Cash Proceeds" } } }, "localname": "ProceedsFromRepaymentsOfRestrictedCashFinancingActivities1", "nsuri": "http://igen.com/20221231", "presentation": [ "http://igen.com/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "igen_PromissoryNoteMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Promissory Note [Member]" } } }, "localname": "PromissoryNoteMember", "nsuri": "http://igen.com/20221231", "presentation": [ "http://igen.com/role/ConvertibleDebenturesAndNotesPayableDetailsNarrative" ], "xbrltype": "domainItemType" }, "igen_ProvisionForIncomeTaxes": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "[Provision for Income Taxes]", "verboseLabel": "Provision for Income Taxes" } } }, "localname": "ProvisionForIncomeTaxes", "nsuri": "http://igen.com/20221231", "presentation": [ "http://igen.com/role/IncomeTaxesDetails" ], "xbrltype": "monetaryItemType" }, "igen_ReclassificationOfSecurityDepositToAccountsPayable": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Reclassification of security deposit to accounts payable" } } }, "localname": "ReclassificationOfSecurityDepositToAccountsPayable", "nsuri": "http://igen.com/20221231", "presentation": [ "http://igen.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "igen_ReconciliationOfIncomeTaxesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Reconciliation of income taxes [Member]" } } }, "localname": "ReconciliationOfIncomeTaxesMember", "nsuri": "http://igen.com/20221231", "presentation": [ "http://igen.com/role/IncomeTaxesDetails1" ], "xbrltype": "domainItemType" }, "igen_RedeemableConvertiblePreferredStockSeriesAAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Redeemable convertible preferred stock - Series A:" } } }, "localname": "RedeemableConvertiblePreferredStockSeriesAAbstract", "nsuri": "http://igen.com/20221231", "presentation": [ "http://igen.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "stringItemType" }, "igen_RedeemableConvertiblePreferredStocksSeriesAMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Redeemable Convertible Preferred Stock Series A [Member]" } } }, "localname": "RedeemableConvertiblePreferredStocksSeriesAMember", "nsuri": "http://igen.com/20221231", "presentation": [ "http://igen.com/role/ConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholdersDeficit" ], "xbrltype": "domainItemType" }, "igen_ReductionInDebtDiscount": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "Reduction in debt discount" } } }, "localname": "ReductionInDebtDiscount", "nsuri": "http://igen.com/20221231", "presentation": [ "http://igen.com/role/ConvertibleDebenturesAndNotesPayableDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "igen_RemainingLeaseTermOperatingLease": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Remaining lease term Operating lease" } } }, "localname": "RemainingLeaseTermOperatingLease", "nsuri": "http://igen.com/20221231", "presentation": [ "http://igen.com/role/CommitmentsAndContingenciesDetails1" ], "xbrltype": "stringItemType" }, "igen_RepurchaseOfSeriesBPreferredStockAmount": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "Repurchase of Series B Preferred Stock, amount" } } }, "localname": "RepurchaseOfSeriesBPreferredStockAmount", "nsuri": "http://igen.com/20221231", "presentation": [ "http://igen.com/role/ConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholdersDeficit" ], "xbrltype": "monetaryItemType" }, "igen_RepurchaseOfSeriesBPreferredStockShares": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Repurchase of Series B Preferred Stock, shares" } } }, "localname": "RepurchaseOfSeriesBPreferredStockShares", "nsuri": "http://igen.com/20221231", "presentation": [ "http://igen.com/role/ConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholdersDeficit" ], "xbrltype": "sharesItemType" }, "igen_RepurchaseShare": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Repurchased share" } } }, "localname": "RepurchaseShare", "nsuri": "http://igen.com/20221231", "presentation": [ "http://igen.com/role/RedeemablePreferredStockAndStockholdersDeficitDetailsNarrative" ], "xbrltype": "sharesItemType" }, "igen_RepurchaseSharePrice": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Repurchase share price" } } }, "localname": "RepurchaseSharePrice", "nsuri": "http://igen.com/20221231", "presentation": [ "http://igen.com/role/RedeemablePreferredStockAndStockholdersDeficitDetailsNarrative" ], "xbrltype": "perShareItemType" }, "igen_RightOfUseAsset": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "Right of use asset" } } }, "localname": "RightOfUseAsset", "nsuri": "http://igen.com/20221231", "presentation": [ "http://igen.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "igen_RightsAndPrivilegesOfTheSeriesAPreferredStockMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Rights and Privileges of the Series A Preferred Stock [Member]" } } }, "localname": "RightsAndPrivilegesOfTheSeriesAPreferredStockMember", "nsuri": "http://igen.com/20221231", "presentation": [ "http://igen.com/role/RedeemablePreferredStockAndStockholdersDeficitDetailsNarrative" ], "xbrltype": "domainItemType" }, "igen_RiskAndUncertainitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Risk and Uncertainities" } } }, "localname": "RiskAndUncertainitiesAbstract", "nsuri": "http://igen.com/20221231", "xbrltype": "stringItemType" }, "igen_SBALoansMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "SBA Loans [Member]" } } }, "localname": "SBALoansMember", "nsuri": "http://igen.com/20221231", "presentation": [ "http://igen.com/role/ConvertibleDebenturesAndNotesPayableDetailsNarrative" ], "xbrltype": "domainItemType" }, "igen_SaleRevenueNetMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Sales Revenue, Net [Member]" } } }, "localname": "SaleRevenueNetMember", "nsuri": "http://igen.com/20221231", "presentation": [ "http://igen.com/role/RisksUncertaintiesDetailsNarrative" ], "xbrltype": "domainItemType" }, "igen_SalesServices": { "auth_ref": [], "calculation": { "http://igen.com/role/ConsolidatedStatementsOfOperations": { "order": 2.0, "parentTag": "us-gaap_Revenues", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "label": "Sales, services" } } }, "localname": "SalesServices", "nsuri": "http://igen.com/20221231", "presentation": [ "http://igen.com/role/ConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "igen_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeaseTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Schedule Future Payments Under Non Cancelable Operating Leases" } } }, "localname": "ScheduleOfFutureMinimumRentalPaymentsForOperatingLeaseTableTextBlock", "nsuri": "http://igen.com/20221231", "presentation": [ "http://igen.com/role/CommitmentsAndContingenciesTables" ], "xbrltype": "textBlockItemType" }, "igen_ScheduleOfOtherInformatoinRelatedToOpeartingLeasetabletextblock": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Schedule of Other Informatoin Related to Opearting Lease" } } }, "localname": "ScheduleOfOtherInformatoinRelatedToOpeartingLeasetabletextblock", "nsuri": "http://igen.com/20221231", "presentation": [ "http://igen.com/role/CommitmentsAndContingenciesTables" ], "xbrltype": "textBlockItemType" }, "igen_ScheduleOfSharePurchaseWarrantsOutstandingTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Schedule of Share Purchase Warrants Outstanding" } } }, "localname": "ScheduleOfSharePurchaseWarrantsOutstandingTableTextBlock", "nsuri": "http://igen.com/20221231", "presentation": [ "http://igen.com/role/SharePurchaseWarrantsTables" ], "xbrltype": "textBlockItemType" }, "igen_SecuritiesPurchaseAgreementMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Securities Purchase Agreement [Member]" } } }, "localname": "SecuritiesPurchaseAgreementMember", "nsuri": "http://igen.com/20221231", "presentation": [ "http://igen.com/role/ConvertibleDebenturesAndNotesPayableDetailsNarrative" ], "xbrltype": "domainItemType" }, "igen_SeptemberThirteenTwentyTwentyOneMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "September 13, 2021 [Member]" } } }, "localname": "SeptemberThirteenTwentyTwentyOneMember", "nsuri": "http://igen.com/20221231", "presentation": [ "http://igen.com/role/RedeemablePreferredStockAndStockholdersDeficitDetailsNarrative" ], "xbrltype": "domainItemType" }, "igen_SeptemberTwentySixTwentyTwentyTwoMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "September 26, 2022 [Member]" } } }, "localname": "SeptemberTwentySixTwentyTwentyTwoMember", "nsuri": "http://igen.com/20221231", "presentation": [ "http://igen.com/role/RedeemablePreferredStockAndStockholdersDeficitDetailsNarrative" ], "xbrltype": "domainItemType" }, "igen_SeriesAConvertiblePreferredStockMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Series A Convertible Preferred Stock [Member]" } } }, "localname": "SeriesAConvertiblePreferredStockMember", "nsuri": "http://igen.com/20221231", "presentation": [ "http://igen.com/role/RedeemablePreferredStockAndStockholdersDeficitDetailsNarrative" ], "xbrltype": "domainItemType" }, "igen_SeriesAPreferredSharesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Series A Preferred shares [Member]" } } }, "localname": "SeriesAPreferredSharesMember", "nsuri": "http://igen.com/20221231", "presentation": [ "http://igen.com/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "domainItemType" }, "igen_SeriesAPreferredStockPurchaseAgreementsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Series A Preferred Stock Purchase Agreements [Member]" } } }, "localname": "SeriesAPreferredStockPurchaseAgreementsMember", "nsuri": "http://igen.com/20221231", "presentation": [ "http://igen.com/role/RedeemablePreferredStockAndStockholdersDeficitDetailsNarrative" ], "xbrltype": "domainItemType" }, "igen_SeriesBPreferredStocksMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Series B Preferred Stocks [Member]" } } }, "localname": "SeriesBPreferredStocksMember", "nsuri": "http://igen.com/20221231", "presentation": [ "http://igen.com/role/ConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholdersDeficit" ], "xbrltype": "domainItemType" }, "igen_SeriesBSuperVotingPreferredStockMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Series B Super Voting Preferred Stock [Member]" } } }, "localname": "SeriesBSuperVotingPreferredStockMember", "nsuri": "http://igen.com/20221231", "presentation": [ "http://igen.com/role/RedeemablePreferredStockAndStockholdersDeficitDetailsNarrative" ], "xbrltype": "domainItemType" }, "igen_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisePrice": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Range of exercise prices" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisePrice", "nsuri": "http://igen.com/20221231", "presentation": [ "http://igen.com/role/StockOptionsDetails1" ], "xbrltype": "perShareItemType" }, "igen_SharePurchaseWarrantDisclosureTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "[Share Purchase Warrants]", "verboseLabel": "Share Purchase Warrants" } } }, "localname": "SharePurchaseWarrantDisclosureTextBlock", "nsuri": "http://igen.com/20221231", "presentation": [ "http://igen.com/role/SharePurchaseWarrants" ], "xbrltype": "textBlockItemType" }, "igen_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsUnvestedNumberOfShares": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Number of options, Unvested" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsUnvestedNumberOfShares", "nsuri": "http://igen.com/20221231", "presentation": [ "http://igen.com/role/StockOptionsDetails" ], "xbrltype": "sharesItemType" }, "igen_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsUnvestedWeightedAverageGrantDateFairValue": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Weighted average exercise price, Unvested" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsUnvestedWeightedAverageGrantDateFairValue", "nsuri": "http://igen.com/20221231", "presentation": [ "http://igen.com/role/StockOptionsDetails" ], "xbrltype": "perShareItemType" }, "igen_SharesIssuedForCashShares": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Shares issued for cash, shares" } } }, "localname": "SharesIssuedForCashShares", "nsuri": "http://igen.com/20221231", "presentation": [ "http://igen.com/role/RedeemablePreferredStockAndStockholdersDeficitDetailsNarrative" ], "xbrltype": "sharesItemType" }, "igen_SharesIssuedShares": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Shares issued, shares" } } }, "localname": "SharesIssuedShares", "nsuri": "http://igen.com/20221231", "presentation": [ "http://igen.com/role/RedeemablePreferredStockAndStockholdersDeficitDetailsNarrative" ], "xbrltype": "sharesItemType" }, "igen_SharesOfCommonStockCashlessExerciseOfWarrants": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Shares of common stock cashless exercise of warrants" } } }, "localname": "SharesOfCommonStockCashlessExerciseOfWarrants", "nsuri": "http://igen.com/20221231", "presentation": [ "http://igen.com/role/RedeemablePreferredStockAndStockholdersDeficitDetailsNarrative" ], "xbrltype": "sharesItemType" }, "igen_SharesOfCommonStockIssuedForCashAmount": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Shares of common stock issued for cash, amount" } } }, "localname": "SharesOfCommonStockIssuedForCashAmount", "nsuri": "http://igen.com/20221231", "presentation": [ "http://igen.com/role/ConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholdersDeficit" ], "xbrltype": "monetaryItemType" }, "igen_SharesOfCommonStockIssuedForCashShares": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Shares of common stock issued for cash, shares" } } }, "localname": "SharesOfCommonStockIssuedForCashShares", "nsuri": "http://igen.com/20221231", "presentation": [ "http://igen.com/role/ConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholdersDeficit" ], "xbrltype": "sharesItemType" }, "igen_SharesOfCommonStockIssuedForExerciseOfConvertibleNoteIncludingFeesAmount": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Shares of common stock issued for exercise of convertible note, including fees, amount" } } }, "localname": "SharesOfCommonStockIssuedForExerciseOfConvertibleNoteIncludingFeesAmount", "nsuri": "http://igen.com/20221231", "presentation": [ "http://igen.com/role/ConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholdersDeficit" ], "xbrltype": "monetaryItemType" }, "igen_SharesOfCommonStockIssuedForExerciseOfConvertibleNoteIncludingFeesShares": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Shares of common stock issued for exercise of convertible note, including fees, shares" } } }, "localname": "SharesOfCommonStockIssuedForExerciseOfConvertibleNoteIncludingFeesShares", "nsuri": "http://igen.com/20221231", "presentation": [ "http://igen.com/role/ConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholdersDeficit" ], "xbrltype": "sharesItemType" }, "igen_SharesOfSeriesAPreferredStockForCashNetOfCostsAndDiscountsAmount": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Shares of Series A preferred stock for cash, net of costs and discounts, amount" } } }, "localname": "SharesOfSeriesAPreferredStockForCashNetOfCostsAndDiscountsAmount", "nsuri": "http://igen.com/20221231", "presentation": [ "http://igen.com/role/ConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholdersDeficit" ], "xbrltype": "monetaryItemType" }, "igen_SharesOfSeriesAPreferredStockForCashNetOfCostsAndDiscountsShares": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Shares of Series A preferred stock for cash, net of costs and discounts, shares" } } }, "localname": "SharesOfSeriesAPreferredStockForCashNetOfCostsAndDiscountsShares", "nsuri": "http://igen.com/20221231", "presentation": [ "http://igen.com/role/ConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholdersDeficit" ], "xbrltype": "sharesItemType" }, "igen_StateTaxes": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "State taxes" } } }, "localname": "StateTaxes", "nsuri": "http://igen.com/20221231", "presentation": [ "http://igen.com/role/IncomeTaxesDetails1" ], "xbrltype": "monetaryItemType" }, "igen_StockBasedCompensationAmount": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Stock-based compensation, amount" } } }, "localname": "StockBasedCompensationAmount", "nsuri": "http://igen.com/20221231", "presentation": [ "http://igen.com/role/ConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholdersDeficit" ], "xbrltype": "monetaryItemType" }, "igen_StockBasedCompensationShares": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Stock-based compensation, shares" } } }, "localname": "StockBasedCompensationShares", "nsuri": "http://igen.com/20221231", "presentation": [ "http://igen.com/role/ConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholdersDeficit" ], "xbrltype": "sharesItemType" }, "igen_StockOptionPlanMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Stock option plan [Member]" } } }, "localname": "StockOptionPlanMember", "nsuri": "http://igen.com/20221231", "presentation": [ "http://igen.com/role/StockOptionsDetailsNarrative" ], "xbrltype": "domainItemType" }, "igen_TenJuliMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "July 10, 2020 [Member]" } } }, "localname": "TenJuliMember", "nsuri": "http://igen.com/20221231", "presentation": [ "http://igen.com/role/ConvertibleDebenturesAndNotesPayableDetailsNarrative" ], "xbrltype": "domainItemType" }, "igen_ThreeSeparateNotesTotalPrincipal": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Three separate notes total principal" } } }, "localname": "ThreeSeparateNotesTotalPrincipal", "nsuri": "http://igen.com/20221231", "presentation": [ "http://igen.com/role/ConvertibleDebenturesAndNotesPayableDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "igen_TotalEndingBalance": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "Total ending balance" } } }, "localname": "TotalEndingBalance", "nsuri": "http://igen.com/20221231", "presentation": [ "http://igen.com/role/DerivativeLiabilitiesDetails2" ], "xbrltype": "monetaryItemType" }, "igen_UnrecognizedTaxBenefitBeginning": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "Unrecognized tax benefit, beginning" } } }, "localname": "UnrecognizedTaxBenefitBeginning", "nsuri": "http://igen.com/20221231", "presentation": [ "http://igen.com/role/IncomeTaxesDetails3" ], "xbrltype": "monetaryItemType" }, "igen_UnrecognizedTaxBenefitEnding": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "Unrecognized tax benefit, ending" } } }, "localname": "UnrecognizedTaxBenefitEnding", "nsuri": "http://igen.com/20221231", "presentation": [ "http://igen.com/role/IncomeTaxesDetails3" ], "xbrltype": "monetaryItemType" }, "igen_VPAndGeneralManagerMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "VP and General Manager [Member]" } } }, "localname": "VPAndGeneralManagerMember", "nsuri": "http://igen.com/20221231", "presentation": [ "http://igen.com/role/RelatedPartyTransactionsDetailsNarrative" ], "xbrltype": "domainItemType" }, "igen_ValuationAllowance": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "[Valuation allowance]", "verboseLabel": "Valuation allowance" } } }, "localname": "ValuationAllowance", "nsuri": "http://igen.com/20221231", "presentation": [ "http://igen.com/role/IncomeTaxesDetails2" ], "xbrltype": "monetaryItemType" }, "igen_VariableConversionPricePercentage": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Variable conversion price percentage" } } }, "localname": "VariableConversionPricePercentage", "nsuri": "http://igen.com/20221231", "presentation": [ "http://igen.com/role/ConvertibleDebenturesAndNotesPayableDetailsNarrative" ], "xbrltype": "percentItemType" }, "igen_WarrantsAt000Member": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Warrants At 0.00 [Member]" } } }, "localname": "WarrantsAt000Member", "nsuri": "http://igen.com/20221231", "presentation": [ "http://igen.com/role/SharePurchaseWarrantsDetails1" ], "xbrltype": "domainItemType" }, "igen_WarrantsAt003Member": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Warrants At 0.03 [Member]" } } }, "localname": "WarrantsAt003Member", "nsuri": "http://igen.com/20221231", "presentation": [ "http://igen.com/role/SharePurchaseWarrantsDetails1" ], "xbrltype": "domainItemType" }, "igen_WarrantsExpirationDate": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Expiry date" } } }, "localname": "WarrantsExpirationDate", "nsuri": "http://igen.com/20221231", "presentation": [ "http://igen.com/role/SharePurchaseWarrantsDetails1" ], "xbrltype": "stringItemType" }, "igen_WarrantsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Warrants [Member]", "verboseLabel": "Warrants [Member]" } } }, "localname": "WarrantsMember", "nsuri": "http://igen.com/20221231", "presentation": [ "http://igen.com/role/DerivativeLiabilitiesDetails", "http://igen.com/role/SharePurchaseWarrantsDetails", "http://igen.com/role/SharePurchaseWarrantsDetailsNarrative" ], "xbrltype": "domainItemType" }, "igen_WeeklyPayments": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Weekly payments" } } }, "localname": "WeeklyPayments", "nsuri": "http://igen.com/20221231", "presentation": [ "http://igen.com/role/ConvertibleDebenturesAndNotesPayableDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "igen_WeightedAverageExercisePriceAdjustedForTriggeredDownRoundProvisions": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Weighted average exercise price, adjusted for triggered down-round provisions" } } }, "localname": "WeightedAverageExercisePriceAdjustedForTriggeredDownRoundProvisions", "nsuri": "http://igen.com/20221231", "presentation": [ "http://igen.com/role/SharePurchaseWarrantsDetails" ], "xbrltype": "perShareItemType" }, "igen_WeightedAverageNumberOfShareOutstandingBasicAndDiluted1": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Weighted Average Number of Common Shares Outstanding" } } }, "localname": "WeightedAverageNumberOfShareOutstandingBasicAndDiluted1", "nsuri": "http://igen.com/20221231", "presentation": [ "http://igen.com/role/ConsolidatedStatementsOfOperations" ], "xbrltype": "sharesItemType" }, "igen_WorkingCapitalDeficit": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Working capital deficit" } } }, "localname": "WorkingCapitalDeficit", "nsuri": "http://igen.com/20221231", "presentation": [ "http://igen.com/role/OrganizationAndDescriptionOfBusinessDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "srt_DirectorMember": { "auth_ref": [ "r535" ], "lang": { "en-us": { "role": { "label": "Director [Member]" } } }, "localname": "DirectorMember", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://igen.com/role/RelatedPartyTransactionsDetailsNarrative" ], "xbrltype": "domainItemType" }, "srt_MaximumMember": { "auth_ref": [ "r261", "r262", "r263", "r264", "r314", "r435", "r454", "r464", "r465", "r498", "r499", "r506", "r547", "r594", "r595", "r596", "r597", "r598", "r599" ], "lang": { "en-us": { "role": { "label": "Maximum [Member]", "verboseLabel": "Maximum [Member]" } } }, "localname": "MaximumMember", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://igen.com/role/ConvertibleDebenturesAndNotesPayableDetailsNarrative", "http://igen.com/role/DerivativeLiabilitiesDetails", "http://igen.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "domainItemType" }, "srt_MinimumMember": { "auth_ref": [ "r261", "r262", "r263", "r264", "r314", "r435", "r454", "r464", "r465", "r498", "r499", "r506", "r547", "r594", "r595", "r596", "r597", "r598", "r599" ], "lang": { "en-us": { "role": { "label": "Minimum [Member]", "verboseLabel": "Minimum [Member]" } } }, "localname": "MinimumMember", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://igen.com/role/ConvertibleDebenturesAndNotesPayableDetailsNarrative", "http://igen.com/role/DerivativeLiabilitiesDetails", "http://igen.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "domainItemType" }, "srt_OfficerMember": { "auth_ref": [ "r230" ], "lang": { "en-us": { "role": { "label": "Officer [Member]" } } }, "localname": "OfficerMember", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://igen.com/role/RelatedPartyTransactionsDetailsNarrative" ], "xbrltype": "domainItemType" }, "srt_RangeAxis": { "auth_ref": [ "r261", "r262", "r263", "r264", "r311", "r314", "r325", "r326", "r327", "r411", "r435", "r454", "r464", "r465", "r498", "r499", "r506", "r543", "r547", "r595", "r596", "r597", "r598", "r599" ], "lang": { "en-us": { "role": { "label": "Range [Axis]" } } }, "localname": "RangeAxis", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://igen.com/role/ConvertibleDebenturesAndNotesPayableDetailsNarrative", "http://igen.com/role/DerivativeLiabilitiesDetails", "http://igen.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "stringItemType" }, "srt_RangeMember": { "auth_ref": [ "r261", "r262", "r263", "r264", "r311", "r314", "r325", "r326", "r327", "r411", "r435", "r454", "r464", "r465", "r498", "r499", "r506", "r543", "r547", "r595", "r596", "r597", "r598", "r599" ], "localname": "RangeMember", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://igen.com/role/ConvertibleDebenturesAndNotesPayableDetailsNarrative", "http://igen.com/role/DerivativeLiabilitiesDetails", "http://igen.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_AccountingPoliciesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Summary of Significant Accounting Policies" } } }, "localname": "AccountingPoliciesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_AccountsAndNontradeReceivableTextBlock": { "auth_ref": [ "r236", "r250" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for accounts receivable, contract receivable, receivable held-for-sale, and nontrade receivable.", "label": "Accounts and Nontrade Receivable [Text Block]", "verboseLabel": "Accounts and Other Receivables" } } }, "localname": "AccountsAndNontradeReceivableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://igen.com/role/AccountsAndOtherReceivables" ], "xbrltype": "textBlockItemType" }, "us-gaap_AccountsAndOtherReceivablesNetCurrent": { "auth_ref": [], "calculation": { "http://igen.com/role/ConsolidatedBalanceSheets": { "order": 3.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after allowance, receivable from customers, clients, or other third-parties, and receivables classified as other due within one year or the normal operating cycle, if longer.", "label": "Accounts and other receivables, net", "verboseLabel": "Accounts and other receivables" } } }, "localname": "AccountsAndOtherReceivablesNetCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://igen.com/role/AccountsAndOtherReceivablesDetails", "http://igen.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent": { "auth_ref": [ "r16" ], "calculation": { "http://igen.com/role/ConsolidatedBalanceSheets": { "order": 11.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying values as of the balance sheet date of obligations incurred through that date and due within one year (or the operating cycle, if longer), including liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received, taxes, interest, rent and utilities, accrued salaries and bonuses, payroll taxes and fringe benefits.", "label": "Accounts payable and accrued liabilities", "verboseLabel": "Accounts payable and accrued liabilities" } } }, "localname": "AccountsPayableAndAccruedLiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://igen.com/role/AccountsPayableAndAccruedLiabilitiesDetails", "http://igen.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock": { "auth_ref": [ "r14" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for accounts payable and accrued liabilities at the end of the reporting period.", "label": "Accounts Payable and Accrued Liabilities Disclosure [Text Block]", "verboseLabel": "Accounts Payable and Accrued Liabilities" } } }, "localname": "AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://igen.com/role/AccountsPayableAndAccruedLiabilities" ], "xbrltype": "textBlockItemType" }, "us-gaap_AccountsPayableCurrent": { "auth_ref": [ "r13", "r505" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Trade accounts payable" } } }, "localname": "AccountsPayableCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://igen.com/role/AccountsPayableAndAccruedLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments": { "auth_ref": [ "r41" ], "calculation": { "http://igen.com/role/ConsolidatedStatementsOfOperations": { "order": 11.0, "parentTag": "us-gaap_OtherNonoperatingIncomeExpense", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The sum of the periodic adjustments of the differences between securities' face values and purchase prices that are charged against earnings. This is called accretion if the security was purchased at a discount and amortization if it was purchased at premium. As a noncash item, this element is an adjustment to net income when calculating cash provided by or used in operations using the indirect method.", "label": "Accretion of discounts on convertible debentures" } } }, "localname": "AccretionAmortizationOfDiscountsAndPremiumsInvestments", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://igen.com/role/ConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccruedLiabilitiesCurrent": { "auth_ref": [ "r18" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Accrued liabilities" } } }, "localname": "AccruedLiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://igen.com/role/AccountsPayableAndAccruedLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdditionalPaidInCapital": { "auth_ref": [ "r8", "r505" ], "calculation": { "http://igen.com/role/ConsolidatedBalanceSheets": { "order": 19.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.", "label": "Additional paid-in capital" } } }, "localname": "AdditionalPaidInCapital", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://igen.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdditionalPaidInCapitalMember": { "auth_ref": [ "r332", "r333", "r334", "r530", "r531", "r532", "r585" ], "lang": { "en-us": { "role": { "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.", "label": "Additional Paid-In Capital" } } }, "localname": "AdditionalPaidInCapitalMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://igen.com/role/ConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholdersDeficit" ], "xbrltype": "domainItemType" }, "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Adjustments to reconcile net loss to net cash used in operating activities:" } } }, "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://igen.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_AllowanceForDoubtfulAccountsPremiumsAndOtherReceivables": { "auth_ref": [ "r536" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The valuation allowance as of the balance sheet date to reduce the gross amount of receivables to estimated net realizable value, which would be presented in parentheses on the face of the balance sheet.", "label": "Allowance for doubtful accounts" } } }, "localname": "AllowanceForDoubtfulAccountsPremiumsAndOtherReceivables", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://igen.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent": { "auth_ref": [ "r152", "r234", "r241" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of allowance for credit loss on accounts receivable, classified as current.", "label": "[Accounts Receivable, Allowance for Credit Loss, Current]", "negatedLabel": "Allowance for doubtful accounts" } } }, "localname": "AllowanceForDoubtfulAccountsReceivableCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://igen.com/role/AccountsAndOtherReceivablesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AmortizationOfDebtDiscountPremium": { "auth_ref": [ "r31", "r40", "r113", "r291" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of noncash expense included in interest expense to amortize debt discount and premium associated with the related debt instruments. Excludes amortization of financing costs. Alternate captions include noncash interest expense.", "label": "Reduction of debt discount" } } }, "localname": "AmortizationOfDebtDiscountPremium", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://igen.com/role/RedeemablePreferredStockAndStockholdersDeficitDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_Assets": { "auth_ref": [ "r118", "r127", "r148", "r172", "r212", "r216", "r221", "r239", "r265", "r266", "r268", "r269", "r270", "r271", "r272", "r274", "r275", "r366", "r370", "r377", "r505", "r545", "r546", "r592" ], "calculation": { "http://igen.com/role/ConsolidatedBalanceSheets": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.", "label": "[Assets]", "totalLabel": "Total Assets" } } }, "localname": "Assets", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://igen.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Assets" } } }, "localname": "AssetsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://igen.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_AssetsCurrent": { "auth_ref": [ "r143", "r155", "r172", "r239", "r265", "r266", "r268", "r269", "r270", "r271", "r272", "r274", "r275", "r366", "r370", "r377", "r505", "r545", "r546", "r592" ], "calculation": { "http://igen.com/role/ConsolidatedBalanceSheets": { "order": 8.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.", "label": "[Assets, Current]", "totalLabel": "Total Current Assets" } } }, "localname": "AssetsCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://igen.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsCurrentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Current Assets" } } }, "localname": "AssetsCurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://igen.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_AwardDateAxis": { "auth_ref": [ "r551", "r552", "r553", "r554", "r555", "r556", "r557", "r558", "r559", "r560", "r561", "r562", "r563", "r564", "r565", "r566", "r567", "r568", "r569", "r570", "r571", "r572", "r573", "r574", "r575", "r576" ], "lang": { "en-us": { "role": { "documentation": "Information by date or year award under share-based payment arrangement is granted.", "label": "Award Date [Axis]" } } }, "localname": "AwardDateAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://igen.com/role/ConvertibleDebenturesAndNotesPayableDetailsNarrative", "http://igen.com/role/RedeemablePreferredStockAndStockholdersDeficitDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_AwardDateDomain": { "auth_ref": [ "r551", "r552", "r553", "r554", "r555", "r556", "r557", "r558", "r559", "r560", "r561", "r562", "r563", "r564", "r565", "r566", "r567", "r568", "r569", "r570", "r571", "r572", "r573", "r574", "r575", "r576" ], "lang": { "en-us": { "role": { "documentation": "Date or year award under share-based payment arrangement is granted." } } }, "localname": "AwardDateDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://igen.com/role/ConvertibleDebenturesAndNotesPayableDetailsNarrative", "http://igen.com/role/RedeemablePreferredStockAndStockholdersDeficitDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_BalanceSheetLocationAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Information by location on balance sheet (statement of financial position).", "label": "Balance Sheet Location [Axis]" } } }, "localname": "BalanceSheetLocationAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://igen.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_BalanceSheetLocationDomain": { "auth_ref": [ "r98", "r100" ], "lang": { "en-us": { "role": { "documentation": "Location in the balance sheet (statement of financial position)." } } }, "localname": "BalanceSheetLocationDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://igen.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_BasisOfAccountingPolicyPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).", "label": "Basic of Presentation and Consolidation" } } }, "localname": "BasisOfAccountingPolicyPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://igen.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock": { "auth_ref": [ "r0", "r49", "r58" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for the business description and basis of presentation concepts. Business description describes the nature and type of organization including but not limited to organizational structure as may be applicable to holding companies, parent and subsidiary relationships, business divisions, business units, business segments, affiliates and information about significant ownership of the reporting entity. Basis of presentation describes the underlying basis used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).", "label": "Business Description and Basis of Presentation [Text Block]", "verboseLabel": "Organization and Description of Business" } } }, "localname": "BusinessDescriptionAndBasisOfPresentationTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://igen.com/role/OrganizationAndDescriptionOfBusiness" ], "xbrltype": "textBlockItemType" }, "us-gaap_CashAndCashEquivalentsAtCarryingValue": { "auth_ref": [ "r42", "r146", "r484" ], "calculation": { "http://igen.com/role/ConsolidatedBalanceSheets": { "order": 2.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.", "label": "Cash" } } }, "localname": "CashAndCashEquivalentsAtCarryingValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://igen.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashAndCashEquivalentsPolicyTextBlock": { "auth_ref": [ "r43" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.", "label": "Cash and Cash Equivalents" } } }, "localname": "CashAndCashEquivalentsPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://igen.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": { "auth_ref": [ "r37", "r42", "r48" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "[Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents]", "periodEndLabel": "Cash, End of Year", "periodStartLabel": "Cash, Beginning of Year" } } }, "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://igen.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect": { "auth_ref": [ "r37", "r112" ], "calculation": { "http://igen.com/role/ConsolidatedStatementsOfCashFlows": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; excluding effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "[Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect]", "totalLabel": "Change in Cash" } } }, "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://igen.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Non-cash Investing and Financing Activities:" } } }, "localname": "CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://igen.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_ClassOfStockDomain": { "auth_ref": [ "r149", "r150", "r151", "r172", "r191", "r192", "r195", "r196", "r199", "r200", "r239", "r265", "r268", "r269", "r270", "r274", "r275", "r294", "r295", "r297", "r301", "r308", "r377", "r466", "r514", "r525", "r533" ], "lang": { "en-us": { "role": { "documentation": "Share of stock differentiated by the voting rights the holder receives. Examples include, but are not limited to, common stock, redeemable preferred stock, nonredeemable preferred stock, and convertible stock." } } }, "localname": "ClassOfStockDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://igen.com/role/ConsolidatedBalanceSheets", "http://igen.com/role/ConsolidatedBalanceSheetsParenthetical", "http://igen.com/role/RedeemablePreferredStockAndStockholdersDeficitDetailsNarrative", "http://igen.com/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1": { "auth_ref": [ "r309" ], "lang": { "en-us": { "role": { "documentation": "Exercise price per share or per unit of warrants or rights outstanding.", "label": "Exercise price", "verboseLabel": "Exercise price (in Dollars per share)" } } }, "localname": "ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://igen.com/role/ConvertibleDebenturesAndNotesPayableDetailsNarrative", "http://igen.com/role/SharePurchaseWarrantsDetails1" ], "xbrltype": "perShareItemType" }, "us-gaap_ClassOfWarrantOrRightOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of warrants or rights outstanding.", "label": "Number of warrants outstanding" } } }, "localname": "ClassOfWarrantOrRightOutstanding", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://igen.com/role/SharePurchaseWarrantsDetails1" ], "xbrltype": "sharesItemType" }, "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Commitments and Contingencies" } } }, "localname": "CommitmentsAndContingenciesDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": { "auth_ref": [ "r65", "r259", "r260", "r461", "r544" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for commitments and contingencies.", "label": "Commitments and Contingencies Disclosure [Text Block]", "verboseLabel": "Commitments and Contingencies" } } }, "localname": "CommitmentsAndContingenciesDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://igen.com/role/CommitmentsAndContingencies" ], "xbrltype": "textBlockItemType" }, "us-gaap_CommonStockCapitalSharesReservedForFutureIssuance": { "auth_ref": [ "r23" ], "lang": { "en-us": { "role": { "documentation": "Aggregate number of common shares reserved for future issuance.", "label": "Issuance of warrants to purchase common stock", "verboseLabel": "Common stock shares reserved under plan" } } }, "localname": "CommonStockCapitalSharesReservedForFutureIssuance", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://igen.com/role/ConvertibleDebenturesAndNotesPayableDetailsNarrative", "http://igen.com/role/StockOptionsDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockMember": { "auth_ref": [ "r530", "r531", "r585" ], "lang": { "en-us": { "role": { "documentation": "Stock that is subordinate to all other stock of the issuer.", "label": "Common Stock" } } }, "localname": "CommonStockMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://igen.com/role/ConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholdersDeficit" ], "xbrltype": "domainItemType" }, "us-gaap_CommonStockParOrStatedValuePerShare": { "auth_ref": [ "r7" ], "lang": { "en-us": { "role": { "documentation": "Face amount or stated value per share of common stock.", "label": "Common stock, shares par value" } } }, "localname": "CommonStockParOrStatedValuePerShare", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://igen.com/role/ConsolidatedBalanceSheetsParenthetical" ], "xbrltype": "perShareItemType" }, "us-gaap_CommonStockSharesAuthorized": { "auth_ref": [ "r7" ], "lang": { "en-us": { "role": { "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.", "label": "Common stock, shares authorized" } } }, "localname": "CommonStockSharesAuthorized", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://igen.com/role/ConsolidatedBalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockSharesIssued": { "auth_ref": [ "r7" ], "lang": { "en-us": { "role": { "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.", "label": "Common stock, shares issued" } } }, "localname": "CommonStockSharesIssued", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://igen.com/role/ConsolidatedBalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockSharesOutstanding": { "auth_ref": [ "r7", "r71" ], "lang": { "en-us": { "role": { "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.", "label": "Common stock, shares outstanding" } } }, "localname": "CommonStockSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://igen.com/role/ConsolidatedBalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockValue": { "auth_ref": [ "r7", "r505" ], "calculation": { "http://igen.com/role/ConsolidatedBalanceSheets": { "order": 18.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.", "label": "Common stock: Authorized - 2,190,000,000 shares with $0.001 par value issued and outstanding - 1,890,261,047 and 1,476,869,532 shares as of December 31, 2022 and 2021, respectively" } } }, "localname": "CommonStockValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://igen.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_ComputerEquipmentMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Long lived, depreciable assets that are used in the creation, maintenance and utilization of information systems.", "label": "Computer Equipment [Member]" } } }, "localname": "ComputerEquipmentMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://igen.com/role/ConvertibleDebenturesAndNotesPayableDetailsNarrative", "http://igen.com/role/SummaryOfSignificantAccountingPoliciesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ConcentrationRiskByTypeAxis": { "auth_ref": [ "r53", "r54", "r108", "r109", "r228", "r460", "r600" ], "lang": { "en-us": { "role": { "documentation": "Information by type of concentration risk, for example, but not limited to, asset, liability, net assets, geographic, customer, employees, supplier, lender.", "label": "Concentration Risk Type [Axis]" } } }, "localname": "ConcentrationRiskByTypeAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://igen.com/role/RisksUncertaintiesDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_ConcentrationRiskDisclosureTextBlock": { "auth_ref": [ "r58" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for any concentrations existing at the date of the financial statements that make an entity vulnerable to a reasonably possible, near-term, severe impact. This disclosure informs financial statement users about the general nature of the risk associated with the concentration, and may indicate the percentage of concentration risk as of the balance sheet date.", "label": "Concentration Risk Disclosure [Text Block]", "verboseLabel": "Risk and Uncertainities" } } }, "localname": "ConcentrationRiskDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://igen.com/role/RiskAndUncertainities" ], "xbrltype": "textBlockItemType" }, "us-gaap_ConcentrationRiskTypeDomain": { "auth_ref": [ "r53", "r54", "r108", "r109", "r228", "r460" ], "lang": { "en-us": { "role": { "documentation": "For an entity that discloses a concentration risk as a percentage of some financial balance or benchmark, identifies the type (for example, asset, liability, net assets, geographic, customer, employees, supplier, lender) of the concentration." } } }, "localname": "ConcentrationRiskTypeDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://igen.com/role/RisksUncertaintiesDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_ConcentrationRisksTypesNoConcentrationPercentageAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Risks Uncertainties (Details Narrative)" } } }, "localname": "ConcentrationRisksTypesNoConcentrationPercentageAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_ConversionOfStockSharesConverted1": { "auth_ref": [ "r45", "r46", "r47" ], "lang": { "en-us": { "role": { "documentation": "The number of shares converted in a noncash (or part noncash) transaction. Noncash is defined as transactions during a period that do not result in cash receipts or cash payments in the period. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.", "label": "Preferred stock shares converted" } } }, "localname": "ConversionOfStockSharesConverted1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://igen.com/role/RedeemablePreferredStockAndStockholdersDeficitDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_ConvertibleDebtCurrent": { "auth_ref": [ "r2" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The portion of the carrying value of long-term convertible debt as of the balance sheet date that is scheduled to be repaid within one year or in the normal operating cycle if longer. Convertible debt is a financial instrument which can be exchanged for a specified amount of another security, typically the entity's common stock, at the option of the issuer or the holder.", "label": "Convertible debentures, current portion, discount" } } }, "localname": "ConvertibleDebtCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://igen.com/role/ConsolidatedBalanceSheetsParenthetical" ], "xbrltype": "monetaryItemType" }, "us-gaap_ConvertibleNotesPayable": { "auth_ref": [ "r4", "r120", "r128", "r134" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Including the current and noncurrent portions, carrying value as of the balance sheet date of a written promise to pay a note, initially due after one year or beyond the operating cycle if longer, which can be exchanged for a specified amount of one or more securities (typically common stock), at the option of the issuer or the holder.", "label": "Note payble" } } }, "localname": "ConvertibleNotesPayable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://igen.com/role/ConvertibleDebenturesAndNotesPayableDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_ConvertibleNotesPayableMember": { "auth_ref": [ "r2", "r119", "r126", "r134" ], "lang": { "en-us": { "role": { "documentation": "Written promise to pay a note which can be exchanged for a specified quantity of securities (typically common stock), at the option of the issuer or the holder.", "label": "Convertible Notes [Member]" } } }, "localname": "ConvertibleNotesPayableMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://igen.com/role/ConvertibleDebenturesAndNotesPayableDetails" ], "xbrltype": "domainItemType" }, "us-gaap_CostOfGoodsAndServicesSold": { "auth_ref": [ "r29", "r437" ], "calculation": { "http://igen.com/role/ConsolidatedStatementsOfOperations": { "order": 4.0, "parentTag": "us-gaap_GrossProfit", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.", "label": "Cost of goods sold" } } }, "localname": "CostOfGoodsAndServicesSold", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://igen.com/role/ConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_CreditConcentrationRiskMember": { "auth_ref": [ "r110" ], "lang": { "en-us": { "role": { "documentation": "Reflects the percentage that a specified receivable or amount at risk from a counterparty under a contractual arrangement is to a specified benchmark, such as total receivables, net revenues, pretax results. Risk is the materially adverse effects of loss attributable to (a) the failure to collect a significant receivable from a major customer or group of homogeneous accounts, or (b) a failure by a counterparty to perform under terms of a contractual arrangement.", "label": "Customer Concentration Risk" } } }, "localname": "CreditConcentrationRiskMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://igen.com/role/RisksUncertaintiesDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_CurrentFederalStateAndLocalTaxExpenseBenefitAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Current:" } } }, "localname": "CurrentFederalStateAndLocalTaxExpenseBenefitAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://igen.com/role/IncomeTaxesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_CurrentFederalTaxExpenseBenefit": { "auth_ref": [ "r528", "r582", "r584" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of current federal tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, current national tax expense (benefit) for non-US (United States of America) jurisdiction.", "label": "Federal" } } }, "localname": "CurrentFederalTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://igen.com/role/IncomeTaxesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_CurrentForeignTaxExpenseBenefit": { "auth_ref": [ "r528", "r582" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of current foreign income tax expense (benefit) pertaining to income (loss) from continuing operations.", "label": "Foreign" } } }, "localname": "CurrentForeignTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://igen.com/role/IncomeTaxesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_CurrentIncomeTaxExpenseBenefit": { "auth_ref": [ "r93", "r351", "r359", "r528" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of current income tax expense (benefit) pertaining to taxable income (loss) from continuing operations.", "label": "Total Current" } } }, "localname": "CurrentIncomeTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://igen.com/role/IncomeTaxesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_CurrentStateAndLocalTaxExpenseBenefit": { "auth_ref": [ "r528", "r582", "r584" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of current state and local tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, current regional, territorial, and provincial tax expense (benefit) for non-US (United States of America) jurisdiction.", "label": "State" } } }, "localname": "CurrentStateAndLocalTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://igen.com/role/IncomeTaxesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtConversionConvertedInstrumentAmount1": { "auth_ref": [ "r45", "r47" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The value of the financial instrument(s) that the original debt is being converted into in a noncash (or part noncash) transaction. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.", "label": "Debt conversion, converted instrument, principal, accrued interest, and fees" } } }, "localname": "DebtConversionConvertedInstrumentAmount1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://igen.com/role/ConvertibleDebenturesAndNotesPayableDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtConversionConvertedInstrumentSharesIssued1": { "auth_ref": [ "r45", "r47" ], "lang": { "en-us": { "role": { "documentation": "The number of shares issued in exchange for the original debt being converted in a noncash (or part noncash) transaction. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or payments in the period.", "label": "Debt conversion, converted instrument, shares issued", "verboseLabel": "Debt conversion, converted instrument, shares issued" } } }, "localname": "DebtConversionConvertedInstrumentSharesIssued1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://igen.com/role/ConvertibleDebenturesAndNotesPayableDetailsNarrative", "http://igen.com/role/RelatedPartyTransactionsDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_DebtInstrumentAxis": { "auth_ref": [ "r2", "r3", "r4", "r119", "r120", "r126", "r176", "r276", "r277", "r278", "r279", "r280", "r281", "r282", "r283", "r284", "r285", "r286", "r287", "r288", "r289", "r290", "r291", "r386", "r493", "r494", "r495", "r496", "r497", "r526" ], "lang": { "en-us": { "role": { "documentation": "Information by type of debt instrument, including, but not limited to, draws against credit facilities.", "label": "Debt Instrument [Axis]" } } }, "localname": "DebtInstrumentAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://igen.com/role/ConvertibleDebenturesAndNotesPayableDetailsNarrative", "http://igen.com/role/DerivativeLiabilitiesDetails", "http://igen.com/role/SharePurchaseWarrantsDetails", "http://igen.com/role/SharePurchaseWarrantsDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_DebtInstrumentDecreaseForgiveness": { "auth_ref": [ "r526" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Decrease for amounts of indebtedness forgiven by the holder of the debt instrument.", "label": "Debt instrument decrease, forgiveness" } } }, "localname": "DebtInstrumentDecreaseForgiveness", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://igen.com/role/ConvertibleDebenturesAndNotesPayableDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtInstrumentDescription": { "auth_ref": [ "r2", "r4", "r72", "r119", "r120", "r125", "r126" ], "lang": { "en-us": { "role": { "documentation": "Identification of the lender and information about a contractual promise to repay a short-term or long-term obligation, which includes borrowings under lines of credit, notes payable, commercial paper, bonds payable, debentures, and other contractual obligations for payment. This may include rationale for entering into the arrangement, significant terms of the arrangement, which may include amount, repayment terms, priority, collateral required, debt covenants, borrowing capacity, call features, participation rights, conversion provisions, sinking-fund requirements, voting rights, basis for conversion if convertible and remarketing provisions. The description may be provided for individual debt instruments, rational groupings of debt instruments, or by debt in total.", "label": "Mandatory Redemption, description" } } }, "localname": "DebtInstrumentDescription", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://igen.com/role/RedeemablePreferredStockAndStockholdersDeficitDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_DebtInstrumentInterestRateStatedPercentage": { "auth_ref": [ "r20", "r277" ], "lang": { "en-us": { "role": { "documentation": "Contractual interest rate for funds borrowed, under the debt agreement.", "label": "Interest rate" } } }, "localname": "DebtInstrumentInterestRateStatedPercentage", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://igen.com/role/ConvertibleDebenturesAndNotesPayableDetailsNarrative" ], "xbrltype": "percentItemType" }, "us-gaap_DebtInstrumentMaturityDateDescription": { "auth_ref": [ "r21" ], "lang": { "en-us": { "role": { "documentation": "Description of the maturity date of the debt instrument including whether the debt matures serially and, if so, a brief description of the serial maturities.", "label": "Debt maturity" } } }, "localname": "DebtInstrumentMaturityDateDescription", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://igen.com/role/ConvertibleDebenturesAndNotesPayableDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_DebtInstrumentNameDomain": { "auth_ref": [ "r22", "r176", "r276", "r277", "r278", "r279", "r280", "r281", "r282", "r283", "r284", "r285", "r286", "r287", "r288", "r289", "r290", "r291", "r386", "r493", "r494", "r495", "r496", "r497", "r526" ], "lang": { "en-us": { "role": { "documentation": "The name for the particular debt instrument or borrowing that distinguishes it from other debt instruments or borrowings, including draws against credit facilities." } } }, "localname": "DebtInstrumentNameDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://igen.com/role/ConvertibleDebenturesAndNotesPayableDetailsNarrative", "http://igen.com/role/DerivativeLiabilitiesDetails", "http://igen.com/role/SharePurchaseWarrantsDetails", "http://igen.com/role/SharePurchaseWarrantsDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_DebtInstrumentTerm": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Period of time between issuance and maturity of debt instrument, in PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "Renewal fee term" } } }, "localname": "DebtInstrumentTerm", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://igen.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "durationItemType" }, "us-gaap_DebtInstrumentUnamortizedDiscount": { "auth_ref": [ "r113", "r115", "r548" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after accumulated amortization, of debt discount.", "label": "Debt discount" } } }, "localname": "DebtInstrumentUnamortizedDiscount", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://igen.com/role/ConvertibleDebenturesAndNotesPayableDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredFederalIncomeTaxExpenseBenefit": { "auth_ref": [ "r528", "r583", "r584" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred federal tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, deferred national tax expense (benefit) for non-US (United States of America) jurisdiction.", "label": "[Deferred Federal Income Tax Expense (Benefit)]", "verboseLabel": "Federal" } } }, "localname": "DeferredFederalIncomeTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://igen.com/role/IncomeTaxesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredFederalStateAndLocalTaxExpenseBenefitAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Deferred:" } } }, "localname": "DeferredFederalStateAndLocalTaxExpenseBenefitAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://igen.com/role/IncomeTaxesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DeferredForeignIncomeTaxExpenseBenefit": { "auth_ref": [ "r93", "r528", "r583" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred foreign income tax expense (benefit) pertaining to income (loss) from continuing operations.", "label": "[Deferred Foreign Income Tax Expense (Benefit)]", "verboseLabel": "Foreign" } } }, "localname": "DeferredForeignIncomeTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://igen.com/role/IncomeTaxesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredIncomeTaxExpenseBenefit": { "auth_ref": [ "r40", "r93", "r352", "r358", "r359", "r528" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.", "label": "Total Deferred" } } }, "localname": "DeferredIncomeTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://igen.com/role/IncomeTaxesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredRevenue": { "auth_ref": [ "r518" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable.", "label": "Deferred revenue" } } }, "localname": "DeferredRevenue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://igen.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredRevenueAdditions": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred revenue recognized for transactions arising during the current reporting period. Deferred revenue is a liability as of the balance sheet date related to a revenue producing activity for which revenue has not yet been recognized. Generally, an Entity records deferred revenue when it receives consideration from a customer before achieving certain criteria that must be met for revenue to be recognized in conformity with GAAP.", "label": "Additional deferred revenue" } } }, "localname": "DeferredRevenueAdditions", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://igen.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredRevenueCurrent": { "auth_ref": [ "r516" ], "calculation": { "http://igen.com/role/ConsolidatedBalanceSheets": { "order": 10.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable, classified as current.", "label": "Current portion of deferred revenue, net of contract assets" } } }, "localname": "DeferredRevenueCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://igen.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredRevenueNoncurrent": { "auth_ref": [ "r518" ], "calculation": { "http://igen.com/role/ConsolidatedBalanceSheets": { "order": 14.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable, classified as noncurrent.", "label": "Deferred revenue, net of contract assets and current portion" } } }, "localname": "DeferredRevenueNoncurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://igen.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit": { "auth_ref": [ "r528", "r583", "r584" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred state and local tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, deferred regional, territorial, and provincial tax expense (benefit) for non-US (United States of America) jurisdiction.", "label": "[Deferred State and Local Income Tax Expense (Benefit)]", "verboseLabel": "State" } } }, "localname": "DeferredStateAndLocalIncomeTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://igen.com/role/IncomeTaxesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsGross": { "auth_ref": [ "r348" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.", "label": "Total Deferred Tax Asset" } } }, "localname": "DeferredTaxAssetsGross", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://igen.com/role/IncomeTaxesDetails2" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsNet": { "auth_ref": [ "r580" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.", "label": "Net Deferred Tax Asset" } } }, "localname": "DeferredTaxAssetsNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://igen.com/role/IncomeTaxesDetails2" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsNetAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Deferred Tax Assets:" } } }, "localname": "DeferredTaxAssetsNetAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://igen.com/role/IncomeTaxesDetails2" ], "xbrltype": "stringItemType" }, "us-gaap_DeferredTaxAssetsOperatingLossCarryforwards": { "auth_ref": [ "r92", "r581" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards.", "label": "Net operating loss carryforwards" } } }, "localname": "DeferredTaxAssetsOperatingLossCarryforwards", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://igen.com/role/IncomeTaxesDetails2" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsForeign": { "auth_ref": [ "r92", "r581" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible foreign operating loss carryforwards.", "label": "Net operating loss carryforwards, federal" } } }, "localname": "DeferredTaxAssetsOperatingLossCarryforwardsForeign", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://igen.com/role/IncomeTaxesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal": { "auth_ref": [ "r92", "r581" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible state and local operating loss carryforwards.", "label": "Net operating loss carryforwards, state" } } }, "localname": "DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://igen.com/role/IncomeTaxesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsOther": { "auth_ref": [ "r92", "r581" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary differences, classified as other.", "label": "Accounts receivable and other timing differences" } } }, "localname": "DeferredTaxAssetsOther", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://igen.com/role/IncomeTaxesDetails2" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost": { "auth_ref": [ "r92", "r581" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from share-based compensation.", "label": "[Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-Based Compensation Cost]", "verboseLabel": "Stock-based compensation" } } }, "localname": "DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://igen.com/role/IncomeTaxesDetails2" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Derivative Liabilities" } } }, "localname": "DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_DerivativeLiabilitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Derivative Liability [Abstract]", "verboseLabel": "Derivative liabilities" } } }, "localname": "DerivativeLiabilitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://igen.com/role/DerivativeLiabilitiesDetails1" ], "xbrltype": "stringItemType" }, "us-gaap_DerivativeLiabilitiesCurrent": { "auth_ref": [ "r156" ], "calculation": { "http://igen.com/role/ConsolidatedBalanceSheets": { "order": 12.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset, expected to be settled within one year or normal operating cycle, if longer. Includes assets not subject to a master netting arrangement and not elected to be offset.", "label": "Derivative liabilities" } } }, "localname": "DerivativeLiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://igen.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativesAndFairValueTextBlock": { "auth_ref": [ "r102", "r106" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for derivatives and fair value of assets and liabilities.", "label": "Derivatives and Fair Value [Text Block]", "verboseLabel": "Derivative Liabilities" } } }, "localname": "DerivativesAndFairValueTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://igen.com/role/DerivativeLiabilities" ], "xbrltype": "textBlockItemType" }, "us-gaap_DerivativesPolicyTextBlock": { "auth_ref": [ "r94", "r95", "r96", "r97", "r101", "r175" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for its derivative instruments and hedging activities.", "label": "Derivative Financial Instruments" } } }, "localname": "DerivativesPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://igen.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock": { "auth_ref": [ "r315", "r329", "r330", "r331", "r336", "r500" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for share-based payment arrangement.", "label": "Share-Based Payment Arrangement [Text Block]", "verboseLabel": "Stock Options" } } }, "localname": "DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://igen.com/role/StockOptions" ], "xbrltype": "textBlockItemType" }, "us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Stock Options" } } }, "localname": "DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_DueToRelatedPartiesCurrent": { "auth_ref": [ "r13", "r267", "r268", "r269", "r273", "r274", "r275", "r399", "r529" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying amount as of the balance sheet date of obligations due all related parties. For classified balance sheets, represents the current portion of such liabilities (due within one year or within the normal operating cycle if longer).", "label": "Due to Related Parties" } } }, "localname": "DueToRelatedPartiesCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://igen.com/role/RelatedPartyTransactionsDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_EarningsPerSharePolicyTextBlock": { "auth_ref": [ "r51", "r52" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.", "label": "Loss Per Share" } } }, "localname": "EarningsPerSharePolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://igen.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount": { "auth_ref": [ "r577", "r578" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying domestic federal statutory income tax rate to pretax income (loss) from continuing operation, attributable to expense for award under share-based payment arrangement. Excludes expense determined to be nondeductible upon grant or after for award under share-based payment arrangement.", "label": "[Effective Income Tax Rate Reconciliation, Tax Expense (Benefit), Share-Based Payment Arrangement, Amount]", "verboseLabel": "Stock-based compensation" } } }, "localname": "EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://igen.com/role/IncomeTaxesDetails1" ], "xbrltype": "monetaryItemType" }, "us-gaap_EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability": { "auth_ref": [ "r99" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Fair value as of the balance sheet date of the embedded derivative or group of embedded derivatives classified as a liability.", "label": "Derivative liability, embedded conversion feature" } } }, "localname": "EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://igen.com/role/ConvertibleDebenturesAndNotesPayableDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_EmployeeBenefitsAndShareBasedCompensation": { "auth_ref": [], "calculation": { "http://igen.com/role/ConsolidatedStatementsOfOperations": { "order": 8.0, "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of expense for employee benefit and equity-based compensation.", "label": "Stock-based director expense", "verboseLabel": "Stock based compensation expense" } } }, "localname": "EmployeeBenefitsAndShareBasedCompensation", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://igen.com/role/ConsolidatedStatementsOfOperations", "http://igen.com/role/RedeemablePreferredStockAndStockholdersDeficitDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_EmployeeRelatedLiabilitiesCurrent": { "auth_ref": [ "r18" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Payroll and commissions payable" } } }, "localname": "EmployeeRelatedLiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://igen.com/role/AccountsPayableAndAccruedLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_EquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Redeemable Preferred Stock and Stockholders Deficit" } } }, "localname": "EquityAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_EquityComponentDomain": { "auth_ref": [ "r71", "r141", "r160", "r161", "r162", "r177", "r178", "r179", "r181", "r186", "r188", "r198", "r240", "r310", "r332", "r333", "r334", "r354", "r355", "r374", "r378", "r379", "r380", "r381", "r382", "r383", "r395", "r455", "r456", "r457" ], "lang": { "en-us": { "role": { "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc." } } }, "localname": "EquityComponentDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://igen.com/role/ConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholdersDeficit" ], "xbrltype": "domainItemType" }, "us-gaap_ExtinguishmentOfDebtAmount": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Gross amount of debt extinguished.", "label": "[Extinguishment of Debt, Amount]", "negatedLabel": "Extinguishment due to conversion of debt instruments" } } }, "localname": "ExtinguishmentOfDebtAmount", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://igen.com/role/DerivativeLiabilitiesDetails2" ], "xbrltype": "monetaryItemType" }, "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock": { "auth_ref": [ "r103", "r104" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, by class that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3). Where the quoted price in an active market for the identical liability is not available, the Level 1 input is the quoted price of an identical liability when traded as an asset.", "label": "Summary of Fair Value of Derivative Liabilities on Recurring Basis" } } }, "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://igen.com/role/DerivativeLiabilitiesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_FairValueOfFinancialInstrumentsPolicy": { "auth_ref": [ "r105", "r107" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for determining the fair value of financial instruments.", "label": "Fair Value Measurements and Financial Instruments" } } }, "localname": "FairValueOfFinancialInstrumentsPolicy", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://igen.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_FairValueOptionChangesInFairValueGainLoss1": { "auth_ref": [ "r111" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "For each line item in the statement of financial position, the amounts of gains and losses from fair value changes included in earnings.", "label": "Fair value of common shares issued" } } }, "localname": "FairValueOptionChangesInFairValueGainLoss1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://igen.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_FinanceLeasePrincipalPayments": { "auth_ref": [ "r389", "r392" ], "calculation": { "http://igen.com/role/ConsolidatedStatementsOfCashFlows": { "order": 16.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of cash outflow for principal payment on finance lease.", "label": "[Finance Lease, Principal Payments]", "negatedLabel": "Repayment of lease liability" } } }, "localname": "FinanceLeasePrincipalPayments", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://igen.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_FinancialInstrumentAxis": { "auth_ref": [ "r237", "r238", "r242", "r243", "r244", "r245", "r246", "r247", "r248", "r249", "r292", "r306", "r372", "r405", "r406", "r407", "r408", "r409", "r410", "r411", "r412", "r413", "r414", "r415", "r416", "r417", "r418", "r419", "r420", "r421", "r422", "r423", "r424", "r425", "r426", "r427", "r428", "r429", "r430", "r431", "r432", "r433", "r434", "r491", "r537", "r538", "r539", "r601", "r602", "r603", "r604", "r605", "r606", "r607" ], "lang": { "en-us": { "role": { "documentation": "Information by type of financial instrument.", "label": "Financial Instrument [Axis]" } } }, "localname": "FinancialInstrumentAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://igen.com/role/SharePurchaseWarrantsDetails1", "http://igen.com/role/StockOptionsDetails", "http://igen.com/role/StockOptionsDetails1" ], "xbrltype": "stringItemType" }, "us-gaap_GainsLossesOnExtinguishmentOfDebt": { "auth_ref": [ "r40", "r67", "r68" ], "calculation": { "http://igen.com/role/ConsolidatedStatementsOfCashFlows": { "order": 5.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 }, "http://igen.com/role/ConsolidatedStatementsOfOperations": { "order": 12.0, "parentTag": "us-gaap_OtherNonoperatingIncomeExpense", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.", "label": "Gain on extinguishment of debt, net", "negatedLabel": "Gain on settlement of debt", "verboseLabel": "Gain on extinguishment of debt" } } }, "localname": "GainsLossesOnExtinguishmentOfDebt", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://igen.com/role/ConsolidatedStatementsOfCashFlows", "http://igen.com/role/ConsolidatedStatementsOfOperations", "http://igen.com/role/IncomeTaxesDetails1" ], "xbrltype": "monetaryItemType" }, "us-gaap_GeographicDistributionAxis": { "auth_ref": [ "r451", "r452", "r466", "r467", "r468", "r469", "r470", "r471", "r472", "r473", "r474", "r475", "r476", "r477", "r478", "r479", "r480", "r481", "r482", "r483", "r490" ], "lang": { "en-us": { "role": { "documentation": "Information by geographic distribution of business activity identified as either domestic or foreign. Excludes names of countries, states and provinces, and cities.", "label": "Geographic Distribution Axis" } } }, "localname": "GeographicDistributionAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://igen.com/role/IncomeTaxesDetails3" ], "xbrltype": "stringItemType" }, "us-gaap_GeographicDistributionDomain": { "auth_ref": [ "r451", "r452", "r466", "r467", "r468", "r469", "r470", "r471", "r472", "r473", "r474", "r475", "r476", "r477", "r478", "r479", "r480", "r481", "r482", "r483" ], "lang": { "en-us": { "role": { "documentation": "Allocation of business activity identified as domestic or foreign. Excludes names of countries, states and provinces, and cities." } } }, "localname": "GeographicDistributionDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://igen.com/role/IncomeTaxesDetails3" ], "xbrltype": "domainItemType" }, "us-gaap_Goodwill": { "auth_ref": [ "r147", "r254", "r450", "r492", "r505", "r541", "r542" ], "calculation": { "http://igen.com/role/ConsolidatedBalanceSheets": { "order": 7.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.", "label": "[Goodwill]", "terseLabel": "Goodwill", "verboseLabel": "Goodwill" } } }, "localname": "Goodwill", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://igen.com/role/ConsolidatedBalanceSheets", "http://igen.com/role/GoodwillDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Goodwill" } } }, "localname": "GoodwillAndIntangibleAssetsDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy": { "auth_ref": [ "r257", "r258", "r492" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for goodwill. This accounting policy also may address how an entity assesses and measures impairment of goodwill, how reporting units are determined, how goodwill is allocated to such units, and how the fair values of the reporting units are determined.", "label": "Goodwill and Intangible Assets, Goodwill, Policy [Policy Text Block]", "verboseLabel": "Goodwill" } } }, "localname": "GoodwillAndIntangibleAssetsGoodwillPolicy", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://igen.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_GoodwillDisclosureTextBlock": { "auth_ref": [ "r255", "r256", "r258", "r492" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for goodwill.", "label": "Goodwill Disclosure [Text Block]", "verboseLabel": "Goodwill" } } }, "localname": "GoodwillDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://igen.com/role/Goodwill" ], "xbrltype": "textBlockItemType" }, "us-gaap_GrossProfit": { "auth_ref": [ "r28", "r172", "r212", "r215", "r220", "r223", "r239", "r265", "r266", "r268", "r269", "r270", "r271", "r272", "r274", "r275", "r377", "r489", "r545" ], "calculation": { "http://igen.com/role/ConsolidatedStatementsOfOperations": { "order": 9.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.", "label": "[Gross Profit]", "totalLabel": "Gross (Loss) Profit" } } }, "localname": "GrossProfit", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://igen.com/role/ConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock": { "auth_ref": [ "r60", "r64" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for recognizing and measuring the impairment of long-lived assets. An entity also may disclose its accounting policy for long-lived assets to be sold. This policy excludes goodwill and intangible assets.", "label": "Impairment of Long-lived Assets" } } }, "localname": "ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://igen.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest": { "auth_ref": [ "r26", "r117", "r122", "r133", "r212", "r215", "r220", "r223", "r452", "r489" ], "calculation": { "http://igen.com/role/ConsolidatedStatementsOfOperations": { "order": 17.0, "parentTag": "us-gaap_NetIncomeLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.", "label": "[Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest]", "totalLabel": "Net Loss before Provision for Income Taxes" } } }, "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://igen.com/role/ConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeStatementAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Consolidated Statements of Operations" } } }, "localname": "IncomeStatementAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_IncomeTaxDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Income Taxes" } } }, "localname": "IncomeTaxDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_IncomeTaxDisclosureTextBlock": { "auth_ref": [ "r173", "r342", "r346", "r350", "r356", "r360", "r362", "r363", "r364" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.", "label": "Income Tax Disclosure [Text Block]", "verboseLabel": "Income Taxes" } } }, "localname": "IncomeTaxDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://igen.com/role/IncomeTaxes" ], "xbrltype": "textBlockItemType" }, "us-gaap_IncomeTaxExpenseBenefit": { "auth_ref": [ "r174", "r187", "r188", "r211", "r340", "r357", "r361", "r453" ], "calculation": { "http://igen.com/role/ConsolidatedStatementsOfOperations": { "order": 18.0, "parentTag": "us-gaap_NetIncomeLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.", "label": "[Income Tax Expense (Benefit)]", "negatedLabel": "Provision for Income Taxes", "verboseLabel": "Provision for income taxes" } } }, "localname": "IncomeTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://igen.com/role/ConsolidatedStatementsOfOperations", "http://igen.com/role/IncomeTaxesDetails1" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeTaxPolicyTextBlock": { "auth_ref": [ "r159", "r338", "r339", "r346", "r347", "r349", "r353" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.", "label": "Income Tax, Policy [Policy Text Block]", "verboseLabel": "Income Taxes" } } }, "localname": "IncomeTaxPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://igen.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance": { "auth_ref": [ "r578" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to increase (decrease) in the valuation allowance for deferred tax assets.", "label": "Valuation allowance" } } }, "localname": "IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://igen.com/role/IncomeTaxesDetails1" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate": { "auth_ref": [ "r341" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of income tax expense or benefit for the period computed by applying the domestic federal statutory tax rates to pretax income from continuing operations.", "label": "Computed tax benefit at federal statutory rate" } } }, "localname": "IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://igen.com/role/IncomeTaxesDetails1" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeTaxReconciliationOtherAdjustments": { "auth_ref": [ "r578" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other adjustments.", "label": "Permanent items" } } }, "localname": "IncomeTaxReconciliationOtherAdjustments", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://igen.com/role/IncomeTaxesDetails1" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeTaxReconciliationTaxContingencies": { "auth_ref": [ "r578" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to increase (decrease) in income tax contingencies. Including, but not limited to, domestic tax contingency, foreign tax contingency, state and local tax contingency, and other contingencies.", "label": "Uncertain tax positions" } } }, "localname": "IncomeTaxReconciliationTaxContingencies", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://igen.com/role/IncomeTaxesDetails1" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeTaxesPaidNet": { "auth_ref": [ "r44" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income, net of any cash received during the current period as refunds for the overpayment of taxes.", "label": "Income taxes paid" } } }, "localname": "IncomeTaxesPaidNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://igen.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInAccountsAndOtherReceivables": { "auth_ref": [ "r39" ], "calculation": { "http://igen.com/role/ConsolidatedStatementsOfCashFlows": { "order": 8.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in the amount due from customers for the credit sale of goods and services; includes accounts receivable and other types of receivables.", "label": "[Increase (Decrease) in Accounts and Other Receivables]", "negatedLabel": "Accounts and other receivables" } } }, "localname": "IncreaseDecreaseInAccountsAndOtherReceivables", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://igen.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities": { "auth_ref": [ "r39" ], "calculation": { "http://igen.com/role/ConsolidatedStatementsOfCashFlows": { "order": 11.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid.", "label": "[Increase (Decrease) in Accounts Payable and Accrued Liabilities]", "verboseLabel": "Accounts payable and accrued liabilities" } } }, "localname": "IncreaseDecreaseInAccountsPayableAndAccruedLiabilities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://igen.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInDeferredRevenue": { "auth_ref": [ "r486" ], "calculation": { "http://igen.com/role/ConsolidatedStatementsOfCashFlows": { "order": 12.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable.", "label": "Deferred revenue, net" } } }, "localname": "IncreaseDecreaseInDeferredRevenue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://igen.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInDerivativeLiabilities": { "auth_ref": [ "r523" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the period in the carrying value of derivative instruments reported as liabilities that are due to be disposed of within one year (or the normal operating cycle, if longer).", "label": "Changes in derivative liability", "terseLabel": "Change in fair value of derivative liability", "verboseLabel": "Changes in derivative liability" } } }, "localname": "IncreaseDecreaseInDerivativeLiabilities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://igen.com/role/ConvertibleDebenturesAndNotesPayableDetailsNarrative", "http://igen.com/role/IncomeTaxesDetails1", "http://igen.com/role/RedeemablePreferredStockAndStockholdersDeficitDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInInventories": { "auth_ref": [ "r39" ], "calculation": { "http://igen.com/role/ConsolidatedStatementsOfCashFlows": { "order": 9.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.", "label": "[Increase (Decrease) in Inventories]", "negatedLabel": "Inventory" } } }, "localname": "IncreaseDecreaseInInventories", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://igen.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Changes in operating assets and liabilities:" } } }, "localname": "IncreaseDecreaseInOperatingCapitalAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://igen.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets": { "auth_ref": [ "r39" ], "calculation": { "http://igen.com/role/ConsolidatedStatementsOfCashFlows": { "order": 10.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in prepaid expenses, and assets classified as other.", "label": "[Increase (Decrease) in Prepaid Expense and Other Assets]", "negatedLabel": "Prepaid expenses and deposits" } } }, "localname": "IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://igen.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestExpense": { "auth_ref": [ "r114", "r124", "r163", "r210", "r385" ], "calculation": { "http://igen.com/role/ConsolidatedStatementsOfOperations": { "order": 13.0, "parentTag": "us-gaap_OtherNonoperatingIncomeExpense", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of the cost of borrowed funds accounted for as interest expense.", "label": "[Interest Expense]", "negatedLabel": "Interest expense", "verboseLabel": "Interest expense" } } }, "localname": "InterestExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://igen.com/role/ConsolidatedStatementsOfOperations", "http://igen.com/role/ConvertibleDebenturesAndNotesPayableDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestExpenseOther": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of interest expense classified as other.", "label": "Interest expense, derivative liability" } } }, "localname": "InterestExpenseOther", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://igen.com/role/IncomeTaxesDetails1" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestPaidNet": { "auth_ref": [ "r165", "r168", "r169" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.", "label": "Interest paid" } } }, "localname": "InterestPaidNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://igen.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestPayableCurrent": { "auth_ref": [ "r18" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of [accrued] interest payable on all forms of debt, including trade payables, that has been incurred and is unpaid. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Accrued interest payable" } } }, "localname": "InterestPayableCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://igen.com/role/AccountsPayableAndAccruedLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InventoryNet": { "auth_ref": [ "r154", "r485", "r505" ], "calculation": { "http://igen.com/role/ConsolidatedBalanceSheets": { "order": 4.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.", "label": "Inventory" } } }, "localname": "InventoryNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://igen.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_InventoryPolicyTextBlock": { "auth_ref": [ "r145", "r153", "r197", "r251", "r252", "r253", "r436", "r487" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of inventory accounting policy for inventory classes, including, but not limited to, basis for determining inventory amounts, methods by which amounts are added and removed from inventory classes, loss recognition on impairment of inventories, and situations in which inventories are stated above cost.", "label": "Inventory, Policy [Policy Text Block]", "verboseLabel": "Inventory" } } }, "localname": "InventoryPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://igen.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_InvestorMember": { "auth_ref": [ "r589", "r590" ], "lang": { "en-us": { "role": { "documentation": "Business entity or individual that puts money, by purchase or expenditure, in something offering potential profitable returns, such as interest income or appreciation in value.", "label": "Investor [Member]", "verboseLabel": "Investor [Member]" } } }, "localname": "InvestorMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://igen.com/role/ConvertibleDebenturesAndNotesPayableDetailsNarrative", "http://igen.com/role/RedeemablePreferredStockAndStockholdersDeficitDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_LaborAndRelatedExpense": { "auth_ref": [ "r522" ], "calculation": { "http://igen.com/role/ConsolidatedStatementsOfOperations": { "order": 7.0, "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of expense for salary, wage, profit sharing; incentive and equity-based compensation; and other employee benefit.", "label": "Payroll and related" } } }, "localname": "LaborAndRelatedExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://igen.com/role/ConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_LandSubjectToGroundLeases": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Area of land subject to a ground lease.", "label": "Lease for office space under an operating lease" } } }, "localname": "LandSubjectToGroundLeases", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://igen.com/role/CommitmentsAndContingenciesDetailsNarrative" ], "xbrltype": "areaItemType" }, "us-gaap_LeaseCostTableTextBlock": { "auth_ref": [ "r588" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of lessee's lease cost. Includes, but is not limited to, interest expense for finance lease, amortization of right-of-use asset for finance lease, operating lease cost, short-term lease cost, variable lease cost and sublease income.", "label": "Summary of Operating Lease Expense" } } }, "localname": "LeaseCostTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://igen.com/role/CommitmentsAndContingenciesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_LeaseExpirationDate1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Date which lease or group of leases is set to expire, in YYYY-MM-DD format.", "label": "Operating lease expired date" } } }, "localname": "LeaseExpirationDate1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://igen.com/role/CommitmentsAndContingenciesDetailsNarrative" ], "xbrltype": "dateItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount": { "auth_ref": [ "r394" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.", "label": "[Lessee, Operating Lease, Liability, Undiscounted Excess Amount]", "negatedLabel": "Less imputed interest" } } }, "localname": "LesseeOperatingLeaseLiabilityUndiscountedExcessAmount", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://igen.com/role/CommitmentsAndContingenciesDetails2" ], "xbrltype": "monetaryItemType" }, "us-gaap_Liabilities": { "auth_ref": [ "r17", "r172", "r239", "r265", "r266", "r268", "r269", "r270", "r271", "r272", "r274", "r275", "r367", "r370", "r371", "r377", "r488", "r545", "r592", "r593" ], "calculation": { "http://igen.com/role/ConsolidatedBalanceSheets": { "order": 23.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.", "label": "[Liabilities]", "totalLabel": "Total Liabilities" } } }, "localname": "Liabilities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://igen.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesAndStockholdersEquity": { "auth_ref": [ "r12", "r121", "r131", "r505", "r527", "r540", "r586" ], "calculation": { "http://igen.com/role/ConsolidatedBalanceSheets": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.", "label": "[Liabilities and Equity]", "totalLabel": "Total Liabilities and Stockholders' Deficit" } } }, "localname": "LiabilitiesAndStockholdersEquity", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://igen.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesAndStockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Liabilities and Stockholders' Deficit" } } }, "localname": "LiabilitiesAndStockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://igen.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_LiabilitiesCurrent": { "auth_ref": [ "r19", "r144", "r172", "r239", "r265", "r266", "r268", "r269", "r270", "r271", "r272", "r274", "r275", "r367", "r370", "r371", "r377", "r505", "r545", "r592", "r593" ], "calculation": { "http://igen.com/role/ConsolidatedBalanceSheets": { "order": 16.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.", "label": "[Liabilities, Current]", "totalLabel": "Total Current Liabilities" } } }, "localname": "LiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://igen.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesCurrentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Current Liabilities" } } }, "localname": "LiabilitiesCurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://igen.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_LineOfCreditFacilityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Share Purchase Warrants" } } }, "localname": "LineOfCreditFacilityAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_LineOfCreditFacilityBorrowingCapacityDescription": { "auth_ref": [ "r515", "r517" ], "lang": { "en-us": { "role": { "documentation": "Description of the credit facility's borrowing capacity including discussion of how the borrowing capacity is determined (for example, borrowing capacity based on the amount of current assets).", "label": "Additional proceeding, description" } } }, "localname": "LineOfCreditFacilityBorrowingCapacityDescription", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://igen.com/role/ConvertibleDebenturesAndNotesPayableDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_LongTermDebt": { "auth_ref": [ "r4", "r120", "r129", "r283", "r293", "r494", "r495" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, excluding unamortized premium (discount) and debt issuance cost, of long-term debt. Excludes lease obligation.", "label": "[Long-Term Debt]", "verboseLabel": "Total" } } }, "localname": "LongTermDebt", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://igen.com/role/ConvertibleDebenturesAndNotesPayableDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive": { "auth_ref": [ "r66", "r176", "r549" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Thereafter" } } }, "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://igen.com/role/ConvertibleDebenturesAndNotesPayableDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths": { "auth_ref": [ "r66", "r176", "r287" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "2023" } } }, "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://igen.com/role/ConvertibleDebenturesAndNotesPayableDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive": { "auth_ref": [ "r66", "r176", "r287" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "2027" } } }, "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://igen.com/role/ConvertibleDebenturesAndNotesPayableDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour": { "auth_ref": [ "r66", "r176", "r287" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "2026" } } }, "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://igen.com/role/ConvertibleDebenturesAndNotesPayableDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree": { "auth_ref": [ "r66", "r176", "r287" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "2025" } } }, "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://igen.com/role/ConvertibleDebenturesAndNotesPayableDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo": { "auth_ref": [ "r66", "r176", "r287" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "2024" } } }, "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://igen.com/role/ConvertibleDebenturesAndNotesPayableDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongTermNotesPayable": { "auth_ref": [ "r22" ], "calculation": { "http://igen.com/role/ConsolidatedBalanceSheets": { "order": 17.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of notes payable (with maturities initially due after one year or beyond the operating cycle if longer), excluding current portion.", "label": "Notes payable, net of current portion" } } }, "localname": "LongTermNotesPayable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://igen.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_ManagementFeeExpense": { "auth_ref": [ "r116" ], "calculation": { "http://igen.com/role/ConsolidatedStatementsOfOperations": { "order": 6.0, "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of expenses related to the managing member or general partner for management of the day-to-day business functions of the limited liability company (LLC) or limited partnership (LP).", "label": "Management and consulting fees", "verboseLabel": "Management and consulting fees" } } }, "localname": "ManagementFeeExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://igen.com/role/ConsolidatedStatementsOfOperations", "http://igen.com/role/RelatedPartyTransactionsDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_MeasurementInputTypeAxis": { "auth_ref": [ "r376" ], "lang": { "en-us": { "role": { "documentation": "Information by type of measurement input used to determine value of asset and liability.", "label": "Measurement Input Type Axis" } } }, "localname": "MeasurementInputTypeAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://igen.com/role/IncomeTaxesDetails1" ], "xbrltype": "stringItemType" }, "us-gaap_MeasurementInputTypeDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Measurement input used to determine value of asset and liability." } } }, "localname": "MeasurementInputTypeDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://igen.com/role/IncomeTaxesDetails1" ], "xbrltype": "domainItemType" }, "us-gaap_NetCashProvidedByUsedInFinancingActivities": { "auth_ref": [ "r167" ], "calculation": { "http://igen.com/role/ConsolidatedStatementsOfCashFlows": { "order": 21.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.", "label": "[Net Cash Provided by (Used in) Financing Activities]", "totalLabel": "Net Cash Provided by Financing Activities" } } }, "localname": "NetCashProvidedByUsedInFinancingActivities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://igen.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Cash Flows from Financing Activities" } } }, "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://igen.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_NetCashProvidedByUsedInOperatingActivities": { "auth_ref": [ "r37", "r38", "r41" ], "calculation": { "http://igen.com/role/ConsolidatedStatementsOfCashFlows": { "order": 20.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect", "weight": 1.0 } }, "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.", "label": "[Net Cash Provided by (Used in) Operating Activities]", "totalLabel": "Net Cash Used in Operating Activities" } } }, "localname": "NetCashProvidedByUsedInOperatingActivities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://igen.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Cash Flows from Operating Activities" } } }, "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://igen.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_NetIncomeLoss": { "auth_ref": [ "r27", "r41", "r123", "r132", "r142", "r157", "r158", "r162", "r172", "r180", "r182", "r183", "r184", "r185", "r187", "r188", "r193", "r212", "r215", "r220", "r223", "r239", "r265", "r266", "r268", "r269", "r270", "r271", "r272", "r274", "r275", "r375", "r377", "r489", "r545" ], "calculation": { "http://igen.com/role/ConsolidatedStatementsOfOperations": { "order": 19.0, "parentTag": "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.", "label": "[Net Income (Loss) Attributable to Parent]", "totalLabel": "Net Loss", "verboseLabel": "Net loss" } } }, "localname": "NetIncomeLoss", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://igen.com/role/ConsolidatedStatementsOfOperations", "http://igen.com/role/ConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholdersDeficit" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic": { "auth_ref": [ "r182", "r183", "r184", "r185", "r189", "r190", "r194", "r196", "r212", "r215", "r220", "r223", "r489" ], "calculation": { "http://igen.com/role/ConsolidatedStatementsOfOperations": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders.", "label": "[Net Income (Loss) Available to Common Stockholders, Basic]", "totalLabel": "Net loss attributable to common stockholders" } } }, "localname": "NetIncomeLossAvailableToCommonStockholdersBasic", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://igen.com/role/ConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.", "label": "Recent Accounting Pronouncements" } } }, "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://igen.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_NonoperatingIncomeExpenseAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Other Income (Expense):" } } }, "localname": "NonoperatingIncomeExpenseAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://igen.com/role/ConsolidatedStatementsOfOperations" ], "xbrltype": "stringItemType" }, "us-gaap_NotesPayableCurrent": { "auth_ref": [ "r16" ], "calculation": { "http://igen.com/role/ConsolidatedBalanceSheets": { "order": 9.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying values as of the balance sheet date of the portions of long-term notes payable due within one year or the operating cycle if longer.", "label": "Notes payable, current portion" } } }, "localname": "NotesPayableCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://igen.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_OfficeEquipmentMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tangible personal property used in an office setting. Examples include, but are not limited to, computers, copiers and fax machine.", "label": "Office Equipment [Member]" } } }, "localname": "OfficeEquipmentMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://igen.com/role/SummaryOfSignificantAccountingPoliciesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_OperatingExpenses": { "auth_ref": [], "calculation": { "http://igen.com/role/ConsolidatedStatementsOfOperations": { "order": 10.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.", "label": "[Operating Expenses]", "totalLabel": "Total Expenses" } } }, "localname": "OperatingExpenses", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://igen.com/role/ConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingExpensesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Expenses:" } } }, "localname": "OperatingExpensesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://igen.com/role/ConsolidatedStatementsOfOperations" ], "xbrltype": "stringItemType" }, "us-gaap_OperatingIncomeLoss": { "auth_ref": [ "r212", "r215", "r220", "r223", "r489" ], "calculation": { "http://igen.com/role/ConsolidatedStatementsOfOperations": { "order": 15.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The net result for the period of deducting operating expenses from operating revenues.", "label": "[Operating Income (Loss)]", "totalLabel": "Loss Before Other Income (Expense)" } } }, "localname": "OperatingIncomeLoss", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://igen.com/role/ConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseCost": { "auth_ref": [ "r391", "r504" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of single lease cost, calculated by allocation of remaining cost of lease over remaining lease term. Includes, but is not limited to, single lease cost, after impairment of right-of-use asset, calculated by amortization of remaining right-of-use asset and accretion of lease liability.", "label": "Operating lease cost" } } }, "localname": "OperatingLeaseCost", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://igen.com/role/CommitmentsAndContingenciesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseExpense": { "auth_ref": [ "r587" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of operating lease expense. Excludes sublease income.", "label": "Rent and other office expenses" } } }, "localname": "OperatingLeaseExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://igen.com/role/RelatedPartyTransactionsDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseLiability": { "auth_ref": [ "r388" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease.", "label": "Present value of lease liabilities" } } }, "localname": "OperatingLeaseLiability", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://igen.com/role/CommitmentsAndContingenciesDetails2" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseLiabilityNoncurrent": { "auth_ref": [ "r388" ], "calculation": { "http://igen.com/role/ConsolidatedBalanceSheets": { "order": 15.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.", "label": "Operating lease liability, net of current portion" } } }, "localname": "OperatingLeaseLiabilityNoncurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://igen.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeasePayments": { "auth_ref": [ "r390", "r392" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.", "label": "Operating lease" } } }, "localname": "OperatingLeasePayments", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://igen.com/role/CommitmentsAndContingenciesDetails1" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseRightOfUseAsset": { "auth_ref": [ "r387" ], "calculation": { "http://igen.com/role/ConsolidatedBalanceSheets": { "order": 6.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's right to use underlying asset under operating lease.", "label": "Operating lease asset, net" } } }, "localname": "OperatingLeaseRightOfUseAsset", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://igen.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense": { "auth_ref": [ "r524" ], "calculation": { "http://igen.com/role/ConsolidatedStatementsOfCashFlows": { "order": 6.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of amortization expense for right-of-use asset from operating lease.", "label": "Amortization of right of use asset" } } }, "localname": "OperatingLeaseRightOfUseAssetAmortizationExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://igen.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent": { "auth_ref": [ "r393", "r504" ], "lang": { "en-us": { "role": { "documentation": "Weighted average discount rate for operating lease calculated at point in time.", "label": "Discount rate Operating lease" } } }, "localname": "OperatingLeaseWeightedAverageDiscountRatePercent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://igen.com/role/CommitmentsAndContingenciesDetails1" ], "xbrltype": "percentItemType" }, "us-gaap_OperatingLeasesFutureMinimumPaymentsDue": { "auth_ref": [ "r139", "r140" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of required minimum rental payments for leases having an initial or remaining non-cancelable letter-terms in excess of one year.", "label": "Total minimum lease payments" } } }, "localname": "OperatingLeasesFutureMinimumPaymentsDue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://igen.com/role/CommitmentsAndContingenciesDetails2" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent": { "auth_ref": [ "r139", "r140" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due in the next fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.", "label": "[Operating Leases, Future Minimum Payments Due, Next 12 Months]", "verboseLabel": "2023" } } }, "localname": "OperatingLeasesFutureMinimumPaymentsDueCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://igen.com/role/CommitmentsAndContingenciesDetails2" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears": { "auth_ref": [ "r139", "r140" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due in the second fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.", "label": "[Operating Leases, Future Minimum Payments, Due in Two Years]", "verboseLabel": "2024" } } }, "localname": "OperatingLeasesFutureMinimumPaymentsDueInTwoYears", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://igen.com/role/CommitmentsAndContingenciesDetails2" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLossCarryforwardsLimitationsOnUse": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "A description of the limitations on the use of all operating loss carryforwards available to reduce future taxable income.", "label": "Operating loss carry forward, expiry date, description" } } }, "localname": "OperatingLossCarryforwardsLimitationsOnUse", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://igen.com/role/IncomeTaxesDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Organization and Description of Business" } } }, "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_OtherNonoperatingIncomeExpense": { "auth_ref": [ "r32" ], "calculation": { "http://igen.com/role/ConsolidatedStatementsOfOperations": { "order": 16.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of income (expense) related to nonoperating activities, classified as other.", "label": "[Other Nonoperating Income (Expense)]", "totalLabel": "Total Other Income (Expense), net" } } }, "localname": "OtherNonoperatingIncomeExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://igen.com/role/ConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_PayablesAndAccrualsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Accounts Payable and Accrued Liabilities" } } }, "localname": "PayablesAndAccrualsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_PaymentsForRepurchaseOfRedeemablePreferredStock": { "auth_ref": [ "r35" ], "calculation": { "http://igen.com/role/ConsolidatedStatementsOfCashFlows": { "order": 18.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow for reacquisition of callable preferred stock.", "label": "[Payments for Repurchase of Redeemable Preferred Stock]", "negatedLabel": "Repurchase of Series B preferred stock" } } }, "localname": "PaymentsForRepurchaseOfRedeemablePreferredStock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://igen.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_PlanNameAxis": { "auth_ref": [ "r551", "r552", "r553", "r554", "r555", "r556", "r557", "r558", "r559", "r560", "r561", "r562", "r563", "r564", "r565", "r566", "r567", "r568", "r569", "r570", "r571", "r572", "r573", "r574", "r575", "r576" ], "lang": { "en-us": { "role": { "documentation": "Information by plan name for share-based payment arrangement.", "label": "Plan Name [Axis]" } } }, "localname": "PlanNameAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://igen.com/role/ConvertibleDebenturesAndNotesPayableDetailsNarrative", "http://igen.com/role/RedeemablePreferredStockAndStockholdersDeficitDetailsNarrative", "http://igen.com/role/RisksUncertaintiesDetailsNarrative", "http://igen.com/role/StockOptionsDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_PlanNameDomain": { "auth_ref": [ "r551", "r552", "r553", "r554", "r555", "r556", "r557", "r558", "r559", "r560", "r561", "r562", "r563", "r564", "r565", "r566", "r567", "r568", "r569", "r570", "r571", "r572", "r573", "r574", "r575", "r576" ], "lang": { "en-us": { "role": { "documentation": "Plan name for share-based payment arrangement." } } }, "localname": "PlanNameDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://igen.com/role/ConvertibleDebenturesAndNotesPayableDetailsNarrative", "http://igen.com/role/RedeemablePreferredStockAndStockholdersDeficitDetailsNarrative", "http://igen.com/role/RisksUncertaintiesDetailsNarrative", "http://igen.com/role/StockOptionsDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_PreferredStockConversionBasis": { "auth_ref": [ "r6", "r72" ], "lang": { "en-us": { "role": { "documentation": "Describe the conversion features of preferred stock if preferred stock is convertible. That is, shares of preferred stock into which another convertible security was converted, or shares of preferred stock into which another class of preferred stock was converted.", "label": "Stock conversion, description" } } }, "localname": "PreferredStockConversionBasis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://igen.com/role/RedeemablePreferredStockAndStockholdersDeficitDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_PreferredStockDividendRatePercentage": { "auth_ref": [ "r295" ], "lang": { "en-us": { "role": { "documentation": "The percentage rate used to calculate dividend payments on preferred stock.", "label": "Dividend, percentage" } } }, "localname": "PreferredStockDividendRatePercentage", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://igen.com/role/RedeemablePreferredStockAndStockholdersDeficitDetailsNarrative" ], "xbrltype": "percentItemType" }, "us-gaap_PreferredStockDividendsAndOtherAdjustments": { "auth_ref": [ "r50", "r534" ], "calculation": { "http://igen.com/role/ConsolidatedStatementsOfOperations": { "order": 20.0, "parentTag": "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate value of preferred stock dividends and other adjustments necessary to derive net income apportioned to common stockholders.", "label": "[Preferred Stock Dividends and Other Adjustments]", "negatedLabel": "Accrued and deemed dividend on redeemable convertible preferred stock" } } }, "localname": "PreferredStockDividendsAndOtherAdjustments", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://igen.com/role/ConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_PreferredStockParOrStatedValuePerShare": { "auth_ref": [ "r6", "r294" ], "lang": { "en-us": { "role": { "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.", "label": "Preferred stock, shares par value", "verboseLabel": "Preferred stock, par value" } } }, "localname": "PreferredStockParOrStatedValuePerShare", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://igen.com/role/ConsolidatedBalanceSheetsParenthetical", "http://igen.com/role/RedeemablePreferredStockAndStockholdersDeficitDetailsNarrative" ], "xbrltype": "perShareItemType" }, "us-gaap_PreferredStockSharesAuthorized": { "auth_ref": [ "r6" ], "lang": { "en-us": { "role": { "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.", "label": "Preferred stock, shares authorized", "verboseLabel": "Preferred stock shares authorized" } } }, "localname": "PreferredStockSharesAuthorized", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://igen.com/role/ConsolidatedBalanceSheetsParenthetical", "http://igen.com/role/RedeemablePreferredStockAndStockholdersDeficitDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockSharesIssued": { "auth_ref": [ "r6", "r294" ], "lang": { "en-us": { "role": { "documentation": "Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.", "label": "Preferred stock, shares issued" } } }, "localname": "PreferredStockSharesIssued", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://igen.com/role/ConsolidatedBalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockSharesOutstanding": { "auth_ref": [ "r6" ], "lang": { "en-us": { "role": { "documentation": "Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.", "label": "Preferred stock, shares outstanding" } } }, "localname": "PreferredStockSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://igen.com/role/ConsolidatedBalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockValue": { "auth_ref": [ "r6", "r505" ], "calculation": { "http://igen.com/role/ConsolidatedBalanceSheets": { "order": 21.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.", "label": "Series B preferred stock - Authorized - 5,000,000 shares with $0.001 par value, issued and outstanding - 3,750,000 and 5,000,000 shares, as of December 31, 2022 and 2021, respectively", "verboseLabel": "Preferred stock, value" } } }, "localname": "PreferredStockValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://igen.com/role/ConsolidatedBalanceSheets", "http://igen.com/role/RedeemablePreferredStockAndStockholdersDeficitDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_PreferredStockVotingRights": { "auth_ref": [ "r6", "r72" ], "lang": { "en-us": { "role": { "documentation": "Description of voting rights of nonredeemable preferred stock. Includes eligibility to vote and votes per share owned. Include also, if any, unusual voting rights.", "label": "Voting right" } } }, "localname": "PreferredStockVotingRights", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://igen.com/role/RedeemablePreferredStockAndStockholdersDeficitDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_ProceedsFromIssuanceOfCommonStock": { "auth_ref": [ "r33" ], "calculation": { "http://igen.com/role/ConsolidatedStatementsOfCashFlows": { "order": 19.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow from the additional capital contribution to the entity.", "label": "Proceeds from issuance of common stock" } } }, "localname": "ProceedsFromIssuanceOfCommonStock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://igen.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock": { "auth_ref": [ "r33" ], "calculation": { "http://igen.com/role/ConsolidatedStatementsOfCashFlows": { "order": 14.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Proceeds from issuance of capital stock which provides for a specific dividend that is paid to the shareholders before any dividends to common stockholders and which takes precedence over common stockholders in the event of liquidation.", "label": "Proceeds from issuance of preferred stock, net of offering costs", "verboseLabel": "Proceeds from issuance of stock" } } }, "localname": "ProceedsFromIssuanceOfPreferredStockAndPreferenceStock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://igen.com/role/ConsolidatedStatementsOfCashFlows", "http://igen.com/role/RedeemablePreferredStockAndStockholdersDeficitDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromNotesPayable": { "auth_ref": [ "r34" ], "calculation": { "http://igen.com/role/ConsolidatedStatementsOfCashFlows": { "order": 15.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow from a borrowing supported by a written promise to pay an obligation.", "label": "Proceeds from notes payable", "verboseLabel": "Proceeds from notes payable" } } }, "localname": "ProceedsFromNotesPayable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://igen.com/role/ConsolidatedStatementsOfCashFlows", "http://igen.com/role/ConvertibleDebenturesAndNotesPayableDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProfitLoss": { "auth_ref": [ "r142", "r157", "r158", "r166", "r172", "r180", "r187", "r188", "r212", "r215", "r220", "r223", "r239", "r265", "r266", "r268", "r269", "r270", "r271", "r272", "r274", "r275", "r365", "r368", "r369", "r375", "r377", "r452", "r489", "r502", "r503", "r521", "r545" ], "calculation": { "http://igen.com/role/ConsolidatedStatementsOfCashFlows": { "order": 2.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.", "label": "[Net Income (Loss), Including Portion Attributable to Noncontrolling Interest]", "negatedLabel": "Net loss" } } }, "localname": "ProfitLoss", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://igen.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_PropertyPlantAndEquipmentByTypeAxis": { "auth_ref": [ "r63" ], "lang": { "en-us": { "role": { "documentation": "Information by type of long-lived, physical assets used to produce goods and services and not intended for resale.", "label": "Long-Lived Tangible Asset [Axis]" } } }, "localname": "PropertyPlantAndEquipmentByTypeAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://igen.com/role/ConvertibleDebenturesAndNotesPayableDetailsNarrative", "http://igen.com/role/SummaryOfSignificantAccountingPoliciesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_PropertyPlantAndEquipmentDepreciationMethods": { "auth_ref": [ "r62" ], "lang": { "en-us": { "role": { "documentation": "Description of the methodology for computing depreciation for classes of depreciable assets.", "label": "Property, Plant and Equipment, Depreciation Methods" } } }, "localname": "PropertyPlantAndEquipmentDepreciationMethods", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://igen.com/role/SummaryOfSignificantAccountingPoliciesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_PropertyPlantAndEquipmentPolicyTextBlock": { "auth_ref": [ "r63", "r462", "r463" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.", "label": "Equipment" } } }, "localname": "PropertyPlantAndEquipmentPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://igen.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_PropertyPlantAndEquipmentTextBlock": { "auth_ref": [ "r63" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.", "label": "Summary of Property, Plant and Equipment" } } }, "localname": "PropertyPlantAndEquipmentTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://igen.com/role/SummaryOfSignificantAccountingPoliciesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_PropertyPlantAndEquipmentTypeDomain": { "auth_ref": [ "r61" ], "lang": { "en-us": { "role": { "documentation": "Listing of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale. Examples include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software." } } }, "localname": "PropertyPlantAndEquipmentTypeDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://igen.com/role/ConvertibleDebenturesAndNotesPayableDetailsNarrative", "http://igen.com/role/SummaryOfSignificantAccountingPoliciesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_PropertyPlantAndEquipmentUsefulLife": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment.", "label": "Property, Plant and Equipment, Useful Life" } } }, "localname": "PropertyPlantAndEquipmentUsefulLife", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://igen.com/role/SummaryOfSignificantAccountingPoliciesDetails" ], "xbrltype": "durationItemType" }, "us-gaap_ReceivablesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Accounts and Other Receivables" } } }, "localname": "ReceivablesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_RecognitionOfDeferredRevenue": { "auth_ref": [ "r135" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The amount of previously reported deferred or unearned revenue that was recognized as revenue during the period. For cash flows, this element primarily pertains to amortization of deferred credits on long-term arrangements. As a noncash item, it is deducted from net income when calculating cash provided by or used in operations using the indirect method.", "label": "Revenues recognized" } } }, "localname": "RecognitionOfDeferredRevenue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://igen.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_RedeemableConvertiblePreferredStockMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Description of type or class of redeemable convertible preferred stock. Convertible redeemable preferred stock possess conversion and redemption features. The stock has redemption features that are outside the control of the issuer.", "label": "Redeemable Convertible Preferred Stock [Member]" } } }, "localname": "RedeemableConvertiblePreferredStockMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://igen.com/role/ConsolidatedBalanceSheetsParenthetical" ], "xbrltype": "domainItemType" }, "us-gaap_RelatedPartyDomain": { "auth_ref": [ "r313", "r398", "r399" ], "lang": { "en-us": { "role": { "documentation": "Related parties include affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests." } } }, "localname": "RelatedPartyDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://igen.com/role/ConvertibleDebenturesAndNotesPayableDetailsNarrative", "http://igen.com/role/RedeemablePreferredStockAndStockholdersDeficitDetailsNarrative", "http://igen.com/role/RelatedPartyTransactionsDetailsNarrative", "http://igen.com/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_RelatedPartyTransactionsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Related Party Transactions" } } }, "localname": "RelatedPartyTransactionsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_RelatedPartyTransactionsByRelatedPartyAxis": { "auth_ref": [ "r313", "r398", "r438", "r439", "r440", "r441", "r442", "r443", "r444", "r445", "r446", "r447", "r448", "r449", "r591" ], "lang": { "en-us": { "role": { "documentation": "Information by type of related party. Related parties include, but not limited to, affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests.", "label": "Related Party [Axis]" } } }, "localname": "RelatedPartyTransactionsByRelatedPartyAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://igen.com/role/ConvertibleDebenturesAndNotesPayableDetailsNarrative", "http://igen.com/role/RedeemablePreferredStockAndStockholdersDeficitDetailsNarrative", "http://igen.com/role/RelatedPartyTransactionsDetailsNarrative", "http://igen.com/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_RelatedPartyTransactionsDisclosureTextBlock": { "auth_ref": [ "r396", "r397", "r399", "r400", "r401" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.", "label": "Related Party Transactions Disclosure [Text Block]", "verboseLabel": "Related Party Transactions" } } }, "localname": "RelatedPartyTransactionsDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://igen.com/role/RelatedPartyTransactions" ], "xbrltype": "textBlockItemType" }, "us-gaap_RepaymentsOfNotesPayable": { "auth_ref": [ "r36" ], "calculation": { "http://igen.com/role/ConsolidatedStatementsOfCashFlows": { "order": 17.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow for a borrowing supported by a written promise to pay an obligation.", "label": "[Repayments of Notes Payable]", "negatedLabel": "Repayment of notes payable" } } }, "localname": "RepaymentsOfNotesPayable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://igen.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_RetainedEarningsAccumulatedDeficit": { "auth_ref": [ "r9", "r73", "r130", "r458", "r459", "r505" ], "calculation": { "http://igen.com/role/ConsolidatedBalanceSheets": { "order": 20.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.", "label": "[Retained Earnings (Accumulated Deficit)]", "terseLabel": "Accumulated Deficit", "verboseLabel": "Accumulated Deficit" } } }, "localname": "RetainedEarningsAccumulatedDeficit", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://igen.com/role/ConsolidatedBalanceSheets", "http://igen.com/role/OrganizationAndDescriptionOfBusinessDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_RetainedEarningsMember": { "auth_ref": [ "r141", "r177", "r178", "r179", "r181", "r186", "r188", "r240", "r332", "r333", "r334", "r354", "r355", "r374", "r455", "r457" ], "lang": { "en-us": { "role": { "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.", "label": "Retained Earnings [Member]", "verboseLabel": "Accumulated Deficit" } } }, "localname": "RetainedEarningsMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://igen.com/role/ConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholdersDeficit" ], "xbrltype": "domainItemType" }, "us-gaap_RevenueRecognitionDeferredRevenue": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for recognizing unearned income or deferred revenue related to transactions involving the sale of a product or performance of services.", "label": "Revenue Recognition and Deferred Revenue" } } }, "localname": "RevenueRecognitionDeferredRevenue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://igen.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_Revenues": { "auth_ref": [ "r164", "r172", "r208", "r209", "r214", "r218", "r219", "r225", "r226", "r228", "r239", "r265", "r266", "r268", "r269", "r270", "r271", "r272", "r274", "r275", "r377", "r452", "r545" ], "calculation": { "http://igen.com/role/ConsolidatedStatementsOfOperations": { "order": 3.0, "parentTag": "us-gaap_GrossProfit", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).", "label": "[Revenues]", "totalLabel": "Total Revenues" } } }, "localname": "Revenues", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://igen.com/role/ConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_RevenuesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Revenues:" } } }, "localname": "RevenuesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://igen.com/role/ConsolidatedStatementsOfOperations" ], "xbrltype": "stringItemType" }, "us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The number of shares issued or sold by the subsidiary or equity method investee per stock transaction.", "label": "Common stock shares issued in connection with convertible debt/equity" } } }, "localname": "SaleOfStockNumberOfSharesIssuedInTransaction", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://igen.com/role/RedeemablePreferredStockAndStockholdersDeficitDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the (a) carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business (accounts payable); (b) other payables; and (c) accrued liabilities. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). An alternative caption includes accrued expenses.", "label": "Schedule of Accounts Payable and Accrued Liabilities" } } }, "localname": "ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://igen.com/role/AccountsPayableAndAccruedLiabilitiesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfAssumptionsUsedTableTextBlock": { "auth_ref": [ "r312" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of assumption used to determine benefit obligation and net periodic benefit cost of defined benefit plan. Includes, but is not limited to, discount rate, rate of compensation increase, expected long-term rate of return on plan assets and interest crediting rate.", "label": "Schedule of Assumptions Used to Value Conversion Features Outstanding" } } }, "localname": "ScheduleOfAssumptionsUsedTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://igen.com/role/DerivativeLiabilitiesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock": { "auth_ref": [ "r91" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets.", "label": "Schedule of Deferred Tax Assets" } } }, "localname": "ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://igen.com/role/IncomeTaxesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of derivative liabilities at fair value.", "label": "Schedule of Derivative Liabilities Measured at Fair Value" } } }, "localname": "ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://igen.com/role/DerivativeLiabilitiesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock": { "auth_ref": [ "r87" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations.", "label": "Schedule of Reconciliation of Income Tax Expense" } } }, "localname": "ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://igen.com/role/IncomeTaxesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock": { "auth_ref": [ "r66" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of maturity and sinking fund requirement for long-term debt.", "label": "Schedule of Maturities of Long-term Debt" } } }, "localname": "ScheduleOfMaturitiesOfLongTermDebtTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://igen.com/role/ConvertibleDebenturesAndNotesPayableTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfOtherAssetsTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the carrying amounts of other assets. This disclosure includes other current assets and other noncurrent assets.", "label": "Schedule of Accounts and Other Receivables" } } }, "localname": "ScheduleOfOtherAssetsTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://igen.com/role/AccountsAndOtherReceivablesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfStockOptionsRollForwardTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the change in stock options.", "label": "Schedule of Stock Options Roll Forward" } } }, "localname": "ScheduleOfStockOptionsRollForwardTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://igen.com/role/StockOptionsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock": { "auth_ref": [ "r74", "r76" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of warrants or rights issued. Warrants and rights outstanding are derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months. Disclose the title of issue of securities called for by warrants and rights outstanding, the aggregate amount of securities called for by warrants and rights outstanding, the date from which the warrants or rights are exercisable, and the price at which the warrant or right is exercisable.", "label": "Schedule of Activity of Share Purchase Warrants" } } }, "localname": "ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://igen.com/role/SharePurchaseWarrantsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock": { "auth_ref": [ "r501", "r579" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the change in unrecognized tax benefits.", "label": "Schedule of Unrecognized Tax Benefits" } } }, "localname": "ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://igen.com/role/IncomeTaxesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_SegmentOperatingActivitiesDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Operations of an entity including continuing and discontinued operations." } } }, "localname": "SegmentOperatingActivitiesDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://igen.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_SegmentReportingAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Segments" } } }, "localname": "SegmentReportingAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_SegmentReportingDisclosureTextBlock": { "auth_ref": [ "r205", "r206", "r207", "r212", "r213", "r217", "r221", "r222", "r223", "r224", "r225", "r227", "r228", "r229" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.", "label": "Segment Reporting Disclosure [Text Block]", "verboseLabel": "Segments" } } }, "localname": "SegmentReportingDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://igen.com/role/Segments" ], "xbrltype": "textBlockItemType" }, "us-gaap_SellingGeneralAndAdministrativeExpense": { "auth_ref": [ "r30" ], "calculation": { "http://igen.com/role/ConsolidatedStatementsOfOperations": { "order": 5.0, "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.", "label": "Selling, general and administrative expenses" } } }, "localname": "SellingGeneralAndAdministrativeExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://igen.com/role/ConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_SeriesAPreferredStockMember": { "auth_ref": [ "r519", "r520", "r550" ], "lang": { "en-us": { "role": { "documentation": "Series A preferred stock.", "label": "Series A Preferred Stock [Member]" } } }, "localname": "SeriesAPreferredStockMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://igen.com/role/RedeemablePreferredStockAndStockholdersDeficitDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_SeriesBPreferredStockMember": { "auth_ref": [ "r519", "r520", "r550" ], "lang": { "en-us": { "role": { "documentation": "Series B preferred stock.", "label": "Series B Preferred Stock [Member]" } } }, "localname": "SeriesBPreferredStockMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://igen.com/role/ConsolidatedBalanceSheets", "http://igen.com/role/ConsolidatedBalanceSheetsParenthetical" ], "xbrltype": "domainItemType" }, "us-gaap_ShareBasedCompensation": { "auth_ref": [ "r39" ], "calculation": { "http://igen.com/role/ConsolidatedStatementsOfCashFlows": { "order": 7.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of noncash expense for share-based payment arrangement.", "label": "Stock-based compensation" } } }, "localname": "ShareBasedCompensation", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://igen.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate": { "auth_ref": [ "r327" ], "lang": { "en-us": { "role": { "documentation": "The risk-free interest rate assumption that is used in valuing an option on its own shares.", "label": "Risk free interest rate" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://igen.com/role/DerivativeLiabilitiesDetails" ], "xbrltype": "percentItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate": { "auth_ref": [ "r325" ], "lang": { "en-us": { "role": { "documentation": "Rate of weighted-average expected volatility for award under share-based payment arrangement.", "label": "Expected volatility" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://igen.com/role/DerivativeLiabilitiesDetails" ], "xbrltype": "percentItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised": { "auth_ref": [ "r81" ], "lang": { "en-us": { "role": { "documentation": "Number of non-option equity instruments exercised by participants.", "label": "[Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Exercised]", "negatedLabel": "Number of warrants, exercised" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://igen.com/role/SharePurchaseWarrantsDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations": { "auth_ref": [ "r82" ], "lang": { "en-us": { "role": { "documentation": "Number of shares under non-option equity instrument agreements for which rights to exercise lapsed.", "label": "[Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Expirations]", "negatedLabel": "Number of warrants, expired" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://igen.com/role/SharePurchaseWarrantsDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted": { "auth_ref": [ "r80" ], "lang": { "en-us": { "role": { "documentation": "Net number of non-option equity instruments granted to participants.", "label": "Number of warrants, issued" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://igen.com/role/SharePurchaseWarrantsDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber": { "auth_ref": [ "r77", "r79" ], "lang": { "en-us": { "role": { "documentation": "Number of equity instruments other than options outstanding, including both vested and non-vested instruments.", "label": "[Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Outstanding, Number]", "periodEndLabel": "Number of warrants, ending balance", "periodStartLabel": "Number of warrants, beginning balance" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://igen.com/role/SharePurchaseWarrantsDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod": { "auth_ref": [ "r321" ], "lang": { "en-us": { "role": { "documentation": "Number of options or other stock instruments for which the right to exercise has lapsed under the terms of the plan agreements.", "label": "[Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Expirations in Period]", "negatedLabel": "Number of options, Cancelled / Forfeited" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://igen.com/role/StockOptionsDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross": { "auth_ref": [ "r319" ], "lang": { "en-us": { "role": { "documentation": "Gross number of share options (or share units) granted during the period.", "label": "Number of options, Granted" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://igen.com/role/StockOptionsDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber": { "auth_ref": [ "r317", "r318" ], "lang": { "en-us": { "role": { "documentation": "Number of options outstanding, including both vested and non-vested options.", "label": "[Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number]", "periodEndLabel": "Number of options, ending balance", "periodStartLabel": "Number of options, beginning balance", "verboseLabel": "Options Outstanding, Number of shares (in Shares)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://igen.com/role/StockOptionsDetails", "http://igen.com/role/StockOptionsDetails1" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice": { "auth_ref": [ "r317", "r318" ], "lang": { "en-us": { "role": { "documentation": "Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.", "label": "[Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price]", "periodEndLabel": "Weighted average exercise price, ending balance", "periodStartLabel": "Weighted average exercise price, beginning balance" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://igen.com/role/SharePurchaseWarrantsDetails", "http://igen.com/role/StockOptionsDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice": { "auth_ref": [ "r320" ], "lang": { "en-us": { "role": { "documentation": "Weighted average price at which option holders acquired shares when converting their stock options into shares.", "label": "Weighted average exercise price, exercised", "verboseLabel": "Weighted average exercise price, Exercised" } } }, "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://igen.com/role/SharePurchaseWarrantsDetails", "http://igen.com/role/StockOptionsDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice": { "auth_ref": [ "r321" ], "lang": { "en-us": { "role": { "documentation": "Weighted average price at which grantees could have acquired the underlying shares with respect to stock options of the plan that expired.", "label": "Weighted average exercise price, expired", "verboseLabel": "Weighted average exercise price Cancelled / Forfeited" } } }, "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://igen.com/role/SharePurchaseWarrantsDetails", "http://igen.com/role/StockOptionsDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice": { "auth_ref": [ "r319" ], "lang": { "en-us": { "role": { "documentation": "Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.", "label": "Weighted average exercise price, issued", "verboseLabel": "Weighted average exercise price, Granted" } } }, "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://igen.com/role/SharePurchaseWarrantsDetails", "http://igen.com/role/StockOptionsDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy": { "auth_ref": [ "r316", "r322", "r323", "r324", "r325", "r328", "r335", "r336" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for award under share-based payment arrangement. Includes, but is not limited to, methodology and assumption used in measuring cost.", "label": "Stock-based Compensation" } } }, "localname": "ShareBasedCompensationOptionAndIncentivePlansPolicy", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://igen.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis": { "auth_ref": [ "r85" ], "lang": { "en-us": { "role": { "documentation": "Information by range of option prices pertaining to options granted.", "label": "Share Based Compensation Shares Authorized Under Stock Option Plans By Exercise Price Range Axis" } } }, "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://igen.com/role/StockOptionsDetails1" ], "xbrltype": "stringItemType" }, "us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain": { "auth_ref": [ "r86" ], "lang": { "en-us": { "role": { "documentation": "Supplementary information on outstanding and exercisable share awards as of the balance sheet date which stratifies outstanding options by ranges of exercise prices." } } }, "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://igen.com/role/StockOptionsDetails1" ], "xbrltype": "domainItemType" }, "us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions": { "auth_ref": [ "r83" ], "lang": { "en-us": { "role": { "documentation": "The number of shares reserved for issuance pertaining to the outstanding exercisable stock options as of the balance sheet date in the customized range of exercise prices for which the market and performance vesting condition has been satisfied.", "label": "Options Exercisable, Number of shares (in Shares)" } } }, "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://igen.com/role/StockOptionsDetails1" ], "xbrltype": "sharesItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1": { "auth_ref": [ "r324" ], "lang": { "en-us": { "role": { "documentation": "Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.", "label": "Expected life (in years)" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://igen.com/role/DerivativeLiabilitiesDetails" ], "xbrltype": "durationItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of options vested.", "label": "Number of options, Vested" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://igen.com/role/StockOptionsDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Weighted average grant-date fair value of options vested.", "label": "Weighted average exercise price, Vested" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://igen.com/role/StockOptionsDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1": { "auth_ref": [ "r78" ], "lang": { "en-us": { "role": { "documentation": "The weighted average price as of the balance sheet date at which grantees could acquire the underlying shares with respect to all outstanding stock options which are in the customized range of exercise prices.", "label": "Options Outstanding, Weighted average exercise price" } } }, "localname": "SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://igen.com/role/StockOptionsDetails1" ], "xbrltype": "perShareItemType" }, "us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2": { "auth_ref": [ "r84" ], "lang": { "en-us": { "role": { "documentation": "Weighted average remaining contractual term of outstanding stock options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "Options Outstanding, Weighted average remaining contractual life" } } }, "localname": "SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://igen.com/role/StockOptionsDetails1" ], "xbrltype": "durationItemType" }, "us-gaap_SharesIssued": { "auth_ref": [ "r71" ], "lang": { "en-us": { "role": { "documentation": "Number of shares of stock issued as of the balance sheet date, including shares that had been issued and were previously outstanding but which are now held in the treasury.", "label": "[Shares, Issued]", "periodEndLabel": "Balance, shares", "periodStartLabel": "Balance, shares" } } }, "localname": "SharesIssued", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://igen.com/role/ConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholdersDeficit" ], "xbrltype": "sharesItemType" }, "us-gaap_ShortTermDebtTextBlock": { "auth_ref": [ "r69" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for short-term debt.", "label": "Short-Term Debt [Text Block]", "verboseLabel": "Convertible Debentures and Notes Payable" } } }, "localname": "ShortTermDebtTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://igen.com/role/ConvertibleDebenturesAndNotesPayable" ], "xbrltype": "textBlockItemType" }, "us-gaap_ShortTermDebtTypeAxis": { "auth_ref": [ "r15" ], "lang": { "en-us": { "role": { "documentation": "Information by type of short-term debt arrangement.", "label": "Short-Term Debt, Type [Axis]" } } }, "localname": "ShortTermDebtTypeAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://igen.com/role/ConvertibleDebenturesAndNotesPayableDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ShortTermDebtTypeDomain": { "auth_ref": [ "r13" ], "lang": { "en-us": { "role": { "documentation": "Type of short-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing." } } }, "localname": "ShortTermDebtTypeDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://igen.com/role/ConvertibleDebenturesAndNotesPayableDetails" ], "xbrltype": "domainItemType" }, "us-gaap_SignificantAccountingPoliciesTextBlock": { "auth_ref": [ "r49", "r170" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for all significant accounting policies of the reporting entity.", "label": "Significant Accounting Policies [Text Block]", "verboseLabel": "Summary of Significant Accounting Policies" } } }, "localname": "SignificantAccountingPoliciesTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://igen.com/role/SummaryOfSignificantAccountingPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_SoftwareAndSoftwareDevelopmentCostsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Purchased software applications and internally developed software for sale, licensing or long-term internal use.", "label": "Software [Member]" } } }, "localname": "SoftwareAndSoftwareDevelopmentCostsMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://igen.com/role/SummaryOfSignificantAccountingPoliciesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_StatementClassOfStockAxis": { "auth_ref": [ "r149", "r150", "r151", "r172", "r191", "r192", "r195", "r196", "r199", "r200", "r239", "r265", "r268", "r269", "r270", "r274", "r275", "r294", "r295", "r297", "r301", "r308", "r377", "r466", "r514", "r525", "r533" ], "lang": { "en-us": { "role": { "documentation": "Information by the different classes of stock of the entity.", "label": "Statement Equity Components [Axis]" } } }, "localname": "StatementClassOfStockAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://igen.com/role/ConsolidatedBalanceSheets", "http://igen.com/role/ConsolidatedBalanceSheetsParenthetical", "http://igen.com/role/RedeemablePreferredStockAndStockholdersDeficitDetailsNarrative", "http://igen.com/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_StatementEquityComponentsAxis": { "auth_ref": [ "r25", "r71", "r141", "r160", "r161", "r162", "r177", "r178", "r179", "r181", "r186", "r188", "r198", "r240", "r310", "r332", "r333", "r334", "r354", "r355", "r374", "r378", "r379", "r380", "r381", "r382", "r383", "r395", "r455", "r456", "r457" ], "lang": { "en-us": { "role": { "documentation": "Information by component of equity.", "label": "Equity Components [Axis]" } } }, "localname": "StatementEquityComponentsAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://igen.com/role/ConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholdersDeficit" ], "xbrltype": "stringItemType" }, "us-gaap_StatementLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Statement [Line Items]" } } }, "localname": "StatementLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://igen.com/role/ConsolidatedBalanceSheets", "http://igen.com/role/ConsolidatedBalanceSheetsParenthetical", "http://igen.com/role/ConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholdersDeficit", "http://igen.com/role/ConvertibleDebenturesAndNotesPayableDetails", "http://igen.com/role/ConvertibleDebenturesAndNotesPayableDetailsNarrative", "http://igen.com/role/DerivativeLiabilitiesDetails", "http://igen.com/role/IncomeTaxesDetails1", "http://igen.com/role/IncomeTaxesDetails3", "http://igen.com/role/RedeemablePreferredStockAndStockholdersDeficitDetailsNarrative", "http://igen.com/role/RelatedPartyTransactionsDetailsNarrative", "http://igen.com/role/RisksUncertaintiesDetailsNarrative", "http://igen.com/role/SharePurchaseWarrantsDetails", "http://igen.com/role/SharePurchaseWarrantsDetails1", "http://igen.com/role/SharePurchaseWarrantsDetailsNarrative", "http://igen.com/role/StockOptionsDetails", "http://igen.com/role/StockOptionsDetails1", "http://igen.com/role/StockOptionsDetailsNarrative", "http://igen.com/role/SubsequentEventsDetailsNarrative", "http://igen.com/role/SummaryOfSignificantAccountingPoliciesDetails", "http://igen.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_StatementOfCashFlowsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Consolidated Statements of Cash Flows" } } }, "localname": "StatementOfCashFlowsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_StatementOfFinancialPositionAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Consolidated Balance Sheets" } } }, "localname": "StatementOfFinancialPositionAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_StatementOfStockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Consolidated Statements of Redeemable Convertible Preferred stock and Stockholders Deficit" } } }, "localname": "StatementOfStockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_StatementOperatingActivitiesSegmentAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Information by continuing and discontinuing operations.", "label": "Operating Activities [Axis]" } } }, "localname": "StatementOperatingActivitiesSegmentAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://igen.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_StatementTable": { "auth_ref": [ "r177", "r178", "r179", "r198", "r437" ], "lang": { "en-us": { "role": { "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.", "label": "Statement [Table]" } } }, "localname": "StatementTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://igen.com/role/ConsolidatedBalanceSheets", "http://igen.com/role/ConsolidatedBalanceSheetsParenthetical", "http://igen.com/role/ConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholdersDeficit", "http://igen.com/role/ConvertibleDebenturesAndNotesPayableDetails", "http://igen.com/role/ConvertibleDebenturesAndNotesPayableDetailsNarrative", "http://igen.com/role/DerivativeLiabilitiesDetails", "http://igen.com/role/IncomeTaxesDetails1", "http://igen.com/role/IncomeTaxesDetails3", "http://igen.com/role/RedeemablePreferredStockAndStockholdersDeficitDetailsNarrative", "http://igen.com/role/RelatedPartyTransactionsDetailsNarrative", "http://igen.com/role/RisksUncertaintiesDetailsNarrative", "http://igen.com/role/SharePurchaseWarrantsDetails", "http://igen.com/role/SharePurchaseWarrantsDetails1", "http://igen.com/role/SharePurchaseWarrantsDetailsNarrative", "http://igen.com/role/StockOptionsDetails", "http://igen.com/role/StockOptionsDetails1", "http://igen.com/role/StockOptionsDetailsNarrative", "http://igen.com/role/SubsequentEventsDetailsNarrative", "http://igen.com/role/SummaryOfSignificantAccountingPoliciesDetails", "http://igen.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities": { "auth_ref": [ "r24", "r71", "r72", "r73", "r286" ], "lang": { "en-us": { "role": { "documentation": "Number of shares issued during the period as a result of the conversion of convertible securities.", "label": "[Stock Issued During Period, Shares, Conversion of Convertible Securities]", "verboseLabel": "Common stock shares issued upon conversion of preferred stock and accrued dividend" } } }, "localname": "StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://igen.com/role/RedeemablePreferredStockAndStockholdersDeficitDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodSharesOther": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of shares of stock issued attributable to transactions classified as other.", "label": "Common stock shares issued duriing period shares" } } }, "localname": "StockIssuedDuringPeriodSharesOther", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://igen.com/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised": { "auth_ref": [ "r6", "r7", "r71", "r73", "r320" ], "lang": { "en-us": { "role": { "documentation": "Number of share options (or share units) exercised during the current period.", "label": "[Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period]", "terseLabel": "Number of options, exercised", "verboseLabel": "Number of warrants, exercised" } } }, "localname": "StockIssuedDuringPeriodSharesStockOptionsExercised", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://igen.com/role/SharePurchaseWarrantsDetailsNarrative", "http://igen.com/role/StockOptionsDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodValueOther": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Value of shares of stock issued attributable to transactions classified as other.", "label": "Common stock shares issued duriing period, value" } } }, "localname": "StockIssuedDuringPeriodValueOther", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://igen.com/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockOptionMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Contracts conveying rights, but not obligations, to buy or sell a specific quantity of stock at a specified price during a specified period (an American option) or at a specified date (a European option).", "label": "Stock Option [Member]" } } }, "localname": "StockOptionMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://igen.com/role/StockOptionsDetails", "http://igen.com/role/StockOptionsDetails1" ], "xbrltype": "domainItemType" }, "us-gaap_StockholdersEquity": { "auth_ref": [ "r7", "r10", "r11", "r59", "r505", "r527", "r540", "r586" ], "calculation": { "http://igen.com/role/ConsolidatedBalanceSheets": { "order": 22.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.", "label": "[Stockholders' Equity Attributable to Parent]", "periodEndLabel": "Balance, amount", "periodStartLabel": "Balance, amount", "totalLabel": "Total Stockholders' Deficit" } } }, "localname": "StockholdersEquity", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://igen.com/role/ConsolidatedBalanceSheets", "http://igen.com/role/ConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholdersDeficit" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Stockholders' Deficit" } } }, "localname": "StockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://igen.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_StockholdersEquityNoteDisclosureTextBlock": { "auth_ref": [ "r75", "r171", "r295", "r296", "r297", "r298", "r299", "r300", "r301", "r302", "r303", "r304", "r305", "r307", "r310", "r373" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.", "label": "Redeemable Preferred Stock and Stockholders' Deficit" } } }, "localname": "StockholdersEquityNoteDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://igen.com/role/RedeemablePreferredStockAndStockholdersDeficit" ], "xbrltype": "textBlockItemType" }, "us-gaap_SubsequentEventMember": { "auth_ref": [ "r384", "r403" ], "lang": { "en-us": { "role": { "documentation": "Identifies event that occurred after the balance sheet date but before financial statements are issued or available to be issued.", "label": "Subsequent Event [Member]" } } }, "localname": "SubsequentEventMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://igen.com/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_SubsequentEventTypeAxis": { "auth_ref": [ "r384", "r403" ], "lang": { "en-us": { "role": { "documentation": "Information by event that occurred after the balance sheet date but before financial statements are issued or available to be issued.", "label": "Subsequent Event Type Axis" } } }, "localname": "SubsequentEventTypeAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://igen.com/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_SubsequentEventTypeDomain": { "auth_ref": [ "r384", "r403" ], "lang": { "en-us": { "role": { "documentation": "Event that occurred after the balance sheet date but before financial statements are issued or available to be issued." } } }, "localname": "SubsequentEventTypeDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://igen.com/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_SubsequentEventsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Subsequent Events" } } }, "localname": "SubsequentEventsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_SubsequentEventsTextBlock": { "auth_ref": [ "r402", "r404" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.", "label": "Subsequent Events [Text Block]", "verboseLabel": "Subsequent Events" } } }, "localname": "SubsequentEventsTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://igen.com/role/SubsequentEvents" ], "xbrltype": "textBlockItemType" }, "us-gaap_SummaryOfIncomeTaxContingenciesTextBlock": { "auth_ref": [ "r88", "r89", "r90" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure for tax positions taken in the tax returns filed or to be filed for which it is more likely than not that the tax position will not be sustained upon examination by taxing authorities and other income tax contingencies. Includes, but is not limited to, interest and penalties, reconciliation of unrecognized tax benefits, unrecognized tax benefits that would affect the effective tax rate, tax years that remain subject to examination by tax jurisdictions, and information about positions for which it is reasonably possible that amounts unrecognized will significantly change within 12 months.", "label": "Schedule of Income Tax Provision" } } }, "localname": "SummaryOfIncomeTaxContingenciesTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://igen.com/role/IncomeTaxesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_SupplementalCashFlowInformationAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Supplemental Disclosures:", "verboseLabel": "Supplemental Cash Flows Information" } } }, "localname": "SupplementalCashFlowInformationAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://igen.com/role/CommitmentsAndContingenciesDetails1", "http://igen.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_TemporaryEquityAggregateAmountOfRedemptionRequirement": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate amount of redemption requirements for each class or type of redeemable stock classified as temporary equity for each of the five years following the latest balance sheet date. The redemption requirement does not constitute an unconditional obligation that will be settled in a variable number of shares constituting a monetary value predominantly indexed to (a) a fixed monetary amount known at inception, (b) an amount inversely correlated with the residual value of the entity, or (c) an amount determined by reference to something other than the fair value of issuer's stock. Does not include mandatorily redeemable stock. The exception is if redemption is required upon liquidation or termination of the reporting entity.", "label": "Series A Preferred stock, discount" } } }, "localname": "TemporaryEquityAggregateAmountOfRedemptionRequirement", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://igen.com/role/ConsolidatedBalanceSheetsParenthetical" ], "xbrltype": "monetaryItemType" }, "us-gaap_TemporaryEquityCarryingAmountAttributableToParent": { "auth_ref": [ "r265", "r268", "r269", "r270", "r274", "r275" ], "calculation": { "http://igen.com/role/ConsolidatedBalanceSheets": { "order": 24.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying amount, attributable to parent, of an entity's issued and outstanding stock which is not included within permanent equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. Includes stock with a put option held by an ESOP and stock redeemable by a holder only in the event of a change in control of the issuer.", "label": "Authorized - 1,250,000 shares with $0.001 par value, 214,500 shares and 199,375 shares issued and outstanding as of December 31, 2022 and 2021, respectively, aggregate liquidation preference of $218,222 and $203,463 as of December 31, 2022 and 2021, respectively, and net of discount of $59,954 and $101,317 as of December 31, 2022 and 2021, respectively" } } }, "localname": "TemporaryEquityCarryingAmountAttributableToParent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://igen.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_TemporaryEquityLiquidationPreference": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The aggregate liquidation preference (or restrictions) of stock classified as temporary equity that has a preference in involuntary liquidation considerably in excess of the par or stated value of the shares. The liquidation preference is the difference between the preference in liquidation and the par or stated values of the share. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.", "label": "Series A Preferred stock, Aggregate liquidation preference" } } }, "localname": "TemporaryEquityLiquidationPreference", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://igen.com/role/ConsolidatedBalanceSheetsParenthetical" ], "xbrltype": "monetaryItemType" }, "us-gaap_TemporaryEquityParOrStatedValuePerShare": { "auth_ref": [ "r1", "r70" ], "lang": { "en-us": { "role": { "documentation": "Per share amount of par value or stated value of stock classified as temporary equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable.", "label": "Series A Preferred stock, shares par value" } } }, "localname": "TemporaryEquityParOrStatedValuePerShare", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://igen.com/role/ConsolidatedBalanceSheetsParenthetical" ], "xbrltype": "perShareItemType" }, "us-gaap_TemporaryEquitySharesAuthorized": { "auth_ref": [ "r5" ], "lang": { "en-us": { "role": { "documentation": "The maximum number of securities classified as temporary equity that are permitted to be issued by an entity's charter and bylaws. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.", "label": "Series A Preferred stock, shares authorized" } } }, "localname": "TemporaryEquitySharesAuthorized", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://igen.com/role/ConsolidatedBalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_TemporaryEquitySharesIssued": { "auth_ref": [ "r5" ], "lang": { "en-us": { "role": { "documentation": "The number of securities classified as temporary equity that have been sold (or granted) to the entity's shareholders. Securities issued include securities outstanding and securities held in treasury. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.", "label": "Series A Preferred stock, shares issued" } } }, "localname": "TemporaryEquitySharesIssued", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://igen.com/role/ConsolidatedBalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_TemporaryEquitySharesOutstanding": { "auth_ref": [ "r5" ], "lang": { "en-us": { "role": { "documentation": "The number of securities classified as temporary equity that have been issued and are held by the entity's shareholders. Securities outstanding equals securities issued minus securities held in treasury. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.", "label": "Series A Preferred stock, shares outstanding" } } }, "localname": "TemporaryEquitySharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://igen.com/role/ConsolidatedBalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_TradeAndOtherAccountsReceivablePolicy": { "auth_ref": [ "r136", "r137", "r138", "r232", "r233", "r235" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for accounts receivable.", "label": "Accounts Receivable" } } }, "localname": "TradeAndOtherAccountsReceivablePolicy", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://igen.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_TradeReceivablesHeldForSaleAmount": { "auth_ref": [ "r231" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, before valuation allowance, of accounts receivable held for sale.", "label": "Trade accounts receivable" } } }, "localname": "TradeReceivablesHeldForSaleAmount", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://igen.com/role/AccountsAndOtherReceivablesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain": { "auth_ref": [ "r237", "r238", "r292", "r306", "r372", "r405", "r406", "r407", "r408", "r409", "r410", "r411", "r412", "r413", "r414", "r415", "r416", "r417", "r418", "r419", "r420", "r421", "r422", "r423", "r424", "r425", "r426", "r427", "r428", "r429", "r430", "r431", "r432", "r433", "r434", "r537", "r538", "r539", "r601", "r602", "r603", "r604", "r605", "r606", "r607" ], "lang": { "en-us": { "role": { "documentation": "Instrument or contract that imposes a contractual obligation to deliver cash or another financial instrument or to exchange other financial instruments on potentially unfavorable terms and conveys a contractual right to receive cash or another financial instrument or to exchange other financial instruments on potentially favorable terms." } } }, "localname": "TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://igen.com/role/SharePurchaseWarrantsDetails1", "http://igen.com/role/StockOptionsDetails", "http://igen.com/role/StockOptionsDetails1" ], "xbrltype": "domainItemType" }, "us-gaap_UnrealizedGainLossOnDerivatives": { "auth_ref": [ "r40" ], "calculation": { "http://igen.com/role/ConsolidatedStatementsOfCashFlows": { "order": 13.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 }, "http://igen.com/role/ConsolidatedStatementsOfOperations": { "order": 14.0, "parentTag": "us-gaap_OtherNonoperatingIncomeExpense", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The net change in the difference between the fair value and the carrying value, or in the comparative fair values, of derivative instruments, including options, swaps, futures, and forward contracts, held at each balance sheet date, that was included in earnings for the period.", "label": "Change in fair value of derivative liabilities", "negatedLabel": "Change in fair value of derivative liabilities" } } }, "localname": "UnrealizedGainLossOnDerivatives", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://igen.com/role/ConsolidatedStatementsOfCashFlows", "http://igen.com/role/ConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_UnrecognizedTaxBenefits": { "auth_ref": [ "r337", "r343" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of unrecognized tax benefits.", "label": "Unrecognized tax position", "verboseLabel": "Unrecognized tex benefit" } } }, "localname": "UnrecognizedTaxBenefits", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://igen.com/role/AccountsPayableAndAccruedLiabilitiesDetails", "http://igen.com/role/IncomeTaxesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions": { "auth_ref": [ "r345" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase in unrecognized tax benefits resulting from tax positions that have been or will be taken in current period tax return.", "label": "Additions for tax positions related to current year" } } }, "localname": "UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://igen.com/role/IncomeTaxesDetails3" ], "xbrltype": "monetaryItemType" }, "us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions": { "auth_ref": [ "r344" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase in unrecognized tax benefits resulting from tax positions taken in prior period tax returns.", "label": "Additions for tax positions related to prior years" } } }, "localname": "UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://igen.com/role/IncomeTaxesDetails3" ], "xbrltype": "monetaryItemType" }, "us-gaap_UseOfEstimates": { "auth_ref": [ "r55", "r56", "r57", "r201", "r202", "r203", "r204" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.", "label": "Use of Estimates" } } }, "localname": "UseOfEstimates", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://igen.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" } }, "unitCount": 5 } }, "std_ref": { "r0": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "205", "URI": "https://asc.fasb.org/topic&trid=2122149", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r1": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(27)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r10": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r100": { "Name": "Accounting Standards Codification", "Paragraph": "4B", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624163-113959", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r101": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=d3e41675-113959", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r102": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "815", "URI": "https://asc.fasb.org/topic&trid=2229140", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r103": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r104": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r105": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "60", "SubTopic": "10", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=7493716&loc=d3e21868-110260", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r106": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "820", "URI": "https://asc.fasb.org/topic&trid=2155941", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r107": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13279-108611", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r108": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13531-108611", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r109": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13537-108611", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r11": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(31))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r110": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13537-108611", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r111": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=123596393&loc=d3e14172-108612", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r112": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "230", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=123444420&loc=d3e33268-110906", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r113": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "835", "URI": "https://asc.fasb.org/extlink&oid=124435984&loc=d3e28541-108399", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r114": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "835", "URI": "https://asc.fasb.org/extlink&oid=124435984&loc=d3e28555-108399", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r115": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "55", "SubTopic": "30", "Topic": "835", "URI": "https://asc.fasb.org/extlink&oid=114775985&loc=d3e28878-108400", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r116": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r117": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "25", "SubTopic": "20", "Topic": "940", "URI": "https://asc.fasb.org/extlink&oid=126941158&loc=d3e41242-110953", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r118": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(11))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r119": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(13))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r12": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(32))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r120": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(16))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r121": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(23))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r122": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(15))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r123": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(22))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r124": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04.9)", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r125": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "470", "Subparagraph": "(a)", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=123599511&loc=d3e64711-112823", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r126": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(16))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r127": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(12))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r128": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(16)(a))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r129": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(16))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r13": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19(a))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r130": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r131": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(25))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r132": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(18))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r133": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(8))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r134": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(13))", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=120401414&loc=d3e603758-122996", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r135": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585", "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef" }, "r136": { "Name": "Accounting Standards Codification", "Paragraph": "11B", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=123577603&loc=SL6953423-111524", "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef" }, "r137": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=123577603&loc=d3e5212-111524", "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef" }, "r138": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=123577603&loc=d3e5093-111524", "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef" }, "r139": { "Name": "Accounting Standards Codification", "Paragraph": "40", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(Note 3)", "Topic": "840", "URI": "https://asc.fasb.org/extlink&oid=123403562&loc=d3e38371-112697", "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef" }, "r14": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19(a),20,24)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r140": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "840", "URI": "https://asc.fasb.org/extlink&oid=123406913&loc=d3e41502-112717", "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef" }, "r141": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "105", "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r142": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "205", "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r143": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r144": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6904-107765", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r145": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=6361739&loc=d3e7789-107766", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r146": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(1))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r147": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(15))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r148": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(18))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r149": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(27)(b))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r15": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r150": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(28))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r151": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(29))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r152": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(4))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r153": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6)(b))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r154": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r155": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(9))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r156": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=51824906&loc=SL20225862-175312", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r157": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669619-108580", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r158": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669625-108580", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r159": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL116659661-227067", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r16": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19,20)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r160": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442407-227067", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r161": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442411-227067", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r162": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r163": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(210.5-03(11))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r164": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(1))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r165": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3367-108585", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r166": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3000-108585", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r167": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3521-108585", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r168": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r169": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4297-108586", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r17": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19-26)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r170": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18726-107790", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r171": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(e)(1))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r172": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(g)(1)(ii))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r173": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(h)(2))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r174": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(h))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r175": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(n))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r176": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.12-04(a))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e24072-122690", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r177": { "Name": "Accounting Standards Codification", "Paragraph": "23", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r178": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r179": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r18": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.20)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r180": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(2)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r181": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(3)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r182": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r183": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r184": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22583-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r185": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22595-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r186": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r187": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22658-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r188": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22663-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r189": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1448-109256", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r19": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.21)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r190": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1377-109256", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r191": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1252-109256", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r192": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1278-109256", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r193": { "Name": "Accounting Standards Codification", "Paragraph": "60B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r194": { "Name": "Accounting Standards Codification", "Paragraph": "60B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r195": { "Name": "Accounting Standards Codification", "Paragraph": "60B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r196": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r197": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "270", "URI": "https://asc.fasb.org/extlink&oid=126900757&loc=d3e543-108305", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r198": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "272", "URI": "https://asc.fasb.org/extlink&oid=125520817&loc=d3e70191-108054", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r199": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "272", "URI": "https://asc.fasb.org/extlink&oid=6373374&loc=d3e70434-108055", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r2": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(19))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r20": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.22(a)(1))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r200": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "272", "URI": "https://asc.fasb.org/extlink&oid=6373374&loc=d3e70478-108055", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r201": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r202": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r203": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6161-108592", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r204": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6191-108592", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r205": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8657-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r206": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8721-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r207": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8721-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r208": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r209": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r21": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.22(a)(2))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r210": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r211": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r212": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r213": { "Name": "Accounting Standards Codification", "Paragraph": "26", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8844-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r214": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r215": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r216": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r217": { "Name": "Accounting Standards Codification", "Paragraph": "31", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8924-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r218": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r219": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r22": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.22)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r220": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r221": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r222": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r223": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r224": { "Name": "Accounting Standards Codification", "Paragraph": "34", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8981-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r225": { "Name": "Accounting Standards Codification", "Paragraph": "40", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9031-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r226": { "Name": "Accounting Standards Codification", "Paragraph": "41", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r227": { "Name": "Accounting Standards Codification", "Paragraph": "41", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r228": { "Name": "Accounting Standards Codification", "Paragraph": "42", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9054-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r229": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "280", "URI": "https://asc.fasb.org/topic&trid=2134510", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r23": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.29)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r230": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=124259787&loc=d3e4647-111522", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r231": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=124259787&loc=d3e4428-111522", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r232": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=123577603&loc=d3e4975-111524", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r233": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=123577603&loc=d3e5033-111524", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r234": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=123577603&loc=d3e5074-111524", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r235": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=84159169&loc=d3e10133-111534", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r236": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "310", "URI": "https://asc.fasb.org/topic&trid=2196771", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r237": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "320", "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27232-111563", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r238": { "Name": "Accounting Standards Codification", "Paragraph": "5A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "320", "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=SL120269820-111563", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r239": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "323", "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r24": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.29-30)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r240": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r241": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=124255206&loc=SL82895884-210446", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r242": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919244-210447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r243": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919249-210447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r244": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919253-210447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r245": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919258-210447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r246": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919230-210447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r247": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=124269663&loc=SL82922888-210455", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r248": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=124269663&loc=SL82922895-210455", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r249": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=124269663&loc=SL82922900-210455", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r25": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.29-31)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r250": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "326", "URI": "https://asc.fasb.org/topic&trid=82887179", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r251": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "330", "URI": "https://asc.fasb.org/extlink&oid=116847112&loc=d3e4492-108314", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r252": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "330", "URI": "https://asc.fasb.org/extlink&oid=116847112&loc=d3e4556-108314", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r253": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "330", "URI": "https://asc.fasb.org/topic&trid=2126998", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r254": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=99380562&loc=d3e13770-109266", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r255": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r256": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13854-109267", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r257": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13854-109267", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r258": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "SubTopic": "20", "Topic": "350", "URI": "https://asc.fasb.org/subtopic&trid=2144439", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r259": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "440", "URI": "https://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r26": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(10))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r260": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "440", "URI": "https://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r261": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "450", "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14435-108349", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r262": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "450", "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r263": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "20", "Subparagraph": "(SAB Topic 5.Y.Q2)", "Topic": "450", "URI": "https://asc.fasb.org/extlink&oid=27011672&loc=d3e149879-122751", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r264": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "20", "Subparagraph": "(SAB Topic 5.Y.Q4)", "Topic": "450", "URI": "https://asc.fasb.org/extlink&oid=27011672&loc=d3e149879-122751", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r265": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(i))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r266": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r267": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iii)(B))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r268": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iv))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r269": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(5))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r27": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(20))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r270": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(i))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r271": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r272": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r273": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(C))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r274": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iv))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r275": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(5))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r276": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r277": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r278": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r279": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(e)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r28": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.1,2)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r280": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(f)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r281": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(h)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r282": { "Name": "Accounting Standards Codification", "Paragraph": "1D", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r283": { "Name": "Accounting Standards Codification", "Paragraph": "1D", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r284": { "Name": "Accounting Standards Codification", "Paragraph": "1D", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r285": { "Name": "Accounting Standards Codification", "Paragraph": "1E", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r286": { "Name": "Accounting Standards Codification", "Paragraph": "1E", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r287": { "Name": "Accounting Standards Codification", "Paragraph": "1E", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r288": { "Name": "Accounting Standards Codification", "Paragraph": "1F", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r289": { "Name": "Accounting Standards Codification", "Paragraph": "1F", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r29": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.2(a),(d))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r290": { "Name": "Accounting Standards Codification", "Paragraph": "1F", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(1)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r291": { "Name": "Accounting Standards Codification", "Paragraph": "1F", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(2)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r292": { "Name": "Accounting Standards Codification", "Paragraph": "1I", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r293": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(3)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466204&loc=SL6031897-161870", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r294": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r295": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r296": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(g)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r297": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r298": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(i)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r299": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r3": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(20))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r30": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.4)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r300": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r301": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r302": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r303": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496180-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r304": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r305": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r306": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r307": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r308": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21463-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r309": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21475-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r31": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.8)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r310": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.3-04)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r311": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(i)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r312": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(k)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r313": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(n)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r314": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(d)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r315": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r316": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r317": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(i)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r318": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(ii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r319": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(01)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r32": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.9)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r320": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(02)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r321": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(04)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r322": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r323": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r324": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(i)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r325": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(ii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r326": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(iii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r327": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(iv)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r328": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(v)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r329": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r33": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3255-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r330": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)(2)(i)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r331": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(l)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r332": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r333": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(f)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r334": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(f)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r335": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 14.D.2.Q6)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=122041274&loc=d3e301413-122809", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r336": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "718", "URI": "https://asc.fasb.org/topic&trid=2228938", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r337": { "Name": "Accounting Standards Codification", "Paragraph": "10B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=SL37586934-109318", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r338": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=d3e32247-109318", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r339": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=d3e32280-109318", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r34": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3255-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r340": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32672-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r341": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32687-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r342": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32705-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r343": { "Name": "Accounting Standards Codification", "Paragraph": "15A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r344": { "Name": "Accounting Standards Codification", "Paragraph": "15A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r345": { "Name": "Accounting Standards Codification", "Paragraph": "15A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(2)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r346": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32809-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r347": { "Name": "Accounting Standards Codification", "Paragraph": "19", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32840-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r348": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r349": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32847-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r35": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r350": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32857-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r351": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r352": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r353": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r354": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)(2)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r355": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)(3)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r356": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB TOPIC 6.I.5.Q1)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r357": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB TOPIC 6.I.7)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r358": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 6.I.Fact.1)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r359": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 6.I.Fact.2)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r36": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r360": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 11.C)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330215-122817", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r361": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=123586238&loc=d3e38679-109324", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r362": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "270", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=6424409&loc=d3e44925-109338", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r363": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=6424122&loc=d3e41874-109331", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r364": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "740", "URI": "https://asc.fasb.org/topic&trid=2144680", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r365": { "Name": "Accounting Standards Codification", "Paragraph": "19", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4569616-111683", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r366": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r367": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r368": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r369": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r37": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3521-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r370": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bb)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r371": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r372": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Subparagraph": "(f)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126731327&loc=d3e90205-114008", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r373": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Subparagraph": "(a)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126731327&loc=SL126733271-114008", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r374": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)(3)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r375": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r376": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bbb)", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r377": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r378": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32136-110900", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r379": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r38": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r380": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(b)", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r381": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(c)", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r382": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(d)", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r383": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r384": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=6450520&loc=d3e32618-110901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r385": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "835", "URI": "https://asc.fasb.org/extlink&oid=6450988&loc=d3e26243-108391", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r386": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "835", "URI": "https://asc.fasb.org/extlink&oid=124429444&loc=SL124452920-239629", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r387": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r388": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r389": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918643-209977", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r39": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r390": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918643-209977", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r391": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r392": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)(1)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r393": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)(4)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r394": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918701-209980", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r395": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)(3)(iii)(03)", "Topic": "848", "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r396": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r397": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r398": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r399": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r4": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(22))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r40": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r400": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39691-107864", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r401": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "850", "URI": "https://asc.fasb.org/topic&trid=2122745", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r402": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "855", "URI": "https://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r403": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "855", "URI": "https://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r404": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "855", "URI": "https://asc.fasb.org/topic&trid=2122774", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r405": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(2)(i)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r406": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(2)(ii)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r407": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(3)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r408": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(bb)(1)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r409": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(bb)(2)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r41": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r410": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(bb)(3)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r411": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(1)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r412": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(2)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r413": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(3)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r414": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(1)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r415": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(2)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r416": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(3)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r417": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r418": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=66007379&loc=d3e113888-111728", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r419": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=109249958&loc=SL34722452-111729", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r42": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3044-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r420": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(1)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122625-111746", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r421": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(2)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122625-111746", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r422": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(3)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122625-111746", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r423": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(4)(i)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122625-111746", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r424": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(1)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r425": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(2)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r426": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(3)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r427": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(4)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r428": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(5)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r429": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(6)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r43": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4273-108586", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r430": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(7)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r431": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(b)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r432": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(e)(1)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r433": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(e)(2)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r434": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(e)(3)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r435": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "910", "URI": "https://asc.fasb.org/extlink&oid=126937589&loc=SL119991595-234733", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r436": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "330", "Topic": "912", "URI": "https://asc.fasb.org/extlink&oid=6471895&loc=d3e55923-109411", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r437": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 11.L)", "Topic": "924", "URI": "https://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r438": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e61929-109447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r439": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e61929-109447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r44": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4297-108586", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r440": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62059-109447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r441": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62059-109447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r442": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62395-109447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r443": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62395-109447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r444": { "Name": "Accounting Standards Codification", "Paragraph": "33", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62479-109447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r445": { "Name": "Accounting Standards Codification", "Paragraph": "33", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62479-109447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r446": { "Name": "Accounting Standards Codification", "Paragraph": "35A", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=SL6807758-109447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r447": { "Name": "Accounting Standards Codification", "Paragraph": "35A", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=SL6807758-109447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r448": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(c)(1)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e61872-109447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r449": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(c)(2)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e61872-109447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r45": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4304-108586", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r450": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(10)(1))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r451": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "235", "Subparagraph": "(SX 210.9-05(b)(1))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399901&loc=d3e537907-122884", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r452": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "235", "Subparagraph": "(SX 210.9-05(b)(2))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399901&loc=d3e537907-122884", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r453": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(9))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r454": { "Name": "Accounting Standards Codification", "Paragraph": "7A", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Subparagraph": "(d)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124506351&loc=SL117782755-158439", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r455": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r456": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)(1)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r457": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)(2)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r458": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(g)(2)(i)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r459": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(h)(2)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r46": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4313-108586", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r460": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "310", "Topic": "954", "URI": "https://asc.fasb.org/extlink&oid=126942805&loc=d3e3115-115594", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r461": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "440", "Subparagraph": "(a)", "Topic": "954", "URI": "https://asc.fasb.org/extlink&oid=6491277&loc=d3e6429-115629", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r462": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "360", "Subparagraph": "(d)", "Topic": "958", "URI": "https://asc.fasb.org/extlink&oid=126982197&loc=d3e99779-112916", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r463": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "360", "Topic": "958", "URI": "https://asc.fasb.org/extlink&oid=126982197&loc=d3e99893-112916", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r464": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "310", "Subparagraph": "(c)", "Topic": "976", "URI": "https://asc.fasb.org/extlink&oid=6497875&loc=d3e22274-108663", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r465": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "310", "Subparagraph": "(b)", "Topic": "978", "URI": "https://asc.fasb.org/extlink&oid=126945304&loc=d3e27327-108691", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r466": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(a)", "Publisher": "SEC", "Section": "1402", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r467": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(b)", "Publisher": "SEC", "Section": "1402", "Subparagraph": "(1)", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r468": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(b)", "Publisher": "SEC", "Section": "1402", "Subparagraph": "(2)", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r469": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(b)", "Publisher": "SEC", "Section": "1402", "Subparagraph": "(3)", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r47": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4332-108586", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r470": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(b)", "Publisher": "SEC", "Section": "1402", "Subparagraph": "(4)", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r471": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(b)", "Publisher": "SEC", "Section": "1402", "Subparagraph": "(5)", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r472": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(c)", "Publisher": "SEC", "Section": "1402", "Subparagraph": "(1)(i)", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r473": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(c)", "Publisher": "SEC", "Section": "1402", "Subparagraph": "(1)(ii)", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r474": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(c)", "Publisher": "SEC", "Section": "1402", "Subparagraph": "(2)(i)", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r475": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(c)", "Publisher": "SEC", "Section": "1402", "Subparagraph": "(2)(ii)", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r476": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(c)", "Publisher": "SEC", "Section": "1402", "Subparagraph": "(2)(iii)", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r477": { "Name": "Regulation S-K (SK)", "Number": "229", "Publisher": "SEC", "Section": "1402", "Subsection": "Instruction 5", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r478": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(a)", "Publisher": "SEC", "Section": "1406", "Subparagraph": "(1)", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r479": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(a)", "Publisher": "SEC", "Section": "1406", "Subparagraph": "(2)", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r48": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=SL98516268-108586", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r480": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(a)", "Publisher": "SEC", "Section": "1406", "Subparagraph": "(3)", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r481": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(a)", "Publisher": "SEC", "Section": "1406", "Subparagraph": "(4)", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r482": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(a)", "Publisher": "SEC", "Section": "1406", "Subparagraph": "(5)", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r483": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(c)", "Publisher": "SEC", "Section": "1406", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r484": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r485": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r486": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r487": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18823-107790", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r488": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r489": { "Name": "Accounting Standards Codification", "Paragraph": "31", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8924-108599", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r49": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "235", "URI": "https://asc.fasb.org/topic&trid=2122369", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r490": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Subparagraph": "(e)", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=124267575&loc=SL82921835-210448", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r491": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "55", "SubTopic": "30", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=121590138&loc=SL82922954-210456", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r492": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=122137925&loc=d3e14258-109268", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r493": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r494": { "Name": "Accounting Standards Codification", "Paragraph": "69B", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495735-112612", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r495": { "Name": "Accounting Standards Codification", "Paragraph": "69C", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495737-112612", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r496": { "Name": "Accounting Standards Codification", "Paragraph": "69E", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495743-112612", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r497": { "Name": "Accounting Standards Codification", "Paragraph": "69F", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495745-112612", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r498": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r499": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "55", "SubTopic": "80", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=35742348&loc=SL14450788-114948", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r5": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(27)(b))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r50": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1377-109256", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r500": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r501": { "Name": "Accounting Standards Codification", "Paragraph": "217", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=126976462&loc=d3e36027-109320", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r502": { "Name": "Accounting Standards Codification", "Paragraph": "4J", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=120409616&loc=SL4591551-111686", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r503": { "Name": "Accounting Standards Codification", "Paragraph": "4K", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=120409616&loc=SL4591552-111686", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r504": { "Name": "Accounting Standards Codification", "Paragraph": "53", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=123414884&loc=SL77918982-209971", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r505": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "852", "URI": "https://asc.fasb.org/extlink&oid=84165509&loc=d3e56426-112766", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r506": { "Name": "Accounting Standards Codification", "Paragraph": "29F", "Publisher": "FASB", "Section": "55", "SubTopic": "40", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126561865&loc=SL117819544-158441", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r507": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r508": { "Name": "Form 10-K", "Number": "249", "Publisher": "SEC", "Section": "310", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r509": { "Name": "Form 20-F", "Number": "249", "Publisher": "SEC", "Section": "220", "Subsection": "f", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r51": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r510": { "Name": "Form 40-F", "Number": "249", "Publisher": "SEC", "Section": "240", "Subsection": "f", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r511": { "Name": "Forms 10-K, 10-Q, 20-F", "Number": "240", "Publisher": "SEC", "Section": "13", "Subsection": "a-1", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r512": { "Name": "Regulation S-T", "Number": "232", "Publisher": "SEC", "Section": "405", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r513": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "405", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r514": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "272", "URI": "https://asc.fasb.org/extlink&oid=125520817&loc=d3e70229-108054", "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef" }, "r515": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(19)(b))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r516": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(20))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r517": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(22)(b))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r518": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(26)(c))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r519": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(27)(b))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r52": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3630-109257", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r520": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(28))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r521": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r522": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(b)(4))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r523": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r524": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r525": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(d))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r526": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(f))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r527": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(g)(1)(ii))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r528": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(h)(1)(Note 1))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r529": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(k)(1))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r53": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r530": { "Name": "Accounting Standards Codification", "Paragraph": "23", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r531": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r532": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r533": { "Name": "Accounting Standards Codification", "Paragraph": "55", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e2626-109256", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r534": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r535": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=124259787&loc=d3e4647-111522", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r536": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=123577603&loc=d3e5074-111524", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r537": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "321", "URI": "https://asc.fasb.org/extlink&oid=126980263&loc=SL75117539-209714", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r538": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "321", "URI": "https://asc.fasb.org/extlink&oid=126980263&loc=SL75117539-209714", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r539": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "321", "URI": "https://asc.fasb.org/extlink&oid=126980263&loc=SL75117539-209714", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r54": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6404-108592", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r540": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "323", "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r541": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r542": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(h)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r543": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(c)", "Topic": "410", "URI": "https://asc.fasb.org/extlink&oid=6393242&loc=d3e13237-110859", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r544": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "450", "URI": "https://asc.fasb.org/topic&trid=2127136", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r545": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(ii))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r546": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iii))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r547": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r548": { "Name": "Accounting Standards Codification", "Paragraph": "1D", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r549": { "Name": "Accounting Standards Codification", "Paragraph": "1E", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r55": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6061-108592", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r550": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21463-112644", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r551": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r552": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r553": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(3)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r554": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(i)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r555": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(ii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r556": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r557": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r558": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(01)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r559": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(02)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r56": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6132-108592", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r560": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(03)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r561": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(04)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r562": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(i)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r563": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(ii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r564": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r565": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(01)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r566": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(02)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r567": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(03)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r568": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r569": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r57": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6143-108592", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r570": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r571": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r572": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(i)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r573": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(ii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r574": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(iii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r575": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(iv)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r576": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(v)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r577": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "35", "SubTopic": "740", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=126970579&loc=d3e23163-113944", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r578": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32687-109319", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r579": { "Name": "Accounting Standards Codification", "Paragraph": "15A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r58": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "275", "URI": "https://asc.fasb.org/topic&trid=2134479", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r580": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r581": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32621-109319", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r582": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r583": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r584": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 6.I.7)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r585": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)(3)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r586": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r587": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918638-209977", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r588": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r589": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r59": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 4.E)", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=122038336&loc=d3e74512-122707", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r590": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r591": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39603-107864", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r592": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "852", "URI": "https://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r593": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "852", "URI": "https://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r594": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(1)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r595": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(2)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r596": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(3)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r597": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(1)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r598": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(2)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r599": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(3)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r6": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(28))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r60": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "05", "SubTopic": "10", "Topic": "360", "URI": "https://asc.fasb.org/extlink&oid=109226317&loc=d3e202-110218", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r600": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "825", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=123600520&loc=SL75241803-196195", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r601": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(a)", "Publisher": "SEC", "Section": "1402", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r602": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(b)", "Publisher": "SEC", "Section": "1402", "Subparagraph": "(1)", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r603": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(b)", "Publisher": "SEC", "Section": "1402", "Subparagraph": "(2)", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r604": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(b)", "Publisher": "SEC", "Section": "1402", "Subparagraph": "(3)", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r605": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(c)", "Publisher": "SEC", "Section": "1402", "Subparagraph": "(2)(i)", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r606": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(c)", "Publisher": "SEC", "Section": "1402", "Subparagraph": "(2)(ii)", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r607": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(c)", "Publisher": "SEC", "Section": "1402", "Subparagraph": "(2)(iii)", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r61": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "360", "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r62": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "360", "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r63": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "360", "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r64": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 5.CC)", "Topic": "360", "URI": "https://asc.fasb.org/extlink&oid=27011434&loc=d3e125687-122742", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r65": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "440", "URI": "https://asc.fasb.org/topic&trid=2144648", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r66": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123465755&loc=d3e1835-112601", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r67": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "40", "SubTopic": "50", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126972273&loc=d3e12317-112629", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r68": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "40", "SubTopic": "50", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126972273&loc=d3e12355-112629", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r69": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "470", "URI": "https://asc.fasb.org/topic&trid=2208564", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r7": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(29))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r70": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Topic": "480", "URI": "https://asc.fasb.org/extlink&oid=122040564&loc=d3e177068-122764", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r71": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21463-112644", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r72": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21475-112644", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r73": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.3-04)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r74": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "50", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=6784392&loc=d3e188667-122775", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r75": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "505", "URI": "https://asc.fasb.org/topic&trid=2208762", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r76": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5047-113901", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r77": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(i)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r78": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(i)-(ii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r79": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(ii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r8": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(1))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r80": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r81": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r82": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(4)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r83": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(iii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r84": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r85": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r86": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(g)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r87": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32687-109319", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r88": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32718-109319", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r89": { "Name": "Accounting Standards Codification", "Paragraph": "15A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r9": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(3))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r90": { "Name": "Accounting Standards Codification", "Paragraph": "19", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32840-109319", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r91": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r92": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32632-109319", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r93": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 6.I.7)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r94": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5579240-113959", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r95": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5579245-113959", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r96": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=d3e41620-113959", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r97": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=d3e41638-113959", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r98": { "Name": "Accounting Standards Codification", "Paragraph": "4A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5618551-113959", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r99": { "Name": "Accounting Standards Codification", "Paragraph": "4B", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624163-113959", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" } }, "version": "2.2" } ZIP 82 0001640334-23-000658-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001640334-23-000658-xbrl.zip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�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
R"U%T__&'3'^ M]$H$(Y/+^9GY$&:[(+!Y"]0I6"MI,Q]E^1N_>T$DPRMZ^HQ@BFB/J+O@6XJH M*@(,=]"8LP%*PE=M@I2 S9>_VWDN./LU1&U"JR0%>T(+("'IV,R-.$N_Q+'_ M/=SO>1-2_,8N1E=PMID8>O>O*-G%9><>[A3PA6N^[6*4Y0^Y^98%NIC\/)4G M?FIJTF4?7%NBUJI<#)$LQZ/O>,1;'789B*9K8[?:BOO?NF#\C:]#&UZI+N:W MN!T3/ITZ\.TTY1'L9VU?V'P.X2[5SS^#*Q2$7FC;]U614>U:249@ M!9(*%TSBT_A&W'SXH\(_TMR1'Y;Q0[/ MLQ('\\Y_#<5X5P *Y&RE@W"Q=.*JO*_@PNN %\:)6D;(>(&],P"^RJ-!'M K MBHY(CE718'.PE(M;12!_)(L(7<+)#CH -A4913:0UF*/(](LW2\B>A+&A[HG M:!?U.*)6E7DM;$/M2YRAXKN2XXP[TAS()()6$<89QDYGZ_E\YX(MZQ2PB2U* M4!BL"^#5H3:*W_Q3'+TBS!X_\ KM\-..B6C%5!AOR*>N(G3I89<-9MN=I;?9 MSBSB15-,3JI%08E-44':@D]IE?PPI4LC^?,_3>BZ^$_SR<5RL[K %BQ]0;0^ MT7[(,O+]5L8D?(5$%.6]G)S$Y"K9+7I]K12/IW,_7_DSB!PP:>J2MN^("DJU MW9?10YW:88[%X2U6L^G.%:=DEY#RFWEWSG'*G[C=#_LLY#@1BBR3K>7IK P> MZOK^?*3$T=,C2@[5S95(5^Y0@VB1B%K#"V<<6_+GNWG@PD&I6\*.K6QQ(!IR M1SMPO$ !]K&:E-DB!SE;<@$0)<>P AXA%\TP";[-Q 'Z:XG;%$!3[CS=' M<=EP2W3B43+>FF=(CC_A8#J1/IHMG#C *XK9WNJJ^8/HT4L9>F:V-1W[&?:A M[::3E3/W\D+I^'M?)_>\W:I9VN6JP&'F0L4*KE"R#>TX8:@/R$?H0!U^)Z], M/5N498)>"JX_>W,QY'KKKV#ID--GD:?6+N#4NION7.&;D#SQ(ZM#Z<=[*;.$ M4YHE_ 'D"<27?[5LM1[1@3122-Y8A$*1'W9Y("[%RRQ+PMTQ(_H\QO=0LFGI MP<>RM9-5.:C-AR]=J-G&BE,N9XK>K4F7/<1+^ T/Z YA>S):3B\ED E+6 M$>Y[F#V#?YK\93*9XD-C EY)NN$%P)_-Q?(TBNR7IMOMQ7R]+/XI3%-RH4MS MODY=Y? &B^RWKI!'D^O!?(IY8233>(WZYO=@N%XSW=#*]F$_7FKQM MUZK0#4%S(^A,+\RL(T1K'JQ7$Q<"RU3E;%=$<2]TK+ZZRC+(N2/-04DB:!5# MG&',:8]VFYD+T>.= @J+F[2W+36SOR0F7\'L"XSZ!S"_6.?K!OFMR>[B?1G, M2D]5:5F$UC"#%1 $(M:*'33&Y!'R6[ATX<)2+EW[*ITVJZ7@_6L=N[.+Z7:B MA%\Q?*<7&\QCMII>3!9KMINY6*Q7%YO5]F(YGY7;G/>$XDO?IV4AX?X>AOYM M] F^A!D4AO>)1AN,K)0+7(NBY ^E&-I-YOC_'$"XDI"MW7A)A'$;^A_""'B, MSHH#\@%E,(R0?PV3"'\JZ:7G'0_'/2D>FN]!>-/33<7NJ&:[N3%WI4(JGJ[8 MG,C68KPC.S3UZ=-^%28MPZ@H=,)6Z,C:M>,; M^]1V&S\P=='9>:'1)23_7L/%DYMX4CI5MNL"T,#.W(6$'IELK>^XCI2\\FG5 MH0>R&#"7GIUON2LKKN-2BDM#WT> EB@P98=U+BX51.Z\S7P/J7_2Z=1\/2YE MIO9&Y-SFA9:^I+(+58H_1F [1E#ADDY:1%F#WN3N5%.I^B95D9A=XGAP&IB* M<9;O5WN)+;EDK29+.%J*N9X)TE&U4C38I(]0)F[=4\@;65P;>DZ_>_?[:%-8@9](< 'LFL-99=O-9(9<"'M5 M%E0)9K D=@UGM_2>1O4E%*,MXJLNL!1;;"B+4_9G_M2QNSBQD$J88C=LKN'I M[G39I_H&:B06D<4170JORGA6FVBZ14Z<&-0E50):Y?[6K;A+S8V;,K6U&$N= M#9PB*9UOM%E,EBXD,?426A!I ,H&$1"FV&JO3157M9PJZ>L!,QJC%B:ES>?KARTLGU44(>](V[MALZ?3XD\]V4> MC]KK$I!:@[)4%0ERN71Y[GJP7;L0N:(OL3HN+SN2NIS*:]$\T*L2V\I^T3G. MJU&R%!3HSU8N]#[J(W,3N:Z?X1MIS6I'^"XB6X!4.<#+*=C=A[> #0[",/%W(F0"%4Y55'FQ#F=IU3W,;V3RB[6 M.@[I'21%>U5O[<()1DM85>BYL1J_4Q[(/?!3Y:.H >N73M^%,V^LS:/8*:4U_A'J7X%/P:>JU*8KP!ABI% M<<4JBT#5?LVC=]?(6,=$WMQVR=5R/$#:5SS-!UM*G&7(DGU!;)>VW"PFIAP^ MG:DO?-'X*2[%6$?,:H=&-LQH]^0[9#%+@3CYI6R$_?C[-+L+2'],F@Z3?]Y? MX[TX5%!,8#*FJTOL>D27:'1>0'ZS<^*Z6%7.]DXMI76UG@@EP)LVR8%SQ$GY M)8G3]#Z) W[N>.5GEN,[F2)W*JL*I6NU#28#P9\^X__],V $MCL(M]^[6#FC M?83U .%"+3&>3.UVPA0";)1M U[6^[[^\8*BM/,H)!EOH8Z[2&AN_?;FX+Q_ MXW8^<<%'K2AF$TS%:-NE3K^B/6;W] N*L!I[THK0/X112%0@I9=R,06ZJQ(; M+'.@I4ZM]($2)0L?V*UG$Q<"P?O(W+Y:ICPNP!/CPGI(UO@ E(/5=I(]W,4) MUO(!T6HL*6TNCYXYDM1&FJ\W$A80I%1E;+FKXAODR2"6,SC*$ M?H41?*(.S1O48=SX0\W!1R9J%3R\<2RR>;%:>BY46>Z6L F<$P7K'Q%'Z7%/ MNYL$R+H9NCZ\[.,WA#YB@XEW@O3,1JY>/L(4^9_B ]&/>LD%KT.#WAS:M)6J M0E"9F+F0M]Y\XX))ZRDVMY[PAQTA GZ8( ]#KE@RK1S(6UM2I>UUGI0SV2+/ ME<-YAXQ\7^JU&YL5X21TZ6CU0*:.%*MM*A1$:YW>3QVRBL%V*G^5)0 MDK[UT["\:3>:(VR'[VB$O7N]!U$ MS/6PGFV@"ZN%IKBM%HM<0DBF]3+ RG!] ^Z8;T+KO)\%;*IO4_0 M(3P>TMOH%:49C>81O*&^S Q6-C]+W5KA\UZ<D /_=X]8 LXS_;U&"X)[$<_\"PX@L"'?1J0^[".B=5.80K:A %;H=)'DI MY<5TXD)0A):PK2ON9_PW!,((!# L>D\07)8,RDZW]IM=$OU2HB#"*E[_(,O, M,4R?R3>'OTFT$U[3=M,9O+Q55:)VI=M%Q"Y5U]O5TH56WYKBMD(!,#FQAZA& MR6"YRV@G7"LGR]LH0_A591)G<6,(.ZNM?6\W>L#IEDU+1),5?=F94BIC.C@'M:E%$QA MWYM!4R$SW?X?#8'Y[EK^J:K#B)KQ!"E-G]8+,>H?&@5]+MS;J,K9=B!1K%4I M6\"S8RE.[J\;_.^?X@C+=L3BG1)NF,N4C7N$/U"*MRT)C!,_C&#R=INA0XKU MPH_*R(T[?2?,!/(M_&B/8[E%T\EDXXR-,J9M$V]?4 :HOWO'_-WW2?P:IN1D MC?]:((\^S_JN973XF9L3\PF#?YCOUHG.K$:4Y.P8*S<*@,PR.#VZDOA8?,O5 MK_<"U!\'BN?97$RP9/F:EH9"?O%;&\"R/'>+Q^O]QE%Q%JE,S9^AJ/D.CAV^HK\Q]Q>?=/!9-Q4DS*QI/R9@1=WMR MZG!5O8E\J==!<:KFC@H0>K],>Y5X1L;WS(70I#XRMXQ6L_M:R89BG+FC*IP< MV$E\69DVWHJ6J)RYY\\OYZ4V@U?W\X#9HH+IB"G"M@;$E\4!7%*;ASIE)C M6>8/Z]YJC=T1QJY(:[ &@(XRM1( *H1Y4<[5OU<4I=V-L@"9UQ1%2[_!&*3M\=-!9 +!.>"UX> >LNL$83SP67 MGX:HK;(IE *<2,#OA&B<7:9"9_:4=6:XK'>EKRXQ/9@8V@;T5J_< &AS8%G_ M\\UT:;T(YIFRM\N?=IA*Y@ J&WG\SIC:SEVKG 2Y$):,L]+)M0U$X2"6*[Z# MDZ4+[L0.\02-6K\ZX-&^]/V0A#[ _3T,_=OH$WP),[B7PJ6#QF"ZF(KPM:PP M&4'N]=ONG-C[:8C:NFDI20&A_7 ;@9S:4H7?#(81\@OO@7AZ^"/S&L9HYIOR MNF$#OXM3)/,HJXC*N0$['HZT4)(CFVCYU"BI;+9<\ !(FKE1?5TN7WL#PL:# M@F"@+8:H(#O=R'QL;)C$VV#Y>%/EVA6$/E5OEPQF;LQ)L(7675CJ8@J:RGUL M;E)5D#/FR;>CI5"K.8\W6_O&\A)>\$N+\4N&228S_F(AVSYO_%U;;/M, MNMM0V6H\I8T+)UP=/*%:MVMLU 5@XRQ]=BWW(=_+U!R5E^2"FYFI4H.JGV"' MJ,(/$1[.;_0J6C59BZ<@=RS4C?9-G'R"Z?,7E-T%I+1[2F\<\OH+C)*[ )S- MT]3J.Y#RIQ7Z3(:Y89YOD,WCW BJM%;ZO#-8*J-]&B.N M&GE<;!D\>!=QWP7OY2F3&@*ZIBHEGA7IF!E<>I.9S;XN_246143[9=PH<0H+ M@#H*]MAE1DK+2K44H-].+9Q,O$WIR<@0+L]2LT1I+RYYSL-B;?].; #Y.=$% M.4N1C64&N!$<.^I60U--\?ZB)R,W,2W82?3BPO(\IINI_8C$ >0?#-,C[A&( MZX <7PLE&PY!L5U6)#2$62TU2HPJ4;' DL5NYEG?&_20MU7W*F=10>#'YH9@ M5"/:H8/8:"H2N@$X@5%4HLJ+R/E;JS7O^LK;#W &?&<58\W\I?D9L-M#UD5I M^+"OIDCK2"\G8PUYO(T?V(QZZ2VP^'A>74E!2/E43N8&'%,B-;K=3UV4CN"N MPY4D)\N;@WN+E?.XXPG<%W>6[-WU#Y1X88K(KV6PX924'"#D,*= MP?F\'AA&X=QD7S6&]MLT+>B"KI?R$H?Q8;2#\;K\?[W7Q)/=8)'<9Y2\$EFICJ0S7BE\13:>PO:D MXTTA7D'H$XHE@_.TOV "[5^**8LIZU;G56C'M*FY$UD\RF'D3 M_=EV.GHYO7ZXX8FICIL1[0W9KN]1FIZ,[=]@DD!I/$PWC2G_NZ+P)U=[!P&; MH& %K59C[R%JRX&>4]<6MN\Y@W&O?H1R2VYY.FFL TIT=]-!P$IE![N9_4.[ MGJB:@#)R[U+9)!)'0^7:Z1Z^D<1 B[B;%6K8, MF"?\( "V8H$/AS#+N\[?12P$_',8H3YFN(.5=2@KJ:J 9RD?EDX$X6)I,[5B M. TTD5UP)FX6VOZ+U:+ L@V4O3,4P/N8Z0Y6K@).<,SCA*_"!'F87,F3(R0R']DH%Y\7U0T]-<^SD,@2KH3B"W'5HF"+Q\);(HU417=U><8CLXTK17K4H6,^Y-=S93V_2E%4;5V;M5267N^+FT#-?'3SLH4Y) M.1D(I0Q8M":<3I!S>S,]T14AVLC(K_JNC)M#@79:UK&#AW.P5;>=4@;LKFFY M6WC60Q#.$WT0V(YH;1_0"WY3SS#53Q%5)C56N%I+E4JY:B4Z5B;*QT='ZWE[ MO21N5X8LF-1R]QI5_T:UF9UZB$VE,JDKX!,81D4Z-I7+'9I8WUKVDK@O^"RZ M3-DWI%%8<+?;SB>F*@VS:G?7D;0#IUC$WN4FQWSAKJ#=#,2"O&Y2,P(F3I1;@<1!FHFO7 MTZ\LDMW;3;:C[_!T6GCSQ1OGPG6 +MO-=RW4QVR7; T(N+#.<$3J;OUZ

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�(QPW<0Z<.ET(EM&2$WU; M+(3Q&<*"W\PW ;G\/I5I4&$K% OVPGG[](6EGS"1J%]Y@H?4/?O.V)^2@/3 M'AW737"0B'*5N4'BJQGW#BOV%!W5C,%3@E^%.)<]DU+HP&-J+V>)==\;\[I< M_ 0!ODZ?37R4S@)XYW*:.&2E._-HA7?F!G$]=HVN\/ M"BS21([#/8 3V+BZ&+-H%99+S'9+E9VE=P0EQ8;8RW+9.=\T'MUG91K$WB:W"4S^[K%ENHLN&82B-NM.*L3,;V, M^Q1S ]S@OY:.SSYB-:,C?S%;+;EI0<-'FP+_Q]XLV&.TE4 M_*%WV1;+@XZU'ES&JYHCG $_=BKF]MW(]F/-R,I85@QW_W3Y@CK?;-WM9B:UR25[P[-4=99>C*SS3=:4SK/YPPP+IEKW+M.,HZ]U)KG=[++R1S&XAMY/- M;+>?;&?O)\^-V]0"N!:U(Z,1_CV45* MRV%E$H-I*X\.LU('8Z]CP=!LSW-^]K)L@ =E\UA47&_SZ&=[?D7=Y MQ/XRNK@23]TQG'QD%WJ0.A-@1;8FOIE_!>'7(I^;N>_SC]&H\O./=,@9$^ G M&[C!>=2Q=>]02_&"14XGN>CB M/:/X7@B"F;D!)9+XI*8@S!]K;H)FYK7-W9QN5?R9KCD\LL.CH@YAL-DA'/XX MVNHH1ZNYC)..+Q LX5U'$)2S^5H+U9/)TZ3HUYE/PU;AUK;;*@X&013K3_%+ M;GWBVC.MC*P<3W+;SH2X[^)>Y-QV:%,K=ZI9,4WN)C=KC^N*2W#YP!]F)W9* MSU_BCF 56Z'3.&J,B;,=,Z.7;Y%M;?9J0<6!A"G0OZU.Q5^"%+5S:\F[ELJ(CII4;H/DVE9UKR/5/U2KE@WC=^,KL M;S@K$(KL1B8<9*LF/GWA4YR[FD]V38O].K[IJZ[9K]3D9ZLE26EE2Q. M69V6V>FMGV4T;M4KYH'%0LB]>A0?)C,Y+A6"&LN](?A\?OUMLU%E!XY6PC%; M)5!3>M_*DY;;[%CYOM_L6^L--G#(4?K63+,HIDRD=!+3DS\[>1YZ3[-3U:[> M,@?#ECELKUM3SJY^=0,;)!.!09)<\3ID,[:FL PLQ\G:*#;,U-AY+3>35>;D MM44C.R53E0:OQ<53N3NZ=M>36L[VP=_(;%GKRX5@YJY-8GK#OWE:LOG]NTX+ MK93?Y'OA9#R$NV[SL[)Z5$9BX;DR:. 7B .*3 (6AC,VC^@U#V'1(#7B8X=M]X:Y9P[Q ?00?Y..GN5 M+S_"K*#LW^H,;C-?($=+L/P#7T@T?WZ79CA M9D@4FZ.*]^G=EF7V,C9AC=NGYQTRS#SWD2=6*3"223(;MYFSF?<]^+G:5WU] M/G(J:.>05XI4T!X_05 _8S=3X0IA3W,S_0P#C\IJ(X3R:FN_%JDEQC-CT["^ MR"T[_OI+B_XO$8%EMRBHN(>5K.W]3UP6KHBXGR[?O=I#8M^-=YXF53?>D<$K MP' & W'_\TV[YO L"I?E;'_-+Y=>I,'.WAN':*57H/1D17@"@%;\:2B>MB:J M*EO][KA\*Z-2.Z-:FA95V)JH5^#D+1EUYU2#3D16<<3U35[]@V=&V^UK]RO( MNO_.9L^,[IQLSS08] M91JBIPAZFVPWFYU[;<$'\@FVMZC>'QGL*/=;SJ .28 M)-?O2#>6/M,.\TCS'WU%\-MDR]F?B*0=;CJ .28)->.TO[&8GS:71YG"F2@"'P;;#B][)HWM<K(KG^^*/8!8":XX\UN.KXXY@DUQ]_9'=1JBS^:)R[5#__R*6VK@EU2Z\_B1/,ZU+&2.*;*5IPSU%R5K%C9=\2BK> M=E_>I#G(#<@Z$.Y,O"4$U?%27N75I-?$5;-S+M"WJMS^8>NN7KV!V1VNEYIY M+93JZ.U!8]#8W=PT<^>];86>-PM2;FWU8J M%1ZV&M3J67?Q:E!QB=O@PIU$C9WRJS_MISZ7K/DQ.(\*?ACR=_$K&XFRO.G" M( TJ5;92BC+(JT5)->G6*]\^V9-4.^F5;H?,Y17.J#1EU"B._6#^V F8;)OV M8 >\Q!W8S9\L-+!<9&"\#1@OP6/T>0?QY+,#T!)\Y@(>(1J;&[S'U&Z21N_2 MS0AX8=^ =UU?:ZF656*ZH/SIDLI!IEX#FWF/41Z5\*<'7=Q]-(96C[_4^@MD M%,!VJ$,4O#A]D&0Q>_P4=08(GA@(I#[F) 'DP6LO/*Z^1^I3CI.--9)9$%"#]!PN\3FV,5_.0N<,&]IA_X^9Z&@WQXYV M6$$X,;C\D8EYH%IYO./L K#'BUP'P7).M39!!\S'+DR\-''\S,R*X GL3LJ; M DG%+[D>E44>4UERY]F9P'>#GP]?QR^[*GVI.GX7\J'A/L/5:UY28^]WV?1L"E>S$!S4_ M^8"QV<=$!](+_,HC!3@?7N*/B,9.%]]M/][1)!;)WPG>;'+!NP7_(P(1UI8N M4TLZH_K06?X4%:_8M."6_1;^4UR,N9HD9XB_8@JYR;0MYB5V[OGN.D;T[PIS'U6:*[,28R#NV7 M3MW[%>_O?'COAQ#Z! A*MM\HX_3..^M%DC9XO<+9$ 6\WHY3TSWO9W'M%/)V MVCL.NX_ CAW:$= MT4FYN]7CCWXKN^EFM;'0P^LF_5#$I"6$D R1[N![%K#QSY.ECY!*=#F5;(&S MW.$/]A#O['OXUGEOG2[1[!,';P4<+6!B\*FG)W>K38X.4%3+L3&:A#= M)\V?X(?U"P@@B<21(/;\G[\,V];@E\! M$R0!I'33]T)@U723T@$B55BSIS9 MP1)_M,,4D\6E_N3CI4_D"\"70PT1,_LG2N+%'AM&YA$K"K>17;6TR& 2[+(O M8FYNW&]R)C[@1*C>)5%W-5.]J]EG]LQF1J=R^F*)AGJP[KRL-:SF&YRN2'+=YG)2OY9D2M%*U=^$FXG M_5)-NWJK)_T 0U>_#ME5_L[5H.VM]PC[&]A54KL?G6!R%/!2W9)=&LGO)3H6FR95L=2#CGJASU%/.E*ND\MP]#U MPBGL N%[8MRS);5ODR ;K W4D#.+O 7=;Z43> MASUS,'A]+5$!O[HR4<,+;O2M0@4W-MO%K5R_[T(Z;]JO7]?E7QJ$QNSFH*6\ M=$5H[/3-4:M!96$:3T3PL')"P!D!GCN_Q4&2]BP<&\^?B%Y )P'C9!E'9 M(D"09%(8U=G;AK=?< M=F9>\IO0ZV^@UFNAU9OIQM-;S1P[)LGUH[%PC3.-QF.*N:]^A+ 0+YW@"=VZ M,<'JWEZ2FJ9]_R&L;>L>$6E]XC'50W@Q!Y@UPZ!.5')5@'N;C[CL:FX;_'M9 MQ)6@@YFCT7I0;U2R67IW+!'Z5Q8:XRY]]L\JOMN)\!"EM:G1' H/[S MS5EN?F;-_C;2,;>P28U<=9!;N'J?4LA%AMIPM'_D'D&8GV)W*;U:-(*VV2Y< M*R]-X20UB73I/C;$*I U-09KPF!VP<+7G'AQ#%9^Y*,"&O4%#[7WNDT;[BE* M/B45'T%L6(1!%=TA,>[4NY&L(=SYT5^RN81"1 M>X3":KX3KH!F-:96,-4IW#)NSY@:M6#6X[,#:T"U0:T/IM>$PE2$+ M,,CTT;F>5LGLTJNI" M5>&&A_M%5:?7-T<9D?WA.&,'"=,U9^Q(F#?Y!E:Z,@T9&"B>DVJ":S8:OE!O1^(@9>EH48.P$A!VMV-] M5 C"IA4H/TC!\LV%J7&\=12BCNJY+AZ>_/A]-B]Z;S:8U,,,%L1$9LNXO_J? M^[/KKY=77^_Y3&15WL1:4@5DQJKXCX7]R,X>?&;_>69/X2$_&_;LN_T2_,?[ MPK4RW_^=S=__W3:>?(3R7T)O#.LH:<&;(B<[Y#4W;'@0?C ?/Q6"-*=P>J_T MJ:*L$O"-S>R036YM/WRY]VTWX,897#K!>.;A-='\6NG[J:$OJZX.SZ.:JX;\ MG7A[@U[?2+Y_Y>5AJ[#0A.YW-,O42ME=6R96(\A:%?36?I>UEA[RE2Z7/C5< M$-3C "-?@$FR?K"!-D$=%G !-),]%?!4;DFL"'NQ\+T?L+"%;/9B_#5OC1U: MA7.%?P1^^,?-=.J,F?^%7F;5(K_8+O@NY&Q\8NSJQX*YP?9+;[=GMEH9I_HX M[@W#*9Q@VO=P!IG#,0V?!0LV1E[2[,7$P]1Y));&"J,)EC,DQ!A3!LCZ[H1/ M\ ?PY/3J]!GX$3[N@"/!L?O>; 8(>'@QGISYN7%!Y/:B /*^EP'/RBXAW=B( M9OC2\6%T7LX47R[9O9=PY X+1#_)K>^%;H.:U<)XZ98X!QG'J!!<0L^8B!<+ M:(P"%?P'&P;%M9J&A1U]R30@.AT_&4Z0.L^WQV-D4P3&PGZAI8&>-A[#XCE) MTG7/L:B\8<_YASET? 8C"; Z YN8$.^Z9PZ&0BP(C0=P:(!CDQZ'K"[0P80! MWB?G)4*;O:R(8D78I[1JZI_7NUX^-&Z]# + M%!%KGLH3*'X S>@?WR\NKEP M)_^XS?$5["&,#S(BQE)<2_[N"8PHN*8WL[;P'_S[;][GN,'\818^7E=JF%VS MWQJ:UJ"S/MR /H++'SC".8R5N*)1(ZHTHW3#\E!XC[)I8@0+^959N>!>]EKX MS&V7C_)+8&$>GC)C;'?-07N=<)%>(U&S0)KFYH:OYQBQ^] M63"?6IH%>DDZCB5IK/J25')%BFY %0W"<^KHYGJG?]R"X?[*7 #ZC&]QDR%K:\V?^/?A9CB(0;Q+?-I? 7GY?KKI_3B<1OMT\Y;K8R+)K!,\ RZ$GK2F25E ,']V$;>!!FW2W\,,&3&Q://>*9:9J4=F'>P7C^-69YEV835 MP@VE>+ GQW'CLOOO(/^%_W_X,6,_FL2EP-7V@.P-S6$OWXUA, =A^YBQ2?": MORI,L=EBS+?B'78KF][KF+T,TVNB97RQ =-5FT6PJUU8A3OV<(S0*/9O%,-6 M549AE=S,%A]P-18Q.!V+N%CXSLSHJ681A?N8<(#0*#[!/OQHUPFK9/:YQ(CU M*K&5371:JAE%X:1+ B+W3XXOX;$_LQB95KM7B5F4/)0K->;*#&.0X0.::!C_ MO72980U4LXO"-?,Y1G 4=^P9WYBY>[:,?BO3BVYC&<4I7=N,NB+;R";J--$V M+I:/\*-A*;>Y*+GIYN.XFB%4CG?9*+GK+C=HO6Z4M(T[M@CYL:C546>+J5$PE.N1H0A MAO/C>,VC;'JBY+"U=91>/2"D:JEE&\6;%$@?^I)&QK[,HF/VJS&+G%8H58RX M&HOH#D]FIR$RN^V.8D91]L28AB&0\00O<;1K1DYOB"I'KI>-K5.\J@56Q4MC MK^8YCSZXRBF[7^G0M:64M)2OWK,P%,7LI.0&78YC_XDKB#VJ,I"2F_-28ZXH MT#J=E&YT^F$IEKLJ7BLS MS"+G&K35RJE=FNL?N3U>N)/8&F^FL!1M?5V1CX4_]DWJ6K'Q9#\SP_6,9_J( M0758@_5:H4J6OU #5J=D%)> QPES)T&N7>1'"=V2Z=G*K4"^_#<[Q N[6);5 M?F3Y]W(A0H2_!J :>.19^\W[X5KH\),Q7LZ7,]Z[>"*>;U*I-2R6#DYA8CM8 MG$T63PN\&5:!H([&\%YLOL#GF,;,^=?2F=C\!XB\XG)$Y\9;QQW[6)\BP*O@ M&R:X9,)KAPGFM7W$>..YO!8O.BDQJ>WUDLH_4?")A0R1B(R!R(1-[>4L?*<= M40V.2%5G\SFV";'*,JKWO]GSK"^__9+;]UWM(O'>\6M?LF#L.V3M;]ZS?RWM MF2P% _^Y!J\E8% Q 31X)W3L&9;ZLX4Q,;X9O!26R(+-KBR3M707 MMC.)7!O?).!7+KE%&A?T,EP.52.8@NXF[TS#F6+5HAF8 _B]U8!"U8):QVW( M:KQ]R;UGM CF&G:RV@5"CV)4A*Y/]73H=S)I >],/SNB@3>LOR&:F.\M'Y^, M]J %OWC!Y,9LYGV7E;G2'UX&\O=\HPGVPBNA4I8)IW8*DQLR7DF7%]_ (G%F MPDG!#XE-]6>T-OXA_%*ARA21^9X;%UCY/7IWTV _QFP11I4+OX (._3\%^-; M(J!(IL0F'FH4S)Z"_>SD?#M^%1<_M/AL6=[> )-QFT$&/5 M9E>48C;2L08U4'*I2 \^N\ ;/+$9%8J.7\.88PUR6-I9] >*8?CDA.E8)AFO M% ]$=@A#M/_2_HO\5UQV=@NO5?)(O/)<1?SR'^S "=Z\OPC)(' .A>_J2U>6 M#F8VNC,S9<;VB\@SA-PK^21B8?NA]#O>,@Q"F_=;R_40=-(6>Y*/O+PR_8U[ MK'_8OD.A5#PJ/&@88^0E=PSH* :]GZ3@+[;_)POYI_A#DK]9^1YY#GBP_LW"[PS6:JO7^DD4'6[]9((Q+=(87WVXDF5G3[N96$\W$Y/%AT75 M7SM*B.=4_JV@!>D',B-A)3SA)I:<1 >!*>](G=X.C+TE1M(LM2G@A5V)(+T:J8_4(H\0&W"V ISC,_M9 M7%X,J2(YES:UG41MUASY<6[E@^-Z/R4%P%["P8^A2_/9')P==@1??3$[Y%_T MV<+S:60+6N#/C8)UVK,:AAC=;@]IB0E]!3)46BUC6X)4TRU-2,T(-27)*:Z$ MP(//J,KKM: ZY<6D_%51MHPK;Z9I$13TRKP7_69K>DXKIPZ,(1OD\<@JB#-V M04Z]_ Q\.^S5&=]<-+CR618-,N2;?HY?=)L6*+RUV*!G]COKYY2\RY(3B%9. M(D)=1>.JTS,X@G[::3&6NSEFR"XB.95\AA//O<-6>[2"[###[3[V4NJ;P]:@:!>MC!4ZCLV"9'ZE M>' 5][Y!9[H^U MFQD8;-\>RS*[HYR^.QD3O&HY,G1X;?9*'O;L.GM5+CG=MMEOE^U,!$,NF2FN M"C#U14+MGMEMK:^]G(:5BD8:2YPO0HC_D$&(;V9GFNMD&:6SPC&8F MZFI6\2REF>!7F RA027BI@]KWA]S2RE^>'RHG,Y[)&."]:,GAY-0&':GGLDS M\3%+4F>#Z%/C!#=FY8 I'7E<3_/#YO6AC",>+>7!/GBV/S'XQ*5A3:ESGRWD M+3'\7>Y3(]J1> NBK^)IT'ASHZ+1J+,?XSA@OZ)R^EGXWL(3&@JQ:]"4\5/) MM?!^[;L9^B.^TTAPO@AND3Z3I+&"V@*+M:I6%T4PWZ+7HFFEH\H]=9)Z]#'5 M2UG5]01NKI:$ST_$]:[C,GD>S;E;4*"W MTKVV00')5LGZV/8WIDQ*$JRR4H+9\EWC%3P9;:U MP7[/[ W6+Y:\NID;YOAWE<9&6E\?&C( 37+O:R>3D?H)%6(EC@G&37,/R1:B M29Y/L_N'RE&C+4KA#1WJ+H>U^<;?+YPM3[ESCC "V"?/!U-[1J+9#EZ]8UI6 M![SZQAQW<@]$ 6P@!&,$C7LIHN;:QC/,C>A)KX),"LX7G[$@,!Z07JKQ M40@?O<*GJWGX2!9P06I?\AQGC59QP8^J=LAL[W"DDW6&4OIL3>.JF-\I?.B4 MAZL+/#^8SQUBDWYB.VTJVF:!_&<**GC'@W[#Y1M3QD12!2<:V6[ABX'<5_HF M8,9I7M!9$S(*'ZC55R=JU,&C0W,TRJ 5;? =_$92,:Y;O_ A6@U5H2SL'--] ME6RB(9JCN\(\Q0)A\ZT(7C^\?+%=^Y'VI[NL>^3'2OFRW%AZ'KU0=/GL@4X/ M\%S4\=DX]/SF+7B)7:5UXOO)E7//P)LA=8+?J 0,Y)_Q]#O:MQ)$D?_BHZ-=T[ MU'N$VS:82_5LG>,"JH;=*N W3WS_M,G+:6QMF3)K0N4Y]/_(B(S=;%EL,&V MTI+F[,X4("DO<6K^)8J!305$1%Y\XX+Z!7@LX_ P?AS'I^:W8."JZZ5#C;/W?H5N^>O MW8MRDNM[)V;OI,"#P]" /+;)*R?8L:>T(OOW&S)W7[C' V :898#<=SS?'@" MF$_>J#52MI3#U"YV=M\D6EE77\2@SF2 )XU%R5#4FR!C3T_,[M'SC8E)M%1T M*1N!DO&GZOE(FV"3T].%E^'/&M7R8TT8O.X==\QN=S5?HXDU;86MBHMX%BJ? MM63HS@7(LZR(J:LI UX2>G?XIH"Y>7S2-D^>@;9>COULF%B.U1PYMX;35O,F M3T^7MG@%_B(6."3LLQ&K=F2>@@MYV"O(%WB&89CA^LR;#7N*?'KZ"ZP6W"E1 M>Z#0'V9JE9LZ^2W4R1\U=?*J3KX@#;FW(.MNJ1"SJA240H@5"*Z/E=?W\+5/ M+AU7>&BQ"0)B@ [=.B1'I]U*,374+VGJ:?\'I4$J&]["/,\,1I!0!O$8V 38 M2:+G@+Y[Q%L:F3$DE3RAD!S_&LH<\21Y5KGR'[:W50NX]V3I?+VY^CIKQ.W8 M52$GB8=^09=55WZD>#J\#D2V_&*6?EZ]9A;F\F&T,76[5ETQVWY@Y$2+? $*0F0&S9Z5Q?A($?1?ZXR!X M[B(M?/?[[H; MUD:)!5)ZYTHA>ZQ=TRP_AZ="93=#[IO^^?GEU9?L?O^Z/19H>&Z-]/Z#M 2W M2V0YBW?JE7-B\G[>H7Z2X#X="W#.RF9_4Z<\; M5G#;7WJSZ=M>^F+1^G4 I]F' -N$[,-V^,&'OUD6Y\-A[@C\ J[A6@#-7(&P M]3_,HQ)?&>W18?=T8ME9-GW1^E.I+,YM05CLI%M<2=/.QE_5*60!1DAAX5H? M7Q&I*I^FZ2,W AVZ#RZ@?>5[UX1.),X[*5IV>)TBO@I_]2V1V*,CL]/&A!8GY&+>:EX/C]MCT%GV\MOD4$%=V:Y47FR?>%.J@CP^HIEM6/1E6S' MD/ZS9=LA+A ML?Z'![[-PM%R.G5_MQ5J*/LU.I"03K)HFPJ.M MV%9MN74<>?.:><7BS^E1)=>8_J*D^AR$^A9E^B81Z<:/+<>/5;1J M7-E&IU9^Y,WKU!5K!S;L[2KA?H7#6TL-7(KC>_%C@BTQ-!&1Y:Z -9#:-5Q2 M*W'>6QRG+H8]V)0\KQZS)N816&=OJ7,^:9L'IP5)H$O=U+XFE/M>'U;7AJ/7 M:8=6++39N!U*N+2Q1/J>!9+[T+G\=TWDILH2VWL9?V_';T1[9N_@V.QUY_$F M-"!P'4?>/%,_6__?W*+J9'%*.?LTMZC-+6H%1MZX(EVU*7=SBUJ^0BW%A6]N M41NU6YN1-Z]V5VQ$VUR15M%);:Y(URUPBP/NAROV[2PAX"Z9X6W8C(?M$[-S M5 3LY9$Z2:ZOEFSL&*GE.:65RLC4E*>37/+J^LM[^&*?8YW])9W4<.D.ESR MUHK3%S-Z,5QM>89+PVOA9[E?1W-6;NGL'(:ZUA;N .9O^_' Y=H*_MP4UR/Y MW<*;N'+-VEJOEP][9OOXU#PH.%2]).(')8CXC@C'.LMSM\/HQ7T,M\'H.EXY MZ\#JA>A^,RVRJP0ZUR?4S 7-15(TN@7 8* M$!.SV!10H$6E, MZ75C,=15U7=_ZSNN3H[4P'U+6_[68YE43;V?-[U?+WM)I\M[2?VHW3XH=I7. MT,]+@*@E7&A&K[_ECL3L=NG_"UR<9WSH[7CJ6QBEN\@97O-!_J=G%MI;9@YE ML&^OLSGVS3GI*]);N*_DB'XG$#OGW MU"2=@T5Z]S'Q_[OD_A_.G7BV3(NW7I$M] A*5P;%4%T+B=C>NBWK'';-D]ZQ MV3F<;]6URTYB>09*4[.T0I!U54[6;5]>F:I=P!#/VI<[/HFD M@3EXV<+H=QA:' TN78R+2_$6-%/8J-UX[DYCIR6S^69MOEFW\/_2O<:9"MX: MH@-+TC)R<1.[D]YZ4P^Q_8NHP1.S%DD8L@ZIX]&V.K)E['.=U\#?7EON?J9%\WQ?MK?H]U.S=]0VC]M+]^M+ M>ZEM77CJW4GM>*DQ4U+4K9/:JWM1I8W32*J2^_9;[H*;:Y_Y813.7;<_TY%J MG4?/I)5:IZB5&K5#E/JQT@W45-M+'B(_.>&(>E^*=I ^K=^8N,RCDD/;";@5 M^4%H I,.X:B*_U)=LD/J$0E\@OI-#@89'@'EA"MB+NK=A!O%W;T_F?A! MA&I\BJ--& 8AG GPJ;),D\ ?.K!+CCO?4(^Z^,9@ M(^1>XHR%M16B_@B.P83,,DTXGE![YWV>_(P0IRXS4')C!T/: /CX+ # MGP4V=7-5NS*W8/C2()YF;$UVNBP"*M.-IL'_@@FJMNC?6/"=1P8%(HP]&GJ( MX[['9L6/#)8.Z_/%?N#EG-PZ89U#L07<;AG/I4D$7*1!+++N1Z=+7&!E'!CD ME07!EFR'U0G0SA76^9:'/'BDFKS/<03J23D!;^JV>GBX( =;DH#A_A'=X?#, M@X3/*]=W=QV-&3,*2(=VC,7MI5=OQRA-RBWL#C ?)I8]FQYCR*ZZW.X#3^(/ M?P[;UFGWX,7$F:8]XRN2=RO9*D^']HQ^D2>U3&Y^TYUQ%UFNZ<[8=&=LA&[+ MQ.X_/ 3\82YA;JMS<+PH<+P07*='YL;:LE[3&+0./2J;36\VO1Z;OD,EI4TW MUNWBF1S-XA_,-+N4<8IL/&WCE7-OK@<],+L+\ XTH*@^(^O9?O5H00I.F1RY MZ5K.TX91&SN]"TA&7\0%C@Z;I1.'OEH)-NBANTV_Q4:L^$:HJ G+^@Q: ]VL M/ZLUQDR;0V>#[=J8LVJ,O'%S=E0,S5NN.7L#]FECT1J+5L'CV1D&45V7V\8O MR.Y#[FAW6*L5&.="V-FC6:BRK2C4U2$YWQ"$/>[5%W%6&UY>IPM0#)1J)PVC[AZC=MK';^14*MM.LETO5:U;1E\DHM5_]3>Q/"WYD0?AFZ>ZLA_(YY5.E0:!^C/IV=7W\/ [U3MX\ M=,Q>NZGGVMV [H%V++GIJX?#AE-WDE.?1?]NKAYV('[R.P\CQ*@L!AC45!ZJ MXW]TVD=+8^$M*4^D5@2E7OM26]7-72@F5*..T M&P[+$DWCRW9EUMEH?B[M0H>.ZCO"!^M4I.NDZ6*_8/F>(=OU6U=T"]:=A='P M_(ZX""?%-;IK=Q& +UFU/ 0M&E3!F!+-G26$U1'1?0&$[?KEK8$9EI?YKT 7 M[K3?K85MEX?VS037GX7U;;9NJ%VDW&AVH^KJV7R]M>9FHW+?H#);; M?$$!T8M^/TT3AJU*="W;?8B&1PVC59K1U+'5*+_51L#'S/'F/).MS@%=>3ST MQ,PM<1:N,^3&'C6.>]_(7RWDKVFRTS39:62M<:H:1JL HS5*O5'J;XZ2- '< MS8%>56-]S8;N^H#-AC8;JO> E=[0M^;)OS'98#:[X+EZL6*T)94I@(D ?ZKZ M&8\O2G-Y4\EZ4WO3%+._/,.U)'G-YLBLPNV[71G9%*?75PYD(E-&# Z63A5; M7B3F4AT%D_;C:.0'L%WV;Y[-@TS*V8W+9M0_W89GY$...Y,!>:NN<\[2.Y5[ M'HR[.4':#[GUP8X#O.P 06D=SJ5U-1+22,AB2W&\)DNQ-;'(O?*)P[:BC$@L MALYV/*M&AAH92F7HM!@%>PW>UBME2)6 9M+:Y/B-#]9(Q[:EXWFP@9=/WOD# M-#)S^; 6.K#X6ZO^ML9\%0ATE3C@,U5A>FF/S,S6@.]TJAV83HE1C(-J9S#4 MB-/G8Q1;PVG8\3A%W65@.Y7&:_#WGH\]:\K$.D85ZL[QU='Z!5+R_'WD&_V; M:L0-ZL[_.Z/Q3]8 )[@+I_PM,N3"@OUL\?R62O8WF7*:#G@>!V!QC6C$#2K< M,3@H+7L>*L@ ,T[M'4UZ%M4>\Z:&[=A CLAPPC#F!O[&%QQE1+[!QQ/7GW(> MMHQ^,0!1_F,CAA\#S@FXY3]XJ$*!PU/]:O ?^&_>$@0K T?A>90$9+O-H"+( M9//)8!2D\WE]T?+ 9=;W3.#1N+_XU_W^Y=7YQ=6]V(FB_.3NR5)CIJ3X^P0T MR/X@X.S[/AO"1SX8S'UBT_#O'Y<)J,FO\?''?S!C%* R^1MHLW"E*(CYFH'"5.9YI]M*\LX-]4LYN7#M&?&ZZ,#[G X" M3>5Q(R!2"&D7Z_]@//*18\$O\+C]';4FZD3456 JIRA),:F^EI']('.!>BR" M^8$%]./ XJ0;\560:8[_1TIPP@,RKG#P0<[FS!H53,*(0QS8\80A1J7(!GX, M"CC" 1ZY1VK8!C7,L84%/0LZE!M[P$_A^_S<;!^W#=0W?V0N&#>>>4T.&,H1 M;>#(@,,3..DH.X%6U=A!\KO8W<'4>.#^ _@;(W37#"(F^6%BYR9 5=2/A+$' MM%9$@!\"#E0,//B3XQ&)?VO=P?[[$7R&=C'$KRO"XN-S'XQ&++?7:M083A[$ M19*Y,KSE!Y*O)DCXH4-(X MU9 H^ALL )2& P[K;,5>A80TJ\;@[^"UA@8H*-N)4"XL> Z47H"Z'#8%7,J0 M6T!"X&\6 LM+@?10/%S@E#@(2>L.4-F![.34Y'_][:3;.?X5! I\)6N*(@-# M2.G"KS./N5/\K!0+:1+8P'&=:(J_%=K9XLXC*O-0B2-'19W3]2AK$^HX1+1$ M)SI$ ^"$(Q+V)Y3FT'@:<5 7;#()_$G@@ *8L3DXH?_ 3OY(.[S_!#,=T4;A3#QE/M1!@MG\KYA9 M4[4?Z<0K9RMFCD\KGI[@P"-F/ 0.% 1_RC(OG'J!,Y@%#$H6 1C.6!0/.%E> MYR6Q@3,BYYS*$W$"D2-PQUQ^*TS:%8\*(@AS;X'P\%Q?XF79DX7J/BA$).YGUSG9UUFB]O:/Y]9IHQB<)F=D<\YZ>KBRLG4THIY*77"2OP$,/ =A4Q0M9NP\VF"ZVFOA52?&KTR9^ M]=RIZ>CPM:>F2XHQW+,?+Y^6#!E*YW8_DABT/7YR,K"W?XXZ+#A'B948L)1Z M')Z2PXT,$T7LAP&GBD=QV@?RP+DF2DXV0Q]=>506V]N2!>$4N"M;#@R+SXF*\'1'(UKF%7A,]9/C-: QP=T5I#3_B6AM9KIW5' M5UHOZ5MMO@_-60RG4M"&FA2*+ :'R$^J:KV=FTTO8>FZ-[44^M3Q;$[N2JLS MB=Y]_,S!MT$LV?+W;V=ZI)P<+5WW/G?I)/2CW'5P2"]$HLLG[O&A$U6B%XI6 M(^O*0<4'\(+ 8!TY2/=^>X6:]"YB$==4"LK.]%ZGY/3>J'N)3GW/_NI;+\K/ M4HG8)$0G31M?74;>/ L6EY0MK[PWQ8(GVK&@[CXQ.,!^ )/R-.'=Y2(F&HC3 M%I -3I9OI;G(21*TW8Z3I -D0<.[VO!N<8[."@Y^W7A7=Z?_W4>1T"OIHY?0 M:2-;ZQ2AI7O5+Q"AY-:O>]XZ93#;?%>X]NOKK#/99:D+M=1V@I, MU99;QY'K1&+=?<4=O&K3AE'78+R[KW418LOF->08?7A@5WTQ/7\[[H9WM>'=I1$:&M[=#8__W<>;I*H9P3G2L\]98 K/(W)LH M7WAIN+7(TVQGU)=M 6%W)"0#ERL1*/X:6.RE4S4*P8<;.U -+BR&#'A&JV^& M"U].VM"!"Q=B86\=M&9+ %$$I>59CNL(K$W$[JD-_" MB$5QY =3@?"90=(($)LS\K/04@G@!B+O&0,.3,3SX\CG"P$YG!!QO@0,1Z@! M",>K[U3OK!&W8Y=?#R^&0P&AE,C6+>S:;8X6!)C3 ',T8 T-,$=#ZRH#<^@2 M7CM3M@[-ST"<71&U=BBR$#(F+]#W^KO<*N^]Q7[HTE93P!SF;6$&MXJ'Q>V) M4DN:>W-!3**ORL;O%%%SEOB5?JX1PF;\][O]=Q\[IVVS=SJ/=VJLA7#O&\9; M^ORS=!+2#O/=Q^.C0[-S. \G7#:?Z!\AH_0$'4-BVL2>URF,2RG,IK)XL:ES>L6%!\?F+]CN!39DW*CTS8O1\DVE MU^I?74TX][:2LIB-OGE67SH)J6+5"_KUO?=^GYMZYOIJ: M,'V5Q6WYWCRO$[=E+E&*FU9?_+!X&,(+ZE1.+69>*Y>=XY[9*8CU:$#D.HZ\ M><9>OI7-;C/VB7G2G6\!4S:)]3^$7%+W': ??!.LCVH/K8E\5%@R3Y=.N7K- MF3XA:Z:]?%B)U/>:CKQY?EPZ^:KAQ]TZ5ISY'@PB,FLYB^* PPX'SB,CM0\$ M%'U0-6'T*HO8INZ552,]2>;/@LKG"9&_*AI70N)J.O+FV7-3U\_U8L]=\/DC M'O P,KBX[S<;>U".P&WJBCD-\@I"R[P."NY60L9J.O+F.7)3%\V5YTC]CP&_ MP1$LB)CCB9(%/W2:2,]VA*JD:^?9QJF5D+.:CKQY)BWIPKF23+H#1X Q[$&$ M)72V,QR"20;C8 3<9513X",1$$/%X"SP@#:-E=B\ &[J"EK$7XG>U\/SA-JW M@MCWOH3+N9"4KH0 UG3DS3/IIJZ3Z\BD^A\9ON!I >@/Y(9=CYUPA$EA9#7X MH.FELFEQ.VUONA -"1Q^]<.0A]?>18[*((9 XTH(6DU'WCQ[;KI>K1[LJ?]I MX6S$X'QF@#$8,B[0ZF%L#+5L#<5B( M_G+:+NDF9//RD$*^')^0"!.NF:B8VQJ\-M*V.T+;*Y%-F%B.C;S#/3H)J<'HU CYT MN141]*S'(WJ44_%EB*&XB(\G?L"":>9"'^%KHR?./7K)8D% D+B,"BWIK05C MH>4;.AZX&@YS863X,L9>C4D<3/R0BQ?PF^I3,9:LY^UE\G#+N(/5.D,0-2^B MNG8?04_$K MP=^VBS0BX7KBZQ9'OE7!UY_P\;#R6$J&!U&U@5AM(W8;6E8?4 MW?+Y+K&UH'<-H7@_:.(ISWBR&4::"\M7])#0;+J>]P>Z-'.^ L?7G_" D3M* M'1K(K077\XD%MF8A&LWQAD\[,Q?)_?!Z^'+7M\1?O5:$P R-LRP97GL^[9JG M1\=F>XFHB@9$;=AIEIT."MGIA49L&V2GH_:AELRD^]5MH>IMP.G*2J#H'+U) M3<,_U.]D%#&+PM7W;!E4#(MANL[\\-7QQE[W5$L!K.G(F^?4WILL0(F<>JRI MW[&37GK?LD18.. 6=QXI4HD18Q^KO3'6@>WX;<> -_':P8F6O+:3'C\86"?,U@<[7O;"4+\2L":!C02P MVUY&V5/%)9$X+;>\])*;R/GJFE>DF9T4:_Z-9YDUS*@-,W9.E[$&VV#&XTXY MS*B["__NX[T?,=>8OQC32[MK(S=K])6ZW3?YY5\"/WQU=/3 [/6.M/26:CKR MYKFM\R;/_$WH^E7R=#=1T+-;GC;]=(QYQ2J/[MOM3(-M&8$9T*+1H6&Y#+/>VB] JLUS=:GMN.?SF M/\)])\B<^>H6C++S":?HNQ%/L/0TIC8M"GW3-)RAP;RI204S\@(58_"B_@:_ M"]2S1E0G$RN3UO;J<[9#PSX5*YUSBXKTC(..:: ! M,;/U2[!)-NWO<_FIHK)J;G\+JJ9PP)\6ZI>#XI/\VS,W)<[B:T_YI^;I\8*8 M/Z[VF06]+1"V>$'4W!PKJWP+Y_[:91T?%&00>C^L![.V34*:@3Y-O3674KY+44 M'?Q\&=NFRM:2*J#)8!2D\UFA3F7&BQBX<,3(G.B,^XM_W>]?7IU?7-V+G2BJ MVSEH+S5F2HJ_3]@#WQ\$G'W?9T/XR =0ND]L&O[]XS+Q+/DU/O[X#V:, N3 MOT6^]>XCU1JBQD$H;JS-_,K?=/C7.8XZ#%Q7#D@E1O1KH"?Q* M3-\9(SHBFAL!58'CNX252#;'@0GX.#_'D]^V8M"9X"V0'A"*:LP9? (,-_T2 M9@L[AW,ZEI\77X?W^0_88X^H4SGK?C]#0&;[$X1!_]R_^V3T[\Z,X\.V:2!) MNNU?146^037[]*O.K[@_3*2\S6&&M-0'4.4$SA"KJZEP6CR/VAE?27RV:(K: M.OL%3*+S'SS@>)L2,#R#U,L$E:K$U,A@"9+>-^!-P-/WLVV EC H;* M"IP!5F^K;TJF@K^,?-.",'U))Q?%D7P C*;\@\+QLE]:_8+6&*>:S<" M/WP'CH+/8>\I2Z+-#[C\O;14J9RE^P>6V8=%^(^.#4MXB!T;74U$)P8!RTP! MJ\KA]8%,%36%KJ?R<_%W,<2 N?1^..(\,E%(1$LL7 'P/'.Q!MO,THGH D\Y M8W@@<'P;_FP[H04RA[XZE<0'($[",V@9EQZ]'8AY/CG12*UEO]/>[[7SWB.0 M2DYT*@8KF@_6P+.TA%ZM5;;QJKY@HK/%@\=U@);BQ^-,S ME%+ZA4P3'H3M^4W U6N% ;$T#.MB#(@%;'4+:_PL_/L&!J*!!E@#-,!GX8;F MT0&V.@-0226.3F& W<-&T.7JZI/TEEAD_ ^#4UHP-:16UNLN0?<2V6XQMN1" M@#LIMGW/)@8NZ)E2;$$^J=C/FAV4LBFM?ZY.'^QFQJ?)>3D9KS5[%M=4A,I. MEUBGV*W86^M9L7OA2*#0R,-;'L8NGAQQM#-![QLZ.,+3-XHIF@X6.HGE!,@3 MB%B8)K)1Q^RFQ7)^'9F_=F=R8]YI>9"[-R V&]I;7RK.H]\\=C)\*; JSRRO4!/D\BZXN" M7X;< 6[W(WE=V!X,.H/!AF,KZ=:HX$*GUTI""X;Z969MXAHQN[JU1T)T"=FK MU>,E\Q].-!IQUS9NV#3P75=&TL+X_99!+XX![C)![P7MD3 M5X3(T-.93+,%MQ@T>;QBF9L2:OP @_Z+KVL.B^M(BVHKK@= %-*+EYZ"(KD1 M%R-YB.575\X=FZ\=<+; M5G=QW5NX.,ZL0DR0NXRN>+*JM":\]XPX4H% !0@/D M!9]"])34@/D3AHM;0GK/'PX=O)E'5POX%I0=9CUDTBJ3)TDI_2"&_\+'7"(7,L*V^75YXRXA7\-(P2V[!5=]X9_Q9BQ.^2@ MCD&@OK+OW+AP0\?S VYF$H\R][^8=TOY.)3C!ZM3 :^#DV,#FUO8-B+$WXJGT+7RT$9A@@X:#U H3J 2CF8G(U;: M,NY]$%)0.6/'XRMO8-Z-4E:,O#R1ZH0I4=R*4:$-_"#PGW " 3T#O@V:59^. ML,J?@M?C0.R03):@T -^3Q[R\J#^-N$JS@0^1/PTA)#I3:H9=V=88\["'@@.$SIV#/\08O0 %@VV#L\P0)#L4Q%8 /FR[W-YNTR'_ T2]23>?P0 :NC>M8Y%93>$_HB5F%C,UUTN^F MV8BA=+G10P#/*!KYJ5Q0)B(C\AM 8J00/( >%D@(677BUDY7_$!T='DH=:UB M)B>7F+J:K'W-3L1+5#W-"!99,#+,+U)%\H>.*ZM64J;C6]K,^+ +)-OET5\^V.MIUO]V],9+W 1-82D]ZR$;AG<]]* MOTQLN'HGLDB;9F*UHO4.-A/3)=]H-MR"\0N]LA%T3Y4].'I[K;1RZEY]3=(Q M.VFYM#;I=EJ-K"O[%&=:%[1FWAS[]! -2SON63K#I#Q EK>OM-ZX IU*X JL MR\O)[5FWUSK%;RT182B&)%AGCM&BFR7JD^)X0NO@Z)G@L(KB, M)*W;NM):FV;O2?EW/)FX*D_C#%-D/Z/;9%RF/M;S"KCT*JO:]"5O-KVLF(#6 M95XDM)B))3(D9'*ZS 6P%<3,#/94/AMM^D&'K:XQES6;KKMHZ])!-KT^H7J6 M(1EK B>[488=W)RA^N'2U9KX<1>TY*F%RG/#%?)S\M3'R[I'9[>@'-*+5 MR+IR4V?5*Y:-<].Q>7S2TXZ9]/>N"JL##'^ :9'"N^(_))C?D)(RM?2KM'$N M*NU0U'3D.I%XQWW&QC-,84SP$^'*Y<_$;AF$3ODQF^!ZT_$XKYV&F=',PFA.J(D5EKXJ^<[KPD\;M: M$W]WW"O$LZ,.0<%+0/3U$J :&=V:CEPG$C=^U:Y3<"LQDY4:DN>T%L0X(0M?]9BMB_J=WN MSA0@Z5M+4 O'X67>7\33:]^3G6M*4@K\!YB> TTX:D?ND7LKM>/-V^8P9\B5 M"3^/N>RZ]6KXCP.S>SB/DEXV4?4/>@K\9YW8O^F?14+6VX"077KW3S[Y,Z_. M 3\QCY;( 6],SRL#?/<^ECV.!>5F4*[U$E-MI'&=0E<<[7N;T+U6U(XZYDFO M,6FKF[2O/ P1[3N.>-JM1!,6KJ.-VULL;\>KR!O2E?.\U*D&.]/?/%L&1[E] M\<."1_M4>/IJZ3./#H_FVX"L9.A6\=_?[[#1NBGNSI!I+:&7]&DC9.LT76^X M94B$Z-7H>3VSVVXR>E]IJE2#\0EVC0":%C1&2>JWC+UL'?VS;;TD]'OX7A,1 M:$Q?3EZ+F^0597XADZBFY()%KH=K%F XUG4*CG6-N2LR=U>^MZ]D=J&@:BUT ME>AG?+1\DT:@F!2@=[BO8'#32!_2PM2B[ P]&-BER)\=XA9'4DOL&>^)ALD849C9!H4.C)4K\G M I)9V+>I>GW(LFKK*W\ ^GYCP,=!Q9MO7\INE-B(F@53Y. @) $=Q*'C42R*;F/2#T9-GAC5+"CWEIBWWECRW173A8G%[YU%"+\\^SB^AOE MT_TI:?SG#(W%7^<8 ?C[^R7-Y3P.0$/< (OY]MT(5&M(L/BO.$F*MS$5PVRW MZ?\+VH_3,RA3:$1@Y2'.!-6X PH85F.*Z#MUK?YIX38=%Q>>;FF;?L<9OG:7 MQ'F[4[@]E?,*LP+1[;Y&((Z+E1U1-TOI;G>K/'YP:+:/X/][R_,X'B,(6A(< M+LQUIR<6L_C)0A9?M' *$=W(C^/CMTG;\^OAK>R&S&W"P!..D/?0Q_[(=*#I MO#IEK6N>'L_?[U>1E[^QP!H9G=?P\6DQE7R ;OQ".=#&2-8;!&+[];EQJUKLZ3LJ/=QHN(C9S1+$)M+ M+_+/:!WTU[?L6>^E_4);*-9D]$%=R%F)_:NN7!V\1JY.%CI,,W)UL%-R== S M#T\W*EQC@=QD2-72:$ M+6(LOF7%@4&G:>*J7/C2P'"*$4]4$)M^3#K>+PBYA!BZ%M%8*@)\9(ZH+(2/ M#+@4=!%'2F,Y8HJ9&0UX](31V05SD@6#*\](])5/IH2RA!.BS^-L,2G+]4,\ MEQ3LH8E7#;B2Y5=O(Z%$M!KX$&-Q%+"&MVTG0P;^PZ''Y$+F5]PR/C&<5CS! M2XF1$\+G'AW^9")\+I]$.-]T\D\./"(V;^C[D>?T=&W#E]]_$2),4X;1EGA)--EU"H M ,^=D#T$7*J;/T#FC;[(L&+X"U 4\D>\"\ 7/B?2=YZ(*4@?3JBZ5S=7&'/B MXQ 5&QB>JBWOU6S%%%_U6R1X@>\*)X%""S:P1EAYWA";)D>B)VR\#:8KH ]T M,T\[]C$5ET5;E>Q4M38HZUQ:+ @P2\*/T8=1OF;F[E_H4FC# &.PGVU):7 MIOA*WJ>D>^H)'8/!2Y[ :8W29^"O-$CLRFMDG!Q0!/\Y>(\Y$_$X%MV&\5=X MJH7#G:6R.7"2X^2F.'N/31>\(X&, M$='Y@R$:"4W?G=(I4U OX \LH)&23;2S!K):,KVLTKM$/]'#KH:"1PT?3O(9 M'^*6. -VK:*ZKU\L_&:&22G]@@Y3A5H'^=91NVAE=S$]!P5J%X52F=4@F;'H MS!?"^2]TU-F5A^@-.^%(>7@(S$-Y7LP&3D:N7WK\)+ DI] R+I=^%:;&#.KK M,DQ4"2A8'L*.XDESBD?#--,MC$%8'YTP8SMFUTU7A&?7U[2JL\_7QAXN-U6B M\ '4+C@XBBS8(MRB8>R)X,9[E':5K08'EM#W1,$!'/8#.EJG,H_#!SPM68 9 M%:U1A1PF\"N6)N(5'OV)-C_D[DWB8.*'TFVW4./2!,C*?>GW;^C+LDP"+8./ M-;1PCK-4@E#&+*#FWR(\TLOGX\S)ZXV'XES2^>%\:JE2K1/-1IZ?P57@[F^1I2:AMCK:>IL4-QR_F M^.%0@1 M7AB0# 7IL2OBEI*KV%/'60-2]ZN".$2F<>+4X/I!F3Q MG4,="HT^<8O%(E?=(86%B=>@-=+:#EL0\4^-.D[ M/,#YF$=@7 M]TY>*_N$$DN\-(QB>!1U&PJ(UHVEY;+IG0' M<>BA8 \\ -LB#G3R#A*W!=_&^H9,3O\39]\]<0J4,:/9 ][LC@,3/CB/\L97 ME:OBX4)MC)_9+5/$P>:^41"_H_A9/IJFSL; 6BG7 1=*/A:!M6SD"/[M8IQ* M*J'?[LC&4PU8X8UIHHC2;:A@%"DM!,K<2ZT0-*IRO1 I/[!+H:@QP\(6T>-6 M!F.7U[>2L61\%1[WI/4DWQ"_E0G$4VV=9\>8_[DP*K_:^ M"X&8F68/BI4)7 MD)\,_P53D_C.(&F!2"Z!QW%#E'#@Z9*FAD%GRL-(%?TT4_KR% MX3;/BY-5&K;/0Z&&A +'^QDLRPLC=3= CRV(M6&Y(QY+4.."\X:9*$C223P MK:= .P1D=S#.N'FM W3'D2!YCC0Q\' M[P/&Q<.>N*=0!;<<&#FM^+Q0/:DS5I@X6!X/1CA8Q$K>>#BZ2WR:KU3LPZ;U*R-L-H< M3OV*2FIR\.[C3?_VWKB\O*RZ0GJM'N^TI1[OM%O&N8I+FF!3U=W]=18JX\P/ MT"##,>L+^@]T3U%Y99_V[E,X(<+KF-VARF[ /9DY3,<@,"IPX$*1T)W;D%RZ MAV"9O \KCR>RL*0M*DNJ?4'Z MQ;M[L(K&I#[2>OV'C)KI.EXO2U%VY+B3U; M^@\Z;)T6!.H>;9EO;^2U@@8$>&EK>EO>&NS6BVI56*'2-NBM:(L+%>(&D%%O M_0'B\%QQYB)+55N47T!%W)86/3HN>PNV,PJJQC6SJ_([3:PI<0)X5#E6GWP6 MV*6ON+?V%?]/[$Z-$W00.VT1LB,0<*UU6@'&\S9UVA5W7..+*#LJFR/JHM(Z M96]!)50:%@3,':9+7_/ZE=H=GT0B DP!X$YG5S1;R=[:-Q9\-_Z (_CSG1XJ M(VZ-7MM]O5;ZTC;@DS%/8.@=D_8ZV17M5;)?UA]PU[AL&7<.#P)6-E_41(,A M EP=-GH+GEG2U* >GAD!A':.RU9N%4YQ5G'+3Q*+&WQ_3%CEWFSPLD)KSE^@ M42E)@,*56JM0)<#G+QFOBV_2JK8_^=MK.>(SU74MXY^9'-<) ;%9=)T+ M;U(U\1.\--T/*?\?\Y8$!^(K(G>?D ",_N^&M >$@O\-41\\F[E\_Y_Q 'P= M5X ZN)R)&GWQ[" ..(N3JF6!C#\)_"&G=+V6D=DC&M'XU.JWQ!"_>0YAYXEJ MWUO?&G',(#3V.J?'Q^]IDM]:Z>/I Y<>4""*16^.>VZ-// ('Z;TXLE[VA"J M]\*58:;?_\0!_/>YC^P"&X^UXP\>,RQLELMBFRO@?UA ?DZ? L=^2+(&.Z&S1$82'S\"_>#!Q[Y3UYV M#/'50YHRE6^/A;F2_#Y@5&A#_*+*$ZZ 6__MP\E9="?!^?SNH-5QF*!0G["[ M@**?X.U^^G92._V9@[P!F6;^GJ-5R(-'49?7M_\/Z[EITX,8MU!D(JE\$5B] M*5>7X>'L(FG]L,R>@>F@+MCA=F^.,8A[D;FPFL@+P;?&/X!J""1X;Z8/0H29 MR+D>"^/8C9Q],,DN+M0&C(S9WB1V$D M%IBE.#CA@5L)4 M2P;QU[R$J>EA,X3<],2&J$J>M/N#JI5A0VKT@JFIP7 M! :)CZG2MBK(5D)CW(T1T";Q6OKVHQ/ZI:E3'8J_.?.]H>L P_>!6::A(_CDEH>^&PLD M4S 0:*-1MA-M)6:45UE7BN.PORNLQHT'B>(YYV/?0AFQTL?P@43Q!-1Y)4\*:J5QGY M\*&><=@C]1H1:&RBS5PPM<9!6VBUEH&@PRA70;0O0%%_.FRWOPDX/IG1#YY. MC/Y5,E&__\?/8>^QLQ>R!P3+*# MBE6H 5OIKKAR%\"-A!V.4D>*"O41V0D-EB-,J,*"/6,>LYGPSD")N90]"E:? MH<$>\!%SAZ+"$KT+'OC4HU TU&/H3V8\-J3RI6>A"PQ*[D%"C@7P5=I\<".Q MB"JEAU@($BG%X%&MQ'"_X,1%YS Y4 :8C%PX\1W8 )GD#^Q$E= YZDGZ$.TR M1$KV3"AZ*P W0JCY;SX(H^\RN1)LNH1>C "I*5K S("BT-$&X0K2RAI!D<*Y MT$IEB4W(AAQ[Y47LAV,:\'>$SA%,,G2XF_)NLO1^F$PX&8S*@G!V:8CH6Z X M1"X%MA!80I9> K=EF.W1=R2!::(>\ FXIZ$R;@A41VYI"*;SAB%*F4750O M M1;!GA#@K:))/1^A4"QJ4C7=JD0UJ$TRD_.4M.(+.,'F M$]>?*I8Y.__6WQ?'P^2+Z2 ) ?#D2170\D0 DN^' @H#&WV9>44 [[CV$]9/ M"0D30%:*<1%C"550MNA:,I?@R#_X .7:^$--2&P9>=+.()9E8(\9P@GP#^(! MQ-<@M2463YL"M!HY$W!M086$69$V2S] M(3IY3K$F%O8OS#I. AV/NI%Q:J:&H_O"W0OC":D406PP1@\\JS]%49I3Y8+C M)3V;]([7U,5SH=F@ZR+CP.Y4AFYX2&6^HA[BXAI90Z6G(O=*UF!N8D#0P>_V M4H[F2),$L"KC!P0W$5,=\(!;;,S! MT,, >,@2Q=8\\2I49:94X'BVD;(N<0P<]!?@*:7>9\0?E_[EYLYXY# AQ'N' M$_EW>C;C/[0PY(9;X,M9FIG5"8Q/GJXRR-+V_X\MO+Q*-):9+@%<$%2N/QT) MDT1K1H!2-G$BY@J4 B)8=G<+*:)*62G> )^T8(7^&.V01/Z24 \WH%;AX.98 M)NCL[QC*P;?Z+N)RNEF*41 -#UXCM.\IGX!%YQ*TE3X NIZ3A&$##L;-XS'Y4*8"^06G1FA@<_8@8F)P2CHU M9#E@GJ"8+?SX0\#&&1A1&!%(Q[T'F+VGX-026,ZDX;3$B5:NLM+3TJE242P\ M/R5420OU09<)54;K)CV!MC;M(QL:_0>PL]-9'82'DT]_8'!+!5US@/MW.1,H M>2$C]8BZ1AWULCWJ0,!-:H3..KJC__$0\X=1EAR&T5F1^Y6YU!=):&R/,.@#5W, M8*MC;$-DH6/ <>44#E)8XK]Y=&RFJPL\> 88!<6[A&TJTWH7M?>:HO823.J9 M;]-B+R+P?*I=4*R*@D<2P6+*(Q$.(:\3O2>71^B4BQWAM",":YDJB6T^I-@+ MXEAA ?MA^XA.Z?PA%G=5QMT^'%-&_A-7$6(K,V0Z5*:U@/RZ:&B..&+B1(\6 MRDYKX_UL13P?8\B%\]D4#4*TQYX(9.*4@<2O)3C@;JW%&./S ML\7H>M(D"\T]M ?%46*3\IY8]N),G!_>1> MDI*B6@A@@D$@W9\# H0: &*FR6 0E '^!I M!%X;"4>N%T4H@=(.]MC[O=[)^[U/[Y5 )?!.?2NBR#3"">9;H0D=,C>G]&Z< M0BXR%(G1$J]HG54C\JLQ03H*$Z33RL1#<;-!4=4#X$GMW1TU6)GF%F^03U+" MTI_W2#-ONWP8;YWWSU+ZIG]^?GGU);O5OVZ/^@V[K9/=L-]RB=S&GL!?7/^)=R5V;WB]'KQ^ M/9EW#VK'['O=AM]KPN_W?L3<1K6N5DH\VW9G;K8TI?S/7U&SO96<,6P[H ML6!]1'963%]TY@-D=9A;Y[!KMMMM#594QY'71<73AH8[3\.&?KM-O\ZA%E+X M5DBQQJMK'?:ON9O22#*7/X%T.SJ<0&HZ M3P!$I'X22WCRB< I 178^ZM!#QFZ8*M[:V4ZB?+V.+?F1LS!1I. M9=NB59@ $A>EI:+'&$%_2UQK)PQC@CJT><0<-S00<4]@[USY$3=$.^*H '$* M(4ZQYI&Z(:20.M2R!$$APP33G, HN8 )YI;H]W% S8Z[G=;F]8!NV#'7<02; M)&#E+_Z*JA M*Y?O_>UYI*?Z**R&>@WUMDR]%U#6ZD.]68J]2Q-!ZFY4*G5PD'[[/!I[XSI7 ME>2QM]]0_:T6[%UC&W2V#:4GFM0&R:[9]&;3FTTO.X]M.\M=-J"D2TX]X3TA MV).)*$^:4%);'EH^%Q(S(77(AJSIR$UB^29&+MZVXOG\M'Y:M-J'&FY*1Y$Z-$8-/ M^D;L<19X6"P9P+\?.55&AJ*TDBKV3/P+%S5\CH>WTEC(.G%94G#I#PWN1",L M91#9Z_@&?:*UO5*^[=8WJI8#M*^JB#>YDC?48_\(X\D"9PC^P@/@5W@I1DYM M:A\UJ7VDBN)) *SN3)AK3/S0F<\0\M?\P[C#:_7@]=++VUJF+UA]FV1^MZ/F-NPVF[BE-[Z QC#N.+,1855 M_8A0@[#>1)2K,W*#K;[[(S _9JFVOO%L+C[K25*PZA3F%V M\@GFAKYL^+;X*TZV51EV&0OC\1A[S.5:QXE"#A;1$P,.%/;PD_X0?@%?N(SX M>(MU."\W%]Q(&8G*NYL,1L&R1A[ MXD0@2 M5O(\7ZE5O?JT"?/42/2$S2U?]#[X(-KL.!Y_]S&GF6#/$MT&.P-?J-R^I+H; M_I<#;]A8^VBQ<)37I:!G\7AH#.+(X,P:I8_W%'B:$8Y8P*GJ$5X=^[C=6.I8 MP5K'U_%2(G]592:JI[VX-HT$I]!X&OEHKP2UPE.<^$OV$-8FA0YU#C$G_=.36-;T%+#@5_>PB8AVX! T\$ZVX[*7-2 MY:ZLPS6!?I=W*<37NXRQJB(FTFS#' M!G)T:6L,\ AA=[UXW**=%P_G]KY7M..&'0>XVTBSW)LCZNF;['_QRYD69+6A M!PA3P*EG;UJ:#JK9!>L,+P3CF9ISJBU'=8/*1OPB[UB3U"DO/"=^5=RZ1+78 M/GQI(DXNL&4V'WNB8#^, ^I];/EPZ@%G<_8< B[2HOV"DQ /!47 N>;@8.%) MQ06J>(P(HKY9N9U]E>F#'\9.%'$.2AOVR 7)%OM["=P*KQ@W#(^=SD2YH)6U MC9(G)<)$SL&RU":U#'QTX+, &3#+D:@HP9[BF=:*0G7TM1@>(B,RFFSA-_NN M6W@!X3# 9!RVNWN#]R@& MM_PA=L7;=_O_:^9$*2)C_R3T0L ?'5BNC_-%+N>>+5Z#/\.4'))]RXU#>3"C M:):8: 596P'&((O+8!:+V$,25K:=$-R=Z0?8">)RP['_^YW3Z;[[2/O?Z8*K M*7KY3HWK)P]TTLB94 2(!Q&#[?O$/0[JT $'5/R=*/.->6# 8>\C^O&6NZ21 MJ(8?=#":K6]"Q;42R:EH[ 3MT=!W7?\))8=B8B+^F@L$1R,6T5'/@LV&O:J- MH[ZL]KU+.DH;+(Y&?N#\!Q@*O4XG#&/R1>EIA2F5LW;DT5=41>?YR^8@E2[H MQ9>WJ]H<-E?F?2'X(F>';A!N[#(5PP8O2PN\+"*+!5KPP9]%%VH0@&EX2Z I@TFGJ]%/^#[#:W]YD,NVJ@)2:!8_%RC4>C ME!JEU"BEQGU$]['$201\S!RO7"7$'N'\3V=*.-66.(]A',4!3Z(-97K3F;!0 MB=.P-IDHMH*UILOM/?[#35NV*M"Q[JW *D#"([/7Z>D@BOK#3"PV&IB%MCN&XP7_1P,V7H.'MK"F MO- OJI/FJ",77/W2;_B@X0,]M8'^QR79,$5CMCV J=I^/'"YMGP[-\6UG)AF M&?B@46-UX(>BDU?#"K5DA84G.!WXH3PTGGKCMQPW^"WYRUR]H6#F>X^^J02J MTJ5-0K 'W/6?C)!'5#R?7F:S/G%\;["'@).,P!-CQ&; (<*T2C 4A7$!U0_* FE"(0N ZH\\ MC*C$<.(_8?[9(_[7#*7P25&;'3!/5B02%P(K)- R8'UAX[ (&L9BL(V#D/\5 M$S5Q6(%V(J!.K!%^1M1E>R#5M"]Q6)&BJ73 C$Y+!=8)L;Z,!TAM$CMF66#* MJ9KLR0&I9Y.)"T*)&N'NXLP(8EW\4,',^R@'0I_ ]CF/ FPC6R@X!)V=Z&FY M&84;D6)5S M[P:$&Q*/Q4118E$[+=I4,]E2PG!Y9ODC[HKK@CB9L_Q^D.RJ\)^"W/:OR!7 M7H^X,)Z6^-B93W*[95S\L/B$%([%0HZZ'A4];G-,\"N3 -47_,-E3W1'CF8K MP(DL;12?:&\=_LC%&C.$,AP;D7&&3OJ5+#$F/H&V<"G!4FY1R(L%%ZE3C&T& MOT9C"].>-X'GL]/@9ILUQCR#G M-Q; X/ FTNQ &Z#+;=6#5C+A*,D..GK%#6UZ)MCNR4,P[:>,@.A0$-MDH:XW M7^UHVWR%!U5[!SCIQ5W?:F'Z%8$H(F*-;0=T'!W.G?X_Z+"K%<^V%!5'NB9< M-M1>+[5OA+.G*[F7U&";OQ?&@&_OYRS(4OA!!G>UN!":N7S),-2<.U;1N[!F MTS5(X]B\A]I0N1&M"F^Z5@;O/'??DC9IN):7#XT%U&/IS:;K(Z:Z)#(FC0[V MNN]UV#&=V'3E *5*0.KUS$X7DQ-/-%A4'4=>%R&[K>.%JRG^2/$:?]Z5BIY, M_XR]@T8AK(V/VN9A^\3L')=>5%;3D==6I]M:3,%-*X12_(-;?P!C&%>*9M G4TB-O8.529WXQ*LS24X-4_:/?/HH#DE[#8A M#UN+E?QK3PD;*!E;(@?]3_6?)2O(,G183S<,\97#-<2%\_HN9Q;6?&3B$]%= M,9S+>E+XHB(6E#?ERAB1YGG+CP<8/N($9XM1AV,ZEU"];4('O]0Y5@#N? M]5\X82T9O#BXN85X2DKHGO9D[IR:QST*6^XJF8L#5ENX5EM5CZUYW;T-ZJH% M:VMJVK=>TW[2U+1OL1[SU9T\#U0GSX-64K!.[3A1=X-'&.8:=-X'S N9)2OG M\"\JO\:X]&P^X?!?GL4KW[1SV:Z4V?T2);"!W$D9H#"Q6&_L1RJ>84D2J.IA M^5A%>U/NL??&>1RHDM(I9[ -R$-V05TD;@_\HS/35=BCRGI;(#K^<,:PN^[4 M^*ES2"@K]!;\<$R.*]:=3H!=G4=XQL3*P'&^$2UL.Q:FXH2&6+ NJI:]7-D] M_(CUCX0M241R13GBR!E3=6LA/$'QY/VG^8EGIGU:-.G(G\$0R,7#F.J]/#,Y MEKQDRG)V1_8YMM-2[1@]OPF;BDI)_)IE!3'\W778P'%E=36B.K"Q>%@L(,#> MJE0IRVW3\'QOWT$K #X>^'H,R2MTA1U3\W*;PZY7KT\X-J)^*S-39T%#D/_0 M/*)K^8-%Y;%#6=&=K^+^23)/]] \[I[FN8>JO"5-^0_$1>62AK+Z]^SBFMX^ MN[ZN'GVL.?JL2!YL&![8\R(K=_QD7EP+]I7(%BB%(PK.A0@G)*GGK^S/CJ^-]IW_V4Q]Y>SN O0U=R032LM 0)>(N3(07P+0$\ M$")+!;GTE3[TH?*A#UO&30+:TQ<6%?7-9P5^9)X7PVM#QV,>1?U#4!%"E-%H/3J<4)>*_HZ:XZ^8!:!AP*8- MP17T'@2B3#)O$!8?WD(514XSOAR#_I@2W\,6Q'#NP1_EV\F<0BS2J!97H&_QP?CIZ$0@06YSW"Z,VSM:Y[BZ;.IJ.D>%-&JG M>R0>3K'<#0DG*(P# NT2HBOV*9'T5113$OL/. M!T0T(X4M\4+K&$QX0%*!' M38*S:BS(:"6"F>(/X ,A5E,R:*&RHI-K0+A7\,[$#^BJ8> _\IJHE1(T2FV5 MR3W[44L5HK MGU+1T!=C:PWLKY> MQ\%UC6LZ*S<2_XS$V[$EK7 B\=ALR;%3B2^2<%,&PRCU"!_*Z(NL$3<;R6XD M>R-' LP8<:*(\\02W01\OT^MPH!5;WS7L1P9R;D)?(O;<5!9/7"?"7S;/GX) MVZ:A2^^$]&T1)X3M%>ZZI3:/ML?S#?+J71!UOL_4%D[4%@I-(7=0?&G*(P%[ MZH"!)U<>L4YQ&@.?!816G;GXLBBP!FK)=7@LT&OG)N*$*F!)IXUT)EQ"8#^H MN[\%(1.IIO V+.^(X!T7C28ZI"=!O6VQ0+U32TZ;U)*-*X(YE+45H^*3PWN1T^ M>)\H@:JM;5DW7*Z?KO]_;-VOWDX%T7)%E>+S)W,E61M(!S_8QLK[>, KLBDNO2 2>2!\65 2@T>RSK;X ME[&/:91O8(>2S6RGU:T'Q5]#V.OK:LBXTF4'W5K+>/=9&;_C5!$#W-!K[[I4 M=^LMU3E2JE_NJC1WVIW6Y=5=/>CYKT^W7\'/PL)IBQOGOA6+7K0[*(1(M[NS M?]:(;O?LA^_YXZEQ\2/B'I7^8(AXS-Y*R/(%\*S_M=Z$/&.N%8L"7"KQP':% MNR^?YQ>?ZTW6M5"U?6+_V/]6;JE\9@E)71TQO;B_J3= ;@8"SG/IM M8$6VG?MQV&YR/[3/_;B[_'+5O__M]N+NW?%E MM4I:*HM\DIZ4,?FMT]NSWZNTL[NTR?C%#VO$O =N]"W*2NN<'AR:,]4OU(#> MCMVI83'$.A(I>2))5G:U#V%NHEC8(:2_$7.'*O>6[EO% _3E@,<>@DK@!UD< MC?P ^'*;\ Q;1&[<##+G?,>@+83^ MI-87].JUM^(Z'&QGE-YV.D%U-S*,-OAW_4G@N$;GF!*F#LJ!POLT_5 T\++= MI#?4L^Z7\!BNLQ-[*Y]M'2P=*!K1$#KA6L,X%+-Z=EV:Y3WIP7YYSO7#,OIEWSF;GGGGOP MT_@E@-Y 1U\'("(B AX0$H"? S0!4A*"0']+,E)2,G(:BIJ"AHD> MPL1(S\@(8>5BA[!PLC R7A.XQLG-P\?'!V$7%!;D%>+BY>/].PD1*1D9.9B< MCIR9D9GW_RQ\%\! #L@#1R B?H"8@0C$0(3O!7@ @(B4Z-\"_D-$Q" 2 M4C(P.04E%:%#$SU 3 0"$1/63P @M$82V@$2!E)&/BD-,B8S1S#_(XAT=$81 MN.RSN/B$Q"1$9M:+[)S?^AM;NGMZ]_8'#H\]CXQ(_)J>F9V>65U;7UCGQ=TH60=GEZ]B_:/\F^]^!Q?R_R/X+[+^Y9@%J M$!'A\$ , !0XET"(-D[1SW:-VQED:,4&*#<3IYL; R:ZOXS,4"K3<;W'\,$J1T5J(4D]'_(7L98!A[=VPG M<^?;LJ&VM+MWRJH U&"\D!@A0L@W9-39%+@%QWPN#%V7VY+K\]X[F6L9.=SE 5AU,A$D!B7L G2=**VN+&QQ7S_ MJTR[@<@I?M6<6@DG1$E&J&*M*O+JXH[4?$]M\+ M[X#22FK<0@-6\$ /'F#Q'OT5Q3-%,W_Q^4M&9-[=0=-[^Y_!ZAYUW'':#PM$ M<*@E$[+?FGI8[D:?W8BRU\,L8T/[^4OK=]/Z:T-U5WB>M0>>=.XE;\>?_U%6 MN?@D^$1A9^YDPEV9H[R,!80J_O"&M2^<+A%U9$LC8&J;7".T-+N@W91=_)Q1 M*H9,1V/-A?,:NAR7I?NC*=):;[RV?6[^^ICR^V/I4Z,>46D=.NY7Q5W^9MJ0 MIR+%"* D),C?V5UN?2(90B^@+X#NL@0)(KL[E+ A*>V6V"?]AH6_])4]O_+9 M&D*4-47P0$YF\-8W$U!+YZ@#5].-QMW8O):9(:M6#TPR*$7LUOSI4]U5>_BY MU*]@/# SNYFX(.>9,NS.P5U1I-FR80,777OW\VUA&BSWQ03E)$_]1:I3:B6N M0CM0QT8<$U)\3GR/Z91RM1ZR,F_FX)]QC=,G?I M^J/%IL@L_?T?2E);17=2PCT"0M#;#!=J[<8PCXV.^TH:*AD2$^[[WU; COE3 M_5#:")!DKR2#GMGYYHWS_ZA>/DQB0Z"H[S\*E&&:1$3Y8684'IO(7SXA0 MN7"W@/0D6.YE+ \>T!FPF40\3K%YXU%^JR]/8;&!NXFF9,AYQ=LV:<+5.9,L M1>IP/BO],[J#$3?LL ?MO7?!6F/(?\\DX%C1M\PG.2RIR_7P%)W_4./,^L=9 M?&6Y9[!)6*7])W>_6/&;^R1FN#S<@F$O=@##SGR,J!%DA36::QEDO%P5RQ6H MZV8R\/KGA1U8I)_F%H_/,2JU0]XKUX%!36GKBF*L=)'Y15)YOZZH4#"9]<4M M\&6/@SENKG_+)RVQNE*D(^],IA?;&)E!]@3\+E"85 FK='-K M_)GQ^=)^Q2[7YRQ.&+H[5423GY8[?8P':'$-MYNP:YW4@4<4W*GEM_D4S_MT MV%4I*)W5/LQOV6>*K:*XDG?CX8T:6$J9=J:?J=J/'[L@;FM5GNZ:81!G&]^V MJ>9$)# NC)JRWOQ*AZX"O%-RBA_DRUIERA7$RD?;M)EA& 3,:'O.QBQ1#5?S M-9GK]V ':_Z%-:X&#SB*0 _!->FQK9.5!,L/9T'7V*NN7W[^XOJJBQ0M4_$+ M^ 5$ ]W+LBV?ZO;\@D^(:878)ON+MK;[-"=ZHH20*? MECX_I3Q2.T2JZZ9$^-Q#-?D3>2CEIW+'5?P6S2UY4[]$DS@PF@E'>L%[44Q> M]A0(5?4(.?0/%=72E_94QZT(:,/@/=$_Z:2Y)-'/Q495[B]SL?9W<+W6G!+_ MTCQ&O_TKN/V.DE)!KS5Q)^E&)_U,:/G &1Y(E/7@LI'=6B-/CWTNZ#B\FFY0 M.HK XV"7SV7Z:CLJ,(DC.RO-V8-)3W>=[RNK+YC8K 1Y!OLD(1D:%=-$>?W/^#TH1(C]EBUY!6/70E9C*U>P/I/6\P7-/(C4XRB1=9I M?E"1*O$ "-NZ:MZ$A?<\214P,38T33=_5=3HJ>4MXVMTP[GK+ \3(5 =>F#^ MXVU"7P%)0D]S%87'9K)IVEK;&LU[>UV2_'.+]J"]8QY.DQ([^:;(4KLMQO;) M QMF6O:G[$/@MZ)TM*%@R]$@G)P8*M&>;](I\1_YD 8QK5-S,G6NAHP=D8X< M]JY0PG;TSL(Q6\VR^TX(I1P-K8@'=:LP3*M+^47,K&(=>J.=,P[F!^I7._,S<4Z4= M=CP0:#H_FDX\+GOIKX[E2543P?FZ?$ :8+4OF\N /TQ<_.]X< M5:/[S<+-BXO&LL+&-@ZJ=R5N;B1=I@BCBKC(_VB'L\9'"+LO!T]%C3P2__P; M]F(V?_@?-MU<=K/HD]!=FP4J7$ QCM5T2D)6(=OQQZ9-W@RZGMI]W8@6*;7T M_2%Z_KLV\W52B)DZMS^V7#O7#J=?/3?'%U;SPR];%RX>JW"EW-J>>^R--?Y8 M,UFSK%QY6S^P>V>:J:>.PXXN@A2J'BFV-:"50=D:4_V/QA;B%+IB_>DCO/OL ML$!H3TN!:>O*O0 ]N_FMP6=S'919@N9,NY0.$^TWR\R_ ZOL-WBD5K_J:];: MT="@-[N]+>::J9U$74_R\\_#=S(36:,AJ$R?3@_)1)AO^;3?*KHM3ZKEZX<6 M1R'X["< V5VAZXW57-7Y2#)^<\Q6P-7-50HV1[O^A.EP^!K*!]E=.X#)PEG. M'!'NQ$N%N"#XV<%KPHV5VRN/C>"H#9VS?FT\"F,(@ @%'Y1.R\>#:E7O6<]F M;IV$^_<\>2._?W9?9X-&2:]@0R/^U3/W?+J#(U1!I]N<[_2B'\N'Q/=QD:%\C% M.$DV%01,M2P$NG;[ <_5!?*S3>'3I#^+","">J/4SCGS+K.+ MY7(PF;9=W_/EI6GU!Y?@60YZ42-7HE?SN,>MQKUM*-G@5_J@WUE<@ M>V25ISRL.2.D;%Z]QC^$J8<7A@_NF%I(N2TR_VHC=JGF)2>_UP MCG8L) HST/QHI.3:TGJV$L)X85/A9N6$<=O/<]HJ!_A W,!E@/^Z%6N9=0<> M2*=*/]M8_-R6-OZM@P@/#)'MC9PWX($MK>PW>RU7!IU]_N<4&GB@4-4C H0' M,JF642?N>& L232A>_%4E!!<=OX1!E\]/;H_],<6RWJ1CXR!_F&/O(@+SP[S M3^Q<6[M@P ,/AG?7Q";>.6CD2_::<,"[68OF]+V=@L0=S-[;JJH-RE./M1@A M-1:WP>%=XVXXC'>5YX$W2P=KY_AFMM4&AXU@FJV+JFW P^ SZHVLU>MI-7X+ MK-BWK\J'*LKCFQ@" KP9_4+BGM)^5M6!VAVC)'#9*T@P;@;:J$*Z@F2P#ZW? M'4(L&J)E!MB(GCH-U0'!.YLA#EZES\)/^E LN-AN-8[OM2H*Q] 6+UBC4NBY M$VL*!8MF ;GJW2CVE;I-K'L?(9#+X[D0EC^C+2OUFOKNN>"7Z:+/FV.$$523 MOG5Y8['QIGC ,@^5K>[#XQ'))%\&M_1='0,#!;I'DQ_:%FGM0AU63>(3>ND8 MO*($1H5]MJRM&YR4O9=']0J=A7$FG*NU-'+>U(?2#VLO9])=[5(NGSS6Y:G$M:TL1OLN8<&IU8&J%CU73F6;QWH9;HU6 MO/ZG[Q]08) ]-78XM'/%5A3_7GJOM[B:K\%B3\-G2=]ECGQ-?HQ$2<<"_,Z, M7,(J"L'-B<4#L7XJ'$NL2/O)IKKFWXRPP62_N&CWYZU/"9]@ !JN3XZYX@L= M-]NKC2X*?6W@_225Q1;'9!IRN]=6'P^(0]:<6^PNEVUX(&HWC)=,(#AWH\:T M&[X[ZP=-\D&"G[PW1/W!O!*&"L(IM%2F@Z5O$Y8]6X2K+QWEV[62XUO M;WX@84JSKO%@#7&L"%M^]=B6(\K!R&5*>.]ZDPG$:Q:5)C=H(^$K[GO(!CKB M-@=);2)?[44F">1;EU[ "%8NMS)R#C8D6/U8_9T>D0C5#[CL2@VRFI7A&C)C MB>,A"?%Q$WTK2_?9GN =J<:"A!K#)22+5P<_5B$U<.X[>8+V1,>0[WJ1U8V8 M*+\P:':@/05ASI#ESG,R6_BO,A3CWF+/&_ #V.4P'VO$UB*I'?URU&;>38- M$J9!+H_O/^ET]TR2@_SI<;L#,(G"NLCLUC6(MN4KJX84J1!%$]G(%)(F5/ESVG(U6X(B4%9L_XTDZD>U$Z8EM4 ?Q!3(T&6;14""EISSK"PSU%Q) MN L)""*6=V=+0.60Y&M"!A4D^P^5"'6W1S^]O_KC_F$ )E+\%(J?^1=02P,$ M% @ ]C615C^MZ^4$'@ _AX ! !I9V5N7S$P:VEM9SL_=SGGTPLY@5X(&:LJHR@(.# M [S%/@!F'E $\.YB#?>?-SX>'CXA*2$A 0'A Y)[1*24#Z@H*1Y04%#1,M-3 MT3#14% P<# PL;"RL;%1T7-R+PP[<(!1L(@KXE-KO"-A=J41#$@L(.9[7_:+6 M&8=SBKUW^T1$3$-+1\_PB(N;AY=/7.*)I)2TC.(+)665EZIJNGKZ!H9&QB:6 M5M8?;&SM[-T_>GAZ>?OXAGX."X^(C(I.2DY)34O/R,PJ+"HN^59:5E[QO;X! MVMC4W-+:U=W3V]<_,#@T\6=R:GIF]N_ M)Q;4_2+B$-.!4[]W&R>FX11??73R#[1_(?N_ _;I_PO9_P3VOW#- =CL89.' M2PZ @!M^*-6'2BV7+VPV]NF/J,NRZ\2^%QY9AA@C&(I%_"LD6>V'6SK2MIY3 M#Y6^TU^+-LZH$#+R@LB4>'';9LKDQKC9TVIND):1:8KI%[2 M4740KTYX9Y#6-,;BZE MK[8^.54; ^"(^]TOC^#6E7^JO$DV\BOXLM>\:>I]\PY#A_D2YF@L>+T>E*FZ-WB?>M18_\&#U O WOI7$-..(XUXH>S4Q4 M'3%PD_EZ3U>E)U^J&G \+GPZ^L'<:-!A/GC(=\K;)HG60#&')37+4?:E(=C- MM-*@,>"K?VG[DZ75ZN+[U:?1?RV$3B>]8#M@XI=9W")-KV?+DC;\!S)E[>,+ MB=)LIY7D&/(OJIB%WG_/,#J9-%C;=I;8U2X?BUL5LI*/YJGYU!7-\_7.?^=? M)B88@$WA#.A!%=FSQR#BEA+E>^&ZD_?TB;(1O>W/T/J5Q?=,DGR/)%8G$"7N M\0P#'RIYK]X=^$ADWY/_V"4##50W;SXOM8LFW6XV:3K6[ XBKZ=Z3J=/Y<+/ MT2///B$G5CQ8;H\ .SJSN!F=]O^^?]'LZVK!$SAI:(@!YDT$8^-W2Z\$9LUC MKXZ1AH48P(N9I%*2<,=3-'"2A8@V3\?N.B5MM3&SQY+NH@\\C1)<.R3KG3.Q MEWFTTAS6 4=SRG_VA(SE9^=V0TKIJ(\ZZP6W2FE[&(?I)&_#U=W^",/#F4G? M:=8[ZT;'^:@9V,RZ]=5D&WUHB2F+I6R5?+4=O>='W#4E]/U3;E0]4J5*/V?>WS0T/>G(-_?4YV3O.J4A9@FED^];!X*F(!/0+M%=2FQ1MHN]+8P=?X9'I8WU#]$ 3^&_O4C\P_]> MN+@IK:^;'#J"@_A^3YA&:*G%Z(=2< [)(TRJK863/T+^-K.WO2PEFMU03U.* M4U5;.$(CU&(TDX=_,#;#J$L#G(0$QY9,H6]K=C;XW.CM1J6&,]S&%_;^9CL/ MFSDGM.$4(Q$O;NX79ULER.MU5V3M"!R'EL7K?I)A-8G0/Y$/+10'5]HW7CIR M\VY+,7:D[CPOMF%63XXM*C_3ODWW2&BDMB!_+N@>__J(WWP=OK_:D0Q'O+(5 M^)5UY.^#X'1;^M20T".,AP%^#[_5NO6@%LR/E^,/\F'.S6NW>=J3PVGWD#/+ M_D%,"TQ#-[9!)OSA?5_B;0]Z__G&?@5#9TB:A$B?VW9GB27JD)M;:'$_":KI M[,%,D7HN:#=^W+9X.P2MD!Q*O#XS$*CNA7:.(F#<$HD>H-R/IB[S\UECZFD, M7^:B)^.HZBOB-PSU:9E\<;TO4D)^+I3(6>H2I;X?F1!W)O5N_M]^<+\:1[:JD:K[:5!W:/W=!X@W:+Z[H')E26%N^5W]E M:5XKN"-$B;)S9_=97U@LJ:"Y#DOM"G7VH/J)4"$U0/5:QHYW=.N\"E11D]6E M*M]PUQQ:RWP^'AU6PZ$;GJAPSI5\^!H#P*PP0$>8QN#6B_/L%%T:V^RC@>IS M\;#?Y;(5$1]5?XF__^[LL;"WYM*M14.H1RB>L]?Z9%'\3F /R-+ MFNU+W\+;BYJ.LB7CZJX3,UF^K^Y%G78V M^0ZD$14XUC2?2S@M:R<)"+15NY5>6CUO'/EVTN;\_54Y3-M"$CTQG_WZ=ZCT MVI.?HP&F6Z8+W/K.EA8"@9/D_2R0 @>ZVS\80,:L<4HLAOJH6W$[]FV\UA;X M.](T%5G]E2D?B62&E;AF]GIB ")]*V3+ZM07%Z<($\.4UKRG?$GN\G/D;771L281,EE*;SWR3Y;HA/G..7'QPUD)'4))<,O&V;5-58.8V4 M07NX:L=7(7)2.#R53L36I[-7K[Z-HT"LEV%[FU9?6)/XKN9-D9GK&KZ>X%Q[ MHP24HZ-U"(4OE.:BW[LKS8 M5RNNBAXMWXL=.;5/?\&Z=F8"L4/SGK!D\J3UF[9%S1102%Y *LZU_B[_>C*G MTUNIX.KGK4?_Z"SZ##W&WR"S7\^D-C6M/F*%0,H2IAOK\"ZJ_U48U4*E.SC0]:3YC>6(%4%^V"3G M68W5%K\>2(Q5=X=_,XC:W_6D*8HS2=:T\Z#28&QV16Y]WTPKQE\K8.V8>A%L M>"K;4/6+*H_C%1SO73I)G@_S8YEI:G[)0JD3NF^+A2;-4QZRY??2?<-&-A!) M.O:U=D0"]8/Y-A*[:!RDV!J(V8A4W=_7*:_G<]J[M*"OYY"7R9=O[@P:@*A$ MLIF.8C9''Q$GZ#RL&-;=KB1[ #8Q*Q<,K_-P?KBCHYMUD8^/_KWT:-PJ?K[' M[K;:'?(?MY%C_?9:E,D"M>MLJ("9L?69:8TE \IJ.%H^D8&(,JW<^C: MJW;;M<:#B)'URB?F"335Q68QD3G^?U>+Y&/Y"Q,[7L4'5*Y /@?*M<)5XJJ; MAK;5V[^HN!.!A$=<&.&0'^RIC^*,Z41K!SB*R$S.>6&99A<[,]M1)S/]HZ;Z M#?F.J7OW\5%96UKCF@R=Q79^H.YKZV)SX-MM#4'E1 M@HS& OK9"9?$U#5]>_*R,K94D-1.KUSJ+PNM7YF]UY^V&43RPLL#HZLD"OL, M'ZI-*X^+J\C> +%UX;\P]?K?3A)D]_>\0+8A)!G?9%.#(9FF[TS71K2EFG/:E4Y']J,=UY?N&9+%D1Y M3B)\-2<;# L#R$UL.3(]!UK.)5)=2UHW"QQN&!;GQ%3C^;-*Z 8&>\62;&W" M0G@4(-F==A\2H1J$+; C4\AT1ZNUC@SQE>)E\>O6L=!@@J/\JQG.G5/^A;,Z M\(+\QQK8JAT(#FT#P5!MQ.O\S4AE'&3O:GLWQR%[RZ1/@YP,WP7YY4PRQREU MMOS4Z?8A>W+WNOK=]+ ;T( ?I86E@*7-G3;NRVBXQ%+[:J2#*D27Y'WZK3*$L N+_1$U4WURI\USO/ MF=![K-\\V&; >:GTAB#4Z$^;E?=DOJ"&UKCX+Y-3X3E"!0Q G'W'H31>T)9DV1HAO]_._2)PT_^7LC2[XALZ3D)+XND,1X%Y\]RO6E MD#7T4*W1G2F7:F:Y*^N>HU,I^I7/Q=8BT]"6>;\$#@H7:C->NR%E7^*R'?DZ MLKRH/0@K<>'V87DJ):TGOXOT_1 484+45P_H"60U_W.U79\YZI&H9X?70 M4,1NU@6I_)3#P7NHTEP=>^$MT.L#.J3[BGK4B@%JRE'[X^D__::HRUFI+&UQ M:W=U?T%KOKZ"GX9\$/F.K\PD+K^4W?7]9N2 M5H=XV8_$3Z7P6P6'0RSRG^13RGF5/J\U\<[:97]-Q2O]$V5_C!)BC43.8R5$ MHN_I,];5-^-524\CWW/0S5ZGKY?$52.Z O1+7[\BYHQ%D!Y:D%$8X3N55G^\ M+NTAH]UO3#+>6WK8W-KTY5V1 P#.<&ICBMXJE__@@\P\^U%0O!(^1N=&UKS5 M^4(.S^L1(EA>;R_E M#6X+01LU, Q@?H(!.,R?=?JVAUY&8N-:0+=^I:<2Z]VWUNX&R'@FPQ,RA]OL MU?CU-7!#8F7&H:I.MZQ6&:3^T^V2C"$VO_5:J)06#+ _57DP=0-=CD Z^65P MMMP;M5,8/R:H$D;%!;KN_5*&>@.[8AA@1[GSI43"U=TW&&"&%JW<*7D1B@$H MAY>O#["+(Z]RY19Z6Z5CT<&_KQ4LL PO7]O /T;RR.&@V!$6( UG "M*F=Q M@9 \HQZF'"BHAA79%D9?:M43*TZDA4X4$\Y:&0YB "@(%=Y YFUQ-3/-7>*? M?Z,7- #NQ@ 7O1@@U])T14HD".L.=4CZ/_GM+UVF6F-[74QS*"+;@$)U M+QA&?ETUK&2)69C*U3*%/8P;7$Z,MMHB\LQ;$6/!3+"T?5IX8?980_6N]4ZOBQXEWZ1LW6?WFK=W.,M)$EH;3P\)P:?&_M+ M%PR$6$U4,Z)G0S03NM!,<8C^HK^5UU?JIG[\N77=C4WRM/#2;C(:9.N>U,'' MEH,57KB'N94-BKF[=20%X7HV7<-.'\70&XN8# MS=361K[K\.H")8[&>);'DT]6*-%*WLN'#*[PZ!ULGZ<'L=GC[PNR+;:3)W]S M0$\B:C4U:;X+#5IM\%=;M#=:%X4Q@7]YSDD?OYI/-A#TO/T^>=(T\CI(YG32 MF6.SZ.ZVY:P@!K !,9@;=[NE>X9POMXCL[0W+P[*N?W3)O+IF#?U8S;49JF'G5"?-+(KGL@SO"*0_W+8@.=Z$ M^LIG!SB7VWVQ^-MQXS,S$KM.3U!BIZ'DX*@F$HW0B@NR3;CBKP^::0N:;@L. MN+[ '.L:+6-;G3NGRN&DQ/$/JSZA(6+&QG1$C@*.M4Y OU#G(U="SKTJ,6I M;LV_/E<12EZK:,K%GRA\SSH,\#"F\WH- PQU2F&I0[J$I0ZVP_H=%_@%S+2# MR/^GKA,AH[=O,4#/Z0WZ!PC]&2RG/9QQH&W1QK\O'!QTJL:.K>N6S@Q(LNYQ M]/7P"BLJ*;)S_\AYBS^>.T&Q_-R#2MM\\/+=4NA$-)D:8/V?E'%^ACT3A5'[ M>Z?S2OX%-[H4'KD -N&T:(\PY\]KO2B",8D%%';BI/[5SNLKZFY/+*.(6.'- M;9+)">>)YO[RG-[B[V\+$&A7.@AL.=HY0+*7V66/> _M,\=8,S8+Z43U\E': MP9AF4E!:2.-5+3KCP3+SD=8W&XKL<":ROG;BNC8M9_+[MJP/0G)(_X[:VP:R M3+^+Z&R5--<2G*'JGB"7_>-0U/,:&$ M8K.EKR!?3JXVF,]3LOQ8KI*"N3E_3V2J_3.9B04<#/#T/364X)#W!)_R9N#@ M$>XT*[K=I1->%?A0!+N=!A@ ?3ME"@&0$[URP_FDR\I/UR4JW&7U*GHN?K#. M1?2]ZOT:&Y*M(X*YAMPHV-5 MVT1S>@>A*8( ^SFU;[L,[.,)!DS15XA+/V2,Q_UF.<:*A8;+>J%]2S986G=A M]'5+,@]QSN.+XS?1YA/4'*B:A6_.G.99? M O;W\F.#[A9/EN;W+%%'DN2W/ZUEW7>?C+X*W.M;Z_)J[&A*FK->*0[%;[OZ MXVH39?*Y0+9HSP*+C=$?Q!5A]Q69=6YW'5;QV;AX(%Z)!0T](#LA^67GN"T9 M)8X!A)E?='7*18>9][#,CN*\D]7;9MF"QME0.6M1\E2*[9#%+=.)+U,:L9(@ MW9SE)SMNHOJ!]<($DZNK]!S"BC>/OF7:2&R<^A>PFUU4 M6?-J[%CR:A;'L+".U\@IK&G(JM3'MJ6+\3U&[VTG!1'?TDX<%/TYSS:EBS@Z M+#2*6!$QEX0;KA+!/RM:S!2152[P$#:OX1P?F^]48K4M\T)B69FI4G>Z>SS% MTM-?XT:1#/E#-__Z;?YTFQ>H#6)Y6_ 3 X1!0:,80( R^N0@\$RBV]28Y0F[ M\!S+ZHU$T*!&"^A\;^K2_ISZ)/U@^@E*O1FF:/\24F]X%'W8C>*N#T$2RS2A M0HY!^S%8L>/JE(2&Q'DB_I.4YQ'8LOJBL7WK%G2+CU6^&H_Y?^M>64_&!^*= MPGS_ #"6L"#AKLB(6WD-5*]_UC^_]HZ#'3KA%7^V,$#Z8&>)JQ*+P/OQ\[A_ MD59!85>)H 1XL<[G.MW6O:;2I2X<.9,FMF1/,1>02 R$UH GP^[JM7^TTB2V M'[GZB1Z6X5J^(L.J[S([%"5V([O+PG"B%-[N7&6F+I%3^*Q*RMD>$=!Q'A:H MJWU0^+[VM^9.B8?HW[^#K@+!*L2TE@?X&OZR)RIK:9#UI[YK)*81HFQ,JQXG67MS8$9!QV<+$5@]\*E<2[HJ\!/ M4N-?F9506\GTLB5=+]'*6B;I*7/$E])+7%.NON%XA;T(V]B4=#/\K!-B?BSI M:I$[]+QF"\]-[#CK/)\$Y7#2%';(T1"^8S[?!QAMT_^\GGG*V^OD,\FO++PD MOT__U'K,\=LXKUD\6A=-)&*;;\@ V9EZ0]%LB[DUK.>!I]DI96L2T#APM>U"-@- X<$D6% >QW+L]4?S<_8SRK M8'EX#/J03V#VXVGNZ&@9]U>'$&/^&T%;QOK;'Q^Q]?Z=?]JYS=2' M-;+H]_DBT]*B1%G;X@];?6XFM(>!O MZ-$.@N_624?J,1/MN;4BYIE?D<+=@8Q*&HRJGR9#XO8Z0=M&UXA8:/6=:?7* M?-)0QZTJM37S%BEJ;V2,4<2KMHY)<1";X*I8,.>"!7,GGW^M*2W#Z_B!O:ZW MIS[EC#@!X/A)E/6[4J2@W&MVOXP2_=-W6NT<2^4SHTC_^+NNI<\X7?C%V-%[.L3>$3%K0HDN1>1@ M *U,L[0+L_<8I3]\V)SY7E5' M8XCN?%3/YUVA1(2 >-3,TO/Z.0TBJ?MA1,S*2OZW[C>B.UZ&R0M/VC_>^TXK M98[O [%(Z$UCG6^MR78CA5S:;_O'QG80';\C,RFHP0!>(U$&.8W5C_/""J"3VY03^ MK#2V\Z^ 'J),*\#D :6*XW(WHB^-K5*$3N_?!_']L"P3JG3ZL[@KD]MP\N/% M>-@2#D'=D?2W\IYM(V_F,"IM$Y9@;24JX!_784G1?D;Z+A5"C4R FRJ=Q R6 MSPZU!E:UU??'0=#PPNBH$LMT>C[NMF%Z/1_+Z=H?7 'J M:^A:=>D7UWZSR94O#]E%=NIK(0#^CUNA$BS/YSO5EQ.? M.]H;/3(TGT=C0%J+O0;U4NDHNPF!:72"NH83M-N;IM[7HH>,TL"D MOYK"Z75H6K7N=R3?_Y9OY>BZI!UR"746"/RHK<-#B7K1U-H,_Q(^1\F17:8Z MI[ BX>'(,&B;.%9$H0)-C=SFN*NMI%VW,6>04,D=+?B1\8;WY7E W;N+!SNK980G/,+VONQ=H@!IZO_>7CR_-[,@0) MG#.6$YL=?XX?&AG-!<.(F/%EIT#4X"3O\*[U;E^#9.^S$3U5\1.?Y]0#,!.> M@EB/F3#A(S2;J;C73)HG?#?D[N4$P!QZGR]N*]'#B[MK_]VIXZ_R-6\I7JB*A3'G729(WW03 M4#]?THJ\9R,CY]4DXY6U;).T0R:2OGPR2J6'@_G['U!+ P04 " #V-9%6 M>58V*UDL2 M6J&&-%(: ALII!+DL.VE,F0 E\2.;&$(<]V(<9ZY]O_I%M M;ZO+PO>V2'/?TTP7Z+,-\M]X<.Q[D_/Z7=#[0,A8K.H2N8:51*HQAUHQOH%H M/ WF,ZHT2D)\K]]I+47>@-)-@=]Z6?28D2")IZD+?VJEV;H9P>1'FKE@6Y4& MS4I4P'$/4I24CV 6S*=Q2I)H8HX,/YX#\WCZ<(ST?*\ZJ;="9!'_BCJU3IE, M@EF<_'3?TG;!J@ZOBYF$QH,FM& ;[DJVV>J1*:*T%'SC1X\/\?AJ5=YL=64&BO*O7N-IE$**>B_D3D$H9'7]GO^? M9E$O%>P9ME0!!<$1]EM1% T1>VXN86@4 MC#&<45!GL]SW9TQ*2W2[LMV>LG(I()-TM6N?H20);XD3Y+E$I2Z(!O9PZ)B! MF&=1P%BR)[R#1!O#5^3*P;LD\.=T?2.MRB?(%WK'L MX<#Y;%O6T+XESMA\(B#6<,:Z'*]XPA82[,$=M(@MVO%;\9\!4$L#!!0 ( M /8UD5:AW2>R)0< (DN . :6=E;E]E>#,Q,2YH=&WM6FU3&S<0_BLJ MG71@Q@XXE$G'=CU#@J&>)M"A?$C[I2/?K7TJNM-%TMFXO[[/ZL[V 28!@E/: M^D,VW6B_1V=TM6[O?-)M' M)BI2RKR(+$E/L2B/Y>.D^VV>QU=TMA0Q//A/,S33]N7?0_7#0/ MWPU.3MOBS\)Y-9IUQ/'9Z45;M/9R+[Q*R8F,IL*:5&8=\?[P_&1PVGS7/\:0 MUR\6#>>#DY]"RU:OF\^ELZ#FKX/?^Z6T4G+S^/#]X-UO[;MDM\5>?M41GJY\ M4VHUSMI6C1/?@6#GK4\\N>KYGFSUOLN& M+N\\F9;E/Y5=TQCA&,G65ON6+$Q0D?3*9,*,Q-O^V7]NU4N-@X8X):7%VT1F M#1&%Q<^$3Z1O_R.+3:4=JZR-65MK;O9RJ&G>-30VAM>Z7$;PY/9>9V0RWW3J M+VJ'Q:Y8P%3%/D'OWHLM[)O6N8QCS/UQ:R](MW/1";$_M5L'E=IXWE$*^/Y% M9\*['DE=*? F[URS>X7RY5+J9[S5:[WD_42LBJ^I>D(- Y'("0E+$T53A#Z? M*">.C4V!BN;/[#"#D_XI0.6GQEZZSL(>?-A/;\R]+:IC9['6Q\_^O&5KV,=7 M:S^I-]+A?!#$TIFXS,Q44SRF1GE@EG)CO8@-.ZU!(@/*;55*+D8S09(5)%1*6*L;-30Z.;&W+)V \@[ MX/+]V@%Y<>WTOOOVAU>MUQU70:ZB1QQDS @RVVPE'.Q#24@ 10*&86."P M!3DF&ZQ1RQQ;S].6M SAIB)HRS#1J'(X=RKD6]CBC%9QN&AQ MQ="I6$FK> &JI)&!.60LJ7!,[4*P=H$'AKQJ',$@CSS.DW+)6UYHR70 RPI& M+"DB9I2$L\Z3\=>0>" R-N93_&_(T.O.[T_C;4_I9,.O[&3W3JJW?.W^Z?C> M+@H[>%:W=N_H3J8L0YQEZ-!JA(E,3@,:MJ*P6W/P>>:O\NKK8"LZ$B<@Y MKBSIAJ;P=UMPG\PJ%Z.)Z]71Y^\@Q'!>"8?X0.5.P)X."]_XPS/TAWC]V::$ MVFW(\C5=59:%GI5^\8 ??AAI$O'[-B8==.:54BW8) C66R8US;3V"+/,< MQX '\.E;9>/".HG2T1OK%A0V-$!DFBKOB3[!)(8&))G[8P7[@I!MQ!DD;L?$ M /]S 3L/CO2Q4# _!,(BB\)]\,[F;FL3)#8765^DXE"CNL3 \"L,.!=?1D>* M$ (J)K^X4)J2O&1J7E:;@9R'.CD\3\[?:!X46*J[G_(R?P6UD#$F.EHPBSN# M4%5=8PHB"8#3*.L#A^+ %2F6#MB$Q52,;N5KUH;[/U?NO_Z;ID-0_)%%[FH MDQ0R+E =GKHK^#=*AJRRB=$38IJ_L&-Q'>G9^16:=%ZW1"O]E[MWQF$GBSB/(,G]#=GYT?] M\^:;LXN+L_? &+8BO(D\.KIT*>WMNMWE;_^ZNVAY?@']NM4U:Y^WH6\312/1 MOZ*HX.M#<5862"'A'U6UQ0WG?DCV^:6\*4?\O:6B\7BQ2ZG'B_A>,_PI!!\N M;_LKR3N/]M__5(H)2^-?BO?^!E!+ P04 " #V-9%6[O/F'T$# !$"P M#@ &EG96Y?97@S,C$N:'1MW59M;]HP$/XK-Z1.K42 @+I.(8M$(:716I@H MD[9]F4QR$&^)G=G.6O;K=PY0VJZMUI=MTCX0A;OS<\^=SX_CIR;/ C]%E@2^ MX2;#@"]0?,:+3MMMD--OKJS^"\<9R+C,41B(%3*#"92:BP6$@V%O4X M@=]<@(X:!)Z# MDCD373CM38;1R#D)CRCD8.?2,(F&QY6E%OC%!MT".6?1IW"%MD)VCGJGTD2L#9*BD40?CB.#J,I=-H-UV^NC7ZS".#9 M4V]Z4@M>BIDNNL^69?OCXEK&F+81U95J^^$8^JB(!H^9X5(\?\F_3^9=J73) M:-",A#.,+1UP._LMD'/HIZR@:'C5L?^F=CC!?6W?38KP7G [F&>&YE-#7R8( MN^1]WSAK]!L5QMY_MY?;C%$=1L@SVR-1A[C:SB7UA1DH_F1+ZU6@VW+>@L)" M*@-SJ2 :AB/B8\ZE^JHKBXV:8SRM]QZ]!NM=O *)QG MY#KG)JU6$>52<<.)07@14WD+)"IYSK6VET",W/W=9&]3Z6U)>K$!)I)5$VT0%U1)7AT12B@,XP*M&Q5R(L*X M(B:%0FUSUBD<6)8!+4#%J6YR%$1"U]?-$$S$UDY0":] ;3:**K,595F@JK+I M#6.IK_0*^B M?\X3D])K:Z=&\YQE!4L2"GQ3:U50:H.3HE5OS]U?YT@VCA5 9W^G>P>EJ\>J M%O0*1>?'/:@&L6.KI@LPJ1#OJFC;H"J4'NI^:K\)=#/TEMUY$HV-XW \&803 MYW \G8Y/:6JH%5IF/+G>L'NS7^^ACWG0U,VM%/E-LORUNA[)>BN<-V;] 1C] ME..HX\6/:R W+R]KRZ[W07W^!XA9!4K^Y$;_ 102P$" M% ,4 " #V-9%6##9E/UL7 "#'@$ $0 @ $ :6=E M;BTR,#(R,3(S,2YXZ;G$0 #/QP %0 M @ &*%P :6=E;BTR,#(R,3(S,5]C86PN>&UL4$L! A0#% M @ ]C615GW3 J70 *H-!@ 5 M " 4Q6 !I9V5N+3(P,C(Q,C,Q7VQA8BYX;6Q02P$"% ,4 M" #V-9%6]86/)4Y: 6# 4 %0 @ $HRP :6=E;BTR,#(R M,3(S,5]P&UL4$L! A0#% @ ]C615I02J!J=- $ OE!!X /X> 0 " ?=K @!I M9V5N7S$P:VEM9S#,Q,2YH=&U0 M2P$"% ,4 " #V-9%6[O/F'T$# !$"P #@ @ %NDP( D:6=E;E]E>#,R,2YH=&U02P4& L "P"U @ VY8" end

+%_Q)\5%\15(K:J+*Z21(:+XW)Y)!S*JK(J$8^B M<&Z+D:D*8EE&P\5TAP9Q1(5V!P7R",5W=91SW28Q@ 7["D5=V03F;XI;C-MF MH5>V4(:+[2Y6V-P#RMAPFMN,#$1V)?_K'.Q $*5,IG70 M9%BUZ,)F_%J(:3B\GBOC'&PA\/STC/DKB)^C91>SD]F+>61;/,+31C"SQ5&Y MO'Y%8)4$M_Y*^$B< O$I %>6IUY/]3A!4:V\)4+'4,/WW\%M4G8-30Z4R8%B MOP.ED")_2"Q6%P*3N$RRE'X49I M.3[K,$J%-.Q'&0Z_$7E0AL70!A?*A1N0Y(R'9P#B6_(%@H%P6>536+6.\L4H M(3861&133D0SBL52-LP4P*FMBQ]/ IX1K87:("HO>Y^.N>PA&)<0Q/\ZH(?_ M\<>]&ZYY]V[X]Z5?V[&057DN*?RH"N6Z"BE[1W$$2M>AJK+8BJSY\GX8J2K' ML&:HJ[.\&OQXU$<!$D6FE^QNC;)1K34U)H8 M5'A]86ZL,S56J3YU7L+(].E^D^JSVF34^JRR2O79K8A1;U.[ME[1IS,%9U,^ MA?EE0]E]RQ>BU\449W&^BV+,D^\&P7[N!PFY0GU M=I^&]UF]:)VI;[&JC1/^K!!3V8"/DB"]WM_3O5@IKU%6 <#3N:$-8A8$T0LQ MJ*XC.(^2IWB5!$7R$@0;/]F(Z@PPGIKNVJ%%&':6L=?C>QKFUU-\$Z(8)JE# M!,"-:(HUVUJ$$(O]^AMZQXEQ$*0R"M) ^!F G%S&(O5CP.H=*H$8C30_2GRL M#!R5S$N!XAL9?NJIET-"H))[*9"JD02HGGPYY11-(3&G%!+S',%T/R [A#R+ MB-/81D([#WQ2.RD<4C%&>0!R^4U$U:6JU@G@"&TW!NHW!-F?_5Q29L:HG? M@ZV[S\MKWD$_]/RM&]R$7_!L?7P!P0[\BJ?NLV#3[]GM"%!5M>EZ2FHVRZ,5 M\_\/N/#Q)=($>M';J6)="&C66=^>9_QAP:&K:W\G#7,FHEG7?VNNKZ-$8-AT M[.Z48-$K%]L MF(-;#4)K83G$M1[]\0!5[[_HZVN *4=VNA XK0N!JXGHN?]$ MZU.-Y$KA.$7&3K52W(@N(8Y69.S]2*\GJM$XXB65U=:J%90E@.&+O2I+7]R- M=(+Q*4:Q-/('E!",LAR&4Y3U03*BA:XW+.7%[.-(%S.R%A..)99AI955"UB5 M=<.YXI09J450:S>*98HU5#C*KBU+6G.0!U?WB):@UBHO+SD_C'3)X;U#=K$O M_T:\(+7IPZKEJHU@0Z2E=\11-L-8;4>QJ+4?C + :LO>CU8",Z+E;P!PR@OD MYZD6R7%KD6B=$-]W+9+/(U7E&%:/;K5(SE0<_4:2&E]FKD&ZZGP,"TYWO5<6H/.1+D#3JQI" MH8K52F\9#LRYCU $]R1V01B,SVYJ7M:J]N[N-W%"L MTVH;\\ID^[(J*JRR7.BN6Q L1WQB]A!?07ZX!<0B$ *+;VTNQXH4DYK7. M]_14]"V4HE"VSHC+J>@<5N@/9LRU&SR[$.Y69J75V]DPG#FL%RK_<2KTI[/0 MW]F[SSI7X$<0_E<2^,(EM];&_*#D'$S+"VR-YYY'::[IL-E$8?J(>.V]]-D: M B \EV6[KC*]>:7+[;46XA1X:#V@/0 OSVJ@WU?#08'.!OTKB%'H7>OI[3^C M 'X-0 I9]0*SUB5-[!,T@ <\M6GF.1>DJG/V:NXK6U0MU LQG* M-V$,\"R-K[YM08@$]EBCH0V*Y_%>3U4VF=_P-70W$8S]O\%2, >8CG$FJ46X M*$A#8[W&@!0=1O=8O%3&Y1V 'OZ%NQ869%?OPUKLQ&+1*#.=VT=>9IA^F+-M M-%K9H&$FXX;SBJMPYS4X]JDC$R /^MNX%+8EFP1<+P&PO7!%E-:JBIJ(@*@Z! M12AQ9:!@:(U-R? '2_I DAM\#?%G'I_3CW/V&QF1#=I6D8-J7&LXR^\ _!GL M[_*:3AP-UQO9HM$ZWU2#6L_4:;W"![!U(68IG2./4>P&17$LWBVIE,P6+_N= G6\_!_XE'F >$QT%"J$!G RB*HE#5=SN\I=08/ T6MFBT ;CAFL^5<^3U"-_C7O!ZUD(D')9 M(":I#:BH2S/(:P5IX79LH163*RR\+Q*35(G2!@24A3'\MD$I6@L?SGULX&5W MC?< ;@#2SQ8KA-2KI-YOTR_W&^#V?U MJKR'#C@/#$Z5=Z?*NR.MO#L5[=!\?_5]%^W0>E*9BG9,-6+'4;U#4"-V'&?S MJ4;L"-[CG&K$RFK$'O4]SBE#5[,WBA[9A)E)]4;FCZUM$O?KW _A5)JR;HUY M =U,3Y#(L$DK_!^:Y*[%-#NVN-F;(91LTG@;]#L@C@NP MG.T =-?@MRC O9$+/A)P*#B]'I$'\Y-/_8Q\1+68?0=5JZ3W/OKS&@)0#G8] MTMAC?_I['7)L;9A-^$NY?Y(+^*0B($E4\/"<(H^K";S;0W[3MK$UD!KJ:8CF MW>3%>"C[R<];^LF=LW\6$AV)[W,6W^_;\GT^"-^\TM J#P=^J(N0=^:DO3GE M[J:G J<+"YLN+%K ,SW#H/<9!E-Y/M,S##S)#/N@IV<8U)YA..H=CL2]M%BM M?$]070BWJ34Q;W7+JPLUN1XBR4VBVKD/L9DN*$N(&]7;6*+<.MO]4LUX$>QW MLW#Y"P@!=(-?W=!=2XI@"=K;H%:)"(,DD%U>+? '?[L3U]&K-;)%F76^^R6$ M]=X=,SS)ZGX-@+26!;NU>=4KGQG8 @Q14TQ>L$DI#[]]-S:@T4VRD1H]*B[0-TF4 (A&5D!#0V 240PVRYL<46$/]>N+XER2O2#8G3 MW"(H.!+4"X<=QWU^#Y8 ;-ST10"P GA$+-,<"&RQI'\^I[51T1Q_S/-C%2?O MQZ:3EW["*;[AI)T[;IC_+?^,DW]G\OY.WM\3]?X64N39*-EL$SI[!216^78% MVWXXC,ASVQ\+&X+MIYLLO3=9=EZ8 MC&3Y&_(FRU3H_G23I7:3==0 _A;X?;H/M@]8XG@RX6>41Y):C6$YL7M]M1K%<'HJ$WG"?0ZVM['Y8]?W,:FM;=,T5 M@"K7T,UK/@849P$US$1$-B"B(@<%1FO%Z6OP!!,7[A'S!._0^^S_^IW#X MR\G,:UWAJ5ZY&%3IW6VI<0F.%NB4R4%UK+?4\VT(_N/9WK90M M([)"VS(AJ+JUEG=./_KX[$/ZP18*%Y+9HW*A&%3I6DL]_U<2@@>PPY\"(&RC M=A5"*Q2O(D@_WP!OO"?K!)%S[JZ=YA7HK%"\@AQ4[YK?6]_&:?_I;&LY[%6) MK4! 51@*@];CZQQXV;?3KSVTG07JY%9 H2X.!4/K"99:LX\O4?FS^)]*MCR? MS KER\6@2M?ZZ%%JTV:?NHX2V$;Q:J16*%]-% J UA-L9G-E,\[_UD;_2I16 MJ%])$JI]S4?9??5S:@-?3&2%SF5"4'7K/O3]$NWRC[>R>>1D5NA>+D;I:E:_U4^V^OJ) M0Z9Y15HKU*\H"\5 ZP$X>PED%B[OH+_S [ &:+%Z? ;M[D](5YUZ,H\/.]:B M#$\GP2A80]SR5K]XEV";V45@ML:[5_HPD\IEKVH?-@#44B0*C:%$W9MP!Y"H M9$G>L-[./!+R: <.ZU3CANZ":P/#A0N8AN MTZ*/=P"F-]>","M%>O,(*><; MJHHT1"V)+$Y@L:J\2H:> X 0?;#J\%85;Q5KUX<-R'00JU<)"7G\RG4$\=*Z M\SW @X'7V!9]\_CO5%J-=E&&X!N8/1SE^"Y<7^4+2HU:+"[L!"%*0R46MIT*C$ MK&K-URTM;$/"NA>K1IV,O&K1W"=\ADLY8OUZMQ#.?@+G6&MU[GY)B(2+5<;9 M0Q0L2^SR'%EB&EMPD8B1:UNK#Q?/80^ );K&'-/G<_,838ZNA12V:%HH1*[G M;AY:#55(,!/9A)PGD.0P .A'RVQ,E*=G*4#\ 7BX*:DU"$<%:?H5[54]ZY09(77U#GNAI&)DIYYL0*BS[O].GA;(Y2NH!1DD88V-_XR<;_L!7(+4!%'5I*%3=W N:W?[9SC=+ MXN<(^G\#UC1A^L:;=!:!)!.%(M3-U]#?4G<#>FBHGMPRT_,F+)73$=CEK7JQ M"+UV@E$LM?H2RM_+_BZ\D*DVM$'5/-ZI-@?Q%>"U,^&Z/^N-;-%BG6^J04-> M@.K2EQ4SR"(Y5%?^*HT-,"B(T:\:'R^("&SS:(MT^MQ!W^/=J;";VJ!# MO/Q=^Y2:.JW5Y##/?G=?+D@4A/(ZD36V0?,B_@V_$WZUV0;1'H +$&+5I?%V M[,>"^;"TZ,(BL%I(12$T%F?%NA-H7()E/P#XE[Q;DF*8=NO/(G"[BDB1UGIS M7[:#KR-((H^4;?Y:>QL@D(A 5:SU'I[I%F1=1V2N+W9C6Y3+XY]J5NM)M7Q\ MRYWI;8,*VW5A"PKMI*+8=#OW:C;#J-?W'LMYAWG%HKIK9;N,1VT#<*T$HIAI MS8BB'SM\B%YR<&\81!0V*%TJA.$"T,3)?GA]; Z0!_VMV"06D-B B%P*"HG6 ML_>M_U?B+U.C^F!YB?5-Z.1D-NA<31*J]U$F'FK2!\F( M"N'WAN4(3Z5QC&"Z]PJSR>N-S%M0LF%4-G/KW/>+A>V_9S/=^C/"8Y8;=+$_ M-+ES]^F0(N4EOD3A(K7+K[#9'N\/XJ-%$J/8#9=^N,Y"2 26P%&^;GZ J%L: M1U%(KPSK,0ZY7\B4$L77#?G-[WMX%6H8(C&FUR2/TUVN M#Z/SZ"6\CQ)R817M?+)#\GSMG7NS >%> O;*/1_C@D"O&8Z[))2^:L.0.8HB M>J75CW-H;7V8=B-RR0S\W>]]>)54T:N>@+D!EHE6MLY^!R1>$BQG.P#==5&C M@A?9V%>];1GX'H9<6YWT2J4??NPAB9RI[89NPBS3=J#QIY.)4QJ#.O4R1)$! MT1?[V>%:>K9A*&@3UG!Q@[Y#F0IM>JEIR8<-0\R0:@Q?I6@0M[ @C8_)EIQ\ M7Z.RI7(:WG3S,0A%I&TY".&'MD$(SMD4AC"%(9Q"&,*U'[JAY[N!:BP"E\"J M@ 2N%(:OP--\[A6 :8Y/6B,0GWH7*P:[Z!&S@=B_DEV;Z_W***(?)..X!K]> M!1@."K9OS(PH/,/Z\4W%%I:=[D'6+$LZ)"*F(/DN-= M_M([92C>?9]0O*M#82CT/'^%/6=M =/*"B4O-7\1E5.:1U2]M*!4&+.1+4S^ M*B?4P]U\_EMF(J9(7'EWM@,JEW"(4!/ZF8/+@3R@)%D:ZXUM4+V(_WH^S(.GY]4!CGA#/%!7>L^B^1X;9\Y(:&Q 04&,^F'O2&>2$O2" M9/+/C1,(H7-RPBF%?#IMG-1I8[J['=7AP[Y[N)$<+?+E-GQ7UY*MMR^OF1_\,M#LR/V30\AI!_!(G[3W*1 MGC@B_09(8EWU"2O) -+^-=M&D'8%#/&J?%].OX8[M:%1E.H?X&,VC(PAY1]Y MWOQ4L\&^/:QMS09#CPU,-1ML'H,#U&R8M#RBT?E*O5U\?Y&IYK;OLQ?:"R7-D'0:C2"U^&L=A85I&CC^_4@F.GTD93>.P4 M'CN%QTZACE-X[!0>.X7'GFQX+--SEEV)SI+X.8+^WV#Y%1MAL&1AW0582Q?[ MBD_LGAQ*Q3O+(!^S:E<:1 .&"Z_UD*DID6R1&N1CH]C?!IR)^@8A7X>E$F[3 M(&S_L1%MF%8/Q/*>^W&L>^Z4DM(])47O _T/7BQ T> =R<_5,J17OI;OW8#3)3^QX@ '?IT\W7 M28PM&UK%EC\7.G1E'C?UIUS:2U=W;Q_'@+WWT9_H*V8 8L,SC'V@9,:>U\W8 MM!NGTL]DS$[&[(D:LY<1'NC$$4MT2X;^Q9[<-XMM6R&15::N4!+#IEB#-\*9 MS"X3$HW")E88<3*0RC(9#MS3#=*(+&FM0!WAB=+I8-_I8&]JYGRG!WM3P9W? M]\%^K&&,EQ L_;BQ;LI"&B5DYD^7"MMB?>\0BS1(Y.*#&X![L -A KZ 6.Q_ M838UKV@%]PN3\T$"$&>>%R5A? \\X._(/B14*;>U#5KE,D\5J[6N2&-:H#ML M&>"?N&O>9:J8Q+R*U:Y.Q5*8\3/=A/BOX-']5CB86'ZE]W6_4D;FI'2E]Z,H MZX,RR,SB_Z#$X93$/[FZ3L/5]2MPR4 G7-V$VR26^[GX%%8=^_AB&/9PL1B3 MG4]$-*,X&LJ&F0(X(_%MZ85G1$=);1 =P:O%L0BQX8E-(S_P4\MHL2KM^4*C M6X'.O&TH'WAE&U%!)+K.&;IK+CBJLEK\^.H;B?<$%R#$RHYG\37 [+H!6=P3 MS,W^0(]7>_[T.<,GR0]7_)HM&@7_A>62R\]])3AP_FLAR/SEDR.6UMP$3 _A#Y&9>D6BHD MQO$U<$FPUAQ ?Y=&,MWZ[A.&/][S'8D*I+;H7$V:7N\;:=C+8@ !BG.K)5VN M11L7J[4-> @%,/N2$&?GQ#\@::M^B$>2YXL>'E/NP"J@%&7J]1(/;U_8;%TO M7JSF/M[&(/X2WKD"S/CR,;J.(/#7X94+29(E=[-HT8$-H+25R>RS-+]@F=%M MA!! "VQ/D-&2^.B92(C9!T\"HTV!U :\U*4QG'&#ISD$V 2<@^S/F["Y1\K6 M/K4.+()-62;#:0V<-?KRF60%$Z;Q.@'Q^N!^F^$A&"-2>#RK2A($T8LXST%' MWW9!WEM<.AI,>T6J#C %B.L$-N)6EZ'QY(NI>(&B@$WY.OZCVG7\^9%"!MZS M>/RDQN/[*61@"ADXA9"!7T"TAN[VV??PJ(^A_Y2D2A8AHK H;$ EB.'" MS9KL;EI,-8K@ ?F 4P)I) $$^F$:41"!5JC,!1+D5Z&D#"U9%(3! YRVYFU# ME8%6]IMP!.D7)L!1\-<0XO/#.B35FPY7*$5-,(ZJI53FE:[FHI(*8K86*IL] M1(_[),L=+P*8T6LL_F6"#WQAG+UMBEO?1W]5 <%5^!><0JMUN>KM+ACJ\69DMB BER*^MV^*5^)L'C'#VK^B%+5 MC@%\)Z1 BI]%TF"#HG(5)L@/^;'.>JD;QPV73J6C81-&Y!(P$T@^=Q.!9)08 M$8+E=OO4>,M248AA_'!R(43SX5.C)J.B,,-.D(?D"8&_$LS$U8YPHB))HRS/ MH1,GZV4JRC.Y'4_4[5A(<1FX""U6:7R8Y%DX/HE53D>!'(:OQ3!EW[3JNG52&7Y E3)!Z_V Y3Z ?KK/+VHQI2;ZB"JT-F+40 MIU11X 2T3NR^_!-GL\%F]9]X $0'EXS%RZZ#E_-#Q J70 *H-!@ 5 :6=E;BTR,#(R,3(S,5]L86(N M>&UL[+U[;^0XEB?Z_P7N=^"M'6"Z 6=7O!^-G5TXTW:-=[/2AM-9O7,+%P.& M1-F:CI \DL*9[D]_^9 4>I 4J9!(NG8QF*[,#)ZC<\2?#LG#\_BO__W'80]> M49*&?CND'F'IA^!-(,QCYD/I3__] MO_W?_]=__7\^?/A?'Q\^@ZO8.QY0E(%/"8(9\L'W,'L&Y*=?89JAY,.'?/1O M[#E_!;._S/\RV93__A&FF"J.* W^<5K^+GZ?KGV>3V;P< M]#4.LN\P00 FWG.8(2\[)G /?)2&3Q' @@.FT%_!Y3][X.H9)@?XDJ #C(A2 MX/(U^TO)ZU/\\I:$3\\9^)/W9T > VX_?+E^!!^/:1BA- 5?X_V1B))>@-O( M^PNXW._! Z%(P0-*4?**_)S=/HS^_E?R/SNL'\ O.DK_^B,-_^6GYRQ[^>O/ M/W___OTOW^=_B9,GK,]D^O/_^O7S5^\9R_4AC,@+]]!/!17APJ.;;K?;G^FO MQ=#6R!^[9%\\8_YS(0X>GH9_3>GC/L<>?;D*9$ X@OSM0S'L _FG#]/9A_GT M+S]2_R?\-@!@[R.)]^@!!8 *_=?L[04C*@T/+WLB$OVWYP0%?%'V2?(SH?\Y M0D\$:.0Q6_*8Z8H\YK_D__P9[M#^)T!&?GNX%6JUK?'*B7Y6%%6/^3U*PMB_ MCHJG#*1HDZVJ\(,^_FL&DZS7*V_3&U;@,<[@OI?H54K#0G]!_=[VB<[T6\96 M'_5[RQ7*$83.V@)KOUK>.]V3?_J,_U03$/W(4.0COQ"1,)!87,J?&G;*N>0= M>S6N>V*[XZ2M=XJY4HXI\O[R%+_^[*.0+)LS\HJQ+_\Q/G]Y[I 9-QE4DB%E^ .Q?(1/WLQ7N!>L@_[JDD,DOC ?6BN M<\SY\=_WNY*>O13\"*Z8M4$)2N-CXB&M^:C**GI#N3R'/1Y!=E$H^O#MZT__ MC8X!OQ>C_K__^O.)R^A3?!UE8?;V@)Y"\O0H^P(/B*,'?YB9"9>)6,P[;XP# MTR\1JXD"-A2A5JUQ)M$@$+(.A\8@9_# METL B'PPH*,!'FX4$L4)[A%SY.A3_]D, '@B%?->_:(TYSE\HA,QAB= MVDO\6)\\^F8/GSC"-WXW,[E"P0X@1T4^@7TA1(!2@8(, M,#H+&/IZ@/M]X1\7ZMD891(O7 'K**D-<08;/*D$B*!#RUL*&RAXQIC\%!]> M8"0^3=8'&<4 1[P&!"HCW$% 6R@1 ,A(D ^U,/_7!Y0\A='3+TG\/7ON H)@ MM$E$2 6N0X,[U!F,R*03@*4@ 8S&(FSR_= #>HF3#$OT-8/94;R*B(8;]4I) M16XXI[ACG8&.5#R1JRK?P99$@%%9\5B55Z"" XY@G%D?%E?(IC.K-L@!@,CD M$KJWV&";!QIZWOZ$G_T4)^+EIS'*I/7@"E@W&K4A#D!!+)7 1-"AH!AKQ3"P M\S7#XPW^-]Z2(AEKUD (A6T:B=9 !]#1)9O06.0ND-QF4!*+4"&>@5$;: M@$E+4#Y(RF'.0:0I61= J(_,/#SR'5)\.,31URSV_O[U&>*7\ UG MC$G\<(2KPZ4RP!ETM&42@($-!'2DE:7G,HJ.<,].4A*[61]F=M'AB=A<<:IC M'$"!1"SA6L/&YH=:.\$7"8S2D 1B=^*A/=1P4(9 U%: 1F.<0]@0B"8.W"C' MV\#(Z03VY7C82>[GJD-,GVKKHK6/M.QW!S @$$ERF 5LH(4YOXV\.,%XHQD: MQ-&&/L7'*$OP%L@7AW!V4)E$AI("=;!(29S!CXJ4 DC52*G[%(&<&!!J"SA[ MA#]N?6SHPB!DV4 =AD8XWB2V.H2NHTHPV!D\R>43( D3@3J535.5(1+:'KZB M*YC!_)Y \OWPAYLU3C*1FU:)-]89^$C%$]JADH;XZV%QMV,!/)>^C]])FO_G MP,M/0 M/N@>_"ZY3^+7,/+$!RO1< M($8C,A4MCK&N8X8O7 1QV;,+(*<^3C.X M_W_#%^FAG#_8 G*XXG)Q4QOI&FIXPG5@AI$ 3&/^G$T,W66"H C]9\-I5]P M1"I3+BJ_.3#S''%:J15TIO$8\W-+2JCL[Y_C2.R?;0\Q,\]&)[HN5&.: MV8_N3')-'M$4DT'@UA]PA@.8[JB@Q_3#$X0O;)K1/DN+?SG-=_X/_TY/#>1& M]RZX"2,8>2%>:F)VLRNH@:-'.CY*^JA" *1#1^;RWQ?>Q-O-+4*LO\3MZCM1 M&N]#G]8G_ CWI+H>29E"V9!!A6]T]) 5FLX"QN IBIH"VJ4$'P$)6D>$O\[H[:-M,LTQ5NSC@UY M;SJ9;!U CDZUU>J-CG4!#'IRB!(K66-/8$ C;ADAC M()V-U7** A?LBX*(H@)'3@#G$TR?+R.?_(Z/ MHC.7(JTY8&DI4P6:$B&=U>D<3I8N *^'R"T@8EK;=LOS2%1OBC6YRYY1\H \ MA'7!A\OT"\KX 9*:M ;MFHXR-3NG0LA6H6"]"%SP&_00N;5PYBQH XJ8, ') MBKO=!HFVXT;.W*Q9$V ME"/%,#"U2^GGRIFF#XG0V[*/!PYDDW?,)\R?1.9ZS9S7\A_Y++